{"generated": "2026-02-16T21:44:51.514722", "total_unmatched": 109, "total_with_suggestions": 75, "items": [{"id": "roche_roche_ebbc09a1", "company": "roche", "gong_entity": "Roche", "gong_parent": "Roche R&D", "entity_type": "business_unit", "team_size": "100,000", "confidence": "high", "mention_count": 10, "snippet": "that's not necessarily the way that Roche does things and it's typically like an annual payment", "snippet_date": "2025-11-12", "person_name": "Ana Alba; Bernardo Antunes; Gaius Augustus", "person_email": "ana.alba.aa1@roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internal_name": "Jacqueline McCoskey; Walid Habboub", "internal_email": "jacqueline@biorender.com; walid@biorender.com", "llm_suggested_match": {"manual_node_id": "roche-rd", "manual_node_name": "Roche Research & Development", "manual_node_path": "Roche Research & Development", "confidence": "high", "reasoning": "Exact match for the top-level Roche organization, representing the overall company in R&D context"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=1868065fa493e4cfb6243991ca30b4cebb116c52362d631f9d2ce7c6f2f35716", "call_id": "2025-11-12_1868065fa493", "call_count": 10, "all_snippets": [{"quote": "that's not necessarily the way that Roche does things and it's typically like an annual payment", "date": "2025-11-12", "callId": "2025-11-12_1868065fa493", "gongUrl": "https://app.gong.io/call?id=1868065fa493e4cfb6243991ca30b4cebb116c52362d631f9d2ce7c6f2f35716", "speakerId": "2746603587780253604", "customerName": "Ana Alba; Bernardo Antunes; Gaius Augustus", "internalName": "Jacqueline McCoskey; Walid Habboub", "customerEmail": "ana.alba.aa1@roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com; walid@biorender.com", "sizeMentions": [], "contextBefore": "...ries.\n[Speaker 2746603587780253604]: No worries at all.\n[Speaker 2746603587780253604]: Thanks for joining.\n[Speaker 2746603587780253604]: We were literally just about to jump in.\n[Speaker 2746603587780253604]: And what I was mentioning before is thanks so much for doing this last minute.\n[Speaker 2746603587780253604]: I know it's last, we're down to the wire.\n[Speaker 2746603587780253604]: So we've been trying to act with urgency on our side.\n[Speaker 2746603587780253604]: So appreciate you all working with urgency on your side as well.\n[Speaker 2746603587780253604]: So we have a couple updates for you.\n[Speaker 2746603587780253604]: I think the very first one we wanted to start with was something I chatted with Gaius earlier this week about payment terms.\n[Speaker 2746603587780253604]: So historically our multi year deals have been that the payment is made at the time of the contract being signed.\n[Speaker 2746603587780253604]: When I was chatting with qual, they were mentioning that ", "contextAfter": ".\n[Speaker 2746603587780253604]: So good news is that we did get the go ahead to be able to have the multi year licensing payment made on an annual basis.\n[Speaker 2746603587780253604]: I know this was your expectation and it wasn't necessarily in our proposal.\n[Speaker 2746603587780253604]: So we did get confirmation that we could do that.\n[Speaker 2746603587780253604]: I think we just have to figure out timing of when the payments would be made, so we can bring this back to our team, but just want to let you know that was.\n[Speaker 6443918410349858226]: Jacqueline, sorry, I can speak to that.\n[Speaker 6443918410349858226]: Yeah, feel free.\n[Speaker 6443918410349858226]: Yeah.\n[Speaker 6443918410349858226]: So part of, the net terms are 60 days.\n[Speaker 6443918410349858226]: So we would treat this like it's two separate one year terms.\n[Speaker 6443918410349858226]: So it would be 60 days for year one from the start date.\n[Speaker 6443918410349858226]: And then there would be another...", "callTitle": "BioRender | Roche"}, {"quote": "So with Roche, you have a net 60 day payment terms.", "date": "2025-11-10", "callId": "2025-11-10_7d151cc88026", "gongUrl": "https://app.gong.io/call?id=7d151cc880268b07ede63bd96137b1540daf90597316865e06249061c9141fcf", "speakerId": "2104112913139912675", "customerName": "Gaius Augustus", "internalName": "Jacqueline McCoskey", "customerEmail": "gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "....\n[Speaker 2104112913139912675]: appreciate it.\n[Speaker 2104112913139912675]: I just wanted to run a couple things by you.\n[Speaker 2104112913139912675]: I know that Ana was looped in later.\n[Speaker 2104112913139912675]: So given the time crunch, I just wanted to kind of get your thoughts on some things to bring back.\n[Speaker 8945427492254429281]: Yeah.\n[Speaker 2104112913139912675]: Our team.\n[Speaker 2104112913139912675]: So, one of the things that I was thinking about, I know that you had mentioned year one being like the main thing that we need to work on right now.\n[Speaker 2104112913139912675]: So, yeah, I was chatting with my boss.\n[Speaker 2104112913139912675]: I was chatting with their boss too.\n[Speaker 2104112913139912675]: And one of the things with the multi year contract which I think we are aligned with wanting to do this as well is it would still like, it would still be our standard payment terms when this contract is signed basically.\n[Speaker 2104112913139912675]: ", "contextAfter": "\n[Speaker 2104112913139912675]: So essentially, within\u2026 if the renewal is January first.\n[Speaker 2104112913139912675]: So within 60 days, it would be the like standard.\n[Speaker 2104112913139912675]: Obviously, this is when, you know, if this isn't exactly what you were thinking, we can work together on, but standard would be within 60 days.\n[Speaker 2104112913139912675]: We'd need the full contract like payment within those days.\n[Speaker 2104112913139912675]: Is that how you typically do these multi year contracts?\n[Speaker 2104112913139912675]: So basically, we would have the payment up front and then for the next two years, it's essentially like open access, but I wanted to hand it to you.\n[Speaker 2104112913139912675]: Like what were you, is that kind of what you guys were thinking or?\n[Speaker 8945427492254429281]: I know that in other contracts we do, we, the multi year contracts are often a commitment.\n[Speaker 8945427492254429281]: So it's not, we don't pay for two, three yea...", "callTitle": "BioRender | Roche connect"}, {"quote": "everything related to Roche", "date": "2025-08-14", "callId": "2025-08-14_f2daf041fcef", "gongUrl": "https://app.gong.io/call?id=f2daf041fcef823a1ca53318a0433be11bf09513ae9914842dd2d09ba887c8cd", "speakerId": "8143937435222082516", "customerName": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "internalName": "Chris Hemberger; Jacqueline McCoskey; Tim Fung", "customerEmail": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "chris.hemberger@biorender.com; jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...I've been seeing that it's been just, very hot yep.\n[Speaker 8143937435222082516]: Yep.\n[Speaker 8143937435222082516]: It's, we're definitely in the midst of that.\n[Speaker 8143937435222082516]: What's it like in san Fran?\n[Speaker 8143937435222082516]: Cool?\n[Speaker 5654559484448408361]: It's 61.\n[Speaker 5654559484448408361]: It's a bit cooler, yeah.\n[Speaker 8143937435222082516]: Okay.\n[Speaker 8143937435222082516]: Similar to Tim.\n[Speaker 2765030990157134975]: Yeah, yeah, very similar here.\n[Speaker 8143937435222082516]: Yeah.\n[Speaker 8143937435222082516]: I think, is this everyone, Tim?\n[Speaker 8143937435222082516]: I don't think Chris was able to come.\n[Speaker 2765030990157134975]: Yeah, yeah, he's on.\n[Speaker 8143937435222082516]: Holiday.\n[Speaker 8143937435222082516]: We, the new CRO that we were, telling you about.\n[Speaker 8143937435222082516]: He wanted to join to meet you guys.\n[Speaker 8143937435222082516]: Just because he's heard a lot about you all and obviously, ", "contextAfter": ".\n[Speaker 8143937435222082516]: So, but it was kind of last minute when we invited him to come today.\n[Speaker 8143937435222082516]: So, next time.\n[Speaker 5654559484448408361]: We can kick off.\n[Speaker 5654559484448408361]: I think it's just four of us.\n[Speaker 2765030990157134975]: Is Anand able to make it?\n[Speaker 5654559484448408361]: No, actually, I need to talk to, Anand transitioned to another project.\n[Speaker 5654559484448408361]: Maybe that's why?\n[Speaker 5654559484448408361]: Oh, okay.\n[Speaker 5654559484448408361]: I think we set up this call a few months back.\n[Speaker 2765030990157134975]: We did.\n[Speaker 2765030990157134975]: Yeah.\n[Speaker 5654559484448408361]: Yeah.\n[Speaker 5654559484448408361]: Okay.\n[Speaker 2765030990157134975]: But yeah, we can definitely get started here.\n[Speaker 2765030990157134975]: So what I wanted to do is really just review some, usage numbers with you today, get a sense of how everything is going.\n[Speaker 2765030990157134975]: And ...", "callTitle": "BioRender | Roche - usage data review"}, {"quote": "And I kind of went all over Roche, trying to find people who might have the answer.", "date": "2025-07-30", "callId": "2025-07-30_96efa1847fca", "gongUrl": "https://app.gong.io/call?id=96efa1847fca7e339b7864178063a3dd935eb334f9469fa9ad633569ed57cfc8", "speakerId": "5659570131243197964", "customerName": "Bernardo Antunes; Bernardo Antunes; Gaius Augustus", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "bernardo.antunes@roche.com; bernardo.antunes@roche.com; gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...593858411384499]: So this is awesome.\n[Speaker 2609593858411384499]: And, hey, Tim\u2026 but yeah, I think to start, we'll probably just dive into it if that works for you all, I know that you guys probably have things to get to.\n[Speaker 2609593858411384499]: So\u2026 guys, I know that you had initially reached out to Tim about kind of starting the conversation for the renewal, I know we're pretty early, but we're happy to start it now too.\n[Speaker 2609593858411384499]: I think this is actually excellent.\n[Speaker 2609593858411384499]: And your email had a few points.\n[Speaker 2609593858411384499]: So, one of them being the refunds for the groups that had joined the Ela, and there were some that weren't\u2026 refunded properly or they weren't able to manage on the back end.\n[Speaker 2609593858411384499]: Is that correct?\n[Speaker 5659570131243197964]: Yeah.\n[Speaker 5659570131243197964]: My understanding is that we don't have the information to process those refunds.\n[Speaker 5659570131243197964]: ", "contextAfter": "\n[Speaker 5659570131243197964]: And I just ended up going full circle as far as people like how to process those refunds, what accounts to use?\n[Speaker 5659570131243197964]: So, instead of continuing to go in circles, it just seems to make more sense.\n[Speaker 5659570131243197964]: Can we just apply that to the next year?\n[Speaker 2609593858411384499]: Yeah, that we're more than happy to do that.\n[Speaker 2609593858411384499]: And we're also more than happy any of the remainder build up from spark from them collapsing into those licenses too.\n[Speaker 2609593858411384499]: That's no problem at all.\n[Speaker 2609593858411384499]: So no issues there.\n[Speaker 2609593858411384499]: I think the main thing that we kind of wanted to chat about today was the multi year agreement.\n[Speaker 2609593858411384499]: So basically like that's it's a little bit out of our norm.\n[Speaker 2609593858411384499]: I know that Bernardo and I had a lot of these conversations last year, but we're obviously op...", "callTitle": "BioRender | Roche - renewal discussion"}, {"quote": "So when you say exclusive content, you're referring to things that pan genentech slash Roche would all be able to access", "date": "2025-07-18", "callId": "2025-07-18_0ad32043fa9e", "gongUrl": "https://app.gong.io/call?id=0ad32043fa9e61cb77e092a60b584ac826b81aec9f2ca6121dba55b20e0588b6", "speakerId": "2427016330480186283", "customerName": "Ryan Cook", "internalName": "Michael Stanfel; Samara Ona; Tim Fung", "customerEmail": "cook.ryan@gene.com", "internalEmail": "michael.stanfel@biorender.com; samara@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "... here.\n[Speaker 3889784214032782990]: Today.\n[Speaker 3889784214032782990]: I brought on Michael who is on our creative team.\n[Speaker 3889784214032782990]: I think you might have seen the note that I've sent.\n[Speaker 3889784214032782990]: We're essentially working on introducing exclusive content into the genentech library.\n[Speaker 3889784214032782990]: I know that you, when we last spoke about this, we were looking at, you provided some feedback about the org content library where it was a mix of curated and some sort of exclusive content for.\n[Speaker 3889784214032782990]: But we've started, we've pivoted a little bit and Michael can add more detail here.\n[Speaker 3889784214032782990]: But what we're trying to do now is actually focus all on exclusive content and then see how we can work with you to essentially start bringing that material in so that folks across, you know, genentech would be able to, across the organization would be able to use it.\n[Speaker 2427016330480186283]: ", "contextAfter": " or would it be exclusive to the people who are requesting it or only to be who's releasing that?\n[Speaker 2427016330480186283]: I just wanted to get a kind of an idea of what's going on there?\n[Speaker 4852116092956591561]: Yeah.\n[Speaker 4852116092956591561]: So the way it's set up right now is everyone on the Roche license has access to the content in the Roche genentech library.\n[Speaker 4852116092956591561]: So everybody on that Roche wide license has access to the content.\n[Speaker 4852116092956591561]: And that is something that has been brought up a couple times as we sort of start to talk to folks from Roche and genentech is that even though you guys are both under one umbrella now, there's still not as much content sharing between the two larger orgs as there might have been expected from our side at least.\n[Speaker 4852116092956591561]: And so there have been concerns around.\n[Speaker 4852116092956591561]: I think it was someone from genentech I was speaking to last week aro...", "callTitle": "Genentech BioRender content"}, {"quote": "If you haven't requested a biorender account or haven't joined the Roche license.", "date": "2025-07-17", "callId": "2025-07-17_1f6129b4d224", "gongUrl": "https://app.gong.io/call?id=1f6129b4d224865fe2b80d1a2559590e5b7d6506d54c7ac5f55c6938670f263d", "speakerId": "3607766076170530565", "customerName": "Bastian Bernhardt; Markus Eckl; Mirko Walter; Sabine Reder; Sebastian Klaus; Simon Jochum", "internalName": "Tim Fung", "customerEmail": "bastian.bernhardt@roche.com; markus.eckl@roche.com; mirko.walter@roche.com; sabine.reder@roche.com; sebastian.klaus@roche.com; simon.jochum@roche.com", "internalEmail": "tim@biorender.com", "sizeMentions": [], "contextBefore": "[Speaker 3607766076170530565]: awesome.\n[Speaker 3607766076170530565]: Perfect.\n[Speaker 3607766076170530565]: So let me just share my screen, just curious who was able to attend the session earlier this week on Tuesday?\n[Speaker 3607766076170530565]: I see a couple hands go up.\n[Speaker 3607766076170530565]: Okay, perfect.\n[Speaker 3607766076170530565]: So let me just share my screen here.\n[Speaker 3607766076170530565]: So the first little parts I think will have a little bit of overlap with what we did on Tuesday, but then we're going to dive into some new things I think that folks might not have seen just yet.\n[Speaker 3607766076170530565]: So just share my screen here.\n[Speaker 3607766076170530565]: And also in case you need it, I'll just pop the link into the chat one more time.\n[Speaker 3607766076170530565]: ", "contextAfter": "\n[Speaker 3607766076170530565]: Yet this link here will provide you with instructions on how to get access.\n[Speaker 3607766076170530565]: And if you do have an account, feel free to sign.\n[Speaker 3607766076170530565]: In that way, you can follow along with some of those newer features that we've released onto the platform.\n[Speaker 3607766076170530565]: And then if you have any questions, you know, great place to get some answers here.\n[Speaker 3607766076170530565]: And so really just to set the stage as to give you a little bit of context as to why we released the features that we did here.\n[Speaker 3607766076170530565]: I just wanted to give like a quick intro.\n[Speaker 3607766076170530565]: This is really the only part that I think that will overlap with the first session on Tuesday.\n[Speaker 3607766076170530565]: But really I think like, you know, for all of us especially since you're more familiar with biorender already, is that visuals play a large part in that storytelling pro...", "callTitle": "BioRender | Roche - New and Advanced Features"}, {"quote": "working with Roche and other pharma organizations", "date": "2025-07-15", "callId": "2025-07-15_30ba3fe48525", "gongUrl": "https://app.gong.io/call?id=30ba3fe48525940522613029cf9b8cb38a4c602aa553aabb44c96f230c72051b", "speakerId": "1140936215716835432", "customerName": "Andreas Woeste; Benno Amplatz; Boris Pinchuk; Christian Vogl; Florian Garrelt; Johanna Theodorou; Juergen Oberstrass; Korbinian Kienle; Markus Eckl; Martina Schaetzl; Sabine Reder; Sebastian Klaus; Tanja Hackl", "internalName": "Tim Fung", "customerEmail": "andreas.woeste@roche.com; benno.amplatz@roche.com; boris.pinchuk@roche.com; christian.vogl.cv1@roche.com; florian.garrelt@roche.com; johanna.theodorou@roche.com; juergen.oberstrass@roche.com; korbinian.kienle@roche.com; markus.eckl@roche.com; martina.schaetzl@roche.com; sabine.reder@roche.com; sebastian.klaus@roche.com; tanja.hackl@roche.com; jordi.sintes@roche.com; marcel_clemens.schmidt@roche.com; isabel_barbara.gosch@roche.com; eirini.frylingou-beier@roche.com; carina.hoering@roche.com", "internalEmail": "tim@biorender.com", "sizeMentions": [], "contextBefore": "...15716835432]: A lot of the questions that you get asked often are surrounding just simply trying to understand what is happening on the screen as opposed to, you know, really discussing the science that underpins, you know, the work that's being done.\n[Speaker 1140936215716835432]: And when you contrast that with when the visuals are clear and you know, the story that you're telling is understood\u2026 you can almost feel that the entire meeting changes like, you know, the questions that are asked are being different, the discussion that you're being had, that, that's being had is also, you know, very different where people are really, you know, engaged and focused on the work itself again as opposed to trying to just figure out what is happening on the screen there.\n[Speaker 1140936215716835432]: And at biorender, we've been really fortunate enough to work in this space for the better part of 10 years now actually.\n[Speaker 1140936215716835432]: And it was, and during this time, you know, ", "contextAfter": ", we've started to realize that it's not just about the creating a pretty picture but it's really about shaping the conversation that picture is facilitating.\n[Speaker 1140936215716835432]: And to do that, what we've really done is develop in four different areas.\n[Speaker 1140936215716835432]: And I'm going to walk you through, you know, all of these as we dive into the platform here as well because these are the four core areas that you know, you should be familiar with.\n[Speaker 1140936215716835432]: The first is the content library that you'll have access to.\n[Speaker 1140936215716835432]: So there are there's a library of over 50,000 different icons and templates that are fully built ready for you to use and you can drag and drop it onto, your canvas to start essentially building out your illustrations.\n[Speaker 1140936215716835432]: And of course, everyone's work is very different.\n[Speaker 1140936215716835432]: So in addition to just giving you a starting point, what we've paire...", "callTitle": "BioRender | Roche - Fundamental Skills & Techniques"}, {"quote": "So then I just wanted to confirm, so, I looked at the Roche contacts that you provided.", "date": "2025-07-09", "callId": "2025-07-09_b18f3f180320", "gongUrl": "https://app.gong.io/call?id=b18f3f18032070f730d62104dcd5db0944f0890e0d5d3d97da7b9f5635e9871d", "speakerId": "6552087390488339969", "customerName": "Gaius Augustus; Kawal Kaur", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "gaius.augustus@roche.com; kaurk5@gene.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...f there is depending on the number of groups, that would be like maybe two or three days that we were thinking.\n[Speaker 5764182407795793704]: Yeah, I think, four five,, four, five, six, we could do that Tuesday, Wednesday, Thursday.\n[Speaker 6552087390488339969]: Okay.\n[Speaker 5764182407795793704]: And of course, if you need some buffer days, Monday and Friday could be your buffer days in\u2026 case you want to connect with folks on site.\n[Speaker 5764182407795793704]: And, yes, Friday is also slow here on the ssf side.\n[Speaker 5764182407795793704]: Monday is still better, but Friday is definitely slower than, than rest of the week.\n[Speaker 5330967402869146782]: That makes sense.\n[Speaker 5330967402869146782]: Yeah.\n[Speaker 5330967402869146782]: And I think, you know, Tuesday to Thursday and having, you know, the buffer on Monday or Friday makes a lot of sense.\n[Speaker 6552087390488339969]: Okay, great.\n[Speaker 6552087390488339969]: Thank you for that.\n[Speaker 6552087390488339969]: ", "contextAfter": "\n[Speaker 6552087390488339969]: One of them is no longer with Roche.\n[Speaker 6552087390488339969]: So I couldn't look up like what group they were a part of or anything, but I did confirm the others are in different groups.\n[Speaker 6552087390488339969]: So they will be the first people that we contact regarding, you know, signing up for potential slots.\n[Speaker 6552087390488339969]: I do want to talk about our slots for maybe the general sessions, but we'll do that in just a minute.\n[Speaker 5764182407795793704]: Guys, can you, help me understand, we want to connect with these folks for, to.\n[Speaker 6552087390488339969]: Organize, smaller sessions, catered to these specific groups.\n[Speaker 6552087390488339969]: Got it.\n[Speaker 6552087390488339969]: So we're gonna do a couple general sessions that are just open to everyone, but, biorender has worked with these groups before.\n[Speaker 6552087390488339969]: So we want to contact them to ask about organizing smaller, more tailored se...", "callTitle": "BioRender | Genentech Onsite Planning"}, {"quote": "biorender's onsite at Roche, pennsburg", "date": "2025-05-15", "callId": "2025-05-15_4b5da9ff8aab", "gongUrl": "https://app.gong.io/call?id=4b5da9ff8aab209746c605092a15a79ae2f827eb33a2f704be6eaad2302af6ce", "speakerId": "4304744265482998161", "customerName": "Helmut Niersbach", "internalName": "Mackay O'Connor", "customerEmail": "helmut.niersbach@roche.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": [], "contextBefore": "[Speaker 4501046303431233142]: I'm going to get this off.\n[Speaker 4304744265482998161]: Hi Helmut.\n[Speaker 4501046303431233142]: Thinking.\n[Speaker 4304744265482998161]: Hi, this is Mckay with biorender.\n[Speaker 4304744265482998161]: How are you doing?\n[Speaker 4501046303431233142]: All right.\n[Speaker 4304744265482998161]: Good, good.\n[Speaker 4304744265482998161]: Sorry, I know I'm calling you a little bit out of the blue.\n[Speaker 4304744265482998161]: It's in regards to ", "contextAfter": ".\n[Speaker 4304744265482998161]: Are you familiar with biorender?\n[Speaker 4501046303431233142]: Yeah.\n[Speaker 4501046303431233142]: I had a look at it but I haven't used it myself so far.\n[Speaker 4304744265482998161]: Okay.\n[Speaker 4304744265482998161]: That's okay.\n[Speaker 4304744265482998161]: What?\n[Speaker 4304744265482998161]: Like are you using visuals in your presentations much?\n[Speaker 4501046303431233142]: Not that much actually, but it might.\n[Speaker 4501046303431233142]: Happen once in a while, yeah.\n[Speaker 4304744265482998161]: Okay.\n[Speaker 4304744265482998161]: And like what would be the purpose of those presentations?\n[Speaker 4304744265482998161]: Would they be internal or external?\n[Speaker 4501046303431233142]: Internal.\n[Speaker 4304744265482998161]: okay.\n[Speaker 4304744265482998161]: Okay.\n[Speaker 4304744265482998161]: Yeah.\n[Speaker 4304744265482998161]: So the reason I'm reaching out is because we're setting specific appointments for our pennsburg ons...", "callTitle": "Call with Roche Ltd. - Helmut Niersbach"}, {"quote": "I help manage the relationship between biorender and Roche", "date": "2025-05-13", "callId": "2025-05-13_ba22facc7146", "gongUrl": "https://app.gong.io/call?id=ba22facc714645f648171e719ca333146861cddb557f272ecf4a2826a35bee03", "speakerId": "5913227701636194607", "customerName": "Jens FischeFr", "internalName": "Mackay O'Connor", "customerEmail": "jens.fischer.jf1@roche.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": [], "contextBefore": "...05]: this is Jens.\n[Speaker 3919618142521288305]: Hello?\n[Speaker 5913227701636194607]: Hi, Jens.\n[Speaker 5913227701636194607]: This is Mckay.\n[Speaker 5913227701636194607]: How are you doing?\n[Speaker 3919618142521288305]: I'm doing good.\n[Speaker 3919618142521288305]: I'm doing gook.\n[Speaker 5913227701636194607]: Good, good.\n[Speaker 5913227701636194607]: Sorry, I know I'm calling you a little bit out of the blue here.\n[Speaker 5913227701636194607]: It's in regards to an email I sent your way about biorender.\n[Speaker 5913227701636194607]: Are you familiar with biorender?\n[Speaker 3919618142521288305]: About what fire?\n[Speaker 5913227701636194607]: Bio render?\n[Speaker 5913227701636194607]: It's a software that I think you have access through Roche to use for visualizations and figures and whatnot?\n[Speaker 3919618142521288305]: I'm\u2026 not sure.\n[Speaker 3919618142521288305]: So, you, may I ask, you are a bosch colleague or I have no idea because.\n[Speaker 5913227701636194607]: So, ", "contextAfter": ".\n[Speaker 5913227701636194607]: And so the reason I'm reaching out to you is because we're coming on site to Roche, pennsburg, may.\n[Speaker 3919618142521288305]: Okay.\n[Speaker 3919618142521288305]: Now, I see the point.\n[Speaker 3919618142521288305]: You found the wrong Jens Fischer.\n[Speaker 5913227701636194607]: Oh, have I, is there too?\n[Speaker 3919618142521288305]: Yes, yes, because I was just, and I'm not dealing with this stuff.\n[Speaker 3919618142521288305]: I'm dealing with tubes, yes, but for the analyzers, and for the pre analytics but not for a control material and other stuff.\n[Speaker 3919618142521288305]: So, you need a different phone number.\n[Speaker 3919618142521288305]: So, this is Jens Fischer in penzberg, and you reached Jens Fischer in Mannheim.\n[Speaker 3919618142521288305]: I'm in Germany Mannheim?\n[Speaker 5913227701636194607]: Okay.\n[Speaker 5913227701636194607]: Ah, my mistake.\n[Speaker 5913227701636194607]: My mistake.\n[Speaker 5913227701636194607]: Thank...", "callTitle": "Call with Roche Ltd. - Jens FischeFr"}]}, {"id": "roche_p_red_a0da8672", "company": "roche", "gong_entity": "P RED", "gong_parent": "Roche", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 10, "snippet": "7,500 split pretty evenly across G, red, P, red and dietec, diet and pharmatec", "snippet_date": "2025-08-14", "person_name": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "person_email": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internal_name": "Chris Hemberger; Jacqueline McCoskey; Tim Fung", "internal_email": "chris.hemberger@biorender.com; jacqueline@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "pharma-research-early-development", "manual_node_name": "Pharma Research & Early Development (pRED)", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED)", "confidence": "high", "reasoning": "Clear acronym match - 'P RED' is the spoken form of 'pRED' which stands for Pharma Research & Early Development"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=f2daf041fcef823a1ca53318a0433be11bf09513ae9914842dd2d09ba887c8cd", "call_id": "2025-08-14_f2daf041fcef", "call_count": 10, "all_snippets": [{"quote": "7,500 split pretty evenly across G, red, P, red and dietec, diet and pharmatec", "date": "2025-08-14", "callId": "2025-08-14_f2daf041fcef", "gongUrl": "https://app.gong.io/call?id=f2daf041fcef823a1ca53318a0433be11bf09513ae9914842dd2d09ba887c8cd", "speakerId": "2765030990157134975", "customerName": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "internalName": "Chris Hemberger; Jacqueline McCoskey; Tim Fung", "customerEmail": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "chris.hemberger@biorender.com; jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...134975]: So let me just share my screen.\n[Speaker 2765030990157134975]: There are some numbers that are related to that here.\n[Speaker 8143937435222082516]: Yeah, Tim, I also did want to say like related to the multi year contract, it's progressing on our side, there's just a lot of approvals that have to, it has to go through as you can imagine because we don't do these very often.\n[Speaker 8143937435222082516]: So, just want you to know it, we're working on it and we just don't have anything ready yet.\n[Speaker 5654559484448408361]: Okay.\n[Speaker 5654559484448408361]: So, this existing contract, we have it until December, right?\n[Speaker 5654559484448408361]: Cool.\n[Speaker 5654559484448408361]: Yeah.\n[Speaker 2765030990157134975]: One thing that would be helpful for us, as well, is just to get a, is to see if like the numbers that we have on our side are correct, I think like the last time that, we spoke, the estimate that we got for the number of scientists across Roche is around ", "contextAfter": ", and I just wanted to get a sense like how accurate is that number?\n[Speaker 2765030990157134975]: Is that still, sort of the estimate there?\n[Speaker 2081859451289848040]: I'm not sure we have any updated numbers on that.\n[Speaker 2081859451289848040]: Do you know, Koal\u2026 I think our estimations are, I mean, the problem in general is just trying to find those numbers, I think, But as far as usage is concerned, obviously, we're much under that.\n[Speaker 2765030990157134975]: As far as the.\n[Speaker 2081859451289848040]: Users, I think that number's just been a little bit difficult for us to estimate?\n[Speaker 2765030990157134975]: That's fair.\n[Speaker 2765030990157134975]: Yeah, I'm just curious like if there was any sort of, if there's any sort of changes, but we can still use that number.\n[Speaker 2765030990157134975]: Since I think there was some work into getting that estimate when we first, launched the license.\n[Speaker 5654559484448408361]: And then, I'm gonna be honest with yo...", "callTitle": "BioRender | Roche - usage data review"}, {"quote": "I joined Roche in 2018 as a communications business partner to P red", "date": "2025-05-07", "callId": "2025-05-07_0ff68150eb69", "gongUrl": "https://app.gong.io/call?id=0ff68150eb6981fea7991b3e7eb653bba89d1ece8b6272dcbc2831801db10158", "speakerId": "8694921314646196652", "customerName": "Jeffrey Matthews", "internalName": "Jacqueline McCoskey; Shiz Aoki; Vijay Shahani", "customerEmail": "jeffrey.matthews.jm1@roche.com", "internalEmail": "jacqueline@biorender.com; shiz@biorender.com; vijay.shahani@biorender.com", "sizeMentions": [], "contextBefore": "...ecursion pharmaceuticals and cyclica, inc.\n[Speaker 7592388193914656289]: We were my background's in computational drug discovery or AI, drug aided drug discovery.\n[Speaker 7592388193914656289]: So I was working on building out those tools but I also have a background in scientific visualization.\n[Speaker 7592388193914656289]: So biorender seemed like a great opportunity to put those two worlds together, and help with some of these special initiatives that we're working on.\n[Speaker 7592388193914656289]: So yeah, we'd love to hear your ideas about pathways, and how you're thinking about the world and maybe we could share a little bit of what we're thinking about as well.\n[Speaker 8694921314646196652]: Now, if you're happy, to have all of you on the call and I really appreciate it.\n[Speaker 8694921314646196652]: So maybe just for my side, I, I've been with the company now for six and a half years.\n[Speaker 8694921314646196652]: My background is actually originally in public health, but ", "contextAfter": ", you know, initially working with the immunology, infectious diseases, and ophthalmology, therapeutic areas.\n[Speaker 8694921314646196652]: And in the past three years, I was on the diagnostic side in our point of care diagnostics group.\n[Speaker 8694921314646196652]: But in January of this year, I transitioned out of comms to our corporate donations and philanthropy group.\n[Speaker 8694921314646196652]: And this biochemical pathways poster.\n[Speaker 8694921314646196652]: The reason it's sitting in CDP as it's called is because this is a, this is a scientific resource that we have provided free of charge to scientists around the globe, you know, students, you know, different individuals who want to have this in their lab and it's kind of changed hands around Roche over the years.\n[Speaker 8694921314646196652]: But given the fact that we kind of held the budget line for the production of the physical posters and then the shipping costs, it was kind of deemed a philanthropic initiative....", "callTitle": "BioRender | Roche - Pathways discussion"}, {"quote": "Majority of folks are P red G red, which makes sense.", "date": "2025-05-06", "callId": "2025-05-06_37066a25169f", "gongUrl": "https://app.gong.io/call?id=37066a25169f230872122dcbc3bcdf337a663fe018af6d05a93aff696dd6e89c", "speakerId": "6088335049672687772", "customerName": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...kend.\n[Speaker 6088335049672687772]: We would just need to make sure that like all the invoices were settled as well with spark because there might've been something outstanding.\n[Speaker 6088335049672687772]: Awesome.\n[Speaker 6088335049672687772]: Yeah, just keep us posted there.\n[Speaker 6088335049672687772]: And the last thing that we are currently working on as well is populating the business area data for users.\n[Speaker 6088335049672687772]: And so what we're doing right now is making a switch to the sso configuration to make room for the business area, the business area attribute to go into the admin panel.\n[Speaker 6088335049672687772]: Once we've have that, it will be pretty quick to just upload the list and then populate all the users.\n[Speaker 6088335049672687772]: So we'll have a better view on which users belong, where basically, and you'll have a good view of like that distribution across the board as a heads up right now for distribution.\n[Speaker 6088335049672687772]: ", "contextAfter": "\n[Speaker 6088335049672687772]: They've had the license for probably like almost this would be year six almost.\n[Speaker 6088335049672687772]: So they make up about 85 percent of the license.\n[Speaker 6088335049672687772]: About 10 percent come from PTD and Dia, which is great that, you know, we're starting to see that number come up.\n[Speaker 6088335049672687772]: And then the last five percent guys is the folks that are unknown at the moment, and we'll work with them to get them to populate that field once it's ready to go.\n[Speaker 1706286059248901810]: Great.\n[Speaker 6088335049672687772]: HMM.\n[Speaker 6088335049672687772]: And then lastly, in terms of progress, just ongoing things that we're doing.\n[Speaker 6088335049672687772]: We're regularly onboarding new users and new groups.\n[Speaker 6088335049672687772]: We have a, we have the in person sessions planned for the Basel and pennsburg sites.\n[Speaker 6088335049672687772]: Now, I think all in all, we have 10 sessions that are p...", "callTitle": "BioRender | Roche - usage review"}, {"quote": "I also got contacted by some colleagues from ptd and P red", "date": "2025-05-05", "callId": "2025-05-05_2ed1375d19d8", "gongUrl": "https://app.gong.io/call?id=2ed1375d19d8a27a712c2c3f0f82054ebe4e731d0e8647a299703532508aff39", "speakerId": "2886391078890217663", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...ker 6848680811226263463]: We're gonna be there in the morning, another group.\n[Speaker 6848680811226263463]: Perfect.\n[Speaker 6848680811226263463]: Thank you.\n[Speaker 6848680811226263463]: Yeah, we're gonna.\n[Speaker 2886391078890217663]: Be there.\n[Speaker 2886391078890217663]: Yeah, that's great.\n[Speaker 2886391078890217663]: Do you, is, does it show anything about capacity or hard to say it might?\n[Speaker 2886391078890217663]: So I think that you're gonna book quite a large room for us, but I will see if I can find the capacity and share it with you.\n[Speaker 6848680811226263463]: Okay, perfect.\n[Speaker 6848680811226263463]: How large is the, and just to confirm it's with for the ptd cell therapy or cell and gene therapy group that we're hosting this for?\n[Speaker 6848680811226263463]: Is there anyone else that you were looking to include or is that the primary group?\n[Speaker 2886391078890217663]: Nope.\n[Speaker 2886391078890217663]: That is only for the, for ptcg and I think ", "contextAfter": " that I think you, you're doing the other session.\n[Speaker 2886391078890217663]: Yeah.\n[Speaker 2886391078890217663]: And we try to make sure that there is no overlap so that there are no double invities.\n[Speaker 2886391078890217663]: So everyone who is invited to our session should not be invited to your session.\n[Speaker 2886391078890217663]: So perfect.\n[Speaker 2886391078890217663]: It's not the case that all of a sudden, no one shows up to our session.\n[Speaker 2886391078890217663]: Okay?\n[Speaker 2886391078890217663]: That's great.\n[Speaker 2886391078890217663]: Yeah, we're hosting.\n[Speaker 6848680811226263463]: A larger like a P red session later in the week.\n[Speaker 6848680811226263463]: So, yeah, that's perfect.\n[Speaker 6848680811226263463]: Ptd.\n[Speaker 6848680811226263463]: I think you folks are a little, we'll get into the content actually later, but yeah, if you want to keep us posted on the amount of people that accept that invite, that'll help us with, you know, nu...", "callTitle": "BioRender | Roche PTD Onsite Planning"}, {"quote": "We are, we are actually part of P red.\nYes.\nOh, okay.\nSo, P red is pharma research and development.\nWe are pharma, yeah.\nYeah, P red is pharma.\nYeah, and we are, PS, is part of P red and it's complica", "date": "2025-04-30", "callId": "2025-04-30_424dead7eb63", "gongUrl": "https://app.gong.io/call?id=424dead7eb63de1e9b1a208d51f62772143e0e527a90b117eea86da2e95d4de1", "speakerId": "4199465303155978425", "customerName": "Uwe Wessels", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "uwe.wessels@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...y to kind of bring some refreshments.\nI know it's kind of a time right before lunch.\nI don't know if there'd be some snacks or anything like that you're like coffee or tea or anything that you'd want us to bring, but we'd be happy to do that.\nIf that would be.\nI don't think that would be necessary.\nOkay.\nGiven the time, I know it's kind of a funny time, it's like mid late morning and.\nafter that, a lot of people were making their pause and so on, no, I don't think it's really necessary to.\nOkay.\nIt's.\nnot common.\nYeah.\nOkay.\nSounds good.\nAnd so the pennsburg site from what our understanding is very large\u2026 yes.\nIt's from the area.\nIt's pretty large.\nYes.\nOkay.\nNot very high buildings, but.\nSprawling sprawling.\nYeah, we're at 8,000 people here, so.\nYeah.\nI know it's crazy.\nOkay.\nWe were just speaking with some folks in P red earlier today that we're doing a session with them on Wednesday is where you're like located close to like where the P red folks are, or are you on the other?\nSide?\n", "contextAfter": "ted.\nHelpful.\nOkay.\nSo that means that you've had access to biorender for, okay, things are starting to make sense a little bit more now.\nYeah.\nWe are using actually we're using biorender.\nYeah, we're using it mostly for we're doing our protocols.\nWhen we, when we generate our protocols, we're doing these little sketches and we do that in biorender there.\nOkay?\nAnd we, this is our go to platform, for these sketches now.\nAnd that's why everybody's using it.\nYeah.\nAnd so I was just interested.\nI saw your emails that you have new functions, new functionality?\nNo, that's perfect.\nYeah, actually.\nAI is always a, big topic.\nYeah, for sure.\nFor sure.\nI think I'm for the most part the logistics once we get the room set up, if you could send that over, to us.\nWe can also even put together like a little flyer that you can attach to the Google meet calendar invite so that people know what we'd be covering\u2026 but yeah, maybe I'll hand it over to Tim if you want to kind of walk through like the actua...", "callTitle": "BioRender | Roche Diagnostics Onsite Planning"}, {"quote": "how many P red folks are there at your site? 500?", "date": "2025-04-30", "callId": "2025-04-30_4c6d88e62acb", "gongUrl": "https://app.gong.io/call?id=4c6d88e62acbd857c8f9e7bf43662d083ad2fee989f680de24704644d4f35f6b", "speakerId": "3614100832644305186", "customerName": "", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "stefanie.lang@roche.com; penzberg.lmradminsupport@roche.com; julia.guschlbauer@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...e can't join virtually or can't join in person.\nBut like, ideally, we would want everyone to come as many people in person as possible.\nSo, if we keep it as like an in person event as like, the main attraction, then that would be ideal.\nOK.\nDo you know what the actual setup is in the room in terms of like, is it, do people typically connect with like a Google meet or is there like a dongle or do you know how the screens are normally projected in that room?\nSo, the hybrid setting is Google meet normally?\nOK.\nPerfect.\nSo we can share our screen through the Google meet?\nIs that does that?\nYeah.\nAnd you can also connect via the hdmi cable.\nOK.\nPerfect.\nAnd your site is all PCS, right?\nLike there's no macs at the pennsburg site.\nIt's primarily.\nYeah.\nOK.\nPerfect.\nSounds good.\nThat's good.\nAnd I know that we have, so the room sits around 150 people.\nHow many people and we're looking to do like a general P red section or session from what I remember, we'll get into that in just a second, but ", "contextAfter": "\nOK.\nAround.\nthat.\nOK.\nPerfect.\nI think normally about 100 would join, I think.\nOK, perfect.\nYeah, that would be awesome.\nAnd what we'll do is probably because the P red folks are a little bit more used to using biorender.\nWe'll probably do the newer and more advanced sort of tips and tricks.\nYeah, that would be great.\nYeah.\nAnd we'll send you a flyer.\nWe're just finalizing it that you can actually like help send it around to your folks and promote it that way.\nOne thing I did want to ask in terms of like catering, are we able to bring?\nI know it's in the afternoon.\nSo it probably doesn't make sense to have a full lunch, but are we able to have like snacks and refreshments available for them that, you know, we would obviously provide?\nBut is that something that room we're allowed to have?\nYeah, that's fine.\nYeah.\nOK.\nPerfect.\nDo you know, is there like an internal caterer that?\nYeah, you have that on site?\nYeah.\nOK.\nWould you be able to connect us with them?\nYeah, I think we can do tha...", "callTitle": "BioRender | Roche Penzberg onsite planning"}, {"quote": "Diagnostics and P, red somewhere along those lines.", "date": "2025-03-25", "callId": "2025-03-25_04a35beb559c", "gongUrl": "https://app.gong.io/call?id=04a35beb559c549d9b90f7d75fe4e5f7df9d30e58a07ffc09e6a10c73e7c4b33", "speakerId": "2537645070975902845", "customerName": "Johannes Then", "internalName": "Jacqueline McCoskey", "customerEmail": "johannes.then@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...[Speaker 5313404589143487983]: Nice.\n[Speaker 5313404589143487983]: That's awesome.\n[Speaker 5313404589143487983]: That's yeah, you guys got a big site there, so that's nice that you guys, have a gym to be able to head to you've.\n[Speaker 2537645070975902845]: been here before I have.\n[Speaker 5313404589143487983]: Been, but looking at pictures now that we're planning this on site, I'm like that is a campus.\n[Speaker 5313404589143487983]: Oh, yes, we.\n[Speaker 2537645070975902845]: have like 7,008 1,000.\n[Speaker 2537645070975902845]: I'm not sure.\n[Speaker 2537645070975902845]: Crazy.\n[Speaker 2537645070975902845]: It's a little village.\n[Speaker 2537645070975902845]: Yeah.\n[Speaker 5313404589143487983]: Yeah, it's a village.\n[Speaker 5313404589143487983]: It looks like it's wild.\n[Speaker 5313404589143487983]: So, I'm excited to come because, yeah, it's I think you guys have close to 6,000 scientists there.\n[Speaker 5313404589143487983]: Is that right?\n[Speaker 2537645070975902845]: ", "contextAfter": "\n[Speaker 2537645070975902845]: Yeah, it's above seven K.\n[Speaker 2537645070975902845]: Yeah, I'm not sure whether we have already hit the eight K but it's.\n[Speaker 5313404589143487983]: wow.\n[Speaker 5313404589143487983]: That's awesome.\n[Speaker 5313404589143487983]: It.\n[Speaker 2537645070975902845]: Is big at once.\n[Speaker 5313404589143487983]: Yeah, yeah, totally.\n[Speaker 5313404589143487983]: But yeah, thanks for taking the time to chat.\n[Speaker 5313404589143487983]: I appreciate it.\n[Speaker 5313404589143487983]: I think it's easiest just to kind of jump on here.\n[Speaker 5313404589143487983]: I can provide you some details and context and then I'll provide some more concrete details once we decide if this is something you want to do, but to start, I guess, yeah, we're basically coming on site the week that I had mentioned between the 28, 26 to 28.\n[Speaker 5313404589143487983]: I know that there's a holiday at the end of that week.\n[Speaker 5313404589143487983]: It's kind ...", "callTitle": "BioRender | Roche"}, {"quote": "It's doing the P RED and G RED renewal", "date": "2024-11-20", "callId": "2024-11-20_bab35eddaea0", "gongUrl": "https://app.gong.io/call?id=bab35eddaea07b221a83febddc3da0e970f84db45391c0cdba0af3789d4b1052", "speakerId": "1169138634469430893", "customerName": "Bernardo Antunes", "internalName": "Jacqueline McCoskey", "customerEmail": "bernardo.antunes@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "... right?\n[Speaker 1169138634469430893]: And, and to, we also understand from your side that, there's not, there might not be much you can do, You might not be ready to go for full enterprise level agreement at a fixed cost.\n[Speaker 1169138634469430893]: But at the moment, we have the same issue is that we are not also ready, to have no visibility and just be at the open for 1,000 users this year, 2000 users next year.\n[Speaker 1169138634469430893]: It doesn't work for us from a budgeting perspective, right?\n[Speaker 1169138634469430893]: We've tried to mitigate that by finding those specific kind of buckets of users where we figure out the cost.\n[Speaker 1169138634469430893]: But even then, it's just not enough, unfortunately, right?\n[Speaker 1169138634469430893]: So, a couple of things\u2026 We have a few options on the table, right?\n[Speaker 1169138634469430893]: And the options on the table is Univis, started to explore this already, which is great, right?\n[Speaker 1169138634469430893]: ", "contextAfter": ", which is unfortunate that we have to go that way after all of this time, But it just might be that we're not ready on both sides to proceed with a bigger picture right at the moment, which is fair.\n[Speaker 1169138634469430893]: So, I think we have, that covered, Our kind of whole scenario would be P RED and G RED.\n[Speaker 1169138634469430893]: And then we have to figure out what to do with the others.\n[Speaker 1169138634469430893]: But I wanted to leave the meeting with a further request which, is there a way\u2026 that we can have a number set of licenses for a fixed cost that we manage as we want, right?\n[Speaker 1169138634469430893]: So say, for example, you give me between, I don't know, you give me several, right?\n[Speaker 1169138634469430893]: But a price for having a 1,000 licenses, a price for having 1,500 licenses, one price for having 2000 licenses.\n[Speaker 1169138634469430893]: And we are not allowed to basically fall off those to manage the numbers, but we manage it interna...", "callTitle": "BioRender | Roche check in"}, {"quote": "when youd mentioned the protection of the P RED and G RED users", "date": "2024-10-25", "callId": "2024-10-25_c6f81d12a0e2", "gongUrl": "https://app.gong.io/call?id=c6f81d12a0e225e6227526f34b1a05fea4db03ba30e6a8cc5c9b1768588fd008", "speakerId": "4521358663271875204", "customerName": "Bernardo Antunes", "internalName": "Jacqueline McCoskey; Walid Habboub", "customerEmail": "bernardo.antunes@roche.com", "internalEmail": "jacqueline@biorender.com; walid@biorender.com", "sizeMentions": [], "contextBefore": "...64792]: How are you?\n[Speaker 6165747735449264792]: Good afternoon, Renardo.\n[Speaker 6165747735449264792]: Im doing good.\n[Speaker 6165747735449264792]: How are you?\n[Speaker 4521358663271875204]: Im good as well.\n[Speaker 4521358663271875204]: Nice.\n[Speaker 4521358663271875204]: Happy Friday.\n[Speaker 4521358663271875204]: We always catch you on Fridays which is always nice.\n[Speaker 4521358663271875204]: Yeah\u2026 thanks so much for joining.\n[Speaker 4521358663271875204]: I know I have a hard cut off at nine 30 and theres probably quite a bit nine 30 my time, two 30 your time, probably quite a bit to go through.\n[Speaker 4521358663271875204]: So you can just jump into it.\n[Speaker 4521358663271875204]: So were happy to walk through the per user cost.\n[Speaker 4521358663271875204]: So, thank you for outlining where the, you know, the\u2026 calculations that you had done Before getting into that.\n[Speaker 4521358663271875204]: I think the one thing that we were hoping for some clarity on was ", "contextAfter": " and preserving like their usage privileges.\n[Speaker 4521358663271875204]: Do you mind explaining a little bit further of what you meant by that?\n[Speaker 4521358663271875204]: Just because its just a little bit confusing just like in terms of like the usage rights and those types of things.\n[Speaker 4521358663271875204]: Yeah.\n[Speaker 4521358663271875204]: So,\n[Speaker 9120235898807115240]: No, thanks for getting back.\n[Speaker 9120235898807115240]: So theres kind of two ways we believe and the business believes they see this, right?\n[Speaker 9120235898807115240]: Which is if we would keep things as they are right now, we would be paying for a few extra 100 licenses, right?\n[Speaker 9120235898807115240]: And P RED and G RED would be allowed to grow until the five K, no matter when that happens, but they would still be in that range of the one point zero 6,000,000.\n[Speaker 9120235898807115240]: If Im not mistaken, right?\n[Speaker 9120235898807115240]: What were doing at the moment i...", "callTitle": "BioRender | Roche"}, {"quote": "everyone in P RED and G RED can have access to it", "date": "2024-09-19", "callId": "2024-09-19_d132aba88672", "gongUrl": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "speakerId": "3068414967322493854", "customerName": "Markus Eckl", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "markus.eckl@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...e past than I used recently, but there's always those project phases, you know, your phases where you have to prepare documents, then it's really nice.\n[Speaker 1493537282318889744]: Totally.\n[Speaker 1493537282318889744]: If you prepare just data, then yeah, there's not much use of it.\n[Speaker 1493537282318889744]: But you can solve this.\n[Speaker 1493537282318889744]: This is a Roche issue just to make you aware of this.\n[Speaker 1493537282318889744]: I know there's this Roche generic account for pharma and Genentech, right?\n[Speaker 1493537282318889744]: And in diagnostics, we are still bound to single licenses.\n[Speaker 1493537282318889744]: Yeah.\n[Speaker 3068414967322493854]: So I actually have a good update on that.\n[Speaker 3068414967322493854]: So we have, I've been, this is, you know, I've been fighting for this and the folks at Roche have been fighting for this too for a little, for quite some time to get access outside of P RED and G RED because I'm sure you're aware like ", "contextAfter": ".\n[Speaker 3068414967322493854]: But we are working towards a larger license that will hopefully be in place at the end of November.\n[Speaker 3068414967322493854]: That's when the period and GRed renewal is due.\n[Speaker 3068414967322493854]: Obviously, we still have some work to do on it, but it is working in a positive direction, which is great.\n[Speaker 3068414967322493854]: In the meantime, because we've had like requests all over the place, I've been working with the central IT folks to set up like what we would call a proof of concept for from now until the end of November that will give anyone outside of P RED and G RED free access until then.\n[Speaker 3068414967322493854]: So we can get your team up and running.\n[Speaker 3068414967322493854]: It's actually supposed to launch on Monday, so it'll be live on Monday.\n[Speaker 3068414967322493854]: This has all been happening the last couple weeks.\n[Speaker 3068414967322493854]: So it's a really good time we're talking now.\n[Speaker...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_ptd_d1414916", "company": "roche", "gong_entity": "PTD", "gong_parent": "P RED", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 9, "snippet": "About 10 percent come from PTD and Dia", "snippet_date": "2025-05-06", "person_name": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "person_email": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internal_name": "Jacqueline McCoskey; Tim Fung", "internal_email": "jacqueline@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=37066a25169f230872122dcbc3bcdf337a663fe018af6d05a93aff696dd6e89c", "call_id": "2025-05-06_37066a25169f", "call_count": 9, "all_snippets": [{"quote": "About 10 percent come from PTD and Dia", "date": "2025-05-06", "callId": "2025-05-06_37066a25169f", "gongUrl": "https://app.gong.io/call?id=37066a25169f230872122dcbc3bcdf337a663fe018af6d05a93aff696dd6e89c", "speakerId": "6088335049672687772", "customerName": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...there.\n[Speaker 6088335049672687772]: And the last thing that we are currently working on as well is populating the business area data for users.\n[Speaker 6088335049672687772]: And so what we're doing right now is making a switch to the sso configuration to make room for the business area, the business area attribute to go into the admin panel.\n[Speaker 6088335049672687772]: Once we've have that, it will be pretty quick to just upload the list and then populate all the users.\n[Speaker 6088335049672687772]: So we'll have a better view on which users belong, where basically, and you'll have a good view of like that distribution across the board as a heads up right now for distribution.\n[Speaker 6088335049672687772]: Majority of folks are P red G red, which makes sense.\n[Speaker 6088335049672687772]: They've had the license for probably like almost this would be year six almost.\n[Speaker 6088335049672687772]: So they make up about 85 percent of the license.\n[Speaker 6088335049672687772]: ", "contextAfter": ", which is great that, you know, we're starting to see that number come up.\n[Speaker 6088335049672687772]: And then the last five percent guys is the folks that are unknown at the moment, and we'll work with them to get them to populate that field once it's ready to go.\n[Speaker 1706286059248901810]: Great.\n[Speaker 6088335049672687772]: HMM.\n[Speaker 6088335049672687772]: And then lastly, in terms of progress, just ongoing things that we're doing.\n[Speaker 6088335049672687772]: We're regularly onboarding new users and new groups.\n[Speaker 6088335049672687772]: We have a, we have the in person sessions planned for the Basel and pennsburg sites.\n[Speaker 6088335049672687772]: Now, I think all in all, we have 10 sessions that are planned along with individual user chats that folks want to speak who want to speak with us.\n[Speaker 6088335049672687772]: So it's great to see that, you know, folks get really excited for it.\n[Speaker 6088335049672687772]: Everyone that we've spoken to in term...", "callTitle": "BioRender | Roche - usage review"}, {"quote": "I also got contacted by some colleagues from ptd and P red", "date": "2025-05-05", "callId": "2025-05-05_2ed1375d19d8", "gongUrl": "https://app.gong.io/call?id=2ed1375d19d8a27a712c2c3f0f82054ebe4e731d0e8647a299703532508aff39", "speakerId": "2886391078890217663", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...ker 6848680811226263463]: We're gonna be there in the morning, another group.\n[Speaker 6848680811226263463]: Perfect.\n[Speaker 6848680811226263463]: Thank you.\n[Speaker 6848680811226263463]: Yeah, we're gonna.\n[Speaker 2886391078890217663]: Be there.\n[Speaker 2886391078890217663]: Yeah, that's great.\n[Speaker 2886391078890217663]: Do you, is, does it show anything about capacity or hard to say it might?\n[Speaker 2886391078890217663]: So I think that you're gonna book quite a large room for us, but I will see if I can find the capacity and share it with you.\n[Speaker 6848680811226263463]: Okay, perfect.\n[Speaker 6848680811226263463]: How large is the, and just to confirm it's with for the ptd cell therapy or cell and gene therapy group that we're hosting this for?\n[Speaker 6848680811226263463]: Is there anyone else that you were looking to include or is that the primary group?\n[Speaker 2886391078890217663]: Nope.\n[Speaker 2886391078890217663]: That is only for the, for ptcg and I think ", "contextAfter": " that I think you, you're doing the other session.\n[Speaker 2886391078890217663]: Yeah.\n[Speaker 2886391078890217663]: And we try to make sure that there is no overlap so that there are no double invities.\n[Speaker 2886391078890217663]: So everyone who is invited to our session should not be invited to your session.\n[Speaker 2886391078890217663]: So perfect.\n[Speaker 2886391078890217663]: It's not the case that all of a sudden, no one shows up to our session.\n[Speaker 2886391078890217663]: Okay?\n[Speaker 2886391078890217663]: That's great.\n[Speaker 2886391078890217663]: Yeah, we're hosting.\n[Speaker 6848680811226263463]: A larger like a P red session later in the week.\n[Speaker 6848680811226263463]: So, yeah, that's perfect.\n[Speaker 6848680811226263463]: Ptd.\n[Speaker 6848680811226263463]: I think you folks are a little, we'll get into the content actually later, but yeah, if you want to keep us posted on the amount of people that accept that invite, that'll help us with, you know, nu...", "callTitle": "BioRender | Roche PTD Onsite Planning"}, {"quote": "So, can we say that the session will be mainly for like ptd? Ptd? Right. Basel ptd?", "date": "2025-04-23", "callId": "2025-04-23_7ae27cb21ae8", "gongUrl": "https://app.gong.io/call?id=7ae27cb21ae825fb1bbf1191193fec0a9564775730a971a17496c2e5716a4f96", "speakerId": "4591976821311352095", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...'s before, let me, it's for the cell and gene therapy group within ptd?\nHow many folks do you have in that group at the Basel location?\nSo.\nWe, so, I would increase the group a little bit.\nSo, there is a, there is the, yeah, I don't want to bore you, with different, departments.\nWe love to hear it.\nActually, it helps us grasp where things are at.\nSo, no worries.\nSo, there, there is, the pharmaceutical development group.\nThis is, this is in our department, and then there will be, the cell and gene therapy.\nThere's a separate department also focusing on cell and gene therapy.\nI would also invite them and I would, to be very honest, I would, invite all interested people from pharmaceutical development in total.\nSo, not only cell and gene therapy because, yeah, it's it, the biorender is new to the whole department.\nYeah.\nSo there might be the one or, the other person interested.\nAnd, yeah, I think that the topics will not be solely, on cell and gene therapy.\nIt, would, will be more.\nOkay.\n", "contextAfter": "\nFolks.\nOkay.\nYeah, perfect.\nHow many, do you know, how big that group is at Basel or is it hard to say, hey, Livia?\nIn, in total, it would be 80, but I don't expect 80 to be interested.\nSo, of course, I think that a quarter would be.\nSo, I guess that's my guess, I, we did not send out it yet, the invite yet?\nYeah.\nThat is what we planned for.\nSo.\nAnd we'll help with the invite too once we get some like content, to do that for sure.\nI think this is just initial.\nOkay.\nSo, we have a basically 80 folks at the Basel location, we have a room for 22 people.\nSo, if we can fill the room, that would be, that would be great.\nAre most of your people within ptd in building one or like, are they kind of spread over campus or?\nNo, we are mainly, in building 62, 64 72.\nBut there are no rooms, for an event like this.\nSo, okay, we will quickly cross the street and that, that's not an issue.\nSo, okay.\nOkay.\nSounds good.\nYep.\nWe never know if it's like, in terms of like making sure that, folks can actua...", "callTitle": "BioRender | Roche PTD onsite planning"}, {"quote": "we are within PD", "date": "2025-03-19", "callId": "2025-03-19_b429b7e52b42", "gongUrl": "https://app.gong.io/call?id=b429b7e52b42b59042c3e7c3a8603aef7dd65db4c536dc921f90301f8a4bf025", "speakerId": "87219535446509535", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...46509535]: So, yeah, let's yeah, keep week of my team.\n[Speaker 87219535446509535]: So that's and if it will be September that's fine too.\n[Speaker 87219535446509535]: Okay.\n[Speaker 87219535446509535]: So, we can schedule that as soon as we know more.\n[Speaker 87219535446509535]: Yeah.\n[Speaker 87219535446509535]: But then, I will reach out to get it.\n[Speaker 87219535446509535]: Let's let's say more on a department level or even bring together analytics and development.\n[Speaker 87219535446509535]: So that the group, is yeah, big enough, to have questions and the real QA if that makes sense?\n[Speaker 87219535446509535]: Yeah, totally.\n[Speaker 2893660636991191012]: Do you, might, can you remind me which group you're in?\n[Speaker 2893660636991191012]: Are you in cell and gene therapy?\n[Speaker 87219535446509535]: Yes, but yeah.\n[Speaker 87219535446509535]: So this, but, this is not a, an official group.\n[Speaker 87219535446509535]: So we are more matrix team working on that topic and ", "contextAfter": ".\n[Speaker 87219535446509535]: So I don't know, how good you are already?\n[Speaker 87219535446509535]: I've gotten pretty.\n[Speaker 2893660636991191012]: Good at it surprisingly over the years.\n[Speaker 2893660636991191012]: So you're within ptd, right?\n[Speaker 2893660636991191012]: Do I have that, right?\n[Speaker 2893660636991191012]: Yes.\n[Speaker 87219535446509535]: So at the moment, still, so, and, we are currently reorganizing, so we are in ptd.\n[Speaker 87219535446509535]: Okay.\n[Speaker 87219535446509535]: And currently, it or it will be ptd Europe.\n[Speaker 87219535446509535]: So, so there will be a us group and a european group and, it is the european and it's pharmaceutical development.\n[Speaker 87219535446509535]: But there is also another analytical group, yes, analytical team Europe.\n[Speaker 87219535446509535]: Okay.\n[Speaker 87219535446509535]: That, okay?\n[Speaker 87219535446509535]: And we could combine that.\n[Speaker 87219535446509535]: I don't know if you have other...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}, {"quote": "Are you in PTD then?", "date": "2024-09-18", "callId": "2024-09-18_3eab42283be2", "gongUrl": "https://app.gong.io/call?id=3eab42283be240e65118381aa5201813f8c57dfab4e64f0ae2bbf1ab6a905579", "speakerId": "4434073071130488898", "customerName": "Christoph Gst\u00f6ttner", "internalName": "Sierra Barnes", "customerEmail": "christoph.gstoettner@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... question for you are you part of P RED or G RED?\n[Speaker 5606602042582878549]: No, but we collaborate with them a lot so.\n[Speaker 4434073071130488898]: Collaborate.\n[Speaker 4434073071130488898]: Which team are you a part of at Roche?\n[Speaker 5606602042582878549]: Gene Therapy actually.\n[Speaker 5606602042582878549]: And does that fall from the analytics?\n[Speaker 5606602042582878549]: So I'm from the analytics department but they are in Gene Therapy.\n[Speaker 5606602042582878549]: We have a new let's say group and there we are very closely collaborating also with the P RED colleagues there.\n[Speaker 4434073071130488898]: And does that fall within diagnostics or?\n[Speaker 5606602042582878549]: No, no, it's pharma.\n[Speaker 4434073071130488898]: Okay.\n[Speaker 4434073071130488898]: But your group doesn't sit within the P RED group?\n[Speaker 5606602042582878549]: No, no, no, no.\n[Speaker 5606602042582878549]: Okay.\n[Speaker 4434073071130488898]: I see.\n[Speaker 4434073071130488898]: ", "contextAfter": "\n[Speaker 4434073071130488898]: I'm just trying to figure out where.\n[Speaker 5606602042582878549]: Yeah, exactly.\n[Speaker 5606602042582878549]: Perfect.\n[Speaker 4434073071130488898]: And how large is the gene therapy team, just out of curiosity?\n[Speaker 5606602042582878549]: In total in Penzberg, I think there are 200 people located which are working full time in gene therapy.\n[Speaker 5606602042582878549]: And then we have also around another 150 which work part time gene therapy and part time still in antibodies, let's say.\n[Speaker 5606602042582878549]: So it's growing quite a lot.\n[Speaker 5606602042582878549]: So it started around three years ago and since then it grew quite a lot already.\n[Speaker 4434073071130488898]: Oh, nice.\n[Speaker 4434073071130488898]: Gene therapy is a, cool area of research to be in too.\n[Speaker 5606602042582878549]: Yes.\n[Speaker 5606602042582878549]: Mainly with antibodies.\n[Speaker 5606602042582878549]: And yeah, now it's nice to work on somethin...", "callTitle": "BioRender & Roche - Intro Call"}, {"quote": "the users who are requesting are primarily in PTD as well as DIA", "date": "2024-09-16", "callId": "2024-09-16_d36b49ea866e", "gongUrl": "https://app.gong.io/call?id=d36b49ea866e8fc066b20a5d96a1a11f1afb1d751f0a926343dc3ca8b2b1b2f1", "speakerId": "1067617882933750578", "customerName": "Gaius Augustus; George Abousleiman; Kawal Kaur", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "gaius.augustus@roche.com; abousleg@gene.com; kaurk5@gene.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "... it I guess this is just more so talking about the renewal date and when we're hoping it to launch the enterprise licensing and then this will be like kind of the running in parallel as we're working towards that enterprise licensing I can clarify that language on here too if that's.\n[Speaker 4443789273359589298]: helpful.\n[Speaker 4443789273359589298]: OK, that's OK.\n[Speaker 4443789273359589298]: And I'm sharing this with you because as we are moving forward, you will hear us saying fine diagnostics like we're getting rid of GYP.\n[Speaker 4443789273359589298]: Totally.\n[Speaker 4443789273359589298]: Yeah, yeah.\n[Speaker 4443789273359589298]: And then...\n[Speaker 4443789273359589298]: Sorry, go ahead.\n[Speaker 1067617882933750578]: I was just going to say the one thing with this is we also have been getting a lot of requests from pharma technical development and they don't have access right now.\n[Speaker 1067617882933750578]: So that's why we're defining these P RED and G RED because ", "contextAfter": ".\n[Speaker 1067617882933750578]: So guys, you might need to provide some context there, but...\n[Speaker 3019586265158603172]: Yeah, exactly.\n[Speaker 3019586265158603172]: I was just about to say the same thing, that we are getting requests from pharma as well that are outside of P RED, but would like to access the system.\n[Speaker 3019586265158603172]: But I...\n[Speaker 3019586265158603172]: Yeah, and I recognize your point, though, Kawal, that like in the future implementation, we're really talking about pharma, which is...\n[Speaker 3019586265158603172]: Everything in it, you know, everything pharma plus P RED, G RED.\n[Speaker 3019586265158603172]: Yeah.\n[Speaker 3019586265158603172]: And then we have DIA as kind of a little bit of a separate entity.\n[Speaker 1067617882933750578]: But correct me if I'm wrong, the goal of the enterprise is just to have one sort of instance, right?\n[Speaker 1067617882933750578]: And like we would have everyone within pharma and diagnostics accessing th...", "callTitle": "BioRender | Roche - short term access"}, {"quote": "we're actively working on setting up those in PTD and diagnostics as well", "date": "2024-09-16", "callId": "2024-09-16_75435aea8ad7", "gongUrl": "https://app.gong.io/call?id=75435aea8ad754e88c3ee5e80e0c7e5fa5fd7343b46e96e4b315ef136260de3b", "speakerId": "6303005417140467437", "customerName": "Johannes Schott", "internalName": "Sierra Barnes", "customerEmail": "johannes.schott@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...unctionality within BioRender that's been very useful for others at Roche.\n[Speaker 6303005417140467437]: So just wanted to see if it's something your team would also find valuable, but would love to start by hearing how you've been using BioRender so far.\n[Speaker 7462781675389340992]: Yeah, sure.\n[Speaker 7462781675389340992]: Just here and there basically for, yeah, just playing around to be honest a little bit.\n[Speaker 7462781675389340992]: But not so much, but to be honest I'm also not, I'm not sure if I'm the right contact person because I'm pretty sure that there is a company license planned or I don't know if there already is one.\n[Speaker 7462781675389340992]: But I'm not really involved in that so I'm not sure if I'm the right person here.\n[Speaker 6303005417140467437]: Yeah.\n[Speaker 6303005417140467437]: Yeah, that's kind of the inspiration for the call.\n[Speaker 6303005417140467437]: We've already set all of the P RED and G RED researchers up with access to BioRender and ", "contextAfter": ".\n[Speaker 6303005417140467437]: So just wanted to see if it's something you and your team would find valuable and if it makes sense to potentially explore that.\n[Speaker 6303005417140467437]: But all of my conversations so far have started from end users like yourself.\n[Speaker 6303005417140467437]: So I promise you are the right person.\n[Speaker 6303005417140467437]: But yeah, I just want to explore if it makes sense for your team to be added to that license as well.\n[Speaker 7462781675389340992]: Mm hmm.\n[Speaker 7462781675389340992]: Maybe at some point but yeah as I said since I haven't used it like that much I think I can't give much input there.\n[Speaker 6303005417140467437]: Okay, what were you hoping to use BioRender for?\n[Speaker 7462781675389340992]: I guess just presentations, internal presentations and visualizing things.\n[Speaker 6303005417140467437]: That's kind of what we're hearing from other users across Roche that they're largely using it for their internal presentat...", "callTitle": "Call with Roche - Johannes Schott"}, {"quote": "So you're in PTD, correct?", "date": "2024-09-10", "callId": "2024-09-10_a7e39ba6d000", "gongUrl": "https://app.gong.io/call?id=a7e39ba6d0002a5c2ce052c12e30cc994a9235b4911c827cb2f492c18c4411fe", "speakerId": "3227459355290943038", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...usiness license or to the Roche license, but not starting this little, I don't know, this little business set up with PTDE or with our group only.\n[Speaker 16832304959900895]: So that makes no sense in the end, I think.\n[Speaker 16832304959900895]: And so the approach from my end would be, I don't know if you can give me the contact from IT to maybe ask what they think.\n[Speaker 3227459355290943038]: Yep.\n[Speaker 3227459355290943038]: Yeah.\n[Speaker 3227459355290943038]: Do you remember who you spoke with in IT when you originally reached.\n[Speaker 16832304959900895]: No, it was the ticket system, so there it was.\n[Speaker 16832304959900895]: Yeah, okay.\n[Speaker 3227459355290943038]: I can definitely give you the contacts from IT just to kind of give your support.\n[Speaker 3227459355290943038]: And there might be some sort of short term solution that we can include you in from that perspective.\n[Speaker 3227459355290943038]: A couple questions for you.\n[Speaker 3227459355290943038]: ", "contextAfter": "\n[Speaker 3227459355290943038]: Yes.\n[Speaker 3227459355290943038]: And within, I'm just looking at Sierra's notes, like pharmaceutical, no, that's cell and gene therapy.\n[Speaker 3227459355290943038]: Is that right?\n[Speaker 3227459355290943038]: Yes.\n[Speaker 3227459355290943038]: Okay.\n[Speaker 3227459355290943038]: How large approximately is the cell and gene therapy group?\n[Speaker 16832304959900895]: So this is the thing that's seen at cell and gene therapy group is only 10 people.\n[Speaker 16832304959900895]: And the next step then would be to reach out.\n[Speaker 16832304959900895]: So if we request a license, I have to do that by pharmaceutical technical development so that the whole department and there that was the quick check in I had with Sierra on is that then we would do something like this introduction or this webinar to maybe get the department informed, then that would be a department level decision.\n[Speaker 16832304959900895]: If we want to have a single license for ...", "callTitle": "BioRender & Roche - Follow Up Call"}, {"quote": "Okay, PTD.", "date": "2024-09-04", "callId": "2024-09-04_18e45c9dd482", "gongUrl": "https://app.gong.io/call?id=18e45c9dd4826de168510161017a2e0e98fd82d6b0edd95ca08f518098665c0e", "speakerId": "3027117464291228307", "customerName": "Christoph Duerr", "internalName": "Sierra Barnes", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... in general, I think it is key that people understand what is presented.\n[Speaker 7347115369096025640]: So I don't want to present on just, okay, now I presented the data.\n[Speaker 7347115369096025640]: So I'm looking forward to have a discussion afterwards.\n[Speaker 7347115369096025640]: And if they don't understand, they cannot bring their thoughts.\n[Speaker 7347115369096025640]: To the discussion.\n[Speaker 7347115369096025640]: So I think that's key.\n[Speaker 3027117464291228307]: Mm hmm.\n[Speaker 3027117464291228307]: Okay, perfect.\n[Speaker 3027117464291228307]: Yeah, that's kind of an alignment from what we're hearing from, you know, other groups at Roche.\n[Speaker 3027117464291228307]: We just want to make sure that everyone's like really understanding what, how the value that BioRender can bring.\n[Speaker 3027117464291228307]: What's the department that you're a part of at Roche?\n[Speaker 7347115369096025640]: That's a pharmaceutical development.\n[Speaker 3027117464291228307]: ", "contextAfter": "\n[Speaker 3027117464291228307]: And how many people are in, your group?\n[Speaker 3027117464291228307]: let's.\n[Speaker 7347115369096025640]: say, maybe in direct, so the team has about 10, but some are part time.\n[Speaker 7347115369096025640]: So yeah, I don't know.\n[Speaker 7347115369096025640]: Do you, do you ask from a potential user perspective or?\n[Speaker 3027117464291228307]: We're just trying to figure out, who sits where.\n[Speaker 3027117464291228307]: These companies, are quite massive, like you mentioned.\n[Speaker 3027117464291228307]: Are you part of a specific, you know, subgroup in the pharmaceutical development or?\n[Speaker 7347115369096025640]: Yes, so that, it's a, it's, there's this agile team working, on cell and gene therapies.\n[Speaker 7347115369096025640]: I see.\n[Speaker 7347115369096025640]: So, it's not in, it's not a rigid organizational setup, but we have, these agile teams.\n[Speaker 7347115369096025640]: Hmm.\n[Speaker 7347115369096025640]: Yeah.\n[Speaker 302...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_cell_and_gene_therapy_9a1dbfe4", "company": "roche", "gong_entity": "Cell and Gene Therapy", "gong_parent": "PTD", "entity_type": "department", "team_size": "10", "confidence": "high", "mention_count": 3, "snippet": "There's a separate department also focusing on cell and gene therapy", "snippet_date": "2025-04-23", "person_name": "Christoph Duerr", "person_email": "christoph.duerr@roche.com", "internal_name": "Jacqueline McCoskey; Livia Guo; Tim Fung", "internal_email": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "gene-therapy-manufacturing", "manual_node_name": "Gene Therapy Manufacturing Sciences", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical) > Gene Therapy Manufacturing Sciences", "confidence": "medium", "reasoning": "Semantic match for gene therapy focus, though manual node is specifically manufacturing-focused rather than general cell and gene therapy"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=7ae27cb21ae825fb1bbf1191193fec0a9564775730a971a17496c2e5716a4f96", "call_id": "2025-04-23_7ae27cb21ae8", "call_count": 3, "all_snippets": [{"quote": "There's a separate department also focusing on cell and gene therapy", "date": "2025-04-23", "callId": "2025-04-23_7ae27cb21ae8", "gongUrl": "https://app.gong.io/call?id=7ae27cb21ae825fb1bbf1191193fec0a9564775730a971a17496c2e5716a4f96", "speakerId": "5741703818535642290", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...812626812192356]: Okay.\n[Speaker 8349812626812192356]: Yeah.\n[Speaker 4591976821311352095]: Perfect.\n[Speaker 4591976821311352095]: And how many people are, and just to confirm it's before, let me, it's for the cell and gene therapy group within ptd?\n[Speaker 4591976821311352095]: How many folks do you have in that group at the Basel location?\n[Speaker 4591976821311352095]: So.\n[Speaker 5741703818535642290]: We, so, I would increase the group a little bit.\n[Speaker 5741703818535642290]: So, there is a, there is the, yeah, I don't want to bore you, with different, departments.\n[Speaker 4591976821311352095]: We love to hear it.\n[Speaker 4591976821311352095]: Actually, it helps us grasp where things are at.\n[Speaker 4591976821311352095]: So, no worries.\n[Speaker 5741703818535642290]: So, there, there is, the pharmaceutical development group.\n[Speaker 5741703818535642290]: This is, this is in our department, and then there will be, the cell and gene therapy.\n[Speaker 5741703818535642290]: ", "contextAfter": ".\n[Speaker 5741703818535642290]: I would also invite them and I would, to be very honest, I would, invite all interested people from pharmaceutical development in total.\n[Speaker 5741703818535642290]: So, not only cell and gene therapy because, yeah, it's it, the biorender is new to the whole department.\n[Speaker 5741703818535642290]: Yeah.\n[Speaker 5741703818535642290]: So there might be the one or, the other person interested.\n[Speaker 5741703818535642290]: And, yeah, I think that the topics will not be solely, on cell and gene therapy.\n[Speaker 5741703818535642290]: It, would, will be more.\n[Speaker 4591976821311352095]: Okay.\n[Speaker 4591976821311352095]: So, can we say that the session will be mainly for like ptd?\n[Speaker 5741703818535642290]: Ptd?\n[Speaker 4591976821311352095]: Right.\n[Speaker 4591976821311352095]: Basel ptd?\n[Speaker 4591976821311352095]: Folks.\n[Speaker 4591976821311352095]: Okay.\n[Speaker 4591976821311352095]: Yeah, perfect.\n[Speaker 4591976821311352095]: Ho...", "callTitle": "BioRender | Roche PTD onsite planning"}, {"quote": "Do you, might, can you remind me which group you're in? Are you in cell and gene therapy?", "date": "2025-03-19", "callId": "2025-03-19_b429b7e52b42", "gongUrl": "https://app.gong.io/call?id=b429b7e52b42b59042c3e7c3a8603aef7dd65db4c536dc921f90301f8a4bf025", "speakerId": "2893660636991191012", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "... location is pretty busy.\nSo like we were maybe going to do the 26 that week.\nBut now, because of this holiday that I just found out about, so I need to just like there's a lot of coordination that we need to do on our side.\nBut, cause if not, I think, you know, summer's busy and I think if we had to push, it would probably be maybe like September, if that makes more sense.\nBut, to start this, we'd love to do may, but, you know, I know we got holidays and those are more important.\nYeah.\nEven, if I like, so I like bio render but you like holidays better?\nI'm.\nwith you, I'm so with you.\nOkay?\nSo, yeah, let's yeah, keep week of my team.\nSo that's and if it will be September that's fine too.\nOkay.\nSo, we can schedule that as soon as we know more.\nYeah.\nBut then, I will reach out to get it.\nLet's let's say more on a department level or even bring together analytics and development.\nSo that the group, is yeah, big enough, to have questions and the real QA if that makes sense?\nYeah, totally.\n", "contextAfter": "\nYes, but yeah.\nSo this, but, this is not a, an official group.\nSo we are more matrix team working on that topic and we are within PD.\nSo I don't know, how good you are already?\nI've gotten pretty.\nGood at it surprisingly over the years.\nSo you're within ptd, right?\nDo I have that, right?\nYes.\nSo at the moment, still, so, and, we are currently reorganizing, so we are in ptd.\nOkay.\nAnd currently, it or it will be ptd Europe.\nSo, so there will be a us group and a european group and, it is the european and it's pharmaceutical development.\nBut there is also another analytical group, yes, analytical team Europe.\nOkay.\nThat, okay?\nAnd we could combine that.\nI don't know if you have other contacts, in.\nOkay.\nSo the,\nthe, I was actually speaking with someone in ptd in the cell and gene therapy from Munich yesterday.\nI don't.\nknow Marco Marcus, maybe also it was.\nAmelie Bauer, I'm not sure.\nOkay.\nAmelie, I know her.\nYeah, yes.\nAre you guys in the same group?\nJust different sites?\nLet's let's ca...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}, {"quote": "So this is the thing that's seen at cell and gene therapy group is only 10 people.", "date": "2024-09-10", "callId": "2024-09-10_a7e39ba6d000", "gongUrl": "https://app.gong.io/call?id=a7e39ba6d0002a5c2ce052c12e30cc994a9235b4911c827cb2f492c18c4411fe", "speakerId": "16832304959900895", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [{"value": "10", "snippetIndex": 2, "source": {"callDate": "2024-09-10", "customerName": "Christoph Duerr"}}], "contextBefore": "...8]: Yeah.\n[Speaker 3227459355290943038]: Do you remember who you spoke with in IT when you originally reached.\n[Speaker 16832304959900895]: No, it was the ticket system, so there it was.\n[Speaker 16832304959900895]: Yeah, okay.\n[Speaker 3227459355290943038]: I can definitely give you the contacts from IT just to kind of give your support.\n[Speaker 3227459355290943038]: And there might be some sort of short term solution that we can include you in from that perspective.\n[Speaker 3227459355290943038]: A couple questions for you.\n[Speaker 3227459355290943038]: So you're in PTD, correct?\n[Speaker 3227459355290943038]: Yes.\n[Speaker 3227459355290943038]: And within, I'm just looking at Sierra's notes, like pharmaceutical, no, that's cell and gene therapy.\n[Speaker 3227459355290943038]: Is that right?\n[Speaker 3227459355290943038]: Yes.\n[Speaker 3227459355290943038]: Okay.\n[Speaker 3227459355290943038]: How large approximately is the cell and gene therapy group?\n[Speaker 16832304959900895]: ", "contextAfter": "\n[Speaker 16832304959900895]: And the next step then would be to reach out.\n[Speaker 16832304959900895]: So if we request a license, I have to do that by pharmaceutical technical development so that the whole department and there that was the quick check in I had with Sierra on is that then we would do something like this introduction or this webinar to maybe get the department informed, then that would be a department level decision.\n[Speaker 16832304959900895]: If we want to have a single license for PDD first, and then we go to the business license, because I think we will not get a license only for cell and gene therapy.\n[Speaker 16832304959900895]: So the dream is too small.\n[Speaker 3227459355290943038]: Yeah.\n[Speaker 3227459355290943038]: No, that's no problem.\n[Speaker 3227459355290943038]: How do you know how large PTD is also by any chance?\n[Speaker 16832304959900895]: And Europe, now I have to calculate with analytics and.\n[Speaker 3227459355290943038]: no just an approxima...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_cell_and_gene_therapy_group_8282977c", "company": "roche", "gong_entity": "Cell and Gene Therapy Group", "gong_parent": "Cell and Gene Therapy", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "for the ptd cell therapy or cell and gene therapy group", "snippet_date": "2025-05-05", "person_name": "Amelie Bauer", "person_email": "amelie.bauer.ab1@roche.com", "internal_name": "Jacqueline McCoskey; Livia Guo; Tim Fung", "internal_email": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "cell-therapies-gred", "manual_node_name": "Cell Therapies", "manual_node_path": "Roche Research & Development > Genentech Research & Early Development (gRED) > Therapeutic Discovery (gRED) > Cell Therapies", "confidence": "medium", "reasoning": "Partial semantic match focusing on cell therapies aspect, though entity mentions both cell and gene therapy while manual node is cell therapy specific"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=2ed1375d19d8a27a712c2c3f0f82054ebe4e731d0e8647a299703532508aff39", "call_id": "2025-05-05_2ed1375d19d8", "call_count": 2, "all_snippets": [{"quote": "for the ptd cell therapy or cell and gene therapy group", "date": "2025-05-05", "callId": "2025-05-05_2ed1375d19d8", "gongUrl": "https://app.gong.io/call?id=2ed1375d19d8a27a712c2c3f0f82054ebe4e731d0e8647a299703532508aff39", "speakerId": "6848680811226263463", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...Speaker 6848680811226263463]: Okay.\n[Speaker 6848680811226263463]: No, that's super helpful.\n[Speaker 6848680811226263463]: I think, if you're okay with it, maybe we'll come around two 30 just to kind of work through some of, the technical things and make sure that set up properly, from the sounds of it.\n[Speaker 6848680811226263463]: We're gonna be there in the morning, another group.\n[Speaker 6848680811226263463]: Perfect.\n[Speaker 6848680811226263463]: Thank you.\n[Speaker 6848680811226263463]: Yeah, we're gonna.\n[Speaker 2886391078890217663]: Be there.\n[Speaker 2886391078890217663]: Yeah, that's great.\n[Speaker 2886391078890217663]: Do you, is, does it show anything about capacity or hard to say it might?\n[Speaker 2886391078890217663]: So I think that you're gonna book quite a large room for us, but I will see if I can find the capacity and share it with you.\n[Speaker 6848680811226263463]: Okay, perfect.\n[Speaker 6848680811226263463]: How large is the, and just to confirm it's with ", "contextAfter": " that we're hosting this for?\n[Speaker 6848680811226263463]: Is there anyone else that you were looking to include or is that the primary group?\n[Speaker 2886391078890217663]: Nope.\n[Speaker 2886391078890217663]: That is only for the, for ptcg and I think I also got contacted by some colleagues from ptd and P red that I think you, you're doing the other session.\n[Speaker 2886391078890217663]: Yeah.\n[Speaker 2886391078890217663]: And we try to make sure that there is no overlap so that there are no double invities.\n[Speaker 2886391078890217663]: So everyone who is invited to our session should not be invited to your session.\n[Speaker 2886391078890217663]: So perfect.\n[Speaker 2886391078890217663]: It's not the case that all of a sudden, no one shows up to our session.\n[Speaker 2886391078890217663]: Okay?\n[Speaker 2886391078890217663]: That's great.\n[Speaker 2886391078890217663]: Yeah, we're hosting.\n[Speaker 6848680811226263463]: A larger like a P red session later in the week.\n[Speaker...", "callTitle": "BioRender | Roche PTD Onsite Planning"}, {"quote": "it's for the cell and gene therapy group within ptd", "date": "2025-04-23", "callId": "2025-04-23_7ae27cb21ae8", "gongUrl": "https://app.gong.io/call?id=7ae27cb21ae825fb1bbf1191193fec0a9564775730a971a17496c2e5716a4f96", "speakerId": "4591976821311352095", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...So, okay, perfect.\n[Speaker 4591976821311352095]: We'll do the actual session from 11 to 12, and then we'll do setup from 10 30 to 11, just to make sure we, I went through a hour long setup last week trying to make sure everything was set up properly.\n[Speaker 4591976821311352095]: So yeah, we just need a little bit of offer time there, but we should be good because we're gonna have sessions the day before.\n[Speaker 4591976821311352095]: So should, we should probably work through some of the kinks on, the Wednesday.\n[Speaker 4591976821311352095]: So, we'll be professionals by the time we reach your group, how large is the actual room itself?\n[Speaker 4591976821311352095]: Like how many people does it seat?\n[Speaker 5741703818535642290]: 20 22?\n[Speaker 8349812626812192356]: 22.\n[Speaker 8349812626812192356]: Okay.\n[Speaker 8349812626812192356]: Yeah.\n[Speaker 4591976821311352095]: Perfect.\n[Speaker 4591976821311352095]: And how many people are, and just to confirm it's before, let me, ", "contextAfter": "?\n[Speaker 4591976821311352095]: How many folks do you have in that group at the Basel location?\n[Speaker 4591976821311352095]: So.\n[Speaker 5741703818535642290]: We, so, I would increase the group a little bit.\n[Speaker 5741703818535642290]: So, there is a, there is the, yeah, I don't want to bore you, with different, departments.\n[Speaker 4591976821311352095]: We love to hear it.\n[Speaker 4591976821311352095]: Actually, it helps us grasp where things are at.\n[Speaker 4591976821311352095]: So, no worries.\n[Speaker 5741703818535642290]: So, there, there is, the pharmaceutical development group.\n[Speaker 5741703818535642290]: This is, this is in our department, and then there will be, the cell and gene therapy.\n[Speaker 5741703818535642290]: There's a separate department also focusing on cell and gene therapy.\n[Speaker 5741703818535642290]: I would also invite them and I would, to be very honest, I would, invite all interested people from pharmaceutical development in total.\n[Speaker 57...", "callTitle": "BioRender | Roche PTD onsite planning"}]}, {"id": "roche_roche_diagnostics_bbbe9485", "company": "roche", "gong_entity": "Roche Diagnostics", "gong_parent": "Roche", "entity_type": "business_unit", "team_size": "25,000", "confidence": "high", "mention_count": 10, "snippet": "So you have, Roche diagnostics and Roche pharma, yeah, those are like almost two separate companies.", "snippet_date": "2025-03-14", "person_name": "Jo Stevens", "person_email": "jo.stevens@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "roche-diagnostics-rd", "manual_node_name": "Roche Diagnostics R&D", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D", "confidence": "high", "reasoning": "Exact match for the Roche Diagnostics division within R&D context"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "call_id": "2025-03-14_d067238de6be", "call_count": 10, "all_snippets": [{"quote": "So you have, Roche diagnostics and Roche pharma, yeah, those are like almost two separate companies.", "date": "2025-03-14", "callId": "2025-03-14_d067238de6be", "gongUrl": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "speakerId": "5895796664693401761", "customerName": "Jo Stevens", "internalName": "Jacqueline McCoskey", "customerEmail": "jo.stevens@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...ut very.\n[Speaker 5895796664693401761]: Well, deserved, just wait until we get to may then.\n[Speaker 6782829348298472977]: I know.\n[Speaker 6782829348298472977]: And then the summer, I know things get crazy.\n[Speaker 6782829348298472977]: So, okay, perfect.\n[Speaker 6782829348298472977]: That's really good to know.\n[Speaker 6782829348298472977]: In terms of your actual group here, I am just looking at my old notes.\n[Speaker 6782829348298472977]: You're in the antibody development team.\n[Speaker 6782829348298472977]: Is that correct?\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: And I know that's on the diagnostic side, how does that sort of like fit organizationally like in the actual, like what group are you under?\n[Speaker 6782829348298472977]: I guess within like the antibody development, is there a group that you kind of report to or like you're.\n[Speaker 5895796664693401761]: situated under?\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: ", "contextAfter": "\n[Speaker 5895796664693401761]: Yeah, but in helzberg, we have both on site.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: We're.\n[Speaker 5895796664693401761]: a bit weird in that sense.\n[Speaker 5895796664693401761]: Normally, the sites of Roche are like exclusively Daya, yeah.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 5895796664693401761]: And then within diagnostics, we have like huge departments that are called, like corelab that work on like devices and the tests that go on the devices, okay?\n[Speaker 5895796664693401761]: And then we have, a group of which I belong to that is called, Roche diagnostics solutions that, we do the research.\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: And within that, on penzberg, we have, biological reagent development, and chemistry, chemical reagent, development.\n[Speaker 5895796664693401761]: Okay?\n[Speaker 58957966646934017...", "callTitle": "BioRender | Roche"}, {"quote": "No, we part of the\u2026 diagnostic solutions.", "date": "2024-07-04", "callId": "2024-07-04_703d92988c66", "gongUrl": "https://app.gong.io/call?id=703d92988c66f21913d2f471e7a3d922e5b76a5822cd28020514066d1685f0c1", "speakerId": "2900785077647915400", "customerName": "Taariq Firfirey", "internalName": "Sierra Barnes", "customerEmail": "taariq.firfirey@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... out around it.\n[Speaker 2900785077647915400]: I was looking into it but then lost interest because I just wasn't using it too often.\n[Speaker 2900785077647915400]: So for me using it currently, it's just to make a certain, I am using some of the images in presentations\u2026 but not\u2026 like maybe drawing out the workflow, or flow.\n[Speaker 2900785077647915400]: I think\u2026 it's quite nice for, but at the moment\u2026 I'm not using it, very, heavily.\n[Speaker 2900785077647915400]: That's.\n[Speaker 2900785077647915400]: mainly,\n[Speaker 2900785077647915400]: the three features that it comes with it.\n[Speaker 2900785077647915400]: And I know there's a lot of more features with, the premium account, but unfortunately, I wasn't able to explore that too much at this point in time.\n[Speaker 6159906293072374701]: Mm, HMM.\n[Speaker 6159906293072374701]: Maybe I can clarify that a little bit.\n[Speaker 6159906293072374701]: I assume you're not part of red or pharma in your role.\n[Speaker 2900785077647915400]: ", "contextAfter": "\n[Speaker 6159906293072374701]: Okay.\n[Speaker 6159906293072374701]: Yeah.\n[Speaker 6159906293072374701]: So we've worked to set up all of Roche read with access and that's kind of what the sso link is giving people access to.\n[Speaker 6159906293072374701]: And that's kind of the inspiration for the outreach.\n[Speaker 6159906293072374701]: We're kind of working towards setting up the same goal for Roche diagnostics.\n[Speaker 6159906293072374701]: And I've been, you know, reaching out to users that have been using BioRender to see if that would be something that would be a value to other groups at Roche.\n[Speaker 6159906293072374701]: But so it sounds like you've been using BioRender for quite a while, but what were you using before you discovered BioRender to kind of help make, your presentations and flow diagrams?\n[Speaker 2900785077647915400]: Basically have to throw your own icons and try to use random things from the internet before that.\n[Speaker 2900785077647915400]: It's quite n...", "callTitle": "BioRender & Roche - Intro Call"}, {"quote": "So you're on the Roach diagnostics?", "date": "2024-03-08", "callId": "2024-03-08_ea7c76d3d479", "gongUrl": "https://app.gong.io/call?id=ea7c76d3d479bbd5090a53006dba841aa0be1364416d73a124d9cb8809d692d8", "speakerId": "6692052275950100221", "customerName": "Ruichen Zheng", "internalName": "Jacqueline McCoskey", "customerEmail": "ren.zheng.rz1@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...67455533012515]: So first name is last name.\n[Speaker 5412767455533012515]: Can you provide last name on my pro look?\n[Speaker 6692052275950100221]: So the reason why I was asking was Stephen sash is who has historically been the product owner of by render and he has a ton of contact, but I think there was a reorg that happened and now he's not, he's no longer with Roach or within that in that current role.\n[Speaker 6692052275950100221]: So I was wondering if that's what you're reaching out to you because it might be the reason why you weren't able to get a hold of someone.\n[Speaker 6692052275950100221]: So Alvaro must have just recently taken over.\n[Speaker 6692052275950100221]: I guess.\n[Speaker 6692052275950100221]: So you're in the diagnostics group, is that right?\n[Speaker 5412767455533012515]: Yes.\n[Speaker 5412767455533012515]: Okay.\n[Speaker 5412767455533012515]: Not the, and it's on the side, not a side, yes.\n[Speaker 6692052275950100221]: Okay.\n[Speaker 6692052275950100221]: ", "contextAfter": "\n[Speaker 6692052275950100221]: So let me give you a little bit of context right now.\n[Speaker 6692052275950100221]: So currently, we have basically by under access for every single person in genentech\u2026 primarily the it's funded by the G red folks.\n[Speaker 6692052275950100221]: And then at Roche, the P red folks have full sort of like access for every single person in pre.\n[Speaker 6692052275950100221]: Amazing.\n[Speaker 6692052275950100221]: So.\n[Speaker 5412767455533012515]: Yeah, the Utica side for now, I\u2026\n[Speaker 6692052275950100221]: They, are like one of our largest customers actually.\n[Speaker 6692052275950100221]: So, they, you know, we're really widespread in that side of the business, but we have been getting numerous requests from diagnostics as well as from the ptd sort of group.\n[Speaker 6692052275950100221]: And, it's funny you reached out now because we're in talks right now to try to figure out a way to make it available on a larger scale.\n[Speaker 6692052275950100221...", "callTitle": "BioRender | Roche"}, {"quote": "Diagnostics and P, red somewhere along those lines.", "date": "2025-03-25", "callId": "2025-03-25_04a35beb559c", "gongUrl": "https://app.gong.io/call?id=04a35beb559c549d9b90f7d75fe4e5f7df9d30e58a07ffc09e6a10c73e7c4b33", "speakerId": "2537645070975902845", "customerName": "Johannes Then", "internalName": "Jacqueline McCoskey", "customerEmail": "johannes.then@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...[Speaker 5313404589143487983]: Nice.\n[Speaker 5313404589143487983]: That's awesome.\n[Speaker 5313404589143487983]: That's yeah, you guys got a big site there, so that's nice that you guys, have a gym to be able to head to you've.\n[Speaker 2537645070975902845]: been here before I have.\n[Speaker 5313404589143487983]: Been, but looking at pictures now that we're planning this on site, I'm like that is a campus.\n[Speaker 5313404589143487983]: Oh, yes, we.\n[Speaker 2537645070975902845]: have like 7,008 1,000.\n[Speaker 2537645070975902845]: I'm not sure.\n[Speaker 2537645070975902845]: Crazy.\n[Speaker 2537645070975902845]: It's a little village.\n[Speaker 2537645070975902845]: Yeah.\n[Speaker 5313404589143487983]: Yeah, it's a village.\n[Speaker 5313404589143487983]: It looks like it's wild.\n[Speaker 5313404589143487983]: So, I'm excited to come because, yeah, it's I think you guys have close to 6,000 scientists there.\n[Speaker 5313404589143487983]: Is that right?\n[Speaker 2537645070975902845]: ", "contextAfter": "\n[Speaker 2537645070975902845]: Yeah, it's above seven K.\n[Speaker 2537645070975902845]: Yeah, I'm not sure whether we have already hit the eight K but it's.\n[Speaker 5313404589143487983]: wow.\n[Speaker 5313404589143487983]: That's awesome.\n[Speaker 5313404589143487983]: It.\n[Speaker 2537645070975902845]: Is big at once.\n[Speaker 5313404589143487983]: Yeah, yeah, totally.\n[Speaker 5313404589143487983]: But yeah, thanks for taking the time to chat.\n[Speaker 5313404589143487983]: I appreciate it.\n[Speaker 5313404589143487983]: I think it's easiest just to kind of jump on here.\n[Speaker 5313404589143487983]: I can provide you some details and context and then I'll provide some more concrete details once we decide if this is something you want to do, but to start, I guess, yeah, we're basically coming on site the week that I had mentioned between the 28, 26 to 28.\n[Speaker 5313404589143487983]: I know that there's a holiday at the end of that week.\n[Speaker 5313404589143487983]: It's kind ...", "callTitle": "BioRender | Roche"}, {"quote": "you have like thousands of people in diagnostics", "date": "2024-09-19", "callId": "2024-09-19_d132aba88672", "gongUrl": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "speakerId": "3068414967322493854", "customerName": "Markus Eckl", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "markus.eckl@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...Yeah.\n[Speaker 3068414967322493854]: I actually do have one quick question for you.\n[Speaker 3068414967322493854]: Do you know, like I know that you're in.\n[Speaker 3068414967322493854]: Diagnostics, like the research, it's quite large, right?\n[Speaker 3068414967322493854]: It's like a.\n[Speaker 1493537282318889744]: large group of people?\n[Speaker 1493537282318889744]: From the outside it looks quite large and from the inside it's...\n[Speaker 1493537282318889744]: I can't oversee everything.\n[Speaker 1493537282318889744]: You know, we have...\n[Speaker 1493537282318889744]: So I'm based in Penzbeck, south of Munich.\n[Speaker 1493537282318889744]: We do Z Core Lab development.\n[Speaker 1493537282318889744]: we have the colleagues of early development right in the building next to us okay we have the pathology guys in tucson yeah so we have some guys in basel we have you're all over not connected to them so okay.\n[Speaker 3068414967322493854]: okay so but as a function though it is like ", "contextAfter": " and.\n[Speaker 1493537282318889744]: Yeah, it's quite large.\n[Speaker 1493537282318889744]: Yeah.\n[Speaker 3068414967322493854]: yeah yeah no that's kind of what we've been hearing too so hopefully this will make this will make access like a lot more widespread beyond those groups that everyone can access it so and i will say i think once we actually get this up and running we are looking to do some like in person sort of training sessions as well so we'll be kind of on site and if that's ever the case i'll let you know and then we could do something for your group while we're in the area awesome well thanks marcus i appreciate your time and i will be in touch shortly.\n[Speaker 1493537282318889744]: Thanks a lot.\n[Speaker 1493537282318889744]: Take care.\n[Speaker 1493537282318889744]: Bye.", "callTitle": "BioRender & Roche - Follow Up Call"}, {"quote": "we want to combine UMP and its pharma unit and then we'll have a diagnostics unit", "date": "2024-09-16", "callId": "2024-09-16_d36b49ea866e", "gongUrl": "https://app.gong.io/call?id=d36b49ea866e8fc066b20a5d96a1a11f1afb1d751f0a926343dc3ca8b2b1b2f1", "speakerId": "4443789273359589298", "customerName": "Gaius Augustus; George Abousleiman; Kawal Kaur", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "gaius.augustus@roche.com; abousleg@gene.com; kaurk5@gene.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...head.\n[Speaker 4443789273359589298]: So I have questions about two of these components.\n[Speaker 4443789273359589298]: So the first one is Roche controlled trial.\n[Speaker 4443789273359589298]: What does that mean?\n[Speaker 1067617882933750578]: The Roche controlled trial?\n[Speaker 1067617882933750578]: Yeah.\n[Speaker 1067617882933750578]: Oh just the fact that it's in line with the timeline so that the like when we the time that we start it and the time that it ends will be in alliance or sorry aligned with the P Red and G Red renewal.\n[Speaker 4443789273359589298]: Okay gotcha.\n[Speaker 4443789273359589298]: Yeah.\n[Speaker 4443789273359589298]: Just for future reference as we are moving towards enterprising licenses I think maybe we also want to work on how we're addressing these different functions because internally for us it's pharma and dial that's it.\n[Speaker 4443789273359589298]: Yeah okay.\n[Speaker 4443789273359589298]: Going forward maybe we come on the BioRender side maybe ", "contextAfter": " and my understanding is that this proof of concept that and that's feel free to jump in this proof of concept we're doing is primarily for diagnostics because we're getting a lot of requests from them.\n[Speaker 1067617882933750578]: Yep totally okay that's good for us to know yeah we because everyone in pharma within like the P RED and G RED divisions has access right now so everyone else it'll be for the people that are outside of it I guess this is just more so talking about the renewal date and when we're hoping it to launch the enterprise licensing and then this will be like kind of the running in parallel as we're working towards that enterprise licensing I can clarify that language on here too if that's.\n[Speaker 4443789273359589298]: helpful.\n[Speaker 4443789273359589298]: OK, that's OK.\n[Speaker 4443789273359589298]: And I'm sharing this with you because as we are moving forward, you will hear us saying fine diagnostics like we're getting rid of GYP.\n[Speaker 44437892733595892...", "callTitle": "BioRender | Roche - short term access"}, {"quote": "We've been getting a number of requests outside within PDD as well as diagnostics.", "date": "2024-09-10", "callId": "2024-09-10_a7e39ba6d000", "gongUrl": "https://app.gong.io/call?id=a7e39ba6d0002a5c2ce052c12e30cc994a9235b4911c827cb2f492c18c4411fe", "speakerId": "3227459355290943038", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...u how this is handled in other departments.\n[Speaker 16832304959900895]: Of course, yeah.\n[Speaker 16832304959900895]: And that would be one of my questions.\n[Speaker 16832304959900895]: So how are the licenses handled for GRAT and PRAT?\n[Speaker 16832304959900895]: And is there or are you in discussions with other departments to move that further?\n[Speaker 16832304959900895]: Or with our IT, I don't know what your primary contact is.\n[Speaker 16832304959900895]: So that would be my first question.\n[Speaker 16832304959900895]: Yeah.\n[Speaker 3227459355290943038]: Perfect.\n[Speaker 3227459355290943038]: So yeah, right now, P RED and G RED both have like, everyone in P RED and G RED are able to access it freely.\n[Speaker 3227459355290943038]: Not for really, but they're able to just go through and request it to the app store, if that makes sense.\n[Speaker 3227459355290943038]: We are in discussions right now of expanding that access beyond P RED and G RED.\n[Speaker 3227459355290943038]: ", "contextAfter": "\n[Speaker 3227459355290943038]: And we're in active discussions with the IT folks right now.\n[Speaker 3227459355290943038]: Not entirely sure what that's going to look like or what the timeline is for that, but it is something that we are actively discussing and we're still trying to work out the logistics of it.\n[Speaker 3227459355290943038]: So what we've been kind of doing with other groups is getting them sort of set up on their own independent kind of license until we get something more centrally long term set up.\n[Speaker 3227459355290943038]: So say if your group decided you to do something on a smaller scale and then you know maybe in a few months or it could be a year that's the thing like it's been kind of in chat for a while of if we were to expand beyond p red and g red from like an it central sort of perspective we would make sure that your group is kind of like wrapped up in that license so that you're not having like this independent license when something is made widely...", "callTitle": "BioRender & Roche - Follow Up Call"}, {"quote": "We are in a diagnostic field, yes.", "date": "2024-07-10", "callId": "2024-07-10_7414642102ff", "gongUrl": "https://app.gong.io/call?id=7414642102ff28ca83e157f8f847b5af917380ac2b7b325cfe2956ff4708414e", "speakerId": "1844047739134457378", "customerName": "Tanja Scheuermann", "internalName": "Sierra Barnes", "customerEmail": "tanja.scheuermann@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...0858522]: Definitely.\n[Speaker 1844047739134457378]: For, for the whole, yeah, to really try, to get a license for the whole chapter and also to convince people using this.\n[Speaker 1844047739134457378]: If they are not willing using this, then it doesn't make sense.\n[Speaker 6715607648140858522]: Definitely.\n[Speaker 6715607648140858522]: Yeah.\n[Speaker 6715607648140858522]: I totally agree with you on that.\n[Speaker 6715607648140858522]: Which team are you a part of at Roche?\n[Speaker 1844047739134457378]: So, we have bio chemicals.\n[Speaker 1844047739134457378]: So diagnostic tools, so antibodies the molecules, molecular drawings, process drawings.\n[Speaker 1844047739134457378]: So, these are, would be in the first line, the things I would like, to draw, and kind of presentation.\n[Speaker 1844047739134457378]: Yeah.\n[Speaker 1844047739134457378]: For, for presentations.\n[Speaker 6715607648140858522]: And are you part of a specific department at Roche?\n[Speaker 1844047739134457378]: ", "contextAfter": "\n[Speaker 6715607648140858522]: Diagnostics?\n[Speaker 6715607648140858522]: Okay.\n[Speaker 6715607648140858522]: And how large is your team at Roche approximately?\n[Speaker 1844047739134457378]: So, the people whom I.\n[Speaker 1844047739134457378]: where I feel that it might make sense, to align them?\n[Speaker 1844047739134457378]: Yeah, it has to be.\n[Speaker 1844047739134457378]: I think at least our chapter and these are, yeah.\n[Speaker 1844047739134457378]: 100 plus people, but not all of them are presenting to only part of them are presenting.\n[Speaker 1844047739134457378]: Yeah, but this is really already, a bigger sized chapter.\n[Speaker 1844047739134457378]: Let's say.\n[Speaker 6715607648140858522]: Okay.\n[Speaker 6715607648140858522]: And what are others on your team currently using to communicate their science\u2026 which tools?\n[Speaker 1844047739134457378]: To be honest, I do not know well.\n[Speaker 1844047739134457378]: A lot of them also use Powerpoint, some of them.\n[Speaker ...", "callTitle": "Call with Roche Ltd. - Tanja Scheuermann"}, {"quote": "So we have the diagnostics, and then we have the pharma, yeah, separate divisions.", "date": "2024-06-14", "callId": "2024-06-14_5820c7bc82da", "gongUrl": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "speakerId": "1372854872117518306", "customerName": "Felix Kuhne", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "felix.kuhne@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... helpful.\n[Speaker 8593743714562823197]: So just to clarify you're within so that we have just looking at my other screen so we have PD and then there's an analytics group.\n[Speaker 8593743714562823197]: And then there's a characterization of molecules, smaller group.\n[Speaker 8593743714562823197]: And that's the part that you're the group that you're part of, right?\n[Speaker 8593743714562823197]: Yeah.\n[Speaker 8593743714562823197]: Got you.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: How many people are within that characterization of molecules group?\n[Speaker 1372854872117518306]: 40 roughly.\n[Speaker 8593743714562823197]: 40?\n[Speaker 8593743714562823197]: Okay, perfect.\n[Speaker 8593743714562823197]: I have a question for you.\n[Speaker 8593743714562823197]: How do I?\n[Speaker 8593743714562823197]: Pt, isn't a part of like diagnostics or\u2026 like it's completely separate from those two groups.\n[Speaker 1372854872117518306]: Yeah.\n[Speaker 1372854872117518306]: ", "contextAfter": "\n[Speaker 1372854872117518306]: And within the pharma division, the research and development is separate organization if you want.\n[Speaker 1372854872117518306]: So, and then we have, the technical development.\n[Speaker 1372854872117518306]: So the process development unit, and then we have the commercial unit which is today basically produce the product in the end.\n[Speaker 1372854872117518306]: And those are the three big organizations and the research so pre and in the us is great.\n[Speaker 1372854872117518306]: The research units are larger than the technical development unit.\n[Speaker 1372854872117518306]: And also the commercial units are larger technical development.\n[Speaker 1372854872117518306]: Is, I mean, we have technical development activities in basel in pennsburg, and in san Francisco.\n[Speaker 1372854872117518306]: Mainly, I would say probably there are some other\u2026 sites where they also have technical development activities.\n[Speaker 1372854872117518306]: But those are ...", "callTitle": "BioRender & Roche - Follow Up Call"}, {"quote": "I'm in diagnostics part of the greater Roche business.\nI don't know the headcount of people india, but maybe it is\u2026 a quarter of the company because it makes up about a quarter of the revenue, somethi", "date": "2024-03-19", "callId": "2024-03-19_9e91cefedfc0", "gongUrl": "https://app.gong.io/call?id=9e91cefedfc0ec5b5b59b080184b441a077782ac8879391f8ae96ded7ab9bd9a", "speakerId": "1570913027692445240", "customerName": "", "internalName": "Jacqueline McCoskey", "customerEmail": "alexander.brown@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [{"value": "25,000", "snippetIndex": 9, "source": {"callDate": "2024-03-19", "customerName": ""}}], "contextBefore": "...this account set up for\u2026 a month or something.\nYeah.\nOkay.\nOkay.\nNo worries.\nI can definitely help you out.\nI can provide you.\nSo I'm sort of like the dedicated account rep here at I've been working with you guys for a couple of years now, so I have some context and can provide you some insight into, you know, where we currently stand and how we can get you access.\nOkay?\nJust a couple of questions for you.\nI know that you had mentioned.\nSo you're in the diagnostics group?\nYeah.\nOkay.\nDo you mind giving me a little bit of an overview in terms of like what team you're part of and sort of like how like where you're located and that kind of like organizationally where you fit in there?\nYeah.\nI think I'll just have to give you like a verbal, we have all these kind of it's over 100,000 people in the company.\nSo there's like hierarchy org, charts and stuff, which is a useful reference point.\nBut I don't know if I can actually share my screen for showing you that.\nBut yeah, yeah.\nSo\u2026 we're I, ", "contextAfter": "ng like that.\nOkay?\nBut still 25,000 people, something like that.\nAnd then I, and then within dy that also kinda includes\u2026 diabetes care, and some other kind of subsidiary businesses like sequencing solutions, things like that.\nBut I'm in R and D.\nSo we call this research and early development.\nAnd then I'm also working a team in anti body development.\nSo for my purposes, I would want it for the greater R and D aspects of the diagnostics business.\nAnd then I'm at the very earliest stages of this R and D pipeline in discovery.\nSo we come up with, very much like the academic side of things where you're kind of figuring out what is an interesting idea.\nHow do we test like the minimum viable way of testing that and then pass it off to somebody in more downstream development if it has like, yeah, yeah.\nHey, I appreciate that overview.\nI am curious because it sounds like you have some good context here.\nWhat is like the primary difference between the diagnostic side of the business versus li...", "callTitle": "BioRender | Roche Diagnostics"}]}, {"id": "roche_protein_chemistry_3e5843dc", "company": "roche", "gong_entity": "Protein Chemistry", "gong_parent": "Roche Diagnostics", "entity_type": "department", "team_size": "150", "confidence": "high", "mention_count": 3, "snippet": "Her name is\u2026 Julian. Ben's. Had also reached out and she is in\u2026 protein chemistry", "snippet_date": "2024-05-16", "person_name": "Bernardo Antunes", "person_email": "bernardo.antunes@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=1aea80dc1bce6461af9b8998abb47ce7f59b1689fa117b641b3551b88729e5a8", "call_id": "2024-05-16_1aea80dc1bce", "call_count": 3, "all_snippets": [{"quote": "Her name is\u2026 Julian. Ben's. Had also reached out and she is in\u2026 protein chemistry", "date": "2024-05-16", "callId": "2024-05-16_1aea80dc1bce", "gongUrl": "https://app.gong.io/call?id=1aea80dc1bce6461af9b8998abb47ce7f59b1689fa117b641b3551b88729e5a8", "speakerId": "3968667140592967963", "customerName": "Bernardo Antunes", "internalName": "Jacqueline McCoskey", "customerEmail": "bernardo.antunes@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...n or?\nI know it hasn't been introduced to me yet.\nI just talked to her manager and then her manager told me like what is needed and I'll assign someone, to you, right?\nSo I'm waiting for the assignment.\nPerfect.\nI got you.\nAnd do you have the name of the like the manager just so I have it in my record.\nYeah.\nIt's a so K, a walkauur?\nOkay, perfect.\nThat's yeah, that's helpful.\nSo she, they're the person that they are trying to find someone who assign, but it's their manager, that will be like she's the manager trying to find someone who assign this project.\nOkay?\nYeah, she's the manager, right?\nShe's the person that I'm in contact with at the moment.\nAnd once you get someone on board, then we can get a better sense of whether or not, you know, we want to do this poc, and\u2026 kind of like, what if we just like get groups started on another way?\nDoes that make sense?\nExactly.\nYeah, exactly.\nCorrect.\nI had another group reach out\u2026 so I can forward.\nYou.\nLet me double.\nI'll just give you one.\n", "contextAfter": " and she had reached out to a,\nJulian or Julian.\nJulianne the chat\u2026 Julia, and\u2026 it's Ben.\nThe.\nso on top of the ones that we've spoken about previously, she reached out on behalf of and so she was entirely sure about the size, but we're doing kind of a webinar for her and the five team leads, that work in that group.\nSo we're trying to figure out how many people but if you want to reach out to her, to get sort of a sense of that sort of demand, that would be helpful.\nProbably I can connect you to whatever you think is easier.\nAll right?\nNo, don't need to connect me.\nI'll just put it here on my list and I'll forward this right now to, yeah.\nOkay, perfect.\nOur.\nperfect.\nAlright.\nOne thing I did mean to ask you when you had, I think it might have been when you had taken over or it was kind of in the transition.\nYou, you all sent us\u2026 an nda and we signed it and sent it back, but I don't think we had a counter signature for it.\nWe were about to do like a, my creative team was about to do a ...", "callTitle": "BioRender | Roche"}, {"quote": "Those are my colleagues in protein chemistry.", "date": "2024-04-30", "callId": "2024-04-30_5a2d7c011f2f", "gongUrl": "https://app.gong.io/call?id=5a2d7c011f2fcde164ae2f8a65ee442a50ab33a7e64f53e24e752f43b54c704b", "speakerId": "3796976292990352198", "customerName": "", "internalName": "Jacqueline McCoskey", "customerEmail": "juliane.benz@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...8499848786963]: That's perfect.\n[Speaker 8638668499848786963]: Yeah, that makes total sense.\n[Speaker 8638668499848786963]: So if you want to kind of like start by asking around making sure a couple of times work, I'm sure I'll be able to make it work on my side.\n[Speaker 8638668499848786963]: That's the only other thing is if I have a similar thing schedule with anyone else, but you should be okay?\n[Speaker 3796976292990352198]: Yeah, I will check their calendars right away and then discuss with them on Thursday because tomorrow we have a public holiday and then I will let you know.\n[Speaker 8638668499848786963]: Perfect.\n[Speaker 8638668499848786963]: Okay.\n[Speaker 8638668499848786963]: Sounds good.\n[Speaker 8638668499848786963]: And just to confirm, would that be, I guess what team would that be for the five or six people?\n[Speaker 8638668499848786963]: Is that for the, just looking at my notes here because protein chemistry is your large department.\n[Speaker 3796976292990352198]: ", "contextAfter": "\n[Speaker 3796976292990352198]: So those are other team leads from protein chemistry.\n[Speaker 8638668499848786963]: Okay.\n[Speaker 8638668499848786963]: So from the, okay, perfect.\n[Speaker 3796976292990352198]: They are from my department, they're just other team leads from my department.\n[Speaker 3796976292990352198]: Perfect.\n[Speaker 8638668499848786963]: Okay.\n[Speaker 8638668499848786963]: So with the leaders of the different groups and he got you.\n[Speaker 8638668499848786963]: Okay, that's great.\n[Speaker 8638668499848786963]: Make sure that it's tailored to, I guess, is there anything in particular that would be super important to cover in, that webinar?\n[Speaker 8638668499848786963]: We a, I have like a standard sort of type of a webinar and tailor it depending.\n[Speaker 8638668499848786963]: But if there's any type of like\u2026 you know, workflows or things that you currently use BioRender for or create?\n[Speaker 3796976292990352198]: A\u2026 I think what it's used so far from some ...", "callTitle": "BioRender | Roche"}, {"quote": "in the department of protein chemistry.\nOkay?\nAnd so our whole department is around 150 members.\nAnd I think for example, frank cone, he's one of my colleagues.\nHe's also in the protein chemistry depa", "date": "2024-04-16", "callId": "2024-04-16_709ead3935e2", "gongUrl": "https://app.gong.io/call?id=709ead3935e2ad83e19cc626e637fd33611c45540648fe5156b451c9bb0a58e3", "speakerId": "2852946406941478705", "customerName": "", "internalName": "Jacqueline McCoskey", "customerEmail": "juliane.benz@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [{"value": "150", "snippetIndex": 2, "source": {"callDate": "2024-04-16", "customerName": ""}}], "contextBefore": "...ime to chat just to give you some context.\nSo I'm kind of like the primary contact between buyer and enoch.\nSo any sort of like communication that happens between us typically goes for me and I have some contexts in terms of like licensing, and where things stand right now from or?\nI know I got your e-mail I got your note.\nIs there anything that you're hoping to gather today besides like pricing for your depart for your group?\nOr was that kind of the primary thing you?\nYeah.\nI think the primary thing is, to get to know which options would be there, to get a license for our team department.\nYeah.\nOkay, perfect.\nAnd so I have a couple of questions just to kind of understand, you know, the team and the setup.\nAnd then we can figure out like what would be the best option\u2026 to start.\nDo you mind giving me?\nLike, I know you're in diagnostics, but do you mind giving me a sort of overview in terms of like the team and department that you sit within in here?\nYeah.\nYeah.\nSo I'm in R and D.\nYeah, ", "contextAfter": "rtment.\nI think he approached you almost a year ago because he had the same question.\nYeah.\nAnd I think he now has some individual licenses.\nYep.\nBut yeah, it pops up in our department from time to time, we were thinking if there would be an option just with, I don't know 10 or dependent on how you offer it floating licences, for our whole department.\nYeah.\nYeah.\nOkay.\nPerfect.\nThanks for that context.\nCouple of questions from there on the like R and D side within diagnostics, like approximately how large because 150 people is a pretty large department?\nLike do you know how large the actual R and D side of diagnostics is?\nPretty big.\nYeah, like thousands or, yeah.\nYeah.\nOkay.\nThat makes sense.\nCause so to give you some context, when I talked to him about a year ago, we were trying to get something for the diagnostic side of the business.\nYes, I heard that, and I think that's that one.\nYou know what?\nThe conversations are still happening because, we get requests quite a bit.\nBut if I wa...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_protein_chemistry_group_731eca59", "company": "roche", "gong_entity": "Protein Chemistry Group", "gong_parent": "Protein Chemistry", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "we have one booked on the 20 eighth for like a protein chemistry group within the diagnostics team.", "snippet_date": "2025-03-25", "person_name": "Johannes Then", "person_email": "johannes.then@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "protein-therapeutics-gred", "manual_node_name": "Protein Therapeutics", "manual_node_path": "Roche Research & Development > Genentech Research & Early Development (gRED) > Therapeutic Discovery (gRED) > Protein Therapeutics", "confidence": "low", "reasoning": "Weak semantic match based on protein focus, but entity seems to be in diagnostics context while matched node is in therapeutics discovery"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=04a35beb559c549d9b90f7d75fe4e5f7df9d30e58a07ffc09e6a10c73e7c4b33", "call_id": "2025-03-25_04a35beb559c", "call_count": 3, "all_snippets": [{"quote": "we have one booked on the 20 eighth for like a protein chemistry group within the diagnostics team.", "date": "2025-03-25", "callId": "2025-03-25_04a35beb559c", "gongUrl": "https://app.gong.io/call?id=04a35beb559c549d9b90f7d75fe4e5f7df9d30e58a07ffc09e6a10c73e7c4b33", "speakerId": "5313404589143487983", "customerName": "Johannes Then", "internalName": "Jacqueline McCoskey", "customerEmail": "johannes.then@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...\n[Speaker 5313404589143487983]: But if there are other folks that were also interested, we want to do as many sessions as possible while we're there and find doing like smaller sessions, about 30 to 50 people tailored to like their specific audience is the best way to do this.\n[Speaker 5313404589143487983]: That's what we've done at other sites and we've visited the genentech site a couple times but have not made our way actually to Roche.\n[Speaker 5313404589143487983]: So\u2026 yeah, that'll be, so, I guess from, in terms of like next steps, like if you want to send over some times that, you know, would work for you, then we can kind of like I can cross reference with the other sessions that we have booked and.\n[Speaker 2537645070975902845]: If you have already booked some sessions, you can tell me which ones are blocked.\n[Speaker 2537645070975902845]: So this way around makes more sense.\n[Speaker 2537645070975902845]: Yeah.\n[Speaker 5313404589143487983]: So, sorry, like there are it's so ", "contextAfter": "\n[Speaker 5313404589143487983]: So, and then we have another booked on the 20 seventh from one 30 to four 30.\n[Speaker 5313404589143487983]: We're still trying to.\n[Speaker 2537645070975902845]: Figure out what's from nine?\n[Speaker 5313404589143487983]: To 11 a.\n[Speaker 5313404589143487983]: M?\n[Speaker 2537645070975902845]: Nine to 11, and then the 26 you.\n[Speaker 5313404589143487983]: Have the 27 or 26.\n[Speaker 5313404589143487983]: We have room from one 30 to four 31.\n[Speaker 2537645070975902845]: 30 to four 30.\n[Speaker 2537645070975902845]: Okay.\n[Speaker 2537645070975902845]: So, Tuesday and then.\n[Speaker 5313404589143487983]: the Tuesday is also, we have something, we have a room booked for one 30 to four 30.\n[Speaker 5313404589143487983]: So again, we're just trying to fill the slots and make sure that we get the most out of being on site.\n[Speaker 5313404589143487983]: So, I think if, you know, your group would want to do something specifically for your group, we would j...", "callTitle": "BioRender | Roche"}, {"quote": "you are within the protein chemistry group", "date": "2025-03-17", "callId": "2025-03-17_6daee1c34511", "gongUrl": "https://app.gong.io/call?id=6daee1c345113c319399d36ffb645a6de510bea40db36c8608c1f9e2da5e7dc3", "speakerId": "1891399847486698875", "customerName": "Juliane Benz", "internalName": "Jacqueline McCoskey", "customerEmail": "juliane.benz@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...ah, what we're hoping to do is we're looking to come on site.\n[Speaker 1891399847486698875]: And I'll provide, some dates and times that we're we've been looking at and then you can cross reference cause I know we've got, we're already approaching almost like the holiday season, which is crazy.\n[Speaker 1891399847486698875]: Yeah.\n[Speaker 1891399847486698875]: But, yeah.\n[Speaker 1891399847486698875]: So this initial training with virtual one next week will be more so like high level, you know, intro to biorender, and then if we were to come, to see you in person, we can do something more tailored to your team, or something more specific to like the things you'd want to learn if that's like different protocols or graphing or different features or new features.\n[Speaker 1891399847486698875]: So we'll make sure it's a little bit more specific in terms of like, the use cases that you'd be using it for.\n[Speaker 1891399847486698875]: Yeah, a couple of questions just to refresh my memory, ", "contextAfter": ".\n[Speaker 1891399847486698875]: Is that correct?\n[Speaker 1891399847486698875]: Yes.\n[Speaker 1891399847486698875]: Okay.\n[Speaker 1891399847486698875]: And are you all located at the penzberg site or are you guys kind of, oh, perfect.\n[Speaker 1891399847486698875]: Okay.\n[Speaker 1891399847486698875]: And I remember last time I noted that you had there's like 150 people within that group.\n[Speaker 1891399847486698875]: Okay?\n[Speaker 1891399847486698875]: Do you imagine if we were to do something in person that, you know, most people would be interested?\n[Speaker 1891399847486698875]: Or do you feel like half or is it so hard to say?\n[Speaker 8572123162027050155]: I would say that if I ask them, everybody says, yeah, they are interested.\n[Speaker 8572123162027050155]: Yeah.\n[Speaker 8572123162027050155]: But at the end, maybe between 30 and 50 will show up.\n[Speaker 8572123162027050155]: I think that's honestly a.\n[Speaker 1891399847486698875]: Perfect.\n[Speaker 1891399847486698875]:...", "callTitle": "BioRender | Roche"}, {"quote": "One question, is this, is everyone within the protein chemistry group?", "date": "2024-08-08", "callId": "2024-08-08_f3629a4da009", "gongUrl": "https://app.gong.io/call?id=f3629a4da00964cabf2f3ca8fb88314ac073586da0468002f56d04f998bb331e", "speakerId": "8135495444955920439", "customerName": "Juliane Benz", "internalName": "Jacqueline McCoskey", "customerEmail": "juliane.benz@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "... His name's Tim.\n[Speaker 8135495444955920439]: He's like Roche's dedicated.\n[Speaker 8135495444955920439]: It's the two of us.\n[Speaker 8135495444955920439]: But he will set up an initial meeting with you to show you how to work the administrative panel.\n[Speaker 8135495444955920439]: There's like a panel.\n[Speaker 8135495444955920439]: You can add the users on the back end.\n[Speaker 8135495444955920439]: Like it's really simple.\n[Speaker 8135495444955920439]: Okay.\n[Speaker 8135495444955920439]: You don't need to send a list of names.\n[Speaker 8135495444955920439]: We can do it for you, but like it's not a requirement because you can easily do it on your side.\n[Speaker 8135495444955920439]: He'll teach you how to do it and then he will also get you access to the licenses and how to actually access them.\n[Speaker 8135495444955920439]: As well as they can do some training and onboarding so that people know what to do.\n[Speaker 8135495444955920439]: Okay.\n[Speaker 8135495444955920439]: ", "contextAfter": "\n[Speaker 8135495444955920439]: Yes.\n[Speaker 8135495444955920439]: Okay, perfect.\n[Speaker 8135495444955920439]: So we'll just make sure that that's the label of the group.\n[Speaker 8135495444955920439]: Do you know internally how to submit for a purchase order?\n[Speaker 8135495444955920439]: Like, is that, okay perfect.\n[Speaker 8135495444955920439]: Yeah.\n[Speaker 8135495444955920439]: So yeah, basically all that we once we get that we can figure out a start date.\n[Speaker 8135495444955920439]: We just need a few days to set it up on the back end.\n[Speaker 8135495444955920439]: And then once we do get that set up, I will connect you with Tim and then he will help you get onboarded.\n[Speaker 4136738277333011197]: Great.\n[Speaker 4136738277333011197]: My manager is on holiday for the next two and a half weeks.\n[Speaker 4136738277333011197]: After that, we can place the purchase order and then I think it takes, I don't know, some days.\n[Speaker 4136738277333011197]: Yeah, yeah.\n[Speake...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_point_of_care_diagnostics_group_37c8c84e", "company": "roche", "gong_entity": "Point of Care Diagnostics Group", "gong_parent": "Roche Diagnostics", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "in the past three years, I was on the diagnostic side in our point of care diagnostics group", "snippet_date": "2025-05-07", "person_name": "Jeffrey Matthews", "person_email": "jeffrey.matthews.jm1@roche.com", "internal_name": "Jacqueline McCoskey; Shiz Aoki; Vijay Shahani", "internal_email": "jacqueline@biorender.com; shiz@biorender.com; vijay.shahani@biorender.com", "llm_suggested_match": {"manual_node_id": "point-of-care-rd", "manual_node_name": "Point-of-Care R&D", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Point-of-Care R&D", "confidence": "high", "reasoning": "Exact semantic match for point-of-care diagnostics focus, with entity type alignment (group/team level)"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=0ff68150eb6981fea7991b3e7eb653bba89d1ece8b6272dcbc2831801db10158", "call_id": "2025-05-07_0ff68150eb69", "call_count": 1, "all_snippets": [{"quote": "in the past three years, I was on the diagnostic side in our point of care diagnostics group", "date": "2025-05-07", "callId": "2025-05-07_0ff68150eb69", "gongUrl": "https://app.gong.io/call?id=0ff68150eb6981fea7991b3e7eb653bba89d1ece8b6272dcbc2831801db10158", "speakerId": "8694921314646196652", "customerName": "Jeffrey Matthews", "internalName": "Jacqueline McCoskey; Shiz Aoki; Vijay Shahani", "customerEmail": "jeffrey.matthews.jm1@roche.com", "internalEmail": "jacqueline@biorender.com; shiz@biorender.com; vijay.shahani@biorender.com", "sizeMentions": [], "contextBefore": "...n building out those tools but I also have a background in scientific visualization.\n[Speaker 7592388193914656289]: So biorender seemed like a great opportunity to put those two worlds together, and help with some of these special initiatives that we're working on.\n[Speaker 7592388193914656289]: So yeah, we'd love to hear your ideas about pathways, and how you're thinking about the world and maybe we could share a little bit of what we're thinking about as well.\n[Speaker 8694921314646196652]: Now, if you're happy, to have all of you on the call and I really appreciate it.\n[Speaker 8694921314646196652]: So maybe just for my side, I, I've been with the company now for six and a half years.\n[Speaker 8694921314646196652]: My background is actually originally in public health, but I joined Roche in 2018 as a communications business partner to P red, you know, initially working with the immunology, infectious diseases, and ophthalmology, therapeutic areas.\n[Speaker 8694921314646196652]: And ", "contextAfter": ".\n[Speaker 8694921314646196652]: But in January of this year, I transitioned out of comms to our corporate donations and philanthropy group.\n[Speaker 8694921314646196652]: And this biochemical pathways poster.\n[Speaker 8694921314646196652]: The reason it's sitting in CDP as it's called is because this is a, this is a scientific resource that we have provided free of charge to scientists around the globe, you know, students, you know, different individuals who want to have this in their lab and it's kind of changed hands around Roche over the years.\n[Speaker 8694921314646196652]: But given the fact that we kind of held the budget line for the production of the physical posters and then the shipping costs, it was kind of deemed a philanthropic initiative.\n[Speaker 8694921314646196652]: We're in a situation now where\u2026 the digital version of the poster has not been updated in several years.\n[Speaker 8694921314646196652]: And we noted that there was some online conversation among scientists...", "callTitle": "BioRender | Roche - Pathways discussion"}]}, {"id": "roche_genentech_f78bcdac", "company": "roche", "gong_entity": "Genentech", "gong_parent": "Roche", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 10, "snippet": "I didn't have access to the genentech fonts", "snippet_date": "2025-12-03", "person_name": "Hayley Bennett", "person_email": "bennett.hayley@gene.com", "internal_name": "Emily Sin; Grace Ou", "internal_email": "emily.sin@biorender.com; grace.ou@biorender.com", "llm_suggested_match": {"manual_node_id": "genentech-research-early-development", "manual_node_name": "Genentech Research & Early Development (gRED)", "manual_node_path": "Roche Research & Development > Genentech Research & Early Development (gRED)", "confidence": "high", "reasoning": "Exact match for Genentech division within Roche R&D structure"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=4baa2e51174419ae3387a1abc6a593ba60c268bbbac107f0c5b8c146a1cdeb78", "call_id": "2025-12-03_4baa2e511744", "call_count": 10, "all_snippets": [{"quote": "I didn't have access to the genentech fonts", "date": "2025-12-03", "callId": "2025-12-03_4baa2e511744", "gongUrl": "https://app.gong.io/call?id=4baa2e51174419ae3387a1abc6a593ba60c268bbbac107f0c5b8c146a1cdeb78", "speakerId": "6555152349785628297", "customerName": "Hayley Bennett", "internalName": "Emily Sin; Grace Ou", "customerEmail": "bennett.hayley@gene.com", "internalEmail": "emily.sin@biorender.com; grace.ou@biorender.com", "sizeMentions": [], "contextBefore": "...peaker 6555152349785628297]: So you'll be able to make all the edits like, that you want.\n[Speaker 7618157350863529944]: Okay, cool.\n[Speaker 7618157350863529944]: Cool.\n[Speaker 7618157350863529944]: Let's do that.\n[Speaker 7618157350863529944]: Let me, okay.\n[Speaker 7618157350863529944]: Okay.\n[Speaker 7618157350863529944]: So, can you see this new screen now?\n[Speaker 6555152349785628297]: Yes.\n[Speaker 6555152349785628297]: Yeah.\n[Speaker 6555152349785628297]: Okay.\n[Speaker 6555152349785628297]: Biorender's loading right now.\n[Speaker 6555152349785628297]: Okay.\n[Speaker 6555152349785628297]: Cool.\n[Speaker 7618157350863529944]: Taking a little while, Ah, Okay.\n[Speaker 7618157350863529944]: I guess a different font?\n[Speaker 6555152349785628297]: Yeah.\n[Speaker 6555152349785628297]: Can you actually see what else is available under there?\n[Speaker 6555152349785628297]: Is Roche, Sarah?\n[Speaker 6555152349785628297]: Yeah, that's, rose sands.\n[Speaker 6555152349785628297]: Yeah, ", "contextAfter": ".\n[Speaker 6555152349785628297]: So I just, you know, the biorender fonts.\n[Speaker 6555152349785628297]: Okay.\n[Speaker 6555152349785628297]: Cool.\n[Speaker 6555152349785628297]: Yeah, please.\n[Speaker 6555152349785628297]: Take a look at these slides.\n[Speaker 6555152349785628297]: Yeah.\n[Speaker 6555152349785628297]: I tried to simulate what we plan to have the AI, sort of be able to, give you.\n[Speaker 6555152349785628297]: So.\n[Speaker 6555152349785628297]: Yeah.\n[Speaker 7618157350863529944]: Cool.\n[Speaker 7618157350863529944]: Okay.\n[Speaker 7618157350863529944]: Cute.\n[Speaker 7618157350863529944]: I like the image.\n[Speaker 7618157350863529944]: Even, this is nice.\n[Speaker 7618157350863529944]: Awesome.\n[Speaker 7618157350863529944]: The background's kind of funny, but hey, it's not like your biology when there's a, these speakers, right?\n[Speaker 7618157350863529944]: Right.\n[Speaker 6555152349785628297]: Yeah, it's like why is the CRISPR over?\n[Speaker 7618157350863529944]...", "callTitle": "Presentation UX Research with BioRender | Hayley Bennett | Genentech"}, {"quote": "Actually genentech should have AI like modify with AI.", "date": "2025-11-26", "callId": "2025-11-26_46bf1a6b7672", "gongUrl": "https://app.gong.io/call?id=46bf1a6b7672e64b07bce9d0e758c1a09f51174106a151ebc791b61f56a0b3e4", "speakerId": "2228613720507676724", "customerName": "Zoe Piran", "internalName": "Emily Sin; Grace Ou", "customerEmail": "piran.zoe@gene.com", "internalEmail": "emily.sin@biorender.com; grace.ou@biorender.com", "sizeMentions": [], "contextBefore": "... the whole flow be somewhat more related to plate based live cell imaging, take the same cell's icons because right now, if I go, so I want like generic cells, they will, I don't know there's something.\n[Speaker 160046131086692848]: It's also the style of biorender.\n[Speaker 160046131086692848]: But, okay, maybe I'm saying maybe add different styles that kind of break it to shift it from a biorender like signature.\n[Speaker 160046131086692848]: I don't know if this goes in line with the brand's like how they.\n[Speaker 2228613720507676724]: Well, I think if you want to change an existing icon to a different style, that would be the custom edit.\n[Speaker 2228613720507676724]: I just showed you like you put something from our library onto the canvas, then you type in how you want to change it.\n[Speaker 160046131086692848]: But it's not something I quietly can.\n[Speaker 2228613720507676724]: Oh, that's what I'm saying we're like about to release that update.\n[Speaker 2228613720507676724]: ", "contextAfter": "\n[Speaker 2228613720507676724]: You don't see modify with AI as one of the possibilities.\n[Speaker 160046131086692848]: I don't think I ever encountered that.\n[Speaker 160046131086692848]: No, okay.\n[Speaker 2228613720507676724]: So,\n[Speaker 160046131086692848]: like, I only have the color overlay and style, which?\n[Speaker 2228613720507676724]: Is, do you have this button on your sidebar?\n[Speaker 2228613720507676724]: This like star thing in your sidebar on the left here, I know it's kind of small.\n[Speaker 160046131086692848]: Where are you pointing at?\n[Speaker 160046131086692848]: I?\n[Speaker 2228613720507676724]: Can't I'm in like the left middle, wait just a second.\n[Speaker 160046131086692848]: I'm just a second.\n[Speaker 160046131086692848]: No, it like.\n[Speaker 2228613720507676724]: Here in the left sidebar?\n[Speaker 160046131086692848]: But that should be in presentation mode.\n[Speaker 160046131086692848]: Like I'm now here, no, I can share my screen.\n[Speaker 160046131086...", "callTitle": "Research with BioRender | Zoe Piran | Genentech"}, {"quote": "maybe just for some background, can you like briefly describe your role at genentech", "date": "2025-08-18", "callId": "2025-08-18_d496271b931c", "gongUrl": "https://app.gong.io/call?id=d496271b931c5cbaa500658d099d64df378123a74cc9018459dd0a345176ba94", "speakerId": "9169555046548135380", "customerName": "Hayley Bennett", "internalName": "Grace Ou", "customerEmail": "bennett.hayley@gene.com", "internalEmail": "grace.ou@biorender.com", "sizeMentions": [], "contextBefore": "[Speaker 9169555046548135380]: all right.\n[Speaker 9169555046548135380]: So, yeah, we have about 30 minutes together.\n[Speaker 9169555046548135380]: I'm hoping we can do a little bit of like step into your mindset, understand, you know, how you approach it and then if there are any like dummy examples or just past presentations, you're willing to go through.\n[Speaker 9169555046548135380]: Those would be really informative as well.\n[Speaker 2551494793157449522]: Yeah.\n[Speaker 2551494793157449522]: I do have a poster that I can share that I made in biorender.\n[Speaker 2551494793157449522]: Yeah, yeah, let's do that because that one is, I presented that externally so I can show you one.\n[Speaker 2551494793157449522]: Let me share my screen.\n[Speaker 9169555046548135380]: ", "contextAfter": " and the type of science that you work on?\n[Speaker 9169555046548135380]: The type of presentations you typically make?\n[Speaker 2551494793157449522]: Oh, yeah.\n[Speaker 2551494793157449522]: So I'm, a scientist, SCI, it's called scientist for genentech.\n[Speaker 2551494793157449522]: I'm in a group that does, a lot of, method development for single cell technologies.\n[Speaker 2551494793157449522]: So yeah, my job is mainly in the lab with a little bit of computational side, as well.\n[Speaker 2551494793157449522]: Yeah.\n[Speaker 2551494793157449522]: It does say that I have to exit to be able to share, oh, no, here, here we go.\n[Speaker 2551494793157449522]: Let's see.\n[Speaker 9169555046548135380]: Okay.\n[Speaker 9169555046548135380]: I see the poster.\n[Speaker 2551494793157449522]: Yeah.\n[Speaker 2551494793157449522]: So I, this is something that I really like in biorender, we've used this multiple times the poster generation.\n[Speaker 2551494793157449522]: And, I really like that yo...", "callTitle": "Meeting with BioRender Team | Hayley Bennett | Genentech"}, {"quote": "breaking down the barriers between genentech and Roche", "date": "2025-08-14", "callId": "2025-08-14_f2daf041fcef", "gongUrl": "https://app.gong.io/call?id=f2daf041fcef823a1ca53318a0433be11bf09513ae9914842dd2d09ba887c8cd", "speakerId": "2765030990157134975", "customerName": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "internalName": "Chris Hemberger; Jacqueline McCoskey; Tim Fung", "customerEmail": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "chris.hemberger@biorender.com; jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...ing transformation when I say all I'm talking about research side, commercial side, global, it side.\n[Speaker 5654559484448408361]: So it's happening everywhere, oh.\n[Speaker 8143937435222082516]: Okay.\n[Speaker 5654559484448408361]: Large scale.\n[Speaker 5654559484448408361]: Okay.\n[Speaker 5654559484448408361]: So guys and I, we belong to global it.\n[Speaker 5654559484448408361]: Yeah.\n[Speaker 5654559484448408361]: And then we're going through a transformation too.\n[Speaker 8143937435222082516]: Oh, so all of, like research is going through a transformation.\n[Speaker 8143937435222082516]: It's all the specific departments that are going through a transformation.\n[Speaker 8143937435222082516]: Yes.\n[Speaker 8143937435222082516]: Okay.\n[Speaker 8143937435222082516]: So, and then, yeah, global, it?\n[Speaker 8143937435222082516]: Okay.\n[Speaker 8143937435222082516]: That makes sense.\n[Speaker 8143937435222082516]: Helpful.\n[Speaker 2765030990157134975]: Is this related to, I guess like ", "contextAfter": " or?\n[Speaker 2765030990157134975]: Yes?\n[Speaker 2765030990157134975]: Is that part of it?\n[Speaker 2765030990157134975]: Oh, okay.\n[Speaker 2765030990157134975]: Yes.\n[Speaker 2765030990157134975]: Okay.\n[Speaker 5654559484448408361]: So, that's the primary goal, right?\n[Speaker 5654559484448408361]: Like how do we synergize different approaches, different strategy, tech, research, all that cool stuff?\n[Speaker 2765030990157134975]: Okay.\n[Speaker 2765030990157134975]: Yeah, that makes sense.\n[Speaker 2765030990157134975]: Because we were chatting with, one of the, our champions on the genentech side, and he was saying that there's been an initiative to essentially like harmonize, like genentech and Roche.\n[Speaker 2765030990157134975]: Yeah.\n[Speaker 2765030990157134975]: And so, I was just curious like if the like these larger scale transformations were.\n[Speaker 5654559484448408361]: Part of that.\n[Speaker 5654559484448408361]: And then there's different components to it like rese...", "callTitle": "BioRender | Roche - usage data review"}, {"quote": "We're essentially working on introducing exclusive content into the genentech library", "date": "2025-07-18", "callId": "2025-07-18_0ad32043fa9e", "gongUrl": "https://app.gong.io/call?id=0ad32043fa9e61cb77e092a60b584ac826b81aec9f2ca6121dba55b20e0588b6", "speakerId": "3889784214032782990", "customerName": "Ryan Cook", "internalName": "Michael Stanfel; Samara Ona; Tim Fung", "customerEmail": "cook.ryan@gene.com", "internalEmail": "michael.stanfel@biorender.com; samara@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...84214032782990]: Yeah.\n[Speaker 3889784214032782990]: And.\n[Speaker 2427016330480186283]: then I'm sorry, no, all.\n[Speaker 3889784214032782990]: Good.\n[Speaker 3889784214032782990]: All good.\n[Speaker 3889784214032782990]: It's still good to know because the flight to Toronto is really straightforward for me.\n[Speaker 2427016330480186283]: Yeah.\n[Speaker 2427016330480186283]: Well, there's other things, Washington DC and all that, but it would be nice to not have to go through, not have to go through the United States for.\n[Speaker 3889784214032782990]: Yeah, we just need to go through customs once.\n[Speaker 2427016330480186283]: Exactly.\n[Speaker 2427016330480186283]: Cool.\n[Speaker 3889784214032782990]: But no, thanks for taking some time to chat here.\n[Speaker 3889784214032782990]: Today.\n[Speaker 3889784214032782990]: I brought on Michael who is on our creative team.\n[Speaker 3889784214032782990]: I think you might have seen the note that I've sent.\n[Speaker 3889784214032782990]: ", "contextAfter": ".\n[Speaker 3889784214032782990]: I know that you, when we last spoke about this, we were looking at, you provided some feedback about the org content library where it was a mix of curated and some sort of exclusive content for.\n[Speaker 3889784214032782990]: But we've started, we've pivoted a little bit and Michael can add more detail here.\n[Speaker 3889784214032782990]: But what we're trying to do now is actually focus all on exclusive content and then see how we can work with you to essentially start bringing that material in so that folks across, you know, genentech would be able to, across the organization would be able to use it.\n[Speaker 2427016330480186283]: So when you say exclusive content, you're referring to things that pan genentech slash Roche would all be able to access or would it be exclusive to the people who are requesting it or only to be who's releasing that?\n[Speaker 2427016330480186283]: I just wanted to get a kind of an idea of what's going on there?\n[Speaker 485...", "callTitle": "Genentech BioRender content"}, {"quote": "Are they, because I think the pleasanton might be more Roche people, and then the ssf might be more genentech.", "date": "2025-07-09", "callId": "2025-07-09_b18f3f180320", "gongUrl": "https://app.gong.io/call?id=b18f3f18032070f730d62104dcd5db0944f0890e0d5d3d97da7b9f5635e9871d", "speakerId": "5330967402869146782", "customerName": "Gaius Augustus; Kawal Kaur", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "gaius.augustus@roche.com; kaurk5@gene.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...me, it still makes sense to just do south San Francisco, but I wanted to open that up and just make sure that we're all on the same page there.\n[Speaker 5764182407795793704]: So, I think what we can do is let's host sessions in ssf, but we send the communication to other folks who are interested in joining.\n[Speaker 5764182407795793704]: They can, they can drive, I think Santa Clara folks, pleasanton.\n[Speaker 5764182407795793704]: Yeah, there's buses going in and out from all over the bay area.\n[Speaker 5764182407795793704]: So that shouldn't be a problem.\n[Speaker 5764182407795793704]: I think it's an incentive for them to come to ssf and, join us for these sessions.\n[Speaker 6552087390488339969]: Okay.\n[Speaker 6552087390488339969]: Sounds good.\n[Speaker 6552087390488339969]: I just wanted to make sure that we were on the same page with that cool.\n[Speaker 5330967402869146782]: Just curious about the, I guess accessibility between the different sites.\n[Speaker 5330967402869146782]: ", "contextAfter": "\n[Speaker 5330967402869146782]: I'm just curious like if people are able to easily access the ssf campus, if they're not in.\n[Speaker 5764182407795793704]: Yeah, they won't be able to do that.\n[Speaker 5764182407795793704]: So, we, what we would have to do is guys, we would, folks who are interested in driving, they would have, we would need their contact information so we can get them badges.\n[Speaker 6552087390488339969]: Okay.\n[Speaker 6552087390488339969]: So then that would mean that we would probably need to set up like an RSVP?\n[Speaker 5764182407795793704]: Yes, yeah, for.\n[Speaker 6552087390488339969]: The users.\n[Speaker 5764182407795793704]: Yeah, guys, also, I'm going to try to get us an admin assigned.\n[Speaker 6552087390488339969]: To.\n[Speaker 5764182407795793704]: this effort so they can help you with all these logistics.\n[Speaker 5330967402869146782]: Yeah, that'd be perfect.\n[Speaker 5330967402869146782]: I think having a central contact or like one person to do a lot...", "callTitle": "BioRender | Genentech Onsite Planning"}, {"quote": "when we consolidated Roche and genentech workspaces into one", "date": "2025-05-06", "callId": "2025-05-06_37066a25169f", "gongUrl": "https://app.gong.io/call?id=37066a25169f230872122dcbc3bcdf337a663fe018af6d05a93aff696dd6e89c", "speakerId": "6088335049672687772", "customerName": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...tually negotiated for 1,399 concurrent active users.\n[Speaker 6088335049672687772]: And right now there are, you know, almost 1,800 people.\n[Speaker 6088335049672687772]: So Roche is getting like a great value, for the license because we are able to bring on so many more people more than, you know, the number of folks that were actually the license was I guess estimated for.\n[Speaker 6088335049672687772]: So the uptake has been really strong across the board here.\n[Speaker 6088335049672687772]: And in terms of the progress updates, this just shows some, the tasks that we've been working on.\n[Speaker 6088335049672687772]: So on the completed side, you know, sso has been enabled and configured.\n[Speaker 6088335049672687772]: The enterprise workspace has been live and the launch communications have gone on.\n[Speaker 6088335049672687772]: I think everything actually has been super smooth.\n[Speaker 6088335049672687772]: We've when the migration happened.\n[Speaker 6088335049672687772]: Like ", "contextAfter": ", there are about 2,500 people that needed to be moved into the one organization and then changing, their sign in flows as well.\n[Speaker 6088335049672687772]: And of those 2,500 people, I think only five or so people have reached out and are experiencing any sort of issues.\n[Speaker 6088335049672687772]: So it has been super smooth from our perspective guys, I don't know if there are just those that have reached out to you that didn't make it all the way to us.\n[Speaker 6088335049672687772]: But from our perspective, the consolidation was went really well.\n[Speaker 1706286059248901810]: Yeah, we've had a few users who I think didn't go through the right, the like total process that they were supposed to go through on our side.\n[Speaker 1706286059248901810]: And so they just submitted tickets to our operations team and we were able to really quickly get them onboarded.\n[Speaker 1706286059248901810]: That was mostly just making sure that they went through our process to get them in the ...", "callTitle": "BioRender | Roche - usage review"}, {"quote": "build on the relationship we have with Genentech", "date": "2025-01-21", "callId": "2025-01-21_15d715990124", "gongUrl": "https://app.gong.io/call?id=15d7159901244fdf6440ac86016ee112cb50e6e60880c5691445667c04b0f878", "speakerId": "6759566690625283106", "customerName": "Luciana Molinero", "internalName": "Matthew Gralewski", "customerEmail": "molinero.luciana@gene.com", "internalEmail": "matt.gralewski@biorender.com", "sizeMentions": [], "contextBefore": "...Speaker 6759566690625283106]: Pacific time?\n[Speaker 6759566690625283106]: Okay.\n[Speaker 6759566690625283106]: So, what I'll do is let me just, send that over to the leadership team, And then they'll just get in touch via your email just to confirm.\n[Speaker 8696315370457490233]: Okay.\n[Speaker 8696315370457490233]: Sounds good.\n[Speaker 8696315370457490233]: Thank you.\n[Speaker 6759566690625283106]: Yeah.\n[Speaker 6759566690625283106]: Awesome.\n[Speaker 6759566690625283106]: Yeah, No, that's perfect.\n[Speaker 6759566690625283106]: And, you know, again, like I'm happy to like, they're happy to talk about the AI tool and how it can help you.\n[Speaker 6759566690625283106]: But like the other, The other component is if there's other things you want to talk about, like you kept mentioning like how time was a huge thing, right?\n[Speaker 6759566690625283106]: If there's other features or things you want to talk about like that's really the whole point They're happy to discuss with you, and ", "contextAfter": ".\n[Speaker 6759566690625283106]: So.\n[Speaker 8696315370457490233]: Mm.\n[Speaker 8696315370457490233]: Hmm.\n[Speaker 6759566690625283106]: Okay.\n[Speaker 8696315370457490233]: Okay.\n[Speaker 8696315370457490233]: But we can talk when we meet.\n[Speaker 6759566690625283106]: I'm sorry?\n[Speaker 8696315370457490233]: I can talk about this issue when I meet with the leadership.\n[Speaker 6759566690625283106]: 100 percent.\n[Speaker 6759566690625283106]: 100 percent.\n[Speaker 6759566690625283106]: Okay.\n[Speaker 6759566690625283106]: Awesome.\n[Speaker 6759566690625283106]: I'll let you know soon.\n[Speaker 6759566690625283106]: Thank you.\n[Speaker 6759566690625283106]: Bye.\n[Speaker 8696315370457490233]: Awesome.\n[Speaker 8696315370457490233]: Thank you.\n[Speaker 8696315370457490233]: Bye.", "callTitle": "Call with Genentech - Luciana Molinero"}, {"quote": "Well, Im, Ryan, I have been at Genentech, basically my entire career.", "date": "2024-11-01", "callId": "2024-11-01_16eec8471b33", "gongUrl": "https://app.gong.io/call?id=16eec8471b339e14de32dbf4ab3a0ceccf8b98bdbb1cbaa20eeb3fb1e18b7c83", "speakerId": "7653985815089673450", "customerName": "Ryan Cook", "internalName": "Katy Brenneman; Michael Stanfel; Samara Ona", "customerEmail": "cook.ryan@gene.com", "internalEmail": "katy@biorender.com; michael.stanfel@biorender.com; samara@biorender.com", "sizeMentions": [], "contextBefore": "...I deal mostly in the production of the icons that youll find in the icon library.\n[Speaker 4542429180852103832]: And my background is in technical illustration.\n[Speaker 4542429180852103832]: So, my specialty is all the lab equipment and machinery type icons that youd find in BioRender.\n[Speaker 7653985815089673450]: Excellent.\n[Speaker 7653985815089673450]: My name is Samara.\n[Speaker 7653985815089673450]: I am part of the creative team as well.\n[Speaker 7653985815089673450]: Im, a science designer And I work in the team that creates the templates that you can see in BioRender.\n[Speaker 7653985815089673450]: And I have an academic background.\n[Speaker 7653985815089673450]: I got a PhD in molecular genetics, And my research field was mainly in structural biology.\n[Speaker 7653985815089673450]: And happy to be here and hear some of your thoughts regarding these icon and template library that you have put together.\n[Speaker 7653985815089673450]: Excellent.\n[Speaker 7653985815089673450]: ", "contextAfter": "\n[Speaker 7653985815089673450]: Im, the subject matter expert here at Genentech on this one, the point of contact for anyone who has any issues or wants to know, I dont know any of the licensing, but I am primarily in the lab, Im, in assay development.\n[Speaker 7653985815089673450]: So, Im, in the Department of Biochemical and Cellular Pharmacology, which is Mainly in vitro assays across a variety of things.\n[Speaker 7653985815089673450]: But my background education is in genetics, but most of the work I do is immunology.\n[Speaker 822964053994105406]: Thanks.\n[Speaker 822964053994105406]: We can jump right into it then, Ryan, And yeah, maybe we can get through it quickly and we can give you some time back.\n[Speaker 822964053994105406]: But is there a chance youd be able to pull up BioRender and share your screen?\n[Speaker 822964053994105406]: Is that possible?\n[Speaker 7653985815089673450]: You want me to pull up mine?\n[Speaker 7653985815089673450]: Okay, sure.\n[Speaker 822964053994105...", "callTitle": "Genentech <> BioRender (Library Review)"}, {"quote": "org libraries where we would start to bring in those custom icons and templates for Genentech", "date": "2024-10-24", "callId": "2024-10-24_e75ac3a8fc9d", "gongUrl": "https://app.gong.io/call?id=e75ac3a8fc9da69f8be1494fabec1ca8c3302a288afcd61b68a43f6354da3bfc", "speakerId": "4343193607969626278", "customerName": "Ryan Cook", "internalName": "Jacqueline McCoskey; Katy Brenneman; Tim Fung", "customerEmail": "cook.ryan@gene.com", "internalEmail": "jacqueline@biorender.com; katy@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...Use the excuse.\n[Speaker 4343193607969626278]: I have a hazy brain.\n[Speaker 7952069281422711793]: Still for like next few years, but,\n[Speaker 4343193607969626278]: I had a hazy head.\n[Speaker 5819580519298809143]: Sometimes before, so I cant blame COVID for that one.\n[Speaker 4343193607969626278]: No.\n[Speaker 4343193607969626278]: Now, theres a reason for it.\n[Speaker 4343193607969626278]: Now, theres a reason for it.\n[Speaker 4343193607969626278]: Exactly.\n[Speaker 4343193607969626278]: Its like vacation brain.\n[Speaker 4343193607969626278]: Oh, yeah, Yeah.\n[Speaker 5819580519298809143]: Over vacation brain from months ago, Yeah.\n[Speaker 4343193607969626278]: Thank you.\n[Speaker 4343193607969626278]: No.\n[Speaker 4343193607969626278]: But thanks so much for taking the time to join us here.\n[Speaker 4343193607969626278]: I have with us on the call, Katie Brenneman, Shes from our product team and shes actually going to be the one walking through what we had in mind for what we call ", "contextAfter": " And we want to just get your thoughts on.\n[Speaker 4343193607969626278]: Would this be helpful?\n[Speaker 4343193607969626278]: And then discuss some next steps if it would be useful for folks.\n[Speaker 4343193607969626278]: Excellent.\n[Speaker 4343193607969626278]: Let me just switch over.\n[Speaker 4343193607969626278]: I think this is going to work if it doesnt crash everything.\n[Speaker 4343193607969626278]: Okay?\n[Speaker 4343193607969626278]: All right.\n[Speaker 4343193607969626278]: Nice.\n[Speaker 5819580519298809143]: Oh, wow.\n[Speaker 4343193607969626278]: Smooth.\n[Speaker 7952069281422711793]: That was a really good transition.\n[Speaker 7952069281422711793]: I thought you were going to log off and log back in?\n[Speaker 3000548241294178576]: Its a new feature and it says, do you want to switch over to this other thing?\n[Speaker 3000548241294178576]: Oh, Log in through this other way?\n[Speaker 3000548241294178576]: So, do you want to switch over?\n[Speaker 3000548241294178576]: S...", "callTitle": "Genentech-specific content library"}]}, {"id": "roche_g_red_5b3697b4", "company": "roche", "gong_entity": "G RED", "gong_parent": "Genentech", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 10, "snippet": "7,500 split pretty evenly across G, red, P, red and dietec, diet and pharmatec", "snippet_date": "2025-08-14", "person_name": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "person_email": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internal_name": "Chris Hemberger; Jacqueline McCoskey; Tim Fung", "internal_email": "chris.hemberger@biorender.com; jacqueline@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "genentech-research-early-development", "manual_node_name": "Genentech Research & Early Development (gRED)", "manual_node_path": "Roche Research & Development > Genentech Research & Early Development (gRED)", "confidence": "high", "reasoning": "Clear acronym match - 'G RED' is the spoken form of 'gRED' which stands for Genentech Research & Early Development"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=f2daf041fcef823a1ca53318a0433be11bf09513ae9914842dd2d09ba887c8cd", "call_id": "2025-08-14_f2daf041fcef", "call_count": 10, "all_snippets": [{"quote": "7,500 split pretty evenly across G, red, P, red and dietec, diet and pharmatec", "date": "2025-08-14", "callId": "2025-08-14_f2daf041fcef", "gongUrl": "https://app.gong.io/call?id=f2daf041fcef823a1ca53318a0433be11bf09513ae9914842dd2d09ba887c8cd", "speakerId": "2765030990157134975", "customerName": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "internalName": "Chris Hemberger; Jacqueline McCoskey; Tim Fung", "customerEmail": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "chris.hemberger@biorender.com; jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...134975]: So let me just share my screen.\n[Speaker 2765030990157134975]: There are some numbers that are related to that here.\n[Speaker 8143937435222082516]: Yeah, Tim, I also did want to say like related to the multi year contract, it's progressing on our side, there's just a lot of approvals that have to, it has to go through as you can imagine because we don't do these very often.\n[Speaker 8143937435222082516]: So, just want you to know it, we're working on it and we just don't have anything ready yet.\n[Speaker 5654559484448408361]: Okay.\n[Speaker 5654559484448408361]: So, this existing contract, we have it until December, right?\n[Speaker 5654559484448408361]: Cool.\n[Speaker 5654559484448408361]: Yeah.\n[Speaker 2765030990157134975]: One thing that would be helpful for us, as well, is just to get a, is to see if like the numbers that we have on our side are correct, I think like the last time that, we spoke, the estimate that we got for the number of scientists across Roche is around ", "contextAfter": ", and I just wanted to get a sense like how accurate is that number?\n[Speaker 2765030990157134975]: Is that still, sort of the estimate there?\n[Speaker 2081859451289848040]: I'm not sure we have any updated numbers on that.\n[Speaker 2081859451289848040]: Do you know, Koal\u2026 I think our estimations are, I mean, the problem in general is just trying to find those numbers, I think, But as far as usage is concerned, obviously, we're much under that.\n[Speaker 2765030990157134975]: As far as the.\n[Speaker 2081859451289848040]: Users, I think that number's just been a little bit difficult for us to estimate?\n[Speaker 2765030990157134975]: That's fair.\n[Speaker 2765030990157134975]: Yeah, I'm just curious like if there was any sort of, if there's any sort of changes, but we can still use that number.\n[Speaker 2765030990157134975]: Since I think there was some work into getting that estimate when we first, launched the license.\n[Speaker 5654559484448408361]: And then, I'm gonna be honest with yo...", "callTitle": "BioRender | Roche - usage data review"}, {"quote": "Majority of folks are P red G red, which makes sense.", "date": "2025-05-06", "callId": "2025-05-06_37066a25169f", "gongUrl": "https://app.gong.io/call?id=37066a25169f230872122dcbc3bcdf337a663fe018af6d05a93aff696dd6e89c", "speakerId": "6088335049672687772", "customerName": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...kend.\n[Speaker 6088335049672687772]: We would just need to make sure that like all the invoices were settled as well with spark because there might've been something outstanding.\n[Speaker 6088335049672687772]: Awesome.\n[Speaker 6088335049672687772]: Yeah, just keep us posted there.\n[Speaker 6088335049672687772]: And the last thing that we are currently working on as well is populating the business area data for users.\n[Speaker 6088335049672687772]: And so what we're doing right now is making a switch to the sso configuration to make room for the business area, the business area attribute to go into the admin panel.\n[Speaker 6088335049672687772]: Once we've have that, it will be pretty quick to just upload the list and then populate all the users.\n[Speaker 6088335049672687772]: So we'll have a better view on which users belong, where basically, and you'll have a good view of like that distribution across the board as a heads up right now for distribution.\n[Speaker 6088335049672687772]: ", "contextAfter": "\n[Speaker 6088335049672687772]: They've had the license for probably like almost this would be year six almost.\n[Speaker 6088335049672687772]: So they make up about 85 percent of the license.\n[Speaker 6088335049672687772]: About 10 percent come from PTD and Dia, which is great that, you know, we're starting to see that number come up.\n[Speaker 6088335049672687772]: And then the last five percent guys is the folks that are unknown at the moment, and we'll work with them to get them to populate that field once it's ready to go.\n[Speaker 1706286059248901810]: Great.\n[Speaker 6088335049672687772]: HMM.\n[Speaker 6088335049672687772]: And then lastly, in terms of progress, just ongoing things that we're doing.\n[Speaker 6088335049672687772]: We're regularly onboarding new users and new groups.\n[Speaker 6088335049672687772]: We have a, we have the in person sessions planned for the Basel and pennsburg sites.\n[Speaker 6088335049672687772]: Now, I think all in all, we have 10 sessions that are p...", "callTitle": "BioRender | Roche - usage review"}, {"quote": "It's doing the P RED and G RED renewal", "date": "2024-11-20", "callId": "2024-11-20_bab35eddaea0", "gongUrl": "https://app.gong.io/call?id=bab35eddaea07b221a83febddc3da0e970f84db45391c0cdba0af3789d4b1052", "speakerId": "1169138634469430893", "customerName": "Bernardo Antunes", "internalName": "Jacqueline McCoskey", "customerEmail": "bernardo.antunes@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "... right?\n[Speaker 1169138634469430893]: And, and to, we also understand from your side that, there's not, there might not be much you can do, You might not be ready to go for full enterprise level agreement at a fixed cost.\n[Speaker 1169138634469430893]: But at the moment, we have the same issue is that we are not also ready, to have no visibility and just be at the open for 1,000 users this year, 2000 users next year.\n[Speaker 1169138634469430893]: It doesn't work for us from a budgeting perspective, right?\n[Speaker 1169138634469430893]: We've tried to mitigate that by finding those specific kind of buckets of users where we figure out the cost.\n[Speaker 1169138634469430893]: But even then, it's just not enough, unfortunately, right?\n[Speaker 1169138634469430893]: So, a couple of things\u2026 We have a few options on the table, right?\n[Speaker 1169138634469430893]: And the options on the table is Univis, started to explore this already, which is great, right?\n[Speaker 1169138634469430893]: ", "contextAfter": ", which is unfortunate that we have to go that way after all of this time, But it just might be that we're not ready on both sides to proceed with a bigger picture right at the moment, which is fair.\n[Speaker 1169138634469430893]: So, I think we have, that covered, Our kind of whole scenario would be P RED and G RED.\n[Speaker 1169138634469430893]: And then we have to figure out what to do with the others.\n[Speaker 1169138634469430893]: But I wanted to leave the meeting with a further request which, is there a way\u2026 that we can have a number set of licenses for a fixed cost that we manage as we want, right?\n[Speaker 1169138634469430893]: So say, for example, you give me between, I don't know, you give me several, right?\n[Speaker 1169138634469430893]: But a price for having a 1,000 licenses, a price for having 1,500 licenses, one price for having 2000 licenses.\n[Speaker 1169138634469430893]: And we are not allowed to basically fall off those to manage the numbers, but we manage it interna...", "callTitle": "BioRender | Roche check in"}, {"quote": "when youd mentioned the protection of the P RED and G RED users", "date": "2024-10-25", "callId": "2024-10-25_c6f81d12a0e2", "gongUrl": "https://app.gong.io/call?id=c6f81d12a0e225e6227526f34b1a05fea4db03ba30e6a8cc5c9b1768588fd008", "speakerId": "4521358663271875204", "customerName": "Bernardo Antunes", "internalName": "Jacqueline McCoskey; Walid Habboub", "customerEmail": "bernardo.antunes@roche.com", "internalEmail": "jacqueline@biorender.com; walid@biorender.com", "sizeMentions": [], "contextBefore": "...64792]: How are you?\n[Speaker 6165747735449264792]: Good afternoon, Renardo.\n[Speaker 6165747735449264792]: Im doing good.\n[Speaker 6165747735449264792]: How are you?\n[Speaker 4521358663271875204]: Im good as well.\n[Speaker 4521358663271875204]: Nice.\n[Speaker 4521358663271875204]: Happy Friday.\n[Speaker 4521358663271875204]: We always catch you on Fridays which is always nice.\n[Speaker 4521358663271875204]: Yeah\u2026 thanks so much for joining.\n[Speaker 4521358663271875204]: I know I have a hard cut off at nine 30 and theres probably quite a bit nine 30 my time, two 30 your time, probably quite a bit to go through.\n[Speaker 4521358663271875204]: So you can just jump into it.\n[Speaker 4521358663271875204]: So were happy to walk through the per user cost.\n[Speaker 4521358663271875204]: So, thank you for outlining where the, you know, the\u2026 calculations that you had done Before getting into that.\n[Speaker 4521358663271875204]: I think the one thing that we were hoping for some clarity on was ", "contextAfter": " and preserving like their usage privileges.\n[Speaker 4521358663271875204]: Do you mind explaining a little bit further of what you meant by that?\n[Speaker 4521358663271875204]: Just because its just a little bit confusing just like in terms of like the usage rights and those types of things.\n[Speaker 4521358663271875204]: Yeah.\n[Speaker 4521358663271875204]: So,\n[Speaker 9120235898807115240]: No, thanks for getting back.\n[Speaker 9120235898807115240]: So theres kind of two ways we believe and the business believes they see this, right?\n[Speaker 9120235898807115240]: Which is if we would keep things as they are right now, we would be paying for a few extra 100 licenses, right?\n[Speaker 9120235898807115240]: And P RED and G RED would be allowed to grow until the five K, no matter when that happens, but they would still be in that range of the one point zero 6,000,000.\n[Speaker 9120235898807115240]: If Im not mistaken, right?\n[Speaker 9120235898807115240]: What were doing at the moment i...", "callTitle": "BioRender | Roche"}, {"quote": "everyone in P RED and G RED can have access to it", "date": "2024-09-19", "callId": "2024-09-19_d132aba88672", "gongUrl": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "speakerId": "3068414967322493854", "customerName": "Markus Eckl", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "markus.eckl@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...e past than I used recently, but there's always those project phases, you know, your phases where you have to prepare documents, then it's really nice.\n[Speaker 1493537282318889744]: Totally.\n[Speaker 1493537282318889744]: If you prepare just data, then yeah, there's not much use of it.\n[Speaker 1493537282318889744]: But you can solve this.\n[Speaker 1493537282318889744]: This is a Roche issue just to make you aware of this.\n[Speaker 1493537282318889744]: I know there's this Roche generic account for pharma and Genentech, right?\n[Speaker 1493537282318889744]: And in diagnostics, we are still bound to single licenses.\n[Speaker 1493537282318889744]: Yeah.\n[Speaker 3068414967322493854]: So I actually have a good update on that.\n[Speaker 3068414967322493854]: So we have, I've been, this is, you know, I've been fighting for this and the folks at Roche have been fighting for this too for a little, for quite some time to get access outside of P RED and G RED because I'm sure you're aware like ", "contextAfter": ".\n[Speaker 3068414967322493854]: But we are working towards a larger license that will hopefully be in place at the end of November.\n[Speaker 3068414967322493854]: That's when the period and GRed renewal is due.\n[Speaker 3068414967322493854]: Obviously, we still have some work to do on it, but it is working in a positive direction, which is great.\n[Speaker 3068414967322493854]: In the meantime, because we've had like requests all over the place, I've been working with the central IT folks to set up like what we would call a proof of concept for from now until the end of November that will give anyone outside of P RED and G RED free access until then.\n[Speaker 3068414967322493854]: So we can get your team up and running.\n[Speaker 3068414967322493854]: It's actually supposed to launch on Monday, so it'll be live on Monday.\n[Speaker 3068414967322493854]: This has all been happening the last couple weeks.\n[Speaker 3068414967322493854]: So it's a really good time we're talking now.\n[Speaker...", "callTitle": "BioRender & Roche - Follow Up Call"}, {"quote": "My first question for you are you part of P RED or G RED?", "date": "2024-09-18", "callId": "2024-09-18_3eab42283be2", "gongUrl": "https://app.gong.io/call?id=3eab42283be240e65118381aa5201813f8c57dfab4e64f0ae2bbf1ab6a905579", "speakerId": "4434073071130488898", "customerName": "Christoph Gst\u00f6ttner", "internalName": "Sierra Barnes", "customerEmail": "christoph.gstoettner@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...88898]: Oh, no.\n[Speaker 4434073071130488898]: No.\n[Speaker 5606602042582878549]: very fast from 30 to seven so it was a quite.\n[Speaker 4434073071130488898]: that's a shocking change that's nice well thanks so much for finding time for us to chat as a quick intro on my side of things I'm part of the team that's helping to support the BioRender users at Roche and love would love for this call just to be an introduction for me to better understand what you're currently using BioRender for maybe what you hope to use it for and I can give you some context about what we're working on with Roche but was there anything in particular you were hoping that we would chat about today?\n[Speaker 5606602042582878549]: Actually I have a question if we have a license from Roche where we can basically use it so a standard the general license basically because so far I'm using the free version but I know that somewhere in Roche there should be some licenses for BioRender.\n[Speaker 4434073071130488898]: ", "contextAfter": "\n[Speaker 5606602042582878549]: No, but we collaborate with them a lot so.\n[Speaker 4434073071130488898]: Collaborate.\n[Speaker 4434073071130488898]: Which team are you a part of at Roche?\n[Speaker 5606602042582878549]: Gene Therapy actually.\n[Speaker 5606602042582878549]: And does that fall from the analytics?\n[Speaker 5606602042582878549]: So I'm from the analytics department but they are in Gene Therapy.\n[Speaker 5606602042582878549]: We have a new let's say group and there we are very closely collaborating also with the P RED colleagues there.\n[Speaker 4434073071130488898]: And does that fall within diagnostics or?\n[Speaker 5606602042582878549]: No, no, it's pharma.\n[Speaker 4434073071130488898]: Okay.\n[Speaker 4434073071130488898]: But your group doesn't sit within the P RED group?\n[Speaker 5606602042582878549]: No, no, no, no.\n[Speaker 5606602042582878549]: Okay.\n[Speaker 4434073071130488898]: I see.\n[Speaker 4434073071130488898]: Are you in PTD then?\n[Speaker 4434073071130488898...", "callTitle": "BioRender & Roche - Intro Call"}, {"quote": "consolidating all the licenses, making access more widely available outside of P RED and G RED", "date": "2024-09-16", "callId": "2024-09-16_d36b49ea866e", "gongUrl": "https://app.gong.io/call?id=d36b49ea866e8fc066b20a5d96a1a11f1afb1d751f0a926343dc3ca8b2b1b2f1", "speakerId": "1067617882933750578", "customerName": "Gaius Augustus; George Abousleiman; Kawal Kaur", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "gaius.augustus@roche.com; abousleg@gene.com; kaurk5@gene.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "..., too.\n[Speaker 4443789273359589298]: It No worries.\n[Speaker 4443789273359589298]: Yeah.\n[Speaker 4443789273359589298]: Thank you for meeting again.\n[Speaker 1067617882933750578]: No problem at all.\n[Speaker 1067617882933750578]: I know things can definitely pop up.\n[Speaker 1067617882933750578]: So I don't want to take, we went through it shortly, like very briefly on Friday, but, so I guess we'll just kind of like go through what we talked about again on Friday.\n[Speaker 1067617882933750578]: Tim, I know is in a coffee shop before because he just traveled for work, so it's very.\n[Speaker 3312880981832114632]: Let me just share my screen.\n[Speaker 1067617882933750578]: I'll walk through what we went through on Friday, and then Koal, feel free to jump in if you have any questions as we go.\n[Speaker 1067617882933750578]: But let me go ahead.\n[Speaker 1067617882933750578]: Okay, so let's just share this here.\n[Speaker 1067617882933750578]: So yeah, as summary, chatting about, you know, ", "contextAfter": ".\n[Speaker 1067617882933750578]: But in the short term, we've been getting a lot of requests outside of, P RED and G RED.\n[Speaker 1067617882933750578]: And guys, do you have, do, you might be able to provide some additional insight, on how many requests we've.\n[Speaker 3019586265158603172]: been getting?\n[Speaker 3019586265158603172]: Yeah, so I've gotten requests from, let's see, it's about 12 or fift-, somewhere between 12 and 15 groups.\n[Speaker 3019586265158603172]: Okay.\n[Speaker 3019586265158603172]: And the total number of licenses so far being requested is around 170.\n[Speaker 1067617882933750578]: Okay.\n[Speaker 1067617882933750578]: Yep, perfect, that's awesome.\n[Speaker 1067617882933750578]: And yeah, so I guess basically what we're trying to do is figure out a solution for those, the group of people, while we work towards the P RED and G RED renewal on, November 20 first.\n[Speaker 1067617882933750578]: So what.\n[Speaker 4443789273359589298]: I'm sorry, I'm interrupting, bu...", "callTitle": "BioRender | Roche - short term access"}, {"quote": "the current licensing models that you're paying, one point zero 6,000,000 for access for within P RED and G RED", "date": "2024-09-16", "callId": "2024-09-16_169ff0f89dab", "gongUrl": "https://app.gong.io/call?id=169ff0f89dab352c4ea3f933d5219eb9d6ffc5a46decffe80aa022abec490665", "speakerId": "578014247824060645", "customerName": "Bernardo Antunes", "internalName": "Jacqueline McCoskey; Tim Fung; Walid Habboub", "customerEmail": "bernardo.antunes@roche.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com; walid@biorender.com", "sizeMentions": [], "contextBefore": "...60645]: No.\n[Speaker 578014247824060645]: I don't think so.\n[Speaker 578014247824060645]: Okay, perfect.\n[Speaker 578014247824060645]: Sounds good.\n[Speaker 578014247824060645]: Feel free to jump in.\n[Speaker 578014247824060645]: I'm just going to walk through it, try to keep it simple.\n[Speaker 578014247824060645]: But one second.\n[Speaker 578014247824060645]: Hi, Bernardo.\n[Speaker 3416604422779552060]: Sorry.\n[Speaker 3416604422779552060]: It's okay.\n[Speaker 3416604422779552060]: I can understand why someone would want to talk to Jacqueline and not me.\n[Speaker 3416604422779552060]: Yeah.\n[Speaker 578014247824060645]: Busy Monday.\n[Speaker 578014247824060645]: Yeah, totally.\n[Speaker 578014247824060645]: Okay.\n[Speaker 578014247824060645]: So hopefully you can see this here.\n[Speaker 578014247824060645]: Okay, perfect.\n[Speaker 578014247824060645]: So just as a quick recap of what we went over, it's almost like two weeks ago.\n[Speaker 578014247824060645]: So essentially right now, ", "contextAfter": ".\n[Speaker 578014247824060645]: Outside of this, you're not able to get access to it.\n[Speaker 578014247824060645]: It's kind of restricted to those groups.\n[Speaker 578014247824060645]: And where, you know, as we've been having these conversations, obviously, that's not a very ideal model from the Roche perspective, essentially, as you were, everyone's trying to centralize and make things a lot more streamlined.\n[Speaker 578014247824060645]: So the enterprise licensing is proposed at one point three 4,000,000, and this would give open access to, you know, everyone at Roche.\n[Speaker 578014247824060645]: It's not going to be restricted to those two groups.\n[Speaker 578014247824060645]: and we'll get into the details in just a second.\n[Speaker 578014247824060645]: And then the, you know, the renewal, we'll also get into it.\n[Speaker 578014247824060645]: This is just high level.\n[Speaker 578014247824060645]: Okay, so when we talk about our enterprise licensing, the structure of it is ess...", "callTitle": "BioRender | Roche - Enterprise discussion"}, {"quote": "We've already set all of the P RED and G RED researchers up with access to BioRender", "date": "2024-09-16", "callId": "2024-09-16_75435aea8ad7", "gongUrl": "https://app.gong.io/call?id=75435aea8ad754e88c3ee5e80e0c7e5fa5fd7343b46e96e4b315ef136260de3b", "speakerId": "6303005417140467437", "customerName": "Johannes Schott", "internalName": "Sierra Barnes", "customerEmail": "johannes.schott@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...467437]: So I help support the BioRender users at Roche and we've recently launched new functionality within BioRender that's been very useful for others at Roche.\n[Speaker 6303005417140467437]: So just wanted to see if it's something your team would also find valuable, but would love to start by hearing how you've been using BioRender so far.\n[Speaker 7462781675389340992]: Yeah, sure.\n[Speaker 7462781675389340992]: Just here and there basically for, yeah, just playing around to be honest a little bit.\n[Speaker 7462781675389340992]: But not so much, but to be honest I'm also not, I'm not sure if I'm the right contact person because I'm pretty sure that there is a company license planned or I don't know if there already is one.\n[Speaker 7462781675389340992]: But I'm not really involved in that so I'm not sure if I'm the right person here.\n[Speaker 6303005417140467437]: Yeah.\n[Speaker 6303005417140467437]: Yeah, that's kind of the inspiration for the call.\n[Speaker 6303005417140467437]: ", "contextAfter": " and we're actively working on setting up those in PTD and diagnostics as well.\n[Speaker 6303005417140467437]: So just wanted to see if it's something you and your team would find valuable and if it makes sense to potentially explore that.\n[Speaker 6303005417140467437]: But all of my conversations so far have started from end users like yourself.\n[Speaker 6303005417140467437]: So I promise you are the right person.\n[Speaker 6303005417140467437]: But yeah, I just want to explore if it makes sense for your team to be added to that license as well.\n[Speaker 7462781675389340992]: Mm hmm.\n[Speaker 7462781675389340992]: Maybe at some point but yeah as I said since I haven't used it like that much I think I can't give much input there.\n[Speaker 6303005417140467437]: Okay, what were you hoping to use BioRender for?\n[Speaker 7462781675389340992]: I guess just presentations, internal presentations and visualizing things.\n[Speaker 6303005417140467437]: That's kind of what we're hearing from other...", "callTitle": "Call with Roche - Johannes Schott"}, {"quote": "So the context at Roche, we've worked to set up all of P RED and G RED with access to BioRender.", "date": "2024-09-04", "callId": "2024-09-04_18e45c9dd482", "gongUrl": "https://app.gong.io/call?id=18e45c9dd4826de168510161017a2e0e98fd82d6b0edd95ca08f518098665c0e", "speakerId": "3027117464291228307", "customerName": "Christoph Duerr", "internalName": "Sierra Barnes", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...llaborative environment for people to kind of work on their visuals.\n[Speaker 3027117464291228307]: But yeah, kind of curious to get your thoughts on that.\n[Speaker 7347115369096025640]: I think that would be helpful because sometimes generating visualizations very much depends on the angle you look at it.\n[Speaker 7347115369096025640]: And if you have different people, different thoughts in the generation of these illustrations, I would think that helps.\n[Speaker 7347115369096025640]: Yeah.\n[Speaker 3027117464291228307]: Awesome.\n[Speaker 3027117464291228307]: Yeah, we're kind of hearing from other groups it helps with the brainstorming side of things too.\n[Speaker 3027117464291228307]: When you can kind of whiteboard on BioRender, you can kind of put all your ideas together as a more of a collaborative activity.\n[Speaker 3027117464291228307]: But that context is really helpful.\n[Speaker 3027117464291228307]: I appreciate you answering all my questions.\n[Speaker 3027117464291228307]: ", "contextAfter": "\n[Speaker 3027117464291228307]: So they kind of already have the full breadth of BioRender features.\n[Speaker 3027117464291228307]: And now we're actively working to set up Roche on more of the enterprise level so that those in PTD and diagnostics can kind of also benefit from those BioRender features.\n[Speaker 3027117464291228307]: And that's kind of the inspiration for the initial reach out, trying to figure out who would kind of benefit from access to that potentially and want to get wrapped.\n[Speaker 3027117464291228307]: into that larger license at a greater point.\n[Speaker 3027117464291228307]: And it sounds like that's something that would be helpful for your group in PTD.\n[Speaker 3027117464291228307]: So what we've been doing is hosting short team based webinars for these individual groups just so they can really understand the full breadth of features and really, you know, make an informed decision about who would want to become part of that license.\n[Speaker 3027117464291228...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_roche_global_procurement_aaa36a71", "company": "roche", "gong_entity": "Roche Global Procurement", "gong_parent": "Roche", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Anna is part of our team at ros global procurement", "snippet_date": "2025-09-23", "person_name": "Ana Alba; Bernardo Antunes; Gaius Augustus; Kawal Kaur", "person_email": "ana.alba.aa1@roche.com; bernardo.antunes@roche.com; gaius.augustus@roche.com; kaurk5@gene.com", "internal_name": "Jacqueline McCoskey; Tim Fung", "internal_email": "jacqueline@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=84c0334abb84a5e7e3850ea0469f62921089dbf56fb0fd8b870acb0628c28b8f", "call_id": "2025-09-23_84c0334abb84", "call_count": 1, "all_snippets": [{"quote": "Anna is part of our team at ros global procurement", "date": "2025-09-23", "callId": "2025-09-23_84c0334abb84", "gongUrl": "https://app.gong.io/call?id=84c0334abb84a5e7e3850ea0469f62921089dbf56fb0fd8b870acb0628c28b8f", "speakerId": "5845257323384585471", "customerName": "Ana Alba; Bernardo Antunes; Gaius Augustus; Kawal Kaur", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "ana.alba.aa1@roche.com; bernardo.antunes@roche.com; gaius.augustus@roche.com; kaurk5@gene.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...got time, 11 30.\n[Speaker 9163913951807243266]: Hey, Bernardo.\n[Speaker 5845257323384585471]: Hey, how's it going good?\n[Speaker 9163913951807243266]: How are you?\n[Speaker 5845257323384585471]: All good as well.\n[Speaker 5845257323384585471]: It's still four 30?\n[Speaker 9163913951807243266]: Is it okay?\n[Speaker 9163913951807243266]: I always get that to one.\n[Speaker 9163913951807243266]: I wish.\n[Speaker 5845257323384585471]: It was five 30.\n[Speaker 9163913951807243266]: But yeah\u2026 I saw that someone named Anna had accepted and then declined.\n[Speaker 9163913951807243266]: I don't know if she's.\n[Speaker 5845257323384585471]: yeah, I think she's yeah, yeah, perfect.\n[Speaker 9163913951807243266]: There she is.\n[Speaker 5845257323384585471]: She's here.\n[Speaker 5845257323384585471]: Okay, great.\n[Speaker 5845257323384585471]: So I did invite Anna to this meeting.\n[Speaker 5845257323384585471]: I'll maybe give a quick intro as well, why I invited her.\n[Speaker 5845257323384585471]: ", "contextAfter": ".\n[Speaker 5845257323384585471]: So she's working on a specific topic, which is\u2026 a list of apps, right?\n[Speaker 5845257323384585471]: In which biorender is one of them.\n[Speaker 5845257323384585471]: So essentially, I thought I'd invite her to this meeting.\n[Speaker 5845257323384585471]: I haven't had a chance to provide her a huge context, but I thought it would be worth for her to be here and also listening.\n[Speaker 5845257323384585471]: And then at some point, probably Anna will deal directly the multi year agreement with you guys.\n[Speaker 5845257323384585471]: I'll always be here as well, given all of the context from last year, but she will probably take over for me, the conclusion of the agreement.\n[Speaker 9163913951807243266]: Perfect.\n[Speaker 9163913951807243266]: Okay.\n[Speaker 9163913951807243266]: I appreciate that insight.\n[Speaker 9163913951807243266]: Nice to meet you, Anna.\n[Speaker 9163913951807243266]: Thanks for joining.\n[Speaker 3962211803684326688]: No problem....", "callTitle": "BioRender | Roche - Renewal Proposal"}]}, {"id": "roche_software_and_tailspin_team_236c385b", "company": "roche", "gong_entity": "Software and Tailspin Team", "gong_parent": "Roche Global Procurement", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm part of the software and tailspin team under the global procurement front rush", "snippet_date": "2025-09-23", "person_name": "Ana Alba; Bernardo Antunes; Gaius Augustus; Kawal Kaur", "person_email": "ana.alba.aa1@roche.com; bernardo.antunes@roche.com; gaius.augustus@roche.com; kaurk5@gene.com", "internal_name": "Jacqueline McCoskey; Tim Fung", "internal_email": "jacqueline@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=84c0334abb84a5e7e3850ea0469f62921089dbf56fb0fd8b870acb0628c28b8f", "call_id": "2025-09-23_84c0334abb84", "call_count": 1, "all_snippets": [{"quote": "I'm part of the software and tailspin team under the global procurement front rush", "date": "2025-09-23", "callId": "2025-09-23_84c0334abb84", "gongUrl": "https://app.gong.io/call?id=84c0334abb84a5e7e3850ea0469f62921089dbf56fb0fd8b870acb0628c28b8f", "speakerId": "3962211803684326688", "customerName": "Ana Alba; Bernardo Antunes; Gaius Augustus; Kawal Kaur", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "ana.alba.aa1@roche.com; bernardo.antunes@roche.com; gaius.augustus@roche.com; kaurk5@gene.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "... the multi year agreement with you guys.\n[Speaker 5845257323384585471]: I'll always be here as well, given all of the context from last year, but she will probably take over for me, the conclusion of the agreement.\n[Speaker 9163913951807243266]: Perfect.\n[Speaker 9163913951807243266]: Okay.\n[Speaker 9163913951807243266]: I appreciate that insight.\n[Speaker 9163913951807243266]: Nice to meet you, Anna.\n[Speaker 9163913951807243266]: Thanks for joining.\n[Speaker 3962211803684326688]: No problem.\n[Speaker 3962211803684326688]: Nice.\n[Speaker 9163913951807243266]: Where are you based out of Anna?\n[Speaker 3962211803684326688]: I'm based in Mexico City.\n[Speaker 9163913951807243266]: Oh, okay.\n[Speaker 9163913951807243266]: Cool.\n[Speaker 9163913951807243266]: Awesome.\n[Speaker 3962211803684326688]: Yeah.\n[Speaker 3962211803684326688]: So I'll be supporting you just a quick intro myself.\n[Speaker 3962211803684326688]: Lovely to meet you all.\n[Speaker 3962211803684326688]: As Bernardo said, ", "contextAfter": ".\n[Speaker 3962211803684326688]: So what we do is exactly deal with all of the pipeline for rush in general that we have services for softwares and apps, and we deal with the renewals, we try to support with benchmarks and other solutions if they're needed just to keep everyone happy with the service that they're getting, keeping the best deal that we can with each supplier.\n[Speaker 3962211803684326688]: I'm happy to help.\n[Speaker 3962211803684326688]: So I'll be listening just getting a little bit of context for this.\n[Speaker 3962211803684326688]: I know that rush, we have been working on this for a while as Bernardo said.\n[Speaker 3962211803684326688]: So I'm happy to be here with you guys and feel free to reach out if anything comes up.\n[Speaker 9163913951807243266]: Awesome.\n[Speaker 9163913951807243266]: Thanks, Anna.\n[Speaker 9163913951807243266]: Appreciate it.\n[Speaker 9163913951807243266]: So, yeah, quick intro.\n[Speaker 9163913951807243266]: From our side, I'm Jacqueline a...", "callTitle": "BioRender | Roche - Renewal Proposal"}]}, {"id": "roche_global_it_a1636447", "company": "roche", "gong_entity": "Global IT", "gong_parent": "Roche", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So guys and I, we belong to global it", "snippet_date": "2025-08-14", "person_name": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "person_email": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internal_name": "Chris Hemberger; Jacqueline McCoskey; Tim Fung", "internal_email": "chris.hemberger@biorender.com; jacqueline@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=f2daf041fcef823a1ca53318a0433be11bf09513ae9914842dd2d09ba887c8cd", "call_id": "2025-08-14_f2daf041fcef", "call_count": 1, "all_snippets": [{"quote": "So guys and I, we belong to global it", "date": "2025-08-14", "callId": "2025-08-14_f2daf041fcef", "gongUrl": "https://app.gong.io/call?id=f2daf041fcef823a1ca53318a0433be11bf09513ae9914842dd2d09ba887c8cd", "speakerId": "5654559484448408361", "customerName": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "internalName": "Chris Hemberger; Jacqueline McCoskey; Tim Fung", "customerEmail": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "chris.hemberger@biorender.com; jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...we have is 7,500.\n[Speaker 2765030990157134975]: I think like that's the number, we can definitely go with, yeah, yeah.\n[Speaker 2765030990157134975]: And then moving forward, like once we do have more refreshed numbers, we can, you know, incorporate it then.\n[Speaker 5654559484448408361]: Yep.\n[Speaker 5654559484448408361]: Sounds good.\n[Speaker 8143937435222082516]: Cool.\n[Speaker 8143937435222082516]: Quick question.\n[Speaker 8143937435222082516]: What type of like, org changes or like transformation are you guys doing internally?\n[Speaker 8143937435222082516]: Is it hard for you to say right now?\n[Speaker 5654559484448408361]: It, I mean, at a very high level, we're all doing transformation when I say all I'm talking about research side, commercial side, global, it side.\n[Speaker 5654559484448408361]: So it's happening everywhere, oh.\n[Speaker 8143937435222082516]: Okay.\n[Speaker 5654559484448408361]: Large scale.\n[Speaker 5654559484448408361]: Okay.\n[Speaker 5654559484448408361]: ", "contextAfter": ".\n[Speaker 5654559484448408361]: Yeah.\n[Speaker 5654559484448408361]: And then we're going through a transformation too.\n[Speaker 8143937435222082516]: Oh, so all of, like research is going through a transformation.\n[Speaker 8143937435222082516]: It's all the specific departments that are going through a transformation.\n[Speaker 8143937435222082516]: Yes.\n[Speaker 8143937435222082516]: Okay.\n[Speaker 8143937435222082516]: So, and then, yeah, global, it?\n[Speaker 8143937435222082516]: Okay.\n[Speaker 8143937435222082516]: That makes sense.\n[Speaker 8143937435222082516]: Helpful.\n[Speaker 2765030990157134975]: Is this related to, I guess like breaking down the barriers between genentech and Roche or?\n[Speaker 2765030990157134975]: Yes?\n[Speaker 2765030990157134975]: Is that part of it?\n[Speaker 2765030990157134975]: Oh, okay.\n[Speaker 2765030990157134975]: Yes.\n[Speaker 2765030990157134975]: Okay.\n[Speaker 5654559484448408361]: So, that's the primary goal, right?\n[Speaker 5654559484448408...", "callTitle": "BioRender | Roche - usage data review"}]}, {"id": "roche_basel_ee33eb23", "company": "roche", "gong_entity": "Basel", "gong_parent": "Roche R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 9, "snippet": "the campuses were so vastly different between Basel and pennsburg", "snippet_date": "2025-06-20", "person_name": "Gaius Augustus", "person_email": "gaius.augustus@roche.com", "internal_name": "Jacqueline McCoskey; Livia Guo; Tim Fung", "internal_email": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "basel-switzerland-pred-center", "manual_node_name": "Basel, Switzerland (pRED Innovation Center)", "manual_node_path": "Roche Research & Development > Global R&D Sites > Basel, Switzerland (pRED Innovation Center)", "confidence": "high", "reasoning": "Exact location match - Basel is clearly the Basel, Switzerland R&D site"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=7f2ea71ba04e78b9703b50feef8d94efbdd7302f0066b1cb6d637232001d3256", "call_id": "2025-06-20_7f2ea71ba04e", "call_count": 9, "all_snippets": [{"quote": "the campuses were so vastly different between Basel and pennsburg", "date": "2025-06-20", "callId": "2025-06-20_7f2ea71ba04e", "gongUrl": "https://app.gong.io/call?id=7f2ea71ba04e78b9703b50feef8d94efbdd7302f0066b1cb6d637232001d3256", "speakerId": "1702020487969860766", "customerName": "Gaius Augustus", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...it all work, which I think was, like the most important part, but to make it more smoother like smoother, in the future, that probably would be something, that could be helpful.\n[Speaker 5407184206049929683]: Yeah, that makes a lot of sense to me.\n[Speaker 5407184206049929683]: And, I definitely think we can, you know, if we do future onsites, we can, we can bring in, perhaps, for example, like a product manager who, is based in that location, and then they can help us coordinate everything and keep everything in one location as far as like, the planning information, you know, typically, I know, in Tucson, if people are shipping stuff in or things, it's all, kind of goes to, the reception desk and they hold on to things.\n[Speaker 5407184206049929683]: And so that person would know for that particular site, what could be what the location for that would be, that would make the most sense as well?\n[Speaker 1702020487969860766]: Yeah, I agree.\n[Speaker 1702020487969860766]: I think like, ", "contextAfter": ".\n[Speaker 1702020487969860766]: And I imagine for all of like the other Roche sites as well, is that having someone that's familiar with just like the physical, geography of everything, would make a big difference?\n[Speaker 1702020487969860766]: Cause I think even for us coming in, we weren't sure like where the packages were going to, how we can actually bring things from one spot to another.\n[Speaker 1702020487969860766]: So having someone to just understand the layout would be super helpful.\n[Speaker 5407184206049929683]: Absolutely.\n[Speaker 5407184206049929683]: How did, organizing the like, the food, and that kind of thing go for you all?\n[Speaker 1702020487969860766]: Livia?\n[Speaker 1702020487969860766]: I think you can probably speak to that better than I can here cause you were pretty involved.\n[Speaker 6871408887928286916]: Yeah, yeah, I can share more.\n[Speaker 6871408887928286916]: Hi, nice to meet you actually on meetings.\n[Speaker 6871408887928286916]: So, Basel has an ...", "callTitle": "BioRender |  Roche - on-site debrief"}, {"quote": "We have the in person sessions planned for the Basel and pennsburg sites.", "date": "2025-05-06", "callId": "2025-05-06_37066a25169f", "gongUrl": "https://app.gong.io/call?id=37066a25169f230872122dcbc3bcdf337a663fe018af6d05a93aff696dd6e89c", "speakerId": "6088335049672687772", "customerName": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...hat distribution across the board as a heads up right now for distribution.\n[Speaker 6088335049672687772]: Majority of folks are P red G red, which makes sense.\n[Speaker 6088335049672687772]: They've had the license for probably like almost this would be year six almost.\n[Speaker 6088335049672687772]: So they make up about 85 percent of the license.\n[Speaker 6088335049672687772]: About 10 percent come from PTD and Dia, which is great that, you know, we're starting to see that number come up.\n[Speaker 6088335049672687772]: And then the last five percent guys is the folks that are unknown at the moment, and we'll work with them to get them to populate that field once it's ready to go.\n[Speaker 1706286059248901810]: Great.\n[Speaker 6088335049672687772]: HMM.\n[Speaker 6088335049672687772]: And then lastly, in terms of progress, just ongoing things that we're doing.\n[Speaker 6088335049672687772]: We're regularly onboarding new users and new groups.\n[Speaker 6088335049672687772]: We have a, ", "contextAfter": "\n[Speaker 6088335049672687772]: Now, I think all in all, we have 10 sessions that are planned along with individual user chats that folks want to speak who want to speak with us.\n[Speaker 6088335049672687772]: So it's great to see that, you know, folks get really excited for it.\n[Speaker 6088335049672687772]: Everyone that we've spoken to in terms of the admins at those sites have like they've been telling us that the folks that their teams are really keen on bringing us in.\n[Speaker 6088335049672687772]: So that's scheduled for the end of may and yeah, we're that's all coming together right now.\n[Speaker 6088335049672687772]: Cool.\n[Speaker 6088335049672687772]: Yes.\n[Speaker 6398962093308799650]: So, your team is traveling to Basel for these sessions.\n[Speaker 6398962093308799650]: It's the end of may.\n[Speaker 6398962093308799650]: I would love to get data on the turnout like how many people are attending it and so forth.\n[Speaker 6398962093308799650]: If there's I don't know.\n[Spea...", "callTitle": "BioRender | Roche - usage review"}, {"quote": "we haven't heard back from anyone from Basel for the catering", "date": "2025-05-05", "callId": "2025-05-05_2ed1375d19d8", "gongUrl": "https://app.gong.io/call?id=2ed1375d19d8a27a712c2c3f0f82054ebe4e731d0e8647a299703532508aff39", "speakerId": "6848680811226263463", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...680811226263463]: Right.\n[Speaker 6848680811226263463]: We have that in here.\n[Speaker 6848680811226263463]: Yeah.\n[Speaker 1329410053624158656]: Andrea was?\n[Speaker 6848680811226263463]: There anything we're missing then?\n[Speaker 6848680811226263463]: Catering, catering?\n[Speaker 6848680811226263463]: Okay?\n[Speaker 1329410053624158656]: Andrew was supposed to take care of catering.\n[Speaker 6848680811226263463]: Right.\n[Speaker 6848680811226263463]: And shipping and receiving, I think I.\n[Speaker 1329410053624158656]: think so.\n[Speaker 1329410053624158656]: Yeah, yeah.\n[Speaker 6848680811226263463]: Yeah.\n[Speaker 6848680811226263463]: Okay.\n[Speaker 6848680811226263463]: Yoshin, yoshin.\n[Speaker 1329410053624158656]: Said, he was able to, we can send swag to him, right?\n[Speaker 6848680811226263463]: Okay.\n[Speaker 6848680811226263463]: Yeah, yeah.\n[Speaker 5193090237181675730]: They just sent an email this morning that's prince burke.\n[Speaker 6848680811226263463]: Sorry, yeah, ", "contextAfter": ".\n[Speaker 6848680811226263463]: I don't think I followed up with Rahel today.\n[Speaker 1329410053624158656]: But.\n[Speaker 6848680811226263463]: yeah\u2026 Livia, it might be worth that for the Timo one.\n[Speaker 6848680811226263463]: I think we have a, I think it was recorded and there was a few things that he was like connect with Andrea on.\n[Speaker 6848680811226263463]: So it might be worth going through the recording and seeing if we need to set up a full meeting or if I can just email her the remaining questions.\n[Speaker 6848680811226263463]: Is that, is that work for you?\n[Speaker 5193090237181675730]: That's work?\n[Speaker 5193090237181675730]: Yeah, let me go over.\n[Speaker 6848680811226263463]: Yeah.\n[Speaker 6848680811226263463]: Okay.\n[Speaker 6848680811226263463]: No, gosh.\n[Speaker 6848680811226263463]: Hey, Emily.\n[Speaker 6848680811226263463]: Hi.\n[Speaker 1329410053624158656]: Everyone.\n[Speaker 1329410053624158656]: So, sorry, no worries.\n[Speaker 6848680811226263463]: N...", "callTitle": "BioRender | Roche PTD Onsite Planning"}, {"quote": "rba is Basel, okay, just for you to understand rba always Basel", "date": "2025-04-23", "callId": "2025-04-23_7ae27cb21ae8", "gongUrl": "https://app.gong.io/call?id=7ae27cb21ae825fb1bbf1191193fec0a9564775730a971a17496c2e5716a4f96", "speakerId": "5741703818535642290", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...ection of it yet.\n[Speaker 4591976821311352095]: So I'm not sure where they all are, but we do have other trainings within the buildings.\n[Speaker 5741703818535642290]: Yeah.\n[Speaker 5741703818535642290]: Okay.\n[Speaker 5741703818535642290]: So if you have a look at the room in the meeting, you can see that rba and then slash zero zero one.\n[Speaker 5741703818535642290]: I don't know if you can see that in your, in light.\n[Speaker 4591976821311352095]: Oh, let's actually double check that.\n[Speaker 4591976821311352095]: Okay.\n[Speaker 4591976821311352095]: Let me.\n[Speaker 5741703818535642290]: see, just to explain to you what that means because we have, of course, I don't know how many buildings we have here in Basel.\n[Speaker 5741703818535642290]: So.\n[Speaker 4591976821311352095]: Yeah.\n[Speaker 4591976821311352095]: Okay.\n[Speaker 4591976821311352095]: So yeah, I see the rba dash zero zero one.\n[Speaker 4591976821311352095]: Yes.\n[Speaker 5741703818535642290]: And that means that ", "contextAfter": ".\n[Speaker 4591976821311352095]: That's where we're going to be.\n[Speaker 4591976821311352095]: I was like, let's confirm that to start.\n[Speaker 5741703818535642290]: So if you have other, if you will get other rooms from other groups, so rba always should be rba for Basel.\n[Speaker 5741703818535642290]: Okay.\n[Speaker 5741703818535642290]: And then zero zero one is the building.\n[Speaker 5741703818535642290]: So that's building one that's one of the, I don't know if you've seen Roche, the one of the towers?\n[Speaker 5741703818535642290]: Yep.\n[Speaker 5741703818535642290]: Yes.\n[Speaker 5741703818535642290]: So, and then the og zero two means second floor.\n[Speaker 4591976821311352095]: Okay, perfect.\n[Speaker 4591976821311352095]: And then, is there room number in there?\n[Speaker 4591976821311352095]: Like is S4?\n[Speaker 5741703818535642290]: That's the south.\n[Speaker 5741703818535642290]: Yeah, south four, seven, three is the room the.\n[Speaker 4591976821311352095]: Room?\n[Speake...", "callTitle": "BioRender | Roche PTD onsite planning"}, {"quote": "What we were looking and just to confirm, are you in Munich or Basel? You're in Basel?", "date": "2025-03-19", "callId": "2025-03-19_b429b7e52b42", "gongUrl": "https://app.gong.io/call?id=b429b7e52b42b59042c3e7c3a8603aef7dd65db4c536dc921f90301f8a4bf025", "speakerId": "2893660636991191012", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "... my team is relatively small, so I think it would not make sense to only focus on the direct team, but I would go to the department level more, okay to get a couple more people involved.\nAnd did I get it, right?\nYou come on site?\nSo it will not be, yeah.\nIt'll be in person.\nSo we would do like a lunch and learn kind of thing or like a breakfast or whatever makes the most sense for you guys?\nOkay.\nThen maybe I will, give me a second.\nYeah, take your time.\nI have to make some notes and these I have to make on paper because if I type it down, I will forget it.\nI know I'm so with you.\nI have a notepad with me all the time because I, I'm yeah, something doesn't it's not the same when I type it, no.\nAnd, it stays on my table exactly.\nSo, so that would mean the lunch and learn would be, I think that would be, nice opportunity because then I could check in with our admins, to organize then lunch yep, and we can do that in parallel.\nThat would be great way.\nAnd then you said may something, so.\n", "contextAfter": "\nOkay.\nYeah, cause we were looking to do both sites and trying to like kind of one week in one spot, one week in the next.\nSo we were looking either the week of may nineteenth or the 20 sixth.\nIt's kind of looking like the Basel location on the nineteenth, the week sometime in that week.\nSo I'm not sure if that's something that you're able to like check in terms of, timing and stuff, but, that's tentatively what we were thinking.\nI'm just checking general.\nSo no, no general holidays that's so, that is one thing.\nThat was what we were, I was chatting with someone else and we had to, there was like, you know, we're approaching that season, there's Easter and I know that you guys have may first and second off and, so there's it's like a pretty limited timeframe of when we can actually make this happen.\nSo we, hopefully we can actually do it.\nYeah, but that looks good.\nSo, the week after would only be the week after 26 is only half a week, right?\nAnd there, there might be many out of offic...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}, {"quote": "we're going to be coming on site both to pennsburg and Basel, pennsburg and Munich.", "date": "2025-03-14", "callId": "2025-03-14_d067238de6be", "gongUrl": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "speakerId": "6782829348298472977", "customerName": "Jo Stevens", "internalName": "Jacqueline McCoskey", "customerEmail": "jo.stevens@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "... appreciate you taking the time to chat, you know, some exciting stuff.\n[Speaker 6782829348298472977]: I'm not sure if you had seen the announcement that the license had been extended beyond P red and G red, you did?\n[Speaker 5895796664693401761]: Okay.\n[Speaker 5895796664693401761]: I was involved also in the beginning when they were discussing, should we do a global license?\n[Speaker 5895796664693401761]: Oh.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: Were you chatting with Gaius?\n[Speaker 6782829348298472977]: Is that the person?\n[Speaker 5895796664693401761]: Yeah, exactly.\n[Speaker 5895796664693401761]: Okay.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: They're the person who gave me your name to reach out to try to say that, you know, you might be interested in doing something in person?\n[Speaker 6782829348298472977]: So, yeah.\n[Speaker 6782829348298472977]: So for some additional context, ", "contextAfter": "\n[Speaker 6782829348298472977]: Those are the same sites, right?\n[Speaker 6782829348298472977]: Do I have that, right?\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 5895796664693401761]: Pennsburg is like a very small town about half an hour from Munich, okay?\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: But when we talk about Roche, it's like pennsburg that's kind.\n[Speaker 5895796664693401761]: Of it, right?\n[Speaker 5895796664693401761]: Yeah, that's why everyone says Munich because no one knows Penn.\n[Speaker 6782829348298472977]: I got you.\n[Speaker 6782829348298472977]: I got you.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: So yeah, we are part of like this whole global license is that we're going to be doing some implementation in person and making sure that people really know how to use the platform to its full extent.\n[Speaker 6782829348298472977]: We'...", "callTitle": "BioRender | Roche"}, {"quote": "Is, I mean, we have technical development activities in basel in pennsburg, and in san Francisco.", "date": "2024-06-14", "callId": "2024-06-14_5820c7bc82da", "gongUrl": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "speakerId": "1372854872117518306", "customerName": "Felix Kuhne", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "felix.kuhne@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... How do I?\n[Speaker 8593743714562823197]: Pt, isn't a part of like diagnostics or\u2026 like it's completely separate from those two groups.\n[Speaker 1372854872117518306]: Yeah.\n[Speaker 1372854872117518306]: So we have the diagnostics, and then we have the pharma, yeah, separate divisions.\n[Speaker 1372854872117518306]: And within the pharma division, the research and development is separate organization if you want.\n[Speaker 1372854872117518306]: So, and then we have, the technical development.\n[Speaker 1372854872117518306]: So the process development unit, and then we have the commercial unit which is today basically produce the product in the end.\n[Speaker 1372854872117518306]: And those are the three big organizations and the research so pre and in the us is great.\n[Speaker 1372854872117518306]: The research units are larger than the technical development unit.\n[Speaker 1372854872117518306]: And also the commercial units are larger technical development.\n[Speaker 1372854872117518306]: ", "contextAfter": "\n[Speaker 1372854872117518306]: Mainly, I would say probably there are some other\u2026 sites where they also have technical development activities.\n[Speaker 1372854872117518306]: But those are the main sites, I would say.\n[Speaker 8593743714562823197]: I understand.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: So pharma has like three, three main groups there's, the P red.\n[Speaker 8593743714562823197]: So like, the research side, and then there's the technical development.\n[Speaker 8593743714562823197]: And then commercial that, do I have that correct?\n[Speaker 8593743714562823197]: Okay?\n[Speaker 1372854872117518306]: We trying to sugar?\n[Speaker 8593743714562823197]: This out for a while.\n[Speaker 8593743714562823197]: So this makes sense.\n[Speaker 1372854872117518306]: Commercial is the manufacturing.\n[Speaker 8593743714562823197]: And within like ptd, how large is that as like a, as a function?\n[Speaker 8593743714562823197]: I guess?\n[Speaker 1372854872117518306...", "callTitle": "BioRender & Roche - Follow Up Call"}, {"quote": "we're reaching out to specific personas like yourself at the Basel campus", "date": "2025-05-07", "callId": "2025-05-07_74bbb9da032e", "gongUrl": "https://app.gong.io/call?id=74bbb9da032e3668ae88f672336d7d39bf62bfa6a61edf20975af16185ab4cb9", "speakerId": "9149980781011298866", "customerName": "Zeinab Barekati", "internalName": "Mackay O'Connor", "customerEmail": "zeinab.barekati@roche.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": [], "contextBefore": "...8866]: This is Zeinab.\n[Speaker 9149980781011298866]: Hi, Zeinab.\n[Speaker 9149980781011298866]: This is Mckay.\n[Speaker 9149980781011298866]: How are you doing?\n[Speaker 8522682431281945319]: Good.\n[Speaker 8522682431281945319]: Thank you.\n[Speaker 9149980781011298866]: Good, good.\n[Speaker 9149980781011298866]: Sorry.\n[Speaker 9149980781011298866]: I know.\n[Speaker 9149980781011298866]: I'm calling you a little bit out of the blue.\n[Speaker 9149980781011298866]: It's in regards to an email I had sent your way about biorender.\n[Speaker 9149980781011298866]: Are you familiar?\n[Speaker 8522682431281945319]: Can you repeat again?\n[Speaker 9149980781011298866]: Yeah, I'm reaching out in regards to an email I sent your way about biorender.\n[Speaker 9149980781011298866]: Are you familiar with biorender?\n[Speaker 8522682431281945319]: Ah, okay.\n[Speaker 8522682431281945319]: I'm not using it at the moment.\n[Speaker 8522682431281945319]: What is it about?\n[Speaker 9149980781011298866]: Yeah, ", "contextAfter": " as our head of product is coming on site.\n[Speaker 9149980781011298866]: And so he's looking to set up meetings to\u2026 just get some feedback on some of the new features we're adding to the product roadmap to specifically adjust it to Roche's scientific communication needs.\n[Speaker 8522682431281945319]: MM, HMM.\n[Speaker 8522682431281945319]: Okay.\n[Speaker 8522682431281945319]: MM.\n[Speaker 8522682431281945319]: HMM.\n[Speaker 8522682431281945319]: Yes.\n[Speaker 9149980781011298866]: And I guess I'm wondering, are you on site on Basel?\n[Speaker 9149980781011298866]: From may 20 first to 20 third?\n[Speaker 8522682431281945319]: Yes.\n[Speaker 8522682431281945319]: Yes, I am there 20 first.\n[Speaker 8522682431281945319]: Just let me see my calendar because I don't go every day.\n[Speaker 8522682431281945319]: 20 first.\n[Speaker 8522682431281945319]: Yeah, I will be there on 20 second or twentieth may.\n[Speaker 9149980781011298866]: Okay.\n[Speaker 9149980781011298866]: On the 20 second, do y...", "callTitle": "Call with Roche Ltd. - Zeinab Barekati"}, {"quote": "we're coming on site at the Basel unit", "date": "2025-05-01", "callId": "2025-05-01_30d962f815d4", "gongUrl": "https://app.gong.io/call?id=30d962f815d4f266da1af2c8acfb7f51c212e0fd06e87cb810bec1b1a8e5cdd3", "speakerId": "6739018369184323842", "customerName": "Yali Fu", "internalName": "Mackay O'Connor", "customerEmail": "yali.fu@roche.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": [], "contextBefore": "[Speaker 666424980798760135]: hello?\n[Speaker 6739018369184323842]: Hi.\n[Speaker 6739018369184323842]: Is this Yali?\n[Speaker 666424980798760135]: Yes, yes.\n[Speaker 6739018369184323842]: Hi, Yali.\n[Speaker 6739018369184323842]: This is Mckay.\n[Speaker 6739018369184323842]: How are you doing?\n[Speaker 666424980798760135]: Good.\n[Speaker 6739018369184323842]: Good, good.\n[Speaker 6739018369184323842]: Sorry.\n[Speaker 6739018369184323842]: I know I'm calling you a little bit out of the blue here.\n[Speaker 6739018369184323842]: It's in regards to biorender and Roche.\n[Speaker 6739018369184323842]: Are you familiar with biorender?\n[Speaker 666424980798760135]: Yeah, I heard about it.\n[Speaker 6739018369184323842]: Okay, great.\n[Speaker 6739018369184323842]: Yeah.\n[Speaker 6739018369184323842]: The reason I'm reaching out is because we're discussing with leaders at Roche that are a part of like evaluating biorender because ", "contextAfter": ".\n[Speaker 6739018369184323842]: I guess, how are you familiar with biorender?\n[Speaker 6739018369184323842]: What do you know about it?\n[Speaker 666424980798760135]: No, not much.\n[Speaker 6739018369184323842]: No.\n[Speaker 6739018369184323842]: Does your team use it?\n[Speaker 666424980798760135]: What is that about?\n[Speaker 666424980798760135]: Can you remind me?\n[Speaker 666424980798760135]: I just come back from a conference there's?\n[Speaker 666424980798760135]: A lot of information?\n[Speaker 666424980798760135]: I mean, just mixed all together?\n[Speaker 6739018369184323842]: Yeah, biorender.\n[Speaker 6739018369184323842]: No worries.\n[Speaker 6739018369184323842]: Yeah, it's an illustration software.\n[Speaker 6739018369184323842]: So it's what a lot of your researchers likely use to create their visuals.\n[Speaker 666424980798760135]: Oh, to make a slide.\n[Speaker 666424980798760135]: Yeah, the pictures.\n[Speaker 666424980798760135]: Yeah, I remember that they made a very lovely ...", "callTitle": "Call with Roche Ltd. - Yali Fu"}]}, {"id": "roche_pharma_technical_development_36f5e993", "company": "roche", "gong_entity": "Pharma Technical Development", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 4, "snippet": "we also have been getting a lot of requests from pharma technical development and they don't have access right now", "snippet_date": "2024-09-16", "person_name": "Gaius Augustus; George Abousleiman; Kawal Kaur", "person_email": "gaius.augustus@roche.com; abousleg@gene.com; kaurk5@gene.com", "internal_name": "Jacqueline McCoskey; Tim Fung", "internal_email": "jacqueline@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-sciences-technical", "manual_node_name": "Pharmaceutical Sciences (Pharma Technical)", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical)", "confidence": "high", "reasoning": "Strong semantic match - 'Pharma Technical Development' aligns with 'Pharmaceutical Sciences (Pharma Technical)' division"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d36b49ea866e8fc066b20a5d96a1a11f1afb1d751f0a926343dc3ca8b2b1b2f1", "call_id": "2024-09-16_d36b49ea866e", "call_count": 4, "all_snippets": [{"quote": "we also have been getting a lot of requests from pharma technical development and they don't have access right now", "date": "2024-09-16", "callId": "2024-09-16_d36b49ea866e", "gongUrl": "https://app.gong.io/call?id=d36b49ea866e8fc066b20a5d96a1a11f1afb1d751f0a926343dc3ca8b2b1b2f1", "speakerId": "1067617882933750578", "customerName": "Gaius Augustus; George Abousleiman; Kawal Kaur", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "gaius.augustus@roche.com; abousleg@gene.com; kaurk5@gene.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...8]: Yep totally okay that's good for us to know yeah we because everyone in pharma within like the P RED and G RED divisions has access right now so everyone else it'll be for the people that are outside of it I guess this is just more so talking about the renewal date and when we're hoping it to launch the enterprise licensing and then this will be like kind of the running in parallel as we're working towards that enterprise licensing I can clarify that language on here too if that's.\n[Speaker 4443789273359589298]: helpful.\n[Speaker 4443789273359589298]: OK, that's OK.\n[Speaker 4443789273359589298]: And I'm sharing this with you because as we are moving forward, you will hear us saying fine diagnostics like we're getting rid of GYP.\n[Speaker 4443789273359589298]: Totally.\n[Speaker 4443789273359589298]: Yeah, yeah.\n[Speaker 4443789273359589298]: And then...\n[Speaker 4443789273359589298]: Sorry, go ahead.\n[Speaker 1067617882933750578]: I was just going to say the one thing with this is ", "contextAfter": ".\n[Speaker 1067617882933750578]: So that's why we're defining these P RED and G RED because the users who are requesting are primarily in PTD as well as DIA.\n[Speaker 1067617882933750578]: So guys, you might need to provide some context there, but...\n[Speaker 3019586265158603172]: Yeah, exactly.\n[Speaker 3019586265158603172]: I was just about to say the same thing, that we are getting requests from pharma as well that are outside of P RED, but would like to access the system.\n[Speaker 3019586265158603172]: But I...\n[Speaker 3019586265158603172]: Yeah, and I recognize your point, though, Kawal, that like in the future implementation, we're really talking about pharma, which is...\n[Speaker 3019586265158603172]: Everything in it, you know, everything pharma plus P RED, G RED.\n[Speaker 3019586265158603172]: Yeah.\n[Speaker 3019586265158603172]: And then we have DIA as kind of a little bit of a separate entity.\n[Speaker 1067617882933750578]: But correct me if I'm wrong, the goal of the enter...", "callTitle": "BioRender | Roche - short term access"}, {"quote": "So I work for the pharma, technical development in the analytics department.", "date": "2024-06-14", "callId": "2024-06-14_5820c7bc82da", "gongUrl": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "speakerId": "1372854872117518306", "customerName": "Felix Kuhne", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "felix.kuhne@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...3714562823197]: Will.\n[Speaker 1372854872117518306]: So\u2026 no, nothing particular, actually.\n[Speaker 1372854872117518306]: So.\n[Speaker 1372854872117518306]: Well, maybe if there is a workaround as long as we don't have a team license, is there may be a workaround for us to use BioRender.\n[Speaker 1372854872117518306]: Also, I mean at least for internal presentations, that will be one question, maybe, yeah.\n[Speaker 8593743714562823197]: Yeah, totally.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: So I can kind of give you an overview of how the setup could work.\n[Speaker 8593743714562823197]: Just a couple of questions for you before, to figure out what sort of option would work best.\n[Speaker 8593743714562823197]: So, you had made a note that you are part of ptd.\n[Speaker 8593743714562823197]: Do you mind giving an overview of kind of like your role and organizationally where that fits in to re.\n[Speaker 1372854872117518306]: Sure.\n[Speaker 1372854872117518306]: ", "contextAfter": "\n[Speaker 1372854872117518306]: There, we have a department for the characterization of our molecules.\n[Speaker 1372854872117518306]: So, and there I work\u2026 in the position of one of our innovation leads, innovation lead.\n[Speaker 1372854872117518306]: They are for technology questions and for improving our technology, for the characterization of our molecules\u2026 my role.\n[Speaker 8593743714562823197]: Perfect.\n[Speaker 8593743714562823197]: That's super helpful.\n[Speaker 8593743714562823197]: So just to clarify you're within so that we have just looking at my other screen so we have PD and then there's an analytics group.\n[Speaker 8593743714562823197]: And then there's a characterization of molecules, smaller group.\n[Speaker 8593743714562823197]: And that's the part that you're the group that you're part of, right?\n[Speaker 8593743714562823197]: Yeah.\n[Speaker 8593743714562823197]: Got you.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: How many people are within tha...", "callTitle": "BioRender & Roche - Follow Up Call"}, {"quote": "In Pharma Tech?", "date": "2024-09-13", "callId": "2024-09-13_41ad3e894be7", "gongUrl": "https://app.gong.io/call?id=41ad3e894be73218a9b76f0569ae8ed8bda3d58ccccd10de379fc82d74a99a52", "speakerId": "3774048525769612921", "customerName": "Gaius Augustus; George Abousleiman", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "gaius.augustus@roche.com; abousleg@gene.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...equests from a bunch of different people okay yeah who have been hearing that we're working on these BioRender negotiations yeah so it's kind of you know expanding as we go so I just wanted to go ahead and give you the idea of what where we are now and hear how you're planning to approach the short term stuff yep for sure so I think right now I'm just double checking my notes I'm still waiting to hear back from a few people but it looks like right now and this is for Amelie I don't have the large number I just have a smaller number of like short term so it's 20 to 30 users which I.\n[Speaker 7698410010917884573]: talking to her on monday too so we can maybe get some exactly yeah yeah for sure.\n[Speaker 3774048525769612921]: but totally right now it looks like somewhere between 160 and 200 users not.\n[Speaker 7698410010917884573]: Nice, okay, that's good.\n[Speaker 7698410010917884573]: Did you hear from Christoph.\n[Speaker 3774048525769612921]: Any chance?\n[Speaker 3774048525769612921]: ", "contextAfter": "\n[Speaker 7698410010917884573]: Yes, I heard from him.\n[Speaker 7698410010917884573]: Okay.\n[Speaker 7698410010917884573]: I had spoken with him and I redirected him your way, so.\n[Speaker 3774048525769612921]: Thank you very much for that.\n[Speaker 3774048525769612921]: I appreciate it.\n[Speaker 3774048525769612921]: And I don't have a number from him yet.\n[Speaker 3774048525769612921]: Okay.\n[Speaker 7698410010917884573]: He was like kind of requesting on behalf of Pharma Tech, so yeah, we will, I guess we'll kind of see where things are at that point, but no rush.\n[Speaker 7698410010917884573]: I mean, I know we want to get up and running sooner than later, but I'm happy that you got in contact with him.\n[Speaker 3774048525769612921]: Absolutely.\n[Speaker 3774048525769612921]: Yeah.\n[Speaker 3774048525769612921]: And I, there's another person who's been contacting me from another area in Pharma Tech.\n[Speaker 3774048525769612921]: Okay.\n[Speaker 3774048525769612921]: So, one of the ...", "callTitle": "BioRender | Roche - short term access"}, {"quote": "when it came to pharma tech and diagnostics, we've had a ton of requests", "date": "2023-01-10", "callId": "2023-01-10_f036bf593e0a", "gongUrl": "https://app.gong.io/call?id=f036bf593e0a7e85e313d125372580b898d48a2e31bd3c50c3333dfcab054725", "speakerId": "5808409350456711249", "customerName": "Anahita Ghosh; Elena Gandia; Sandra Krause; Steffen Sachse", "internalName": "Jacqueline McCoskey; Jeff Roy", "customerEmail": "anahita.ghosh@roche.com; elena.gandia@roche.com; sandra.krause@roche.com; steffen.sachse@roche.com", "internalEmail": "jacqueline@biorender.com; jeff@biorender.com", "sizeMentions": [], "contextBefore": "...\n[Speaker 6971271811317687966]: And again, the curve is based on the curve we had in the past it.\n[Speaker 5808409350456711249]: You got it.\n[Speaker 5808409350456711249]: Exactly.\n[Speaker 5808409350456711249]: Yeah.\n[Speaker 5808409350456711249]: So that's the here's the growth rates up here.\n[Speaker 5808409350456711249]: So we actually like in the year one, we grew 60 percent and then 30 percent.\n[Speaker 5808409350456711249]: So we've kind of a yeah, like a more of a conservative estimate especially with G red as well because they had some pretty high growth rates.\n[Speaker 5808409350456711249]: And then, yeah, we did the exact same thing with Gene tech.\n[Speaker 5808409350456711249]: So here's the G red situation where the renewal would have been 443,000.\n[Speaker 5808409350456711249]: And this is how we're going to estimate the growth over the course of the year\u2026 where it comes a little bit.\n[Speaker 5808409350456711249]: You know, we had to sort of extrapolate our data with is ", "contextAfter": ".\n[Speaker 5808409350456711249]: We have a number of one off licenses here and there.\n[Speaker 5808409350456711249]: And because it's such a large group, it's a little, you know, we had to sort of use our best estimate to try to come up with what we think the usage would be in those groups.\n[Speaker 5808409350456711249]: And yeah, given the usage in P red and G red, we sort of did the same thing where we started off at around, you know, maybe 200 at the beginning of the year given how many free users we have right now and kind of like extrapolated that to get to these different dollar values.\n[Speaker 5808409350456711249]: Does that help clarify, Jeff?\n[Speaker 5808409350456711249]: Is?\n[Speaker 6971271811317687966]: May, may I ask, I, may I ask question, how many active users do we have in county?\n[Speaker 6971271811317687966]: So it's really countly how many active users do we have in get?\n[Speaker 6971271811317687966]: How many active users do we have in prod?\n[Speaker 6971271811317...", "callTitle": "BioRender/Roche"}]}, {"id": "roche_pennsburg_33d538e7", "company": "roche", "gong_entity": "Pennsburg", "gong_parent": "Roche R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 4, "snippet": "the campuses were so vastly different between Basel and pennsburg", "snippet_date": "2025-06-20", "person_name": "Gaius Augustus", "person_email": "gaius.augustus@roche.com", "internal_name": "Jacqueline McCoskey; Livia Guo; Tim Fung", "internal_email": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "munich-penzberg-germany", "manual_node_name": "Munich/Penzberg, Germany (Innovation Center Munich)", "manual_node_path": "Roche Research & Development > Global R&D Sites > Munich/Penzberg, Germany (Innovation Center Munich)", "confidence": "medium", "reasoning": "Likely mispronunciation or mishearing of 'Penzberg' - the context suggests a major Roche site being compared to Basel"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=7f2ea71ba04e78b9703b50feef8d94efbdd7302f0066b1cb6d637232001d3256", "call_id": "2025-06-20_7f2ea71ba04e", "call_count": 4, "all_snippets": [{"quote": "the campuses were so vastly different between Basel and pennsburg", "date": "2025-06-20", "callId": "2025-06-20_7f2ea71ba04e", "gongUrl": "https://app.gong.io/call?id=7f2ea71ba04e78b9703b50feef8d94efbdd7302f0066b1cb6d637232001d3256", "speakerId": "1702020487969860766", "customerName": "Gaius Augustus", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...it all work, which I think was, like the most important part, but to make it more smoother like smoother, in the future, that probably would be something, that could be helpful.\n[Speaker 5407184206049929683]: Yeah, that makes a lot of sense to me.\n[Speaker 5407184206049929683]: And, I definitely think we can, you know, if we do future onsites, we can, we can bring in, perhaps, for example, like a product manager who, is based in that location, and then they can help us coordinate everything and keep everything in one location as far as like, the planning information, you know, typically, I know, in Tucson, if people are shipping stuff in or things, it's all, kind of goes to, the reception desk and they hold on to things.\n[Speaker 5407184206049929683]: And so that person would know for that particular site, what could be what the location for that would be, that would make the most sense as well?\n[Speaker 1702020487969860766]: Yeah, I agree.\n[Speaker 1702020487969860766]: I think like, ", "contextAfter": ".\n[Speaker 1702020487969860766]: And I imagine for all of like the other Roche sites as well, is that having someone that's familiar with just like the physical, geography of everything, would make a big difference?\n[Speaker 1702020487969860766]: Cause I think even for us coming in, we weren't sure like where the packages were going to, how we can actually bring things from one spot to another.\n[Speaker 1702020487969860766]: So having someone to just understand the layout would be super helpful.\n[Speaker 5407184206049929683]: Absolutely.\n[Speaker 5407184206049929683]: How did, organizing the like, the food, and that kind of thing go for you all?\n[Speaker 1702020487969860766]: Livia?\n[Speaker 1702020487969860766]: I think you can probably speak to that better than I can here cause you were pretty involved.\n[Speaker 6871408887928286916]: Yeah, yeah, I can share more.\n[Speaker 6871408887928286916]: Hi, nice to meet you actually on meetings.\n[Speaker 6871408887928286916]: So, Basel has an ...", "callTitle": "BioRender |  Roche - on-site debrief"}, {"quote": "We have the in person sessions planned for the Basel and pennsburg sites.", "date": "2025-05-06", "callId": "2025-05-06_37066a25169f", "gongUrl": "https://app.gong.io/call?id=37066a25169f230872122dcbc3bcdf337a663fe018af6d05a93aff696dd6e89c", "speakerId": "6088335049672687772", "customerName": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...hat distribution across the board as a heads up right now for distribution.\n[Speaker 6088335049672687772]: Majority of folks are P red G red, which makes sense.\n[Speaker 6088335049672687772]: They've had the license for probably like almost this would be year six almost.\n[Speaker 6088335049672687772]: So they make up about 85 percent of the license.\n[Speaker 6088335049672687772]: About 10 percent come from PTD and Dia, which is great that, you know, we're starting to see that number come up.\n[Speaker 6088335049672687772]: And then the last five percent guys is the folks that are unknown at the moment, and we'll work with them to get them to populate that field once it's ready to go.\n[Speaker 1706286059248901810]: Great.\n[Speaker 6088335049672687772]: HMM.\n[Speaker 6088335049672687772]: And then lastly, in terms of progress, just ongoing things that we're doing.\n[Speaker 6088335049672687772]: We're regularly onboarding new users and new groups.\n[Speaker 6088335049672687772]: We have a, ", "contextAfter": "\n[Speaker 6088335049672687772]: Now, I think all in all, we have 10 sessions that are planned along with individual user chats that folks want to speak who want to speak with us.\n[Speaker 6088335049672687772]: So it's great to see that, you know, folks get really excited for it.\n[Speaker 6088335049672687772]: Everyone that we've spoken to in terms of the admins at those sites have like they've been telling us that the folks that their teams are really keen on bringing us in.\n[Speaker 6088335049672687772]: So that's scheduled for the end of may and yeah, we're that's all coming together right now.\n[Speaker 6088335049672687772]: Cool.\n[Speaker 6088335049672687772]: Yes.\n[Speaker 6398962093308799650]: So, your team is traveling to Basel for these sessions.\n[Speaker 6398962093308799650]: It's the end of may.\n[Speaker 6398962093308799650]: I would love to get data on the turnout like how many people are attending it and so forth.\n[Speaker 6398962093308799650]: If there's I don't know.\n[Spea...", "callTitle": "BioRender | Roche - usage review"}, {"quote": "Is, I mean, we have technical development activities in basel in pennsburg, and in san Francisco.", "date": "2024-06-14", "callId": "2024-06-14_5820c7bc82da", "gongUrl": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "speakerId": "1372854872117518306", "customerName": "Felix Kuhne", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "felix.kuhne@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... How do I?\n[Speaker 8593743714562823197]: Pt, isn't a part of like diagnostics or\u2026 like it's completely separate from those two groups.\n[Speaker 1372854872117518306]: Yeah.\n[Speaker 1372854872117518306]: So we have the diagnostics, and then we have the pharma, yeah, separate divisions.\n[Speaker 1372854872117518306]: And within the pharma division, the research and development is separate organization if you want.\n[Speaker 1372854872117518306]: So, and then we have, the technical development.\n[Speaker 1372854872117518306]: So the process development unit, and then we have the commercial unit which is today basically produce the product in the end.\n[Speaker 1372854872117518306]: And those are the three big organizations and the research so pre and in the us is great.\n[Speaker 1372854872117518306]: The research units are larger than the technical development unit.\n[Speaker 1372854872117518306]: And also the commercial units are larger technical development.\n[Speaker 1372854872117518306]: ", "contextAfter": "\n[Speaker 1372854872117518306]: Mainly, I would say probably there are some other\u2026 sites where they also have technical development activities.\n[Speaker 1372854872117518306]: But those are the main sites, I would say.\n[Speaker 8593743714562823197]: I understand.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: So pharma has like three, three main groups there's, the P red.\n[Speaker 8593743714562823197]: So like, the research side, and then there's the technical development.\n[Speaker 8593743714562823197]: And then commercial that, do I have that correct?\n[Speaker 8593743714562823197]: Okay?\n[Speaker 1372854872117518306]: We trying to sugar?\n[Speaker 8593743714562823197]: This out for a while.\n[Speaker 8593743714562823197]: So this makes sense.\n[Speaker 1372854872117518306]: Commercial is the manufacturing.\n[Speaker 8593743714562823197]: And within like ptd, how large is that as like a, as a function?\n[Speaker 8593743714562823197]: I guess?\n[Speaker 1372854872117518306...", "callTitle": "BioRender & Roche - Follow Up Call"}, {"quote": "And at the penceburg location, it's primarily PCS, right?", "date": "2025-05-05", "callId": "2025-05-05_2ed1375d19d8", "gongUrl": "https://app.gong.io/call?id=2ed1375d19d8a27a712c2c3f0f82054ebe4e731d0e8647a299703532508aff39", "speakerId": "6848680811226263463", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...but do you know how most of them are set up in terms of like sharing your screen?\n[Speaker 6848680811226263463]: Is it, do people typically just connect to a Google me or is there like, a different way to connect to your screen?\n[Speaker 2886391078890217663]: So, most of our rooms at the moment, they have built in systems where you can directly connect to the meeting, like to a Google meets, meeting with the screen itself.\n[Speaker 2886391078890217663]: So they have like a tablet.\n[Speaker 2886391078890217663]: So if you join the meeting via the companion mode, you can directly share it, on the screen or on the TV that we have in the meeting room.\n[Speaker 2886391078890217663]: And actually that's how most of our meeting rooms are set up.\n[Speaker 6848680811226263463]: Perfect.\n[Speaker 6848680811226263463]: Okay.\n[Speaker 6848680811226263463]: That's that's super helpful.\n[Speaker 6848680811226263463]: Yeah, that's what it sounds like for the most part.\n[Speaker 6848680811226263463]: ", "contextAfter": "\n[Speaker 6848680811226263463]: There's no macs, at the penceburg location.\n[Speaker 6848680811226263463]: No good to know.\n[Speaker 6848680811226263463]: It's funny because some in the Basel locations both.\n[Speaker 6848680811226263463]: And then penceburg, it's it sounds like it's just PC.\n[Speaker 6848680811226263463]: So we are going to be ready with both to make sure that we're all set there.\n[Speaker 6848680811226263463]: So.\n[Speaker 2886391078890217663]: Awesome.\n[Speaker 2886391078890217663]: But I think usually since anyway, all of the connections are wireless.\n[Speaker 2886391078890217663]: So most of the time there is no plugging in necessary.\n[Speaker 2886391078890217663]: So I think it should work with both.\n[Speaker 6848680811226263463]: Okay.\n[Speaker 6848680811226263463]: Do you know, hopefully we're not gonna have to deal with this because we have a session in the morning and it sounds like things are pretty simple in terms of connecting to the rooms.\n[Speaker 6848680...", "callTitle": "BioRender | Roche PTD Onsite Planning"}]}, {"id": "roche_penzberg_1d085473", "company": "roche", "gong_entity": "Penzberg", "gong_parent": "Roche R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "are you all based in the pensberg location?", "snippet_date": "2025-03-18", "person_name": "Amelie Bauer", "person_email": "amelie.bauer.ab1@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "munich-penzberg-germany", "manual_node_name": "Munich/Penzberg, Germany (Innovation Center Munich)", "manual_node_path": "Roche Research & Development > Global R&D Sites > Munich/Penzberg, Germany (Innovation Center Munich)", "confidence": "high", "reasoning": "Exact location match - Penzberg is part of the Munich/Penzberg, Germany R&D site"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "call_id": "2025-03-18_b967005befa5", "call_count": 3, "all_snippets": [{"quote": "are you all based in the pensberg location?", "date": "2025-03-18", "callId": "2025-03-18_b967005befa5", "gongUrl": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "speakerId": "289705782262410669", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...er 6724612687015910624]: Something around that?\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: And do you have smaller teams within gene therapy or is that kind of the like you guys all kind of work together within that group?\n[Speaker 6724612687015910624]: I know.\n[Speaker 6724612687015910624]: So we do have smaller teams.\n[Speaker 6724612687015910624]: So we are based, so basically separated based on area of expertise.\n[Speaker 6724612687015910624]: So, where we are in the process.\n[Speaker 6724612687015910624]: So since we are in the process development, we do have the cell culture process.\n[Speaker 6724612687015910624]: We do have purification process, and then we have the analytical team.\n[Speaker 6724612687015910624]: So, I would say, in general, we do have three large teams, that are more or less separated from each other.\n[Speaker 289705782262410669]: I gotcha.\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: Cause what we would typically do ", "contextAfter": "\n[Speaker 289705782262410669]: Yes?\n[Speaker 6724612687015910624]: We are.\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: Cause, with a group of around 150 people, typically, I would say we see kind of like 25 to 30 percent of people actually show up to these.\n[Speaker 289705782262410669]: So if we were to keep it for the gene therapy department, I wouldn't obviously, not all 140 people would come.\n[Speaker 289705782262410669]: We probably, it would probably be closer to like 30 to 50 maybe.\n[Speaker 289705782262410669]: And again, it would kind of depend on the room size.\n[Speaker 289705782262410669]: So, like, who we can invite, and what we would typically do is once we secure the room, we can kind of finalize which group we want to invite to it.\n[Speaker 289705782262410669]: And then we would send out like a calendar invite and then people would accept or not accept.\n[Speaker 289705782262410669]: We also understand like that number is kind of a, estimate because s...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}, {"quote": "Pennsburg is like a very small town about half an hour from Munich", "date": "2025-03-14", "callId": "2025-03-14_d067238de6be", "gongUrl": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "speakerId": "5895796664693401761", "customerName": "Jo Stevens", "internalName": "Jacqueline McCoskey", "customerEmail": "jo.stevens@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "... the beginning when they were discussing, should we do a global license?\n[Speaker 5895796664693401761]: Oh.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: Were you chatting with Gaius?\n[Speaker 6782829348298472977]: Is that the person?\n[Speaker 5895796664693401761]: Yeah, exactly.\n[Speaker 5895796664693401761]: Okay.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: They're the person who gave me your name to reach out to try to say that, you know, you might be interested in doing something in person?\n[Speaker 6782829348298472977]: So, yeah.\n[Speaker 6782829348298472977]: So for some additional context, we're going to be coming on site both to pennsburg and Basel, pennsburg and Munich.\n[Speaker 6782829348298472977]: Those are the same sites, right?\n[Speaker 6782829348298472977]: Do I have that, right?\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 5895796664693401761]: ", "contextAfter": ", okay?\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: But when we talk about Roche, it's like pennsburg that's kind.\n[Speaker 5895796664693401761]: Of it, right?\n[Speaker 5895796664693401761]: Yeah, that's why everyone says Munich because no one knows Penn.\n[Speaker 6782829348298472977]: I got you.\n[Speaker 6782829348298472977]: I got you.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: So yeah, we are part of like this whole global license is that we're going to be doing some implementation in person and making sure that people really know how to use the platform to its full extent.\n[Speaker 6782829348298472977]: We're also in the process of launching like quite a few new features.\n[Speaker 6782829348298472977]: So we'll make sure that everyone's kind of up to speed with that.\n[Speaker 6782829348298472977]: And yeah, we're still finalizing the date.\n[Speaker 6782829348298472977]: So I wanted to reach ...", "callTitle": "BioRender | Roche"}, {"quote": "Actually in Penzberg, so below Munich.", "date": "2024-09-18", "callId": "2024-09-18_3eab42283be2", "gongUrl": "https://app.gong.io/call?id=3eab42283be240e65118381aa5201813f8c57dfab4e64f0ae2bbf1ab6a905579", "speakerId": "5606602042582878549", "customerName": "Christoph Gst\u00f6ttner", "internalName": "Sierra Barnes", "customerEmail": "christoph.gstoettner@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "[Speaker 5606602042582878549]: Hello.\n[Speaker 5606602042582878549]: Hi.\n[Speaker 4434073071130488898]: How are you?\n[Speaker 4434073071130488898]: good and you didn't get thanks how's your summer been.\n[Speaker 5606602042582878549]: Good, actually.\n[Speaker 5606602042582878549]: Yes.\n[Speaker 5606602042582878549]: Thank you.\n[Speaker 4434073071130488898]: Pretty good.\n[Speaker 4434073071130488898]: We're having some really nice stretches of weather still in Toronto so trying to squeeze as much of the summer as I can before it starts getting chilly again but no it's been nice.\n[Speaker 4434073071130488898]: Where are you based?\n[Speaker 5606602042582878549]: ", "contextAfter": "\n[Speaker 5606602042582878549]: Okay, in Germany.\n[Speaker 5606602042582878549]: For the Alps, yes, exactly.\n[Speaker 4434073071130488898]: Nice.\n[Speaker 4434073071130488898]: And did you guys get a warm summer or what was it like for you?\n[Speaker 5606602042582878549]: Actually this year was very nice and warm but now it really dropped the temperature so it's seven degrees around so it's.\n[Speaker 4434073071130488898]: Oh, no.\n[Speaker 4434073071130488898]: No.\n[Speaker 5606602042582878549]: very fast from 30 to seven so it was a quite.\n[Speaker 4434073071130488898]: that's a shocking change that's nice well thanks so much for finding time for us to chat as a quick intro on my side of things I'm part of the team that's helping to support the BioRender users at Roche and love would love for this call just to be an introduction for me to better understand what you're currently using BioRender for maybe what you hope to use it for and I can give you some context about what we're working...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_ptc_f9a624f3", "company": "roche", "gong_entity": "PTC", "gong_parent": "Roche R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "So, it is part of PTC", "snippet_date": "2025-03-18", "person_name": "Amelie Bauer", "person_email": "amelie.bauer.ab1@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-sciences-technical", "manual_node_name": "Pharmaceutical Sciences (Pharma Technical)", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical)", "confidence": "medium", "reasoning": "Likely acronym for 'Pharma Technical' - PTC could stand for Pharma Technical division, though not explicitly confirmed"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "call_id": "2025-03-18_b967005befa5", "call_count": 2, "all_snippets": [{"quote": "So, it is part of PTC", "date": "2025-03-18", "callId": "2025-03-18_b967005befa5", "gongUrl": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "speakerId": "6724612687015910624", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...: So what we will do, and this is like a very common kind of like concern once we're starting to figure out like what the planning or like what, the scope of the training session will look like.\n[Speaker 289705782262410669]: But, there's a couple of ways that we can do it.\n[Speaker 289705782262410669]: I think a lot of it honestly depends on like room availability and what is available in terms of that side of things, we will.\n[Speaker 6724612687015910624]: bring.\n[Speaker 289705782262410669]: in like lunch, and, or breakfast or whatever time of the day it makes sense just, to make sure that people are fed in that sense.\n[Speaker 289705782262410669]: But what we, I can, I'm just looking at my notes from when we chatted before.\n[Speaker 289705782262410669]: So, you're in gene, are you still in the gene therapy department?\n[Speaker 6724612687015910624]: Yeah.\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: And that's a part of ptd, right?\n[Speaker 6724612687015910624]: ", "contextAfter": ",\n[Speaker 289705782262410669]: PTC?\n[Speaker 289705782262410669]: Oh, yeah.\n[Speaker 289705782262410669]: Pharmatex cell gene therapies, okay.\n[Speaker 289705782262410669]: Yep.\n[Speaker 289705782262410669]: And gene therapy has about 140 people.\n[Speaker 289705782262410669]: Is that right?\n[Speaker 289705782262410669]: Yeah.\n[Speaker 6724612687015910624]: Something around that?\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: And do you have smaller teams within gene therapy or is that kind of the like you guys all kind of work together within that group?\n[Speaker 6724612687015910624]: I know.\n[Speaker 6724612687015910624]: So we do have smaller teams.\n[Speaker 6724612687015910624]: So we are based, so basically separated based on area of expertise.\n[Speaker 6724612687015910624]: So, where we are in the process.\n[Speaker 6724612687015910624]: So since we are in the process development, we do have the cell culture process.\n[Speaker 6724612687015910624]: We do have pur...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}, {"quote": "I have a request from PTC which is our chemical development of the format.", "date": "2024-03-04", "callId": "2024-03-04_e9ca751608b7", "gongUrl": "https://app.gong.io/call?id=e9ca751608b71c925eb73dbc8e7b1de69b0d03a78155a6ebe0fa0191bc8850f7", "speakerId": "2737888729397026981", "customerName": "Bernardo Antunes", "internalName": "Jacqueline McCoskey; Jeff Roy", "customerEmail": "bernardo.antunes@roche.com", "internalEmail": "jacqueline@biorender.com; jeff@biorender.com", "sizeMentions": [], "contextBefore": "..., in such a big company as this takes a little bit of time and bureaucracy, to kind of get everything right.\n[Speaker 2737888729397026981]: But nonetheless, I think the buyer under suit, is very much secure.\n[Speaker 2737888729397026981]: So I'm not really concerned about that.\n[Speaker 2737888729397026981]: I would like to see that done, right?\n[Speaker 2737888729397026981]: Because we worked for it, but we will be able to sign the msa.\n[Speaker 2737888729397026981]: I think if not now a month from now, or sometime in the future\u2026 I came to you, and I've had this meeting because I think I have more interesting questions to pose besides, the msa, I've been getting a lot of requests since I'm working on the BioRender\u2026 licences from other parts of the business to join in the main contract, right?\n[Speaker 2737888729397026981]: So there's a couple of things I have here.\n[Speaker 2737888729397026981]: I have a request from PTT which is our pharma development.\n[Speaker 2737888729397026981]: ", "contextAfter": "\n[Speaker 2737888729397026981]: And I also have a request from the guy\u2026 to get a poc for BioRender.\n[Speaker 2737888729397026981]: So I see there's a lot of interest\u2026 with the BioRender and\u2026 I wondered if we can already consolidate a few of these\u2026 while we work, on the services agreement and nature.\n[Speaker 803669528727365128]: Got it.\n[Speaker 803669528727365128]: Yeah, that's helpful background and context.\n[Speaker 803669528727365128]: So I'm gonna play back what I heard from you Bernardo, if that's okay.\n[Speaker 803669528727365128]: So, it sounds like in the shift from, and like the restructuring within it and the shift from the previous team to the new team, there's a delay in getting the ssa msa approved and signed.\n[Speaker 803669528727365128]: So the legal piece is sort of still being resolved.\n[Speaker 803669528727365128]: But for legal pieces, the legal piece is approved, it's approved.\n[Speaker 803669528727365128]: It's just a matter of getting.\n[Speaker 273788872939702698...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_ptt_066819f8", "company": "roche", "gong_entity": "PTT", "gong_parent": "Roche R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "I have a request from PTT which is our pharma development.", "snippet_date": "2024-03-04", "person_name": "Bernardo Antunes", "person_email": "bernardo.antunes@roche.com", "internal_name": "Jacqueline McCoskey; Jeff Roy", "internal_email": "jacqueline@biorender.com; jeff@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-sciences-technical", "manual_node_name": "Pharmaceutical Sciences (Pharma Technical)", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical)", "confidence": "medium", "reasoning": "Context mentions 'pharma development' and PTT appears to be another acronym variant for Pharma Technical, though the exact expansion is unclear"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=e9ca751608b71c925eb73dbc8e7b1de69b0d03a78155a6ebe0fa0191bc8850f7", "call_id": "2024-03-04_e9ca751608b7", "call_count": 2, "all_snippets": [{"quote": "I have a request from PTT which is our pharma development.", "date": "2024-03-04", "callId": "2024-03-04_e9ca751608b7", "gongUrl": "https://app.gong.io/call?id=e9ca751608b71c925eb73dbc8e7b1de69b0d03a78155a6ebe0fa0191bc8850f7", "speakerId": "2737888729397026981", "customerName": "Bernardo Antunes", "internalName": "Jacqueline McCoskey; Jeff Roy", "customerEmail": "bernardo.antunes@roche.com", "internalEmail": "jacqueline@biorender.com; jeff@biorender.com", "sizeMentions": [], "contextBefore": "...the responsibility to it.\n[Speaker 2737888729397026981]: And there's well as you guys know, in such a big company as this takes a little bit of time and bureaucracy, to kind of get everything right.\n[Speaker 2737888729397026981]: But nonetheless, I think the buyer under suit, is very much secure.\n[Speaker 2737888729397026981]: So I'm not really concerned about that.\n[Speaker 2737888729397026981]: I would like to see that done, right?\n[Speaker 2737888729397026981]: Because we worked for it, but we will be able to sign the msa.\n[Speaker 2737888729397026981]: I think if not now a month from now, or sometime in the future\u2026 I came to you, and I've had this meeting because I think I have more interesting questions to pose besides, the msa, I've been getting a lot of requests since I'm working on the BioRender\u2026 licences from other parts of the business to join in the main contract, right?\n[Speaker 2737888729397026981]: So there's a couple of things I have here.\n[Speaker 2737888729397026981]: ", "contextAfter": "\n[Speaker 2737888729397026981]: I have a request from PTC which is our chemical development of the format.\n[Speaker 2737888729397026981]: And I also have a request from the guy\u2026 to get a poc for BioRender.\n[Speaker 2737888729397026981]: So I see there's a lot of interest\u2026 with the BioRender and\u2026 I wondered if we can already consolidate a few of these\u2026 while we work, on the services agreement and nature.\n[Speaker 803669528727365128]: Got it.\n[Speaker 803669528727365128]: Yeah, that's helpful background and context.\n[Speaker 803669528727365128]: So I'm gonna play back what I heard from you Bernardo, if that's okay.\n[Speaker 803669528727365128]: So, it sounds like in the shift from, and like the restructuring within it and the shift from the previous team to the new team, there's a delay in getting the ssa msa approved and signed.\n[Speaker 803669528727365128]: So the legal piece is sort of still being resolved.\n[Speaker 803669528727365128]: But for legal pieces, the legal piece is approve...", "callTitle": "BioRender | Roche"}, {"quote": "And then if we do end up getting enough interest in enough support from Dia and PTT within the next couple of months", "date": "2023-01-31", "callId": "2023-01-31_25b8801d44f0", "gongUrl": "https://app.gong.io/call?id=25b8801d44f0457ff99075347ab2eaca6112d714499b735b9fe5fb22954c4d90", "speakerId": "3227655351600220052", "customerName": "Maria Benitez Mendo; Piotr Motyka; Sandra Krause", "internalName": "Jacqueline McCoskey; Jeff Roy; Ryan Marien", "customerEmail": "maria.benitez_mendo@roche.com; piotr.motyka@roche.com; sandra.krause@roche.com", "internalEmail": "jacqueline@biorender.com; jeff@biorender.com; ryan@biorender.com", "sizeMentions": [], "contextBefore": "... most of\u2026 the biggest part of diagnostic, it's really about equipment and assets, you know, and therefore, he doesn't so he doesn't see the need that we will end up with 200 licenses.\n[Speaker 3263602972573753591]: So he challenged me a bit about this.\n[Speaker 2644704622019160508]: I mean, that's good feedback I know for actually equipment is one of the number one use cases for, but we use a lot of protocols\u2026 and live equipment.\n[Speaker 2644704622019160508]: So I think that was one of the interests, but I, if he's not expressing a huge amount of interest today, maybe it's a good incentive for us to continue on the path that Jacqueline had proposed, yes.\n[Speaker 3227655351600220052]: And that was basically if you didn't have a chance to look at it yet, we kind of, you know, spoken internally and given the renewal date and the pressure that we're feeling from our finance team, we thought, you know, let's just like get this renewal done for pre and grid.\n[Speaker 3227655351600220052]: ", "contextAfter": ", we can revisit or maybe upon renewal, but, you know, I don't know if you're aligned with this, but we're hoping to just like let's start with grid and red and then we can go from there.\n[Speaker 2914284550316935309]: Really that it will be important, is it because Piotr is not here?\n[Speaker 2914284550316935309]: But what I will say is to have a quick call with him tomorrow because what we need to understand whether the offer that you have signed as we need to understand the number of users that we have today, we need to understand what is the licensing model.\n[Speaker 2914284550316935309]: So let us this type a little bit more in the model that you have.\n[Speaker 2914284550316935309]: And then we can discuss, but this conversation needs to happen.\n[Speaker 600260475015031128]: So, Maria, we've shared that information with Sandra and Stephen.\n[Speaker 600260475015031128]: So like in detail, are there, is there anything that you need to better understand that?\n[Speaker 326360297257375...", "callTitle": "BioRender/Roche"}]}, {"id": "roche_pdd_28ca5660", "company": "roche", "gong_entity": "PDD", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "We've been getting a number of requests outside within PDD as well as diagnostics.", "snippet_date": "2024-09-10", "person_name": "Christoph Duerr", "person_email": "christoph.duerr@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "global-product-development", "manual_node_name": "Global Product Development (Pharma)", "manual_node_path": "Roche Research & Development > Global Product Development (Pharma)", "confidence": "medium", "reasoning": "PDD likely stands for Product Development Division, which aligns with Global Product Development (Pharma) based on context mentioning requests from both PDD and diagnostics"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=a7e39ba6d0002a5c2ce052c12e30cc994a9235b4911c827cb2f492c18c4411fe", "call_id": "2024-09-10_a7e39ba6d000", "call_count": 2, "all_snippets": [{"quote": "We've been getting a number of requests outside within PDD as well as diagnostics.", "date": "2024-09-10", "callId": "2024-09-10_a7e39ba6d000", "gongUrl": "https://app.gong.io/call?id=a7e39ba6d0002a5c2ce052c12e30cc994a9235b4911c827cb2f492c18c4411fe", "speakerId": "3227459355290943038", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...u how this is handled in other departments.\n[Speaker 16832304959900895]: Of course, yeah.\n[Speaker 16832304959900895]: And that would be one of my questions.\n[Speaker 16832304959900895]: So how are the licenses handled for GRAT and PRAT?\n[Speaker 16832304959900895]: And is there or are you in discussions with other departments to move that further?\n[Speaker 16832304959900895]: Or with our IT, I don't know what your primary contact is.\n[Speaker 16832304959900895]: So that would be my first question.\n[Speaker 16832304959900895]: Yeah.\n[Speaker 3227459355290943038]: Perfect.\n[Speaker 3227459355290943038]: So yeah, right now, P RED and G RED both have like, everyone in P RED and G RED are able to access it freely.\n[Speaker 3227459355290943038]: Not for really, but they're able to just go through and request it to the app store, if that makes sense.\n[Speaker 3227459355290943038]: We are in discussions right now of expanding that access beyond P RED and G RED.\n[Speaker 3227459355290943038]: ", "contextAfter": "\n[Speaker 3227459355290943038]: And we're in active discussions with the IT folks right now.\n[Speaker 3227459355290943038]: Not entirely sure what that's going to look like or what the timeline is for that, but it is something that we are actively discussing and we're still trying to work out the logistics of it.\n[Speaker 3227459355290943038]: So what we've been kind of doing with other groups is getting them sort of set up on their own independent kind of license until we get something more centrally long term set up.\n[Speaker 3227459355290943038]: So say if your group decided you to do something on a smaller scale and then you know maybe in a few months or it could be a year that's the thing like it's been kind of in chat for a while of if we were to expand beyond p red and g red from like an it central sort of perspective we would make sure that your group is kind of like wrapped up in that license so that you're not having like this independent license when something is made widely...", "callTitle": "BioRender & Roche - Follow Up Call"}, {"quote": "Because you mentioned PDD and you mentioned die because I tried to follow up on this, you know, and if you have a look, so in Pittsburgh in Germany, we have this Dyer side but PDD is on this Dyer side.", "date": "2023-01-26", "callId": "2023-01-26_13f5a7f5540a", "gongUrl": "https://app.gong.io/call?id=13f5a7f5540ac7ae5100686c53caa67ddfba2e0ef0cb0747e0d599b552d2c405", "speakerId": "3472540537450315387", "customerName": "Sandra Krause; Steffen Sachse", "internalName": "Jacqueline McCoskey; Jeff Roy; Ryan Marien", "customerEmail": "sandra.krause@roche.com; steffen.sachse@roche.com", "internalEmail": "jacqueline@biorender.com; jeff@biorender.com; ryan@biorender.com", "sizeMentions": [], "contextBefore": "... know, 45 at least different individuals reaching out and they're all inquiring on their group like they all want group access just because, you know, it makes it a lot easier once you're all on the same application.\n[Speaker 4819851621399133775]: And also this is not, there's no promotion like this is just organic people outside of pre and grad reaching out to us, reaching out to Stephen requesting access.\n[Speaker 4819851621399133775]: It's not like we've reached out to anyone directly.\n[Speaker 4819851621399133775]: Yeah.\n[Speaker 4819851621399133775]: And when you look at the groups at the bottom, these are just the ones that I've sort of collected.\n[Speaker 4819851621399133775]: You know, we have about 12 different groups that we're looking for access.\n[Speaker 4819851621399133775]: And here's a kind of a summary as you see, it ranges a different group size and different groups across Roche.\n[Speaker 3472540537450315387]: May I ask you one question?\n[Speaker 3472540537450315387]: ", "contextAfter": "\n[Speaker 3472540537450315387]: So I'm wondering what is the differentiation in this case?\n[Speaker 3472540537450315387]: Because, you know, we have diagnostic of course, but we have PDD as well.\n[Speaker 3472540537450315387]: And in your offer, you have both, you know, and for me is, how do you manage PDD?\n[Speaker 3472540537450315387]: That is on the dial side\u2026 you see what I mean?\n[Speaker 3472540537450315387]: Because there's a kind of mix.\n[Speaker 4819851621399133775]: So there's like an overlap between and Stephen, go ahead.\n[Speaker 6947064351635144366]: To, to explain it, we have a land load for each site and to land load for pens book for example is diagnostics, but we have also colleagues from red, significant number of colleagues from pre at the site.\n[Speaker 6947064351635144366]: From a legal entities, it would be, yeah, they would be diagnostics because the land load is diagnostics, but from an organizational\u2026 site, it would be pre.\n[Speaker 6947064351635144366]: So this...", "callTitle": "BioRender/Roche"}]}, {"id": "roche_research_and_development_0e1aafc0", "company": "roche", "gong_entity": "Research and Development", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "And then we form part of the research and development overall", "snippet_date": "2024-07-23", "person_name": "", "person_email": "taariq.firfirey@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "roche-rd", "manual_node_name": "Roche Research & Development", "manual_node_path": "Roche Research & Development", "confidence": "high", "reasoning": "Exact match with the top-level R&D organization at Roche"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=f695efd2365316965777efe7b21bffcad2f773f9df8b56f25b0971e12f671c0b", "call_id": "2024-07-23_f695efd23653", "call_count": 2, "all_snippets": [{"quote": "And then we form part of the research and development overall", "date": "2024-07-23", "callId": "2024-07-23_f695efd23653", "gongUrl": "https://app.gong.io/call?id=f695efd2365316965777efe7b21bffcad2f773f9df8b56f25b0971e12f671c0b", "speakerId": "1844243140848428691", "customerName": "", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "taariq.firfirey@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...swer all of your questions?\n[Speaker 1844243140848428691]: Yeah.\n[Speaker 1844243140848428691]: It was just like see mentioned that there is an ongoing collaboration between pharma and band, and she was saying that you are trying to\u2026 foster similar relationship with the do side and then, how do we use it and how could it be integrate it with, across the diagnostics are?\n[Speaker 1844243140848428691]: I suppose.\n[Speaker 1844243140848428691]: Yeah.\n[Speaker 1844243140848428691]: So we are very small.\n[Speaker 1844243140848428691]: Yeah.\n[Speaker 1844243140848428691]: In terms of\u2026 the guys specifically, the department, I mean, and, but we, as a site around 300 odd individuals spanning different areas.\n[Speaker 1844243140848428691]: So, we a manufacturing site primarily as, the largest component of the people working here.\n[Speaker 1844243140848428691]: Okay?\n[Speaker 1844243140848428691]: And then there is from a finance all the support it\u2026 type of groups.\n[Speaker 1844243140848428691]: ", "contextAfter": ".\n[Speaker 1844243140848428691]: My team specifically being age in research and design, focusing on insintechnology.\n[Speaker 1844243140848428691]: So, my team is a project, special purification based workflows.\n[Speaker 1844243140848428691]: And basically me and my team used by line for like throwing out workflows, or trying to illustrate certain items of the work that we do for presentations and oppose this for internal consumption mainly.\n[Speaker 1844243140848428691]: Yeah.\n[Speaker 7082279788539399834]: Perfect.\n[Speaker 7082279788539399834]: No, that's super helpful.\n[Speaker 7082279788539399834]: I really appreciate that context.\n[Speaker 7082279788539399834]: I just, I have a couple of questions for you.\n[Speaker 7082279788539399834]: So, do you know?\n[Speaker 7082279788539399834]: So you said there's about 300 people at your site.\n[Speaker 7082279788539399834]: Is that including like manufacturing and like it, or is that the research?\n[Speaker 1844243140848428691]: Everybody's...", "callTitle": "BioRender & Roche - Follow Up Call"}, {"quote": "And within the pharma division, the research and development is separate organization if you want.", "date": "2024-06-14", "callId": "2024-06-14_5820c7bc82da", "gongUrl": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "speakerId": "1372854872117518306", "customerName": "Felix Kuhne", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "felix.kuhne@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... screen so we have PD and then there's an analytics group.\n[Speaker 8593743714562823197]: And then there's a characterization of molecules, smaller group.\n[Speaker 8593743714562823197]: And that's the part that you're the group that you're part of, right?\n[Speaker 8593743714562823197]: Yeah.\n[Speaker 8593743714562823197]: Got you.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: How many people are within that characterization of molecules group?\n[Speaker 1372854872117518306]: 40 roughly.\n[Speaker 8593743714562823197]: 40?\n[Speaker 8593743714562823197]: Okay, perfect.\n[Speaker 8593743714562823197]: I have a question for you.\n[Speaker 8593743714562823197]: How do I?\n[Speaker 8593743714562823197]: Pt, isn't a part of like diagnostics or\u2026 like it's completely separate from those two groups.\n[Speaker 1372854872117518306]: Yeah.\n[Speaker 1372854872117518306]: So we have the diagnostics, and then we have the pharma, yeah, separate divisions.\n[Speaker 1372854872117518306]: ", "contextAfter": "\n[Speaker 1372854872117518306]: So, and then we have, the technical development.\n[Speaker 1372854872117518306]: So the process development unit, and then we have the commercial unit which is today basically produce the product in the end.\n[Speaker 1372854872117518306]: And those are the three big organizations and the research so pre and in the us is great.\n[Speaker 1372854872117518306]: The research units are larger than the technical development unit.\n[Speaker 1372854872117518306]: And also the commercial units are larger technical development.\n[Speaker 1372854872117518306]: Is, I mean, we have technical development activities in basel in pennsburg, and in san Francisco.\n[Speaker 1372854872117518306]: Mainly, I would say probably there are some other\u2026 sites where they also have technical development activities.\n[Speaker 1372854872117518306]: But those are the main sites, I would say.\n[Speaker 8593743714562823197]: I understand.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_research_and_early_development_e9d7f5fc", "company": "roche", "gong_entity": "Research and Early Development", "gong_parent": "Research and Development", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "And then there's a research and early development team as well.", "snippet_date": "2024-07-04", "person_name": "Taariq Firfirey", "person_email": "taariq.firfirey@roche.com", "internal_name": "Sierra Barnes", "internal_email": "sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "pharma-research-early-development", "manual_node_name": "Pharma Research & Early Development (pRED)", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED)", "confidence": "high", "reasoning": "Strong match with pRED division - the entity name closely matches the formal name pattern used at Roche"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=703d92988c66f21913d2f471e7a3d922e5b76a5822cd28020514066d1685f0c1", "call_id": "2024-07-04_703d92988c66", "call_count": 2, "all_snippets": [{"quote": "And then there's a research and early development team as well.", "date": "2024-07-04", "callId": "2024-07-04_703d92988c66", "gongUrl": "https://app.gong.io/call?id=703d92988c66f21913d2f471e7a3d922e5b76a5822cd28020514066d1685f0c1", "speakerId": "2900785077647915400", "customerName": "Taariq Firfirey", "internalName": "Sierra Barnes", "customerEmail": "taariq.firfirey@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...072374701]: So that's a funny coincidence.\n[Speaker 6159906293072374701]: But, how large is the reagent research and design team?\n[Speaker 2900785077647915400]: It's not actually very big.\n[Speaker 2900785077647915400]: Currently.\n[Speaker 2900785077647915400]: I think we, there is a few hirings taking place.\n[Speaker 2900785077647915400]: I think we have now maybe two more later this year joining.\n[Speaker 2900785077647915400]: So it's fairly small group.\n[Speaker 2900785077647915400]: So that department split into two sections, enzyme evolution.\n[Speaker 2900785077647915400]: It works on.\n[Speaker 2900785077647915400]: If you're familiar with Cap, they used to do the compartmentalized of replication in bubbles so that team is still existing.\n[Speaker 2900785077647915400]: And then there is my team that does the project station purification work.\n[Speaker 2900785077647915400]: And then the, so that's just what we call our, the reign research and design.\n[Speaker 2900785077647915400]: ", "contextAfter": "\n[Speaker 2900785077647915400]: That is a more focus on the workflows of Ng.\n[Speaker 2900785077647915400]: So they will put together the kids.\n[Speaker 2900785077647915400]: I, we will provide a buffer and, or enzyme solutions that they can re, formulate into kits.\n[Speaker 2900785077647915400]: So, there is a library prep kit that consists probably of six or seven people and ordinary library pre kit that consists about the same amount of people.\n[Speaker 2900785077647915400]: So that to constitute research at the on site, then we have a development team of maybe 40 plus individuals for.\n[Speaker 2900785077647915400]: that.\n[Speaker 2900785077647915400]: work on a range of things like new product development as well as product and process improvements.\n[Speaker 6159906293072374701]: Okay.\n[Speaker 6159906293072374701]: So quite a few different groups.\n[Speaker 6159906293072374701]: I think you said 11 ish people in rrd?\n[Speaker 2900785077647915400]: Yeah.\n[Speaker 2900785077647915400...", "callTitle": "BioRender & Roche - Intro Call"}, {"quote": "But I'm in R and D. So we call this research and early development.", "date": "2024-03-19", "callId": "2024-03-19_9e91cefedfc0", "gongUrl": "https://app.gong.io/call?id=9e91cefedfc0ec5b5b59b080184b441a077782ac8879391f8ae96ded7ab9bd9a", "speakerId": "1570913027692445240", "customerName": "", "internalName": "Jacqueline McCoskey", "customerEmail": "alexander.brown@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...d mentioned.\nSo you're in the diagnostics group?\nYeah.\nOkay.\nDo you mind giving me a little bit of an overview in terms of like what team you're part of and sort of like how like where you're located and that kind of like organizationally where you fit in there?\nYeah.\nI think I'll just have to give you like a verbal, we have all these kind of it's over 100,000 people in the company.\nSo there's like hierarchy org, charts and stuff, which is a useful reference point.\nBut I don't know if I can actually share my screen for showing you that.\nBut yeah, yeah.\nSo\u2026 we're I, I'm in diagnostics part of the greater Roche business.\nI don't know the headcount of people india, but maybe it is\u2026 a quarter of the company because it makes up about a quarter of the revenue, something like that.\nOkay?\nBut still 25,000 people, something like that.\nAnd then I, and then within dy that also kinda includes\u2026 diabetes care, and some other kind of subsidiary businesses like sequencing solutions, things like that.\n", "contextAfter": "\nAnd then I'm also working a team in anti body development.\nSo for my purposes, I would want it for the greater R and D aspects of the diagnostics business.\nAnd then I'm at the very earliest stages of this R and D pipeline in discovery.\nSo we come up with, very much like the academic side of things where you're kind of figuring out what is an interesting idea.\nHow do we test like the minimum viable way of testing that and then pass it off to somebody in more downstream development if it has like, yeah, yeah.\nHey, I appreciate that overview.\nI am curious because it sounds like you have some good context here.\nWhat is like the primary difference between the diagnostic side of the business versus like red and like the pharma side?\nYeah.\nThe diagnose is in part plays a supportive role towards red, but it also so right?\nSo, P, red and G red or I guess the pharma side, you could say check and the red is pharma, right?\nSo yeah, they're making small and large molecules that go into clinical tr...", "callTitle": "BioRender | Roche Diagnostics"}]}, {"id": "roche_discovery_sciences_397a4e6b", "company": "roche", "gong_entity": "Discovery Sciences", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "And in this discovery sciences chapter, that is more again, I guess like a basic science thing.", "snippet_date": "2024-03-19", "person_name": "", "person_email": "alexander.brown@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=9e91cefedfc0ec5b5b59b080184b441a077782ac8879391f8ae96ded7ab9bd9a", "call_id": "2024-03-19_9e91cefedfc0", "call_count": 2, "all_snippets": [{"quote": "And in this discovery sciences chapter, that is more again, I guess like a basic science thing.", "date": "2024-03-19", "callId": "2024-03-19_9e91cefedfc0", "gongUrl": "https://app.gong.io/call?id=9e91cefedfc0ec5b5b59b080184b441a077782ac8879391f8ae96ded7ab9bd9a", "speakerId": "1570913027692445240", "customerName": "", "internalName": "Jacqueline McCoskey", "customerEmail": "alexander.brown@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...r can create, to me makes sense even if it doesn't have a little image of a cell on it.\n[Speaker 7332779724309139706]: Yeah, yeah, exactly.\n[Speaker 7332779724309139706]: And I think, I, we're expanding the ways that like our use cases like we have a graphic feature.\n[Speaker 7332779724309139706]: We have different types of like types of figures now that people can make so that expand beyond that like core sort of like science, basic science research.\n[Speaker 7332779724309139706]: So, and I just a couple of questions, I know you said you're in the anti body development team, is that right?\n[Speaker 1570913027692445240]: Yes.\n[Speaker 7332779724309139706]: I'm.\n[Speaker 1570913027692445240]: a post to, right?\n[Speaker 1570913027692445240]: So basically, I'm landing in between antibided development, which is technically not within research and development but they make\u2026 antibodies that serve as the basis for many diagnostic essays and then within R and D.\n[Speaker 1570913027692445240]: ", "contextAfter": "\n[Speaker 1570913027692445240]: So, yeah, two different divisions within diagnostics that probably both could benefit in my mind from having a BioRender account.\n[Speaker 7332779724309139706]: Okay, perfect.\n[Speaker 7332779724309139706]: And I know you mentioned you kind of it's been like a month or so that you've been sort of looking into this.\n[Speaker 7332779724309139706]: Do you have a timeline of when you were looking to get access kinda, is it like sooner than later or is that something a presentation moving towards?\n[Speaker 7332779724309139706]: Yeah.\n[Speaker 7332779724309139706]: So right now,\n[Speaker 1570913027692445240]: because I recently started, I still have a site license from my old university.\n[Speaker 1570913027692445240]: I was in Colorado.\n[Speaker 1570913027692445240]: Okay?\n[Speaker 1570913027692445240]: At the university of Colorado and yeah.\n[Speaker 1570913027692445240]: So I technically.\n[Speaker 1570913027692445240]: You know, I did my PHD defended but I'm...", "callTitle": "BioRender | Roche Diagnostics"}, {"quote": "So I was in mark at discovery before, but now we're called discovery sign", "date": "2023-01-19", "callId": "2023-01-19_3fe3c13a2bf2", "gongUrl": "https://app.gong.io/call?id=3fe3c13a2bf23db655c903fed7ba84675ca3b4e4655e74aef7517af0d72992cd", "speakerId": "5655305010336001872", "customerName": "Ines Sophie Keller", "internalName": "Zein Idriss", "customerEmail": "ines_sophie.keller@contractors.roche.com", "internalEmail": "zein@biorender.com", "sizeMentions": [], "contextBefore": "...ask you a few questions, but was there anything specific that you were hoping to gather today?\n[Speaker 2739650650387146672]: Any specific questions you had for me?\n[Speaker 5655305010336001872]: Just in general, like how does it usually work?\n[Speaker 5655305010336001872]: Like getting a license?\n[Speaker 5655305010336001872]: Like we have a team of like 30 people, but I guess only like a few people will use it.\n[Speaker 5655305010336001872]: Actually, I think of a time.\n[Speaker 5655305010336001872]: So we have like different departments in all sections and there's like, I would guess maybe around 10 to 15 people.\n[Speaker 5655305010336001872]: May, I would guess we won't use that?\n[Speaker 2739650650387146672]: And what?\n[Speaker 2739650650387146672]: Just out of curiosity, what's your, what is that team call?\n[Speaker 2739650650387146672]: That actually first question?\n[Speaker 5655305010336001872]: Yeah.\n[Speaker 5655305010336001872]: So we changed.\n[Speaker 5655305010336001872]: ", "contextAfter": ".\n[Speaker 5655305010336001872]: Okay.\n[Speaker 5655305010336001872]: So we just for this year.\n[Speaker 5655305010336001872]: So first of January.\n[Speaker 5655305010336001872]: Okay.\n[Speaker 5655305010336001872]: So there was kind of managing of two teams now and we became one by team.\n[Speaker 2739650650387146672]: Okay.\n[Speaker 2739650650387146672]: I see.\n[Speaker 2739650650387146672]: And what is your role within the discovery sciences team?\n[Speaker 5655305010336001872]: So I'm a science coordinator.\n[Speaker 2739650650387146672]: Okay.\n[Speaker 5655305010336001872]: Just\u2026\n[Speaker 2739650650387146672]: Okay.\n[Speaker 5655305010336001872]: People to coordinate that stuff like the are?\n[Speaker 2739650650387146672]: Good to know.\n[Speaker 2739650650387146672]: No, that's good to know because I actually just right before this call, I spoke with my colleague who I work closely with to help manage our relationship with Roche and she let me know that we're actually approaching like...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_discovery_oncology_f4e15e47", "company": "roche", "gong_entity": "Discovery Oncology", "gong_parent": "Discovery Sciences", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Like Sarah in discovery oncology. So, I'm based here in Basel. Mostly here, but, you know, that we also have a site, in schlieren, near Zurich.", "snippet_date": "2025-06-04", "person_name": "Thomas Radimerski", "person_email": "thomas.radimerski@roche.com", "internal_name": "Jacqueline McCoskey; Jon Fan", "internal_email": "jacqueline@biorender.com; jon.fan@biorender.com", "llm_suggested_match": {"manual_node_id": "oncology-hematology-research", "manual_node_name": "Oncology & Hematology Research", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Oncology & Hematology Research", "confidence": "medium", "reasoning": "Good semantic match - Discovery Oncology aligns with the research-focused Oncology & Hematology Research area under pRED"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ccb013af6bce76ef7361b4ff4dcb3f03d5a26b3e0f7dc5e32752df67731bdf67", "call_id": "2025-06-04_ccb013af6bce", "call_count": 1, "all_snippets": [{"quote": "Like Sarah in discovery oncology.\nSo, I'm based here in Basel.\nI'll be.\nMostly here, but, you know, that we also have a site, in schlieren, near Zurich.\nYes.\nOkay.\nRight, right.\nWe, one of the origina", "date": "2025-06-04", "callId": "2025-06-04_ccb013af6bce", "gongUrl": "https://app.gong.io/call?id=ccb013af6bce76ef7361b4ff4dcb3f03d5a26b3e0f7dc5e32752df67731bdf67", "speakerId": "1697093225649429822", "customerName": "Thomas Radimerski", "internalName": "Jacqueline McCoskey; Jon Fan", "customerEmail": "thomas.radimerski@roche.com", "internalEmail": "jacqueline@biorender.com; jon.fan@biorender.com", "sizeMentions": [], "contextBefore": "...ur company.\nYou got out there, John, he leads our, Thomas, he leads our, he leads our product team.\nSo, he's kind of the visionary and gets all of these really cool, ideas kind of in the works.\nSo, I guess for some additional context, when we were at Roche, we were chatting with a number of folks like Sarah, about like where she would like to see the product going.\nAnd, yeah, that's kind of like the thing, some of the things that we'd love to sort of hear from you too.\nSo, and then, John, you are, graphically visually implementing these ideas into the software into the tool.\nHuh?\nYeah.\nExactly.\nSo we're building both the tool out and then, we also spend a lot of time thinking about what are the different icons or templates we could have in there for you?\nSo then, you know, there's lots of the, of your own illustration.\nYou can do, you have more, you can start from right as well.\nSo let me share my screen.\nAnd Thomas, correct me if I'm wrong, you're in discovery oncology, correct?\nYes.\n", "contextAfter": "l, like, I guess fields that we started in when we started building up the library was oncology and immunology.\nSo, oncology is where we have like a really large, like a, like library.\nSo, hopefully, there'll be tons of stuff that will be helpful for you to create your presentations.\nYeah, absolutely.\nSo, I'm going to show you maybe two or three things at, there's sort of one area at the end, which we talked with Sarah about that.\nI'd love to get just your input on Thomas, but maybe just as a starting point, maybe the next time you log into biorender, when you log into biorender, you'll see, normally biorender has like John?\nBefore you get there, so, do I have to kind of install an app, in my system here?\nOr how does this work?\nYeah.\nHow do you guys know that I'm entitled that I have a license to use your software?\nI kind of jumped the gun there, I guess.\nSo everyone at Roche has actually access to biorender right now, so you can access it.\nOh.\nThat's fabulous.\nYeah.\nYou're one of the ...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_gene_therapy_11585c42", "company": "roche", "gong_entity": "Gene Therapy", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "you're in gene, are you still in the gene therapy department?", "snippet_date": "2025-03-18", "person_name": "Amelie Bauer", "person_email": "amelie.bauer.ab1@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "spark-therapeutics", "manual_node_name": "Spark Therapeutics (Gene Therapy)", "manual_node_path": "Roche Research & Development > Spark Therapeutics (Gene Therapy)", "confidence": "high", "reasoning": "Direct match with Spark Therapeutics division which is explicitly focused on gene therapy"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "call_id": "2025-03-18_b967005befa5", "call_count": 2, "all_snippets": [{"quote": "you're in gene, are you still in the gene therapy department?", "date": "2025-03-18", "callId": "2025-03-18_b967005befa5", "gongUrl": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "speakerId": "6724612687015910624", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...624]: Or if it's too vague, people are maybe okay, why would I spend the time in person?\n[Speaker 6724612687015910624]: You know, where I'm coming from?\n[Speaker 289705782262410669]: Yes, great point.\n[Speaker 289705782262410669]: So what we will do, and this is like a very common kind of like concern once we're starting to figure out like what the planning or like what, the scope of the training session will look like.\n[Speaker 289705782262410669]: But, there's a couple of ways that we can do it.\n[Speaker 289705782262410669]: I think a lot of it honestly depends on like room availability and what is available in terms of that side of things, we will.\n[Speaker 6724612687015910624]: bring.\n[Speaker 289705782262410669]: in like lunch, and, or breakfast or whatever time of the day it makes sense just, to make sure that people are fed in that sense.\n[Speaker 289705782262410669]: But what we, I can, I'm just looking at my notes from when we chatted before.\n[Speaker 289705782262410669]: So, ", "contextAfter": "\n[Speaker 6724612687015910624]: Yeah.\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: And that's a part of ptd, right?\n[Speaker 6724612687015910624]: So, it is part of PTC,\n[Speaker 289705782262410669]: PTC?\n[Speaker 289705782262410669]: Oh, yeah.\n[Speaker 289705782262410669]: Pharmatex cell gene therapies, okay.\n[Speaker 289705782262410669]: Yep.\n[Speaker 289705782262410669]: And gene therapy has about 140 people.\n[Speaker 289705782262410669]: Is that right?\n[Speaker 289705782262410669]: Yeah.\n[Speaker 6724612687015910624]: Something around that?\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: And do you have smaller teams within gene therapy or is that kind of the like you guys all kind of work together within that group?\n[Speaker 6724612687015910624]: I know.\n[Speaker 6724612687015910624]: So we do have smaller teams.\n[Speaker 6724612687015910624]: So we are based, so basically separated based on area of expertise.\n[Speaker 6724612687015910624]: S...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}, {"quote": "Gene Therapy actually. And does that fall from the analytics? So I'm from the analytics department but they are in Gene Therapy.", "date": "2024-09-18", "callId": "2024-09-18_3eab42283be2", "gongUrl": "https://app.gong.io/call?id=3eab42283be240e65118381aa5201813f8c57dfab4e64f0ae2bbf1ab6a905579", "speakerId": "5606602042582878549", "customerName": "Christoph Gst\u00f6ttner", "internalName": "Sierra Barnes", "customerEmail": "christoph.gstoettner@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... so it's.\nOh, no.\nNo.\nvery fast from 30 to seven so it was a quite.\nthat's a shocking change that's nice well thanks so much for finding time for us to chat as a quick intro on my side of things I'm part of the team that's helping to support the BioRender users at Roche and love would love for this call just to be an introduction for me to better understand what you're currently using BioRender for maybe what you hope to use it for and I can give you some context about what we're working on with Roche but was there anything in particular you were hoping that we would chat about today?\nActually I have a question if we have a license from Roche where we can basically use it so a standard the general license basically because so far I'm using the free version but I know that somewhere in Roche there should be some licenses for BioRender.\nMy first question for you are you part of P RED or G RED?\nNo, but we collaborate with them a lot so.\nCollaborate.\nWhich team are you a part of at Roche?\n", "contextAfter": "\nWe have a new let's say group and there we are very closely collaborating also with the P RED colleagues there.\nAnd does that fall within diagnostics or?\nNo, no, it's pharma.\nOkay.\nBut your group doesn't sit within the P RED group?\nNo, no, no, no.\nOkay.\nI see.\nAre you in PTD then?\nI'm just trying to figure out where.\nYeah, exactly.\nPerfect.\nAnd how large is the gene therapy team, just out of curiosity?\nIn total in Penzberg, I think there are 200 people located which are working full time in gene therapy.\nAnd then we have also around another 150 which work part time gene therapy and part time still in antibodies, let's say.\nSo it's growing quite a lot.\nSo it started around three years ago and since then it grew quite a lot already.\nOh, nice.\nGene therapy is a, cool area of research to be in too.\nYes.\nMainly with antibodies.\nAnd yeah, now it's nice to work on something new.\nAlso, it's a lot of development still setting up everything.\nYeah.\nI studied genetics in my master's, but I'm a fe...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_oncology_48ffcf79", "company": "roche", "gong_entity": "Oncology", "gong_parent": "Roche R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "I'm just grabbing my notes here on the Friday may 20 third from 10 to 11 for the oncology group", "snippet_date": "2025-05-09", "person_name": "Davina Di Pace", "person_email": "davina.di_pace@roche.com", "internal_name": "Jacqueline McCoskey; Livia Guo; Tim Fung", "internal_email": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "oncology-hematology-research", "manual_node_name": "Oncology & Hematology Research", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Oncology & Hematology Research", "confidence": "high", "reasoning": "Strong match with the main oncology research therapeutic area under pRED"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=e7d9fdba809186b66eb3985488a8224414f5ca3246e2ecfb51dfd263fddd71ab", "call_id": "2025-05-09_e7d9fdba8091", "call_count": 2, "all_snippets": [{"quote": "I'm just grabbing my notes here on the Friday may 20 third from 10 to 11 for the oncology group", "date": "2025-05-09", "callId": "2025-05-09_e7d9fdba8091", "gongUrl": "https://app.gong.io/call?id=e7d9fdba809186b66eb3985488a8224414f5ca3246e2ecfb51dfd263fddd71ab", "speakerId": "8303029591033173485", "customerName": "Davina Di Pace", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "davina.di_pace@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...ay.\n[Speaker 8303029591033173485]: We'll provide you some context.\n[Speaker 2085626399449549853]: And.\n[Speaker 8303029591033173485]: then just to make sure we have everything set and ready to go content wise.\n[Speaker 8303029591033173485]: We'll work with one of the scientists on that.\n[Speaker 8303029591033173485]: So no worries.\n[Speaker 8303029591033173485]: Because I know that you're more of the like logistics operations sort of side of things.\n[Speaker 8303029591033173485]: Is that right?\n[Speaker 8303029591033173485]: Yes.\n[Speaker 8303029591033173485]: Okay.\n[Speaker 8303029591033173485]: Perfect.\n[Speaker 8303029591033173485]: Yeah, thanks so much.\n[Speaker 8303029591033173485]: We're super excited to come on site.\n[Speaker 8303029591033173485]: We're coming from, we're going to be at the Basel location from the 20 first to the 20 third and then to pennsburg the following week.\n[Speaker 8303029591033173485]: So, right now, we have you scheduled.\n[Speaker 8303029591033173485]: ", "contextAfter": ".\n[Speaker 8303029591033173485]: Is that, does that sound right?\n[Speaker 2085626399449549853]: Yes, okay.\n[Speaker 8303029591033173485]: Perfect.\n[Speaker 8303029591033173485]: And I know it's I think before we had the room in terms of being able to, so, the session we have set from 10 to 11, just, I know that we kind of talked about having sooner than later because people like to take off early on Fridays, totally get that.\n[Speaker 8303029591033173485]: Is it okay if we come around like nine, nine 30 to test some of the room tech and make sure that everything is functioning properly.\n[Speaker 8303029591033173485]: Is that okay?\n[Speaker 2085626399449549853]: So, the technician, well, the technical support will be there at 945, but I can ask if he can join, if he can be there earlier.\n[Speaker 2085626399449549853]: Yeah, if, you know, an exact time, because I don't think he will be waiting there for you, right?\n[Speaker 8303029591033173485]: Yeah, nine 30 would be perfect.\n[Speaker 8...", "callTitle": "BioRender | Roche Oncology Onsite Logistics"}, {"quote": "there are others, cardiac oncology", "date": "2024-09-19", "callId": "2024-09-19_d132aba88672", "gongUrl": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "speakerId": "1493537282318889744", "customerName": "Markus Eckl", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "markus.eckl@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... and G RED.\n[Speaker 3068414967322493854]: These are things that we're like just working through the final licensing logistics of it.\n[Speaker 3068414967322493854]: But yeah, that's kind of where we're at right now.\n[Speaker 1493537282318889744]: Yeah, that's really good news.\n[Speaker 1493537282318889744]: We have a distribution list, so around my peer levels or team leads and development leads.\n[Speaker 1493537282318889744]: Yeah.\n[Speaker 1493537282318889744]: So I would be happy to share the info.\n[Speaker 3068414967322493854]: Perfect.\n[Speaker 3068414967322493854]: That would be because I just if I'm clear, you're in the development and infectious disease.\n[Speaker 3068414967322493854]: Is that right?\n[Speaker 3068414967322493854]: Okay.\n[Speaker 1493537282318889744]: Yeah, so it's core lab development.\n[Speaker 1493537282318889744]: So everything that's in the central lab, this is my peer group, right?\n[Speaker 1493537282318889744]: I'm in the infectious disease department, but ", "contextAfter": ", I don't know.\n[Speaker 1493537282318889744]: Yeah, okay.\n[Speaker 3068414967322493854]: And yeah, so if you want to, is there, Sierra made a note that there's about 150 people in your group.\n[Speaker 3068414967322493854]: Is that within infectious disease or is that within like all the other groups.\n[Speaker 1493537282318889744]: So that's all of the color people there.\n[Speaker 3068414967322493854]: Okay, perfect.\n[Speaker 3068414967322493854]: Yeah, because if you want to send, like once we get the information, I can send it to you as well as a way to get access on the back end.\n[Speaker 3068414967322493854]: It's just like a link and it'll be able to redirect them.\n[Speaker 3068414967322493854]: And then if you want to pass that around to those other 150 people as well as training options.\n[Speaker 3068414967322493854]: Yeah, the more the merrier that we definitely want to use this as an opportunity for people to test it out and figure out when they would use it.\n[Speaker 30684149...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_technical_development_d5b59417", "company": "roche", "gong_entity": "Technical Development", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "We have a technical pot team, and also teams around technical development who are also more interested in publishing things and going to conferences", "snippet_date": "2024-07-23", "person_name": "Katrin Heinrich", "person_email": "katrin.heinrich@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "manufacturing-science-technology", "manual_node_name": "Manufacturing Science & Technology", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical) > Manufacturing Science & Technology", "confidence": "medium", "reasoning": "Good semantic match - Technical Development aligns with Manufacturing Science & Technology which handles technical aspects of development"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=27366b82e72972b21a6cd862d41b89aed8f9023aab6276fa478051ccb37afd8a", "call_id": "2024-07-23_27366b82e729", "call_count": 2, "all_snippets": [{"quote": "We have a technical pot team, and also teams around technical development who are also more interested in publishing things and going to conferences", "date": "2024-07-23", "callId": "2024-07-23_27366b82e729", "gongUrl": "https://app.gong.io/call?id=27366b82e72972b21a6cd862d41b89aed8f9023aab6276fa478051ccb37afd8a", "speakerId": "450567784861528043", "customerName": "Katrin Heinrich", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "katrin.heinrich@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... this up with Felix.\n[Speaker 829132564431108852]: I don't know what your thoughts are, and I think that side too, we can host like webinars where we would show everyone, you know, how BioRender works.\n[Speaker 829132564431108852]: So, like, when they ask that question, like what did you use?\n[Speaker 829132564431108852]: We can show them how to use it and give them a trial.\n[Speaker 829132564431108852]: It kind of helps build a business case, right?\n[Speaker 829132564431108852]: Like for the people who are signing off on it and like signing off on the budget for them to know why they should do this as well as like get a better sense of who's actually interested in it.\n[Speaker 829132564431108852]: Do you think that your group would be interested in something like that?\n[Speaker 829132564431108852]: It might, it might not have to be now, but maybe like come, you know, once people are a little bit more back in the office, but, yeah, what are your thoughts?\n[Speaker 450567784861528043]: ", "contextAfter": " or something like this.\n[Speaker 450567784861528043]: Maybe I can ask around, yeah, if this team also can organize something.\n[Speaker 450567784861528043]: And we have one half an hour in our monthly meeting also.\n[Speaker 450567784861528043]: Yeah.\n[Speaker 829132564431108852]: That would be super.\n[Speaker 829132564431108852]: I find it really helpful with a lot of other groups who join this with other groups are.\n[Speaker 450567784861528043]: But I have to ask, maybe they don't like this kind of advertising, but I have to check.\n[Speaker 450567784861528043]: I can't say.\n[Speaker 829132564431108852]: Totally.\n[Speaker 829132564431108852]: No, I totally get it, I think or we try to do it more like, you know, informative way of like how you can use it so that it's hopefully not as like advertising is.\n[Speaker 829132564431108852]: So it's more of like an informative sort of training, but, I get it like, I know that you probably have these with other vendors too, but we would basicall...", "callTitle": "BioRender & Roche - Follow Up Call"}, {"quote": "So, and then we have, the technical development.", "date": "2024-06-14", "callId": "2024-06-14_5820c7bc82da", "gongUrl": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "speakerId": "1372854872117518306", "customerName": "Felix Kuhne", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "felix.kuhne@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...olecules, smaller group.\n[Speaker 8593743714562823197]: And that's the part that you're the group that you're part of, right?\n[Speaker 8593743714562823197]: Yeah.\n[Speaker 8593743714562823197]: Got you.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: How many people are within that characterization of molecules group?\n[Speaker 1372854872117518306]: 40 roughly.\n[Speaker 8593743714562823197]: 40?\n[Speaker 8593743714562823197]: Okay, perfect.\n[Speaker 8593743714562823197]: I have a question for you.\n[Speaker 8593743714562823197]: How do I?\n[Speaker 8593743714562823197]: Pt, isn't a part of like diagnostics or\u2026 like it's completely separate from those two groups.\n[Speaker 1372854872117518306]: Yeah.\n[Speaker 1372854872117518306]: So we have the diagnostics, and then we have the pharma, yeah, separate divisions.\n[Speaker 1372854872117518306]: And within the pharma division, the research and development is separate organization if you want.\n[Speaker 1372854872117518306]: ", "contextAfter": "\n[Speaker 1372854872117518306]: So the process development unit, and then we have the commercial unit which is today basically produce the product in the end.\n[Speaker 1372854872117518306]: And those are the three big organizations and the research so pre and in the us is great.\n[Speaker 1372854872117518306]: The research units are larger than the technical development unit.\n[Speaker 1372854872117518306]: And also the commercial units are larger technical development.\n[Speaker 1372854872117518306]: Is, I mean, we have technical development activities in basel in pennsburg, and in san Francisco.\n[Speaker 1372854872117518306]: Mainly, I would say probably there are some other\u2026 sites where they also have technical development activities.\n[Speaker 1372854872117518306]: But those are the main sites, I would say.\n[Speaker 8593743714562823197]: I understand.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: So pharma has like three, three main groups there's, the P red.\n[Spe...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_roche_pharma_d85334a3", "company": "roche", "gong_entity": "Roche Pharma", "gong_parent": "Roche R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "So you have, Roche diagnostics and Roche pharma, yeah, those are like almost two separate companies.", "snippet_date": "2025-03-14", "person_name": "Jo Stevens", "person_email": "jo.stevens@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "call_id": "2025-03-14_d067238de6be", "call_count": 2, "all_snippets": [{"quote": "So you have, Roche diagnostics and Roche pharma, yeah, those are like almost two separate companies.", "date": "2025-03-14", "callId": "2025-03-14_d067238de6be", "gongUrl": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "speakerId": "5895796664693401761", "customerName": "Jo Stevens", "internalName": "Jacqueline McCoskey", "customerEmail": "jo.stevens@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...ut very.\n[Speaker 5895796664693401761]: Well, deserved, just wait until we get to may then.\n[Speaker 6782829348298472977]: I know.\n[Speaker 6782829348298472977]: And then the summer, I know things get crazy.\n[Speaker 6782829348298472977]: So, okay, perfect.\n[Speaker 6782829348298472977]: That's really good to know.\n[Speaker 6782829348298472977]: In terms of your actual group here, I am just looking at my old notes.\n[Speaker 6782829348298472977]: You're in the antibody development team.\n[Speaker 6782829348298472977]: Is that correct?\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: And I know that's on the diagnostic side, how does that sort of like fit organizationally like in the actual, like what group are you under?\n[Speaker 6782829348298472977]: I guess within like the antibody development, is there a group that you kind of report to or like you're.\n[Speaker 5895796664693401761]: situated under?\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: ", "contextAfter": "\n[Speaker 5895796664693401761]: Yeah, but in helzberg, we have both on site.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: We're.\n[Speaker 5895796664693401761]: a bit weird in that sense.\n[Speaker 5895796664693401761]: Normally, the sites of Roche are like exclusively Daya, yeah.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 5895796664693401761]: And then within diagnostics, we have like huge departments that are called, like corelab that work on like devices and the tests that go on the devices, okay?\n[Speaker 5895796664693401761]: And then we have, a group of which I belong to that is called, Roche diagnostics solutions that, we do the research.\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: And within that, on penzberg, we have, biological reagent development, and chemistry, chemical reagent, development.\n[Speaker 5895796664693401761]: Okay?\n[Speaker 58957966646934017...", "callTitle": "BioRender | Roche"}, {"quote": "internally for us it's pharma and dial that's it", "date": "2024-09-16", "callId": "2024-09-16_d36b49ea866e", "gongUrl": "https://app.gong.io/call?id=d36b49ea866e8fc066b20a5d96a1a11f1afb1d751f0a926343dc3ca8b2b1b2f1", "speakerId": "4443789273359589298", "customerName": "Gaius Augustus; George Abousleiman; Kawal Kaur", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "gaius.augustus@roche.com; abousleg@gene.com; kaurk5@gene.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...s it and then Gaius will have access to or whoever wants to be this person will have access to an administrative panel so you can see everyone that's on the license yeah cool go ahead.\n[Speaker 4443789273359589298]: So I have questions about two of these components.\n[Speaker 4443789273359589298]: So the first one is Roche controlled trial.\n[Speaker 4443789273359589298]: What does that mean?\n[Speaker 1067617882933750578]: The Roche controlled trial?\n[Speaker 1067617882933750578]: Yeah.\n[Speaker 1067617882933750578]: Oh just the fact that it's in line with the timeline so that the like when we the time that we start it and the time that it ends will be in alliance or sorry aligned with the P Red and G Red renewal.\n[Speaker 4443789273359589298]: Okay gotcha.\n[Speaker 4443789273359589298]: Yeah.\n[Speaker 4443789273359589298]: Just for future reference as we are moving towards enterprising licenses I think maybe we also want to work on how we're addressing these different functions because ", "contextAfter": ".\n[Speaker 4443789273359589298]: Yeah okay.\n[Speaker 4443789273359589298]: Going forward maybe we come on the BioRender side maybe we want to combine UMP and its pharma unit and then we'll have a diagnostics unit and my understanding is that this proof of concept that and that's feel free to jump in this proof of concept we're doing is primarily for diagnostics because we're getting a lot of requests from them.\n[Speaker 1067617882933750578]: Yep totally okay that's good for us to know yeah we because everyone in pharma within like the P RED and G RED divisions has access right now so everyone else it'll be for the people that are outside of it I guess this is just more so talking about the renewal date and when we're hoping it to launch the enterprise licensing and then this will be like kind of the running in parallel as we're working towards that enterprise licensing I can clarify that language on here too if that's.\n[Speaker 4443789273359589298]: helpful.\n[Speaker 444378927335958929...", "callTitle": "BioRender | Roche - short term access"}]}, {"id": "roche_pharmaceutical_technical_development_8545139d", "company": "roche", "gong_entity": "Pharmaceutical Technical Development", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "So if we request a license, I have to do that by pharmaceutical technical development so that the whole department", "snippet_date": "2024-09-10", "person_name": "Christoph Duerr", "person_email": "christoph.duerr@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-sciences-technical", "manual_node_name": "Pharmaceutical Sciences (Pharma Technical)", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical)", "confidence": "high", "reasoning": "Excellent match - the entity name closely aligns with the Pharmaceutical Sciences (Pharma Technical) division"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=a7e39ba6d0002a5c2ce052c12e30cc994a9235b4911c827cb2f492c18c4411fe", "call_id": "2024-09-10_a7e39ba6d000", "call_count": 2, "all_snippets": [{"quote": "So if we request a license, I have to do that by pharmaceutical technical development so that the whole department", "date": "2024-09-10", "callId": "2024-09-10_a7e39ba6d000", "gongUrl": "https://app.gong.io/call?id=a7e39ba6d0002a5c2ce052c12e30cc994a9235b4911c827cb2f492c18c4411fe", "speakerId": "16832304959900895", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...[Speaker 16832304959900895]: Yeah, okay.\n[Speaker 3227459355290943038]: I can definitely give you the contacts from IT just to kind of give your support.\n[Speaker 3227459355290943038]: And there might be some sort of short term solution that we can include you in from that perspective.\n[Speaker 3227459355290943038]: A couple questions for you.\n[Speaker 3227459355290943038]: So you're in PTD, correct?\n[Speaker 3227459355290943038]: Yes.\n[Speaker 3227459355290943038]: And within, I'm just looking at Sierra's notes, like pharmaceutical, no, that's cell and gene therapy.\n[Speaker 3227459355290943038]: Is that right?\n[Speaker 3227459355290943038]: Yes.\n[Speaker 3227459355290943038]: Okay.\n[Speaker 3227459355290943038]: How large approximately is the cell and gene therapy group?\n[Speaker 16832304959900895]: So this is the thing that's seen at cell and gene therapy group is only 10 people.\n[Speaker 16832304959900895]: And the next step then would be to reach out.\n[Speaker 16832304959900895]: ", "contextAfter": " and there that was the quick check in I had with Sierra on is that then we would do something like this introduction or this webinar to maybe get the department informed, then that would be a department level decision.\n[Speaker 16832304959900895]: If we want to have a single license for PDD first, and then we go to the business license, because I think we will not get a license only for cell and gene therapy.\n[Speaker 16832304959900895]: So the dream is too small.\n[Speaker 3227459355290943038]: Yeah.\n[Speaker 3227459355290943038]: No, that's no problem.\n[Speaker 3227459355290943038]: How do you know how large PTD is also by any chance?\n[Speaker 16832304959900895]: And Europe, now I have to calculate with analytics and.\n[Speaker 3227459355290943038]: no just an approximation are we talking a 1,000 people or a couple 100 people.\n[Speaker 16832304959900895]: No, no, no.\n[Speaker 16832304959900895]: It's smaller.\n[Speaker 16832304959900895]: It's, I think, 300 altogether.\n[Speaker 3227459...", "callTitle": "BioRender & Roche - Follow Up Call"}, {"quote": "That's a pharmaceutical development.", "date": "2024-09-04", "callId": "2024-09-04_18e45c9dd482", "gongUrl": "https://app.gong.io/call?id=18e45c9dd4826de168510161017a2e0e98fd82d6b0edd95ca08f518098665c0e", "speakerId": "7347115369096025640", "customerName": "Christoph Duerr", "internalName": "Sierra Barnes", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...e visuals you've created for them.\n[Speaker 7347115369096025640]: So in general, I think it is key that people understand what is presented.\n[Speaker 7347115369096025640]: So I don't want to present on just, okay, now I presented the data.\n[Speaker 7347115369096025640]: So I'm looking forward to have a discussion afterwards.\n[Speaker 7347115369096025640]: And if they don't understand, they cannot bring their thoughts.\n[Speaker 7347115369096025640]: To the discussion.\n[Speaker 7347115369096025640]: So I think that's key.\n[Speaker 3027117464291228307]: Mm hmm.\n[Speaker 3027117464291228307]: Okay, perfect.\n[Speaker 3027117464291228307]: Yeah, that's kind of an alignment from what we're hearing from, you know, other groups at Roche.\n[Speaker 3027117464291228307]: We just want to make sure that everyone's like really understanding what, how the value that BioRender can bring.\n[Speaker 3027117464291228307]: What's the department that you're a part of at Roche?\n[Speaker 7347115369096025640]: ", "contextAfter": "\n[Speaker 3027117464291228307]: Okay, PTD.\n[Speaker 3027117464291228307]: And how many people are in, your group?\n[Speaker 3027117464291228307]: let's.\n[Speaker 7347115369096025640]: say, maybe in direct, so the team has about 10, but some are part time.\n[Speaker 7347115369096025640]: So yeah, I don't know.\n[Speaker 7347115369096025640]: Do you, do you ask from a potential user perspective or?\n[Speaker 3027117464291228307]: We're just trying to figure out, who sits where.\n[Speaker 3027117464291228307]: These companies, are quite massive, like you mentioned.\n[Speaker 3027117464291228307]: Are you part of a specific, you know, subgroup in the pharmaceutical development or?\n[Speaker 7347115369096025640]: Yes, so that, it's a, it's, there's this agile team working, on cell and gene therapies.\n[Speaker 7347115369096025640]: I see.\n[Speaker 7347115369096025640]: So, it's not in, it's not a rigid organizational setup, but we have, these agile teams.\n[Speaker 7347115369096025640]: Hmm.\n[Speake...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_development_and_diagnostics_839893dc", "company": "roche", "gong_entity": "Development and Diagnostics", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": "300", "confidence": "high", "mention_count": 2, "snippet": "I'm, a team lead in the development and diagnostics", "snippet_date": "2024-07-30", "person_name": "Markus Eckl", "person_email": "markus.eckl@roche.com", "internal_name": "Sierra Barnes", "internal_email": "sierra.barnes@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=cb2dc2e4e91e696868fb33a086efad02fc365fe962078aee0c9ff366d3ac7658", "call_id": "2024-07-30_cb2dc2e4e91e", "call_count": 2, "all_snippets": [{"quote": "I'm, a team lead in the development and diagnostics", "date": "2024-07-30", "callId": "2024-07-30_cb2dc2e4e91e", "gongUrl": "https://app.gong.io/call?id=cb2dc2e4e91e696868fb33a086efad02fc365fe962078aee0c9ff366d3ac7658", "speakerId": "1779939919727253638", "customerName": "Markus Eckl", "internalName": "Sierra Barnes", "customerEmail": "markus.eckl@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...day it's.\n[Speaker 6006134561462791049]: wow, that makes it hard to plan around.\n[Speaker 6006134561462791049]: I bet.\n[Speaker 1779939919727253638]: It's okay.\n[Speaker 6006134561462791049]: Yeah.\n[Speaker 6006134561462791049]: Well, happy we were able to find a time, to quickly chat maybe as a quick intro on my side of things.\n[Speaker 6006134561462791049]: I'm part of the BioRender team that's helping to support our users at Roche and would love for this call just to be an introduction for me to better understand what you're currently using BioRender for maybe what you'd hope to use it for.\n[Speaker 6006134561462791049]: And I can explain some of the things that we're currently working on with Roche, but was there anything in particular you were hoping that, we cover today?\n[Speaker 6006134561462791049]: Yeah.\n[Speaker 1779939919727253638]: No, that's fine.\n[Speaker 1779939919727253638]: Now.\n[Speaker 1779939919727253638]: Thanks for reaching out.\n[Speaker 1779939919727253638]: So, ", "contextAfter": ".\n[Speaker 1779939919727253638]: And as you may have heard or experience Rose is not Rose.\n[Speaker 1779939919727253638]: So we are a global company with at least two fractions, let's say, so pharma and I, and this is very interesting always how they interact.\n[Speaker 1779939919727253638]: So we and I cannot profit from this bike license from pharma.\n[Speaker 1779939919727253638]: There are intercom intro company.\n[Speaker 1779939919727253638]: I don't know what I, yeah, from my end, it's a nuisance.\n[Speaker 1779939919727253638]: But, okay, I use BioRender, I would say on a monthly basis for internal communication just to illustrate some point, something out, maybe bring a nice picture to, at internal document.\n[Speaker 6006134561462791049]: Okay, perfect.\n[Speaker 6006134561462791049]: That's really good context and it sounds like you've been using bar under for a little while now, but what were you using before to kind of make the graphics for your internal communication?\n[Speaker ...", "callTitle": "BioRender & Roche - Intro Call"}, {"quote": "We're about 300\u2026 people in the, yeah, 300 people.", "date": "2024-07-15", "callId": "2024-07-15_2d305aa082f5", "gongUrl": "https://app.gong.io/call?id=2d305aa082f505a7ea08ecfc91c8df4bcb7c11b0bba713bcabb107df0cebc7f8", "speakerId": "8823219584383707337", "customerName": "Katrin Heinrich", "internalName": "Sierra Barnes", "customerEmail": "katrin.heinrich@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [{"value": "300", "snippetIndex": 1, "source": {"callDate": "2024-07-15", "customerName": "Katrin Heinrich"}}], "contextBefore": "...Huh.\n[Speaker 8823219584383707337]: How to say it in English that there?\n[Speaker 8823219584383707337]: Ambitions, that also the development department get some free license for all people.\n[Speaker 8823219584383707337]: I do not know if you have any information about this.\n[Speaker 62159824319951106]: It's kind of the inspiration, for the phone call.\n[Speaker 62159824319951106]: We've like in the past few years work to set up, the red researchers with access.\n[Speaker 62159824319951106]: And now we want to make sure that it's more equitable across the ocean that other teams that could benefit from having access to by render also have access.\n[Speaker 62159824319951106]: So, yeah, making these phone calls to see where it's been a value, to different teams.\n[Speaker 62159824319951106]: So, I'm happy we're connected.\n[Speaker 62159824319951106]: How large is the development department?\n[Speaker 8823219584383707337]: Sure.\n[Speaker 8823219584383707337]: No.\n[Speaker 8823219584383707337]: ", "contextAfter": "\n[Speaker 8823219584383707337]: I the.\n[Speaker 62159824319951106]: are you part of a specific team within the development department?\n[Speaker 8823219584383707337]: I'm in the analytical department.\n[Speaker 8823219584383707337]: Yeah.\n[Speaker 8823219584383707337]: And there is, yeah, it's not hard, to tell people what's going on in our essays and so on.\n[Speaker 8823219584383707337]: And it's really cool to have\u2026 the visualization very easy and simple.\n[Speaker 62159824319951106]: And how large is the analytical department?\n[Speaker 8823219584383707337]: We're about 100, I think.\n[Speaker 62159824319951106]: Okay.\n[Speaker 62159824319951106]: And are all those people based, in germany or?\n[Speaker 8823219584383707337]: In germany and in switzerland?\n[Speaker 62159824319951106]: Okay.\n[Speaker 62159824319951106]: Very cool.\n[Speaker 62159824319951106]: And so, it sounds like, you know, there's at least a few people across the department that are still using older tools like Powerpoin...", "callTitle": "Call with Roche Ltd. - Katrin Heinrich"}]}, {"id": "roche_seattle_e27bb184", "company": "roche", "gong_entity": "Seattle", "gong_parent": "Roche R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I'll contact Fernando and let him know that there is some demand within the Seattle office as well.", "snippet_date": "2024-03-08", "person_name": "Ruichen Zheng", "person_email": "ren.zheng.rz1@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=ea7c76d3d479bbd5090a53006dba841aa0be1364416d73a124d9cb8809d692d8", "call_id": "2024-03-08_ea7c76d3d479", "call_count": 1, "all_snippets": [{"quote": "So I'll contact Fernando and let him know that there is some demand within the Seattle office as well.", "date": "2024-03-08", "callId": "2024-03-08_ea7c76d3d479", "gongUrl": "https://app.gong.io/call?id=ea7c76d3d479bbd5090a53006dba841aa0be1364416d73a124d9cb8809d692d8", "speakerId": "5412767455533012515", "customerName": "Ruichen Zheng", "internalName": "Jacqueline McCoskey", "customerEmail": "ren.zheng.rz1@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...y to figure out a way to make it available on a larger scale.\n[Speaker 6692052275950100221]: Like for everyone at Roche\u2026 I actually spoke with someone earlier this week and we're trying to figure out a way to sort of incorporate your group within there.\n[Speaker 6692052275950100221]: If you wanted.\n[Speaker 6692052275950100221]: Let me give you the name of the person that I've been working with.\n[Speaker 6692052275950100221]: His name is Bernardo and he is the person who's sort of working through the contracting.\n[Speaker 6692052275950100221]: So if you're able to reach out to him and let him know that your group is interested, I'll pass that information along as well.\n[Speaker 6692052275950100221]: I have like biweekly meetings with him but it'll at least allow him to understand sort of where these requests are coming from.\n[Speaker 6692052275950100221]: His name is Bernardo and tunes this, his e-mail right here?\n[Speaker 5412767455533012515]: Got that.\n[Speaker 5412767455533012515]: ", "contextAfter": "\n[Speaker 5412767455533012515]: I didn't get this information.\n[Speaker 5412767455533012515]: I have no idea who could reach out to you and you.\n[Speaker 6692052275950100221]: Yeah, I know it's a big company, but if you do have any questions, I am the person that like I'll be able to provide you all the insight from like the buyer under like where we're currently stand and who to reach out to.\n[Speaker 6692052275950100221]: But yeah, he's sort of the peo, and do you know, I know that you're at the Seattle site?\n[Speaker 6692052275950100221]: Is there other sites that you've heard have been interested in getting access as well?\n[Speaker 6692052275950100221]: I?\n[Speaker 5412767455533012515]: To, of other sites?\n[Speaker 5412767455533012515]: Okay?\n[Speaker 5412767455533012515]: But\u2026 probably there are other sites but they don't really share there's so many sides that we going to.\n[Speaker 6692052275950100221]: Kind quite.\n[Speaker 5412767455533012515]: Yeah.\n[Speaker 5412767455533012515...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_seattle_team_e9c3dc0a", "company": "roche", "gong_entity": "Seattle Team", "gong_parent": "Seattle", "entity_type": "team", "team_size": "100", "confidence": "high", "mention_count": 1, "snippet": "So here in the Seattle team, we have a little bit less than 100 people.", "snippet_date": "2024-03-08", "person_name": "Ruichen Zheng", "person_email": "ren.zheng.rz1@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=ea7c76d3d479bbd5090a53006dba841aa0be1364416d73a124d9cb8809d692d8", "call_id": "2024-03-08_ea7c76d3d479", "call_count": 1, "all_snippets": [{"quote": "So here in the Seattle team, we have a little bit less than 100 people.", "date": "2024-03-08", "callId": "2024-03-08_ea7c76d3d479", "gongUrl": "https://app.gong.io/call?id=ea7c76d3d479bbd5090a53006dba841aa0be1364416d73a124d9cb8809d692d8", "speakerId": "5412767455533012515", "customerName": "Ruichen Zheng", "internalName": "Jacqueline McCoskey", "customerEmail": "ren.zheng.rz1@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [{"value": "100", "snippetIndex": 0, "source": {"callDate": "2024-03-08", "customerName": "Ruichen Zheng"}}], "contextBefore": "...to you're.\n[Speaker 6692052275950100221]: Talking to someone of my support team.\n[Speaker 6692052275950100221]: I'm the dedicated account up here at brand for Roche, so I can provide you all sort of the context\u2026 in terms of like what's going on right now before doing that.\n[Speaker 6692052275950100221]: Do you mind providing me a little bit of an overview of what you're hoping to gather today just to make sure I can answer your questions properly.\n[Speaker 6692052275950100221]: Okay?\n[Speaker 5412767455533012515]: Okay.\n[Speaker 5412767455533012515]: So, can you repeat that?\n[Speaker 5412767455533012515]: I, someone I had to answer someone's questions?\n[Speaker 6692052275950100221]: No worries.\n[Speaker 6692052275950100221]: Yeah, I was just gonna say, I know that you have reached out, but I was hoping to get a better sense of like exactly what you're looking for, just to make sure I answer all your questions properly.\n[Speaker 5412767455533012515]: Yes.\n[Speaker 5412767455533012515]: ", "contextAfter": "\n[Speaker 5412767455533012515]: So people are in the lab science research diagnostic group.\n[Speaker 5412767455533012515]: So within Rose, there's all these offices across United States, you know, Europe and everything we primarily work with people in the United States and Europe.\n[Speaker 5412767455533012515]: Okay.\n[Speaker 5412767455533012515]: And, I reached out to product managers within Rose and no one really knows who has additional information for is not related to, you know, the product manager.\n[Speaker 5412767455533012515]: They don't know anything of that or maybe I'm just not reaching the correct product manager.\n[Speaker 5412767455533012515]: Yes, there are many within.\n[Speaker 5412767455533012515]: Yeah, and not all the information is transparent.\n[Speaker 5412767455533012515]: So we have a couple teams that want to use the BioRender web product.\n[Speaker 5412767455533012515]: I don't know what they call it specifically because I don't use that product, but I'm on their...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_spark_5652f4f3", "company": "roche", "gong_entity": "Spark", "gong_parent": "Roche R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "you had mentioned that spark was looking to join the license as well", "snippet_date": "2025-05-06", "person_name": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "person_email": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internal_name": "Jacqueline McCoskey; Tim Fung", "internal_email": "jacqueline@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "spark-therapeutics", "manual_node_name": "Spark Therapeutics (Gene Therapy)", "manual_node_path": "Roche Research & Development > Spark Therapeutics (Gene Therapy)", "confidence": "high", "reasoning": "Clear acronym/shortened name match for Spark Therapeutics division. Context about licensing aligns with this being the gene therapy business unit"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=37066a25169f230872122dcbc3bcdf337a663fe018af6d05a93aff696dd6e89c", "call_id": "2025-05-06_37066a25169f", "call_count": 1, "all_snippets": [{"quote": "you had mentioned that spark was looking to join the license as well", "date": "2025-05-06", "callId": "2025-05-06_37066a25169f", "gongUrl": "https://app.gong.io/call?id=37066a25169f230872122dcbc3bcdf337a663fe018af6d05a93aff696dd6e89c", "speakerId": "6088335049672687772", "customerName": "Anand Thanumalayan; Bernardo Antunes; Gaius Augustus", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "anand.thanumalayan@contractors.roche.com; kaur.kawaljit@gene.com; gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...6088335049672687772]: So the, we are working through that right now, it's just, it's been a little bit tricky to get ahold of some of the admins.\n[Speaker 6398962093308799650]: That's fine.\n[Speaker 6398962093308799650]: I was just thinking, I mean, I'm always looking for budget transfers.\n[Speaker 6398962093308799650]: So if there's if it's a big number, if I need to look into it, but if it's only six K, that's fine.\n[Speaker 6398962093308799650]: Yeah.\n[Speaker 6088335049672687772]: Yeah.\n[Speaker 6088335049672687772]: So we have been working through it, a lot of them were individual licenses that were there.\n[Speaker 6088335049672687772]: So they were a little shy of like a 1,000 dollars per license and there weren't that many people to begin with.\n[Speaker 6398962093308799650]: Okay.\n[Speaker 6398962093308799650]: Thank you.\n[Speaker 6398962093308799650]: Yeah.\n[Speaker 6088335049672687772]: No problem.\n[Speaker 6088335049672687772]: One question that I did have for the team guys, ", "contextAfter": ".\n[Speaker 6088335049672687772]: I think the last communication that I saw was to Bernardo who was out of office.\n[Speaker 6088335049672687772]: I'm not sure if you've heard anything back from him since.\n[Speaker 1706286059248901810]: I have not, I'll write a note to follow up with Bernardo again.\n[Speaker 1706286059248901810]: Okay?\n[Speaker 1706286059248901810]: Sounds good.\n[Speaker 1706286059248901810]: Thank you.\n[Speaker 6088335049672687772]: Yeah, no problem.\n[Speaker 6088335049672687772]: And so, yeah, from our perspective, it will be very similar to the Roche, the, when we consolidated G red and P red together, we can transfer people on our backend.\n[Speaker 6088335049672687772]: We would just need to make sure that like all the invoices were settled as well with spark because there might've been something outstanding.\n[Speaker 6088335049672687772]: Awesome.\n[Speaker 6088335049672687772]: Yeah, just keep us posted there.\n[Speaker 6088335049672687772]: And the last thing that w...", "callTitle": "BioRender | Roche - usage review"}]}, {"id": "roche_ridgeline_discovery_6d254346", "company": "roche", "gong_entity": "Ridgeline Discovery", "gong_parent": "Roche R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Prior to joining Roche, I've been at ridgeline discovery that's an incubator also here in Basel.", "snippet_date": "2025-06-04", "person_name": "Thomas Radimerski", "person_email": "thomas.radimerski@roche.com", "internal_name": "Jacqueline McCoskey; Jon Fan", "internal_email": "jacqueline@biorender.com; jon.fan@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=ccb013af6bce76ef7361b4ff4dcb3f03d5a26b3e0f7dc5e32752df67731bdf67", "call_id": "2025-06-04_ccb013af6bce", "call_count": 1, "all_snippets": [{"quote": "Prior to joining Roche, I've been at ridgeline discovery that's an incubator also here in Basel.", "date": "2025-06-04", "callId": "2025-06-04_ccb013af6bce", "gongUrl": "https://app.gong.io/call?id=ccb013af6bce76ef7361b4ff4dcb3f03d5a26b3e0f7dc5e32752df67731bdf67", "speakerId": "1697093225649429822", "customerName": "Thomas Radimerski", "internalName": "Jacqueline McCoskey; Jon Fan", "customerEmail": "thomas.radimerski@roche.com", "internalEmail": "jacqueline@biorender.com; jon.fan@biorender.com", "sizeMentions": [], "contextBefore": "...49429822]: That's why I'm also sorry that I couldn't manage to meet you when you were here in person.\n[Speaker 7679576031344393063]: You.\n[Speaker 1697093225649429822]: met with Sarah, right?\n[Speaker 687147209638632693]: Yes, we did.\n[Speaker 687147209638632693]: Yeah, we had an awesome conversation with Sarah.\n[Speaker 687147209638632693]: She was great.\n[Speaker 687147209638632693]: And so, yeah, that's how we got connected to you.\n[Speaker 687147209638632693]: So this is great.\n[Speaker 687147209638632693]: But we'll\u2026 be back is the moral of the story.\n[Speaker 687147209638632693]: Hopefully we'll be back.\n[Speaker 687147209638632693]: And now we have a better idea of like where people are located.\n[Speaker 687147209638632693]: So it'll be a lot easier to chat in person once we are, but I guess to start like, have you used biorender before or is it something completely new to you?\n[Speaker 687147209638632693]: Yes?\n[Speaker 1697093225649429822]: Yes.\n[Speaker 1697093225649429822]: ", "contextAfter": "\n[Speaker 1697093225649429822]: It's a discovery engine owned by a venture capital firm, and, you know, they also were using biorender.\n[Speaker 1697093225649429822]: I think we had limited licenses, right?\n[Speaker 1697093225649429822]: Some people that used it.\n[Speaker 1697093225649429822]: I don't know how many licenses we had back then, but.\n[Speaker 687147209638632693]: OK.\n[Speaker 687147209638632693]: Yeah, yeah.\n[Speaker 1697093225649429822]: It definitely was something that people appreciated, a lot, right?\n[Speaker 1697093225649429822]: Because it helps them put together presentations et cetera.\n[Speaker 1697093225649429822]: I was also at novartis, but I don't know if the software was around back then, how long are you already offering?\n[Speaker 687147209638632693]: Yeah.\n[Speaker 687147209638632693]: So we, it's funny.\n[Speaker 687147209638632693]: We have this like company onsite this week and, so we've flown every we're a remote first company, but we flew everyone in, li...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_neuroscience_as_rare_diseases_biomarker_department_602c6af9", "company": "roche", "gong_entity": "Neuroscience as Rare Diseases Biomarker Department", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I'm bastian, I'm leading the fluid biomarker group within the neuroscience as rare diseases biomarker department.", "snippet_date": "2025-05-23", "person_name": "Bastian Zinnhardt", "person_email": "bastian.zinnhardt@roche.com", "internal_name": "Jacqueline McCoskey; Jon Fan", "internal_email": "jacqueline@biorender.com; jon.fan@biorender.com", "llm_suggested_match": {"manual_node_id": "neuroscience-rare-diseases-research", "manual_node_name": "Neuroscience & Rare Diseases Research", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Neuroscience & Rare Diseases Research", "confidence": "medium", "reasoning": "Strong semantic match with Neuroscience & Rare Diseases Research therapeutic area. The biomarker focus suggests this could be a specialized department within this area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=5a4d20ed98db302157123cc91d48004b811107a3afeed5742a338eb74146fc5f", "call_id": "2025-05-23_5a4d20ed98db", "call_count": 1, "all_snippets": [{"quote": "So I'm bastian, I'm leading the fluid biomarker group within the neuroscience as rare diseases biomarker department.", "date": "2025-05-23", "callId": "2025-05-23_5a4d20ed98db", "gongUrl": "https://app.gong.io/call?id=5a4d20ed98db302157123cc91d48004b811107a3afeed5742a338eb74146fc5f", "speakerId": "3154769298458164648", "customerName": "Bastian Zinnhardt", "internalName": "Jacqueline McCoskey; Jon Fan", "customerEmail": "bastian.zinnhardt@roche.com", "internalEmail": "jacqueline@biorender.com; jon.fan@biorender.com", "sizeMentions": [], "contextBefore": "... to give you some insight in terms of like where we're looking to head with the product to get your feedback on that there, but would love, to start with just like, you know, how you're currently using it and things you would quite, I mean, things that you possibly like to see.\n[Speaker 1001438637037505996]: We continue to build up the product.\n[Speaker 1001438637037505996]: I should also mention, sorry, it's early.\n[Speaker 1001438637037505996]: I am the one of the main points of contact here at biorender for Roche.\n[Speaker 1001438637037505996]: And then I'm joined by John who's our head of product.\n[Speaker 1001438637037505996]: So he's kind of the Guy that, you know, helped build up this whole vision.\n[Speaker 1001438637037505996]: So we're just loving to hear what you guys have to say.\n[Speaker 3154769298458164648]: Good.\n[Speaker 3154769298458164648]: So thanks for the intro.\n[Speaker 3154769298458164648]: Maybe I can also quickly introduce myself.\n[Speaker 3154769298458164648]: ", "contextAfter": "\n[Speaker 3154769298458164648]: So obviously, I'm using the biorender toolbox, let's say mostly for drawing kind of moa mode or mechanism of action representations and not so much, for plotting, not so much\u2026 for powerpoints, and these kind of things.\n[Speaker 3154769298458164648]: And, and the reason being, I mean the powerpoint, it's the easy answer is we're not using powerpoint that much, right?\n[Speaker 3154769298458164648]: We're using the Google suite.\n[Speaker 3154769298458164648]: So that's why I'm not using that so much, but again, I'm happily using it for like kind of making biological concepts more understandable to let's say the non biologists in the team which I find quite useful.\n[Speaker 3154769298458164648]: And in the future, I would also like to use it a bit more for patient facing materials so that we can also kind of make things more accessible, for patients.\n[Speaker 3154769298458164648]: Well, we traditionally used to collaborate with agencies that would build thes...", "callTitle": "Roche & BioRender Basel Onsite - Bastian Zinnhardt"}]}, {"id": "roche_fluid_biomarker_group_2f1c5ce4", "company": "roche", "gong_entity": "Fluid Biomarker Group", "gong_parent": "Neuroscience as Rare Diseases Biomarker Department", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I'm bastian, I'm leading the fluid biomarker group within the neuroscience as rare diseases biomarker department.", "snippet_date": "2025-05-23", "person_name": "Bastian Zinnhardt", "person_email": "bastian.zinnhardt@roche.com", "internal_name": "Jacqueline McCoskey; Jon Fan", "internal_email": "jacqueline@biorender.com; jon.fan@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=5a4d20ed98db302157123cc91d48004b811107a3afeed5742a338eb74146fc5f", "call_id": "2025-05-23_5a4d20ed98db", "call_count": 1, "all_snippets": [{"quote": "So I'm bastian, I'm leading the fluid biomarker group within the neuroscience as rare diseases biomarker department.", "date": "2025-05-23", "callId": "2025-05-23_5a4d20ed98db", "gongUrl": "https://app.gong.io/call?id=5a4d20ed98db302157123cc91d48004b811107a3afeed5742a338eb74146fc5f", "speakerId": "3154769298458164648", "customerName": "Bastian Zinnhardt", "internalName": "Jacqueline McCoskey; Jon Fan", "customerEmail": "bastian.zinnhardt@roche.com", "internalEmail": "jacqueline@biorender.com; jon.fan@biorender.com", "sizeMentions": [], "contextBefore": "... to give you some insight in terms of like where we're looking to head with the product to get your feedback on that there, but would love, to start with just like, you know, how you're currently using it and things you would quite, I mean, things that you possibly like to see.\n[Speaker 1001438637037505996]: We continue to build up the product.\n[Speaker 1001438637037505996]: I should also mention, sorry, it's early.\n[Speaker 1001438637037505996]: I am the one of the main points of contact here at biorender for Roche.\n[Speaker 1001438637037505996]: And then I'm joined by John who's our head of product.\n[Speaker 1001438637037505996]: So he's kind of the Guy that, you know, helped build up this whole vision.\n[Speaker 1001438637037505996]: So we're just loving to hear what you guys have to say.\n[Speaker 3154769298458164648]: Good.\n[Speaker 3154769298458164648]: So thanks for the intro.\n[Speaker 3154769298458164648]: Maybe I can also quickly introduce myself.\n[Speaker 3154769298458164648]: ", "contextAfter": "\n[Speaker 3154769298458164648]: So obviously, I'm using the biorender toolbox, let's say mostly for drawing kind of moa mode or mechanism of action representations and not so much, for plotting, not so much\u2026 for powerpoints, and these kind of things.\n[Speaker 3154769298458164648]: And, and the reason being, I mean the powerpoint, it's the easy answer is we're not using powerpoint that much, right?\n[Speaker 3154769298458164648]: We're using the Google suite.\n[Speaker 3154769298458164648]: So that's why I'm not using that so much, but again, I'm happily using it for like kind of making biological concepts more understandable to let's say the non biologists in the team which I find quite useful.\n[Speaker 3154769298458164648]: And in the future, I would also like to use it a bit more for patient facing materials so that we can also kind of make things more accessible, for patients.\n[Speaker 3154769298458164648]: Well, we traditionally used to collaborate with agencies that would build thes...", "callTitle": "Roche & BioRender Basel Onsite - Bastian Zinnhardt"}]}, {"id": "roche_early_development_biomarker_department_2683f76e", "company": "roche", "gong_entity": "Early Development Biomarker Department", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": "40", "confidence": "high", "mention_count": 1, "snippet": "I mean within the early development biomarker department we are about, I would say 40 people roughly speaking", "snippet_date": "2025-05-23", "person_name": "Bastian Zinnhardt", "person_email": "bastian.zinnhardt@roche.com", "internal_name": "Jacqueline McCoskey; Jon Fan", "internal_email": "jacqueline@biorender.com; jon.fan@biorender.com", "llm_suggested_match": {"manual_node_id": "biomarker-development-pharma", "manual_node_name": "Biomarker Development", "manual_node_path": "Roche Research & Development > Global Product Development (Pharma) > Personalized Healthcare & Companion Diagnostics > Biomarker Development", "confidence": "medium", "reasoning": "Good semantic match with Biomarker Development team. The 'early development' qualifier aligns with biomarker work in drug development"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=5a4d20ed98db302157123cc91d48004b811107a3afeed5742a338eb74146fc5f", "call_id": "2025-05-23_5a4d20ed98db", "call_count": 1, "all_snippets": [{"quote": "I mean within the early development biomarker department we are about, I would say 40 people roughly speaking", "date": "2025-05-23", "callId": "2025-05-23_5a4d20ed98db", "gongUrl": "https://app.gong.io/call?id=5a4d20ed98db302157123cc91d48004b811107a3afeed5742a338eb74146fc5f", "speakerId": "3154769298458164648", "customerName": "Bastian Zinnhardt", "internalName": "Jacqueline McCoskey; Jon Fan", "customerEmail": "bastian.zinnhardt@roche.com", "internalEmail": "jacqueline@biorender.com; jon.fan@biorender.com", "sizeMentions": [{"value": "40", "snippetIndex": 0, "source": {"callDate": "2025-05-23", "customerName": "Bastian Zinnhardt"}}], "contextBefore": "...ker 1001438637037505996]: Or like the main moments that you typically use biorender at this point?\n[Speaker 3154769298458164648]: Yeah.\n[Speaker 3154769298458164648]: It's mostly internal presentations.\n[Speaker 3154769298458164648]: We, we also recently used it for one manuscript that we created in submission due to the nature where I sit in the company.\n[Speaker 3154769298458164648]: So early development, we are not disclosing very much to the outside world.\n[Speaker 3154769298458164648]: So it's not that we are using it for conference presentations at this stage, but if it ever comes to it, I would certainly consider using biorender to make concepts understandable.\n[Speaker 3154769298458164648]: Yeah.\n[Speaker 32972158885668949]: Great.\n[Speaker 1001438637037505996]: Okay.\n[Speaker 1001438637037505996]: I'm curious how many folks are within like your, the section, that you currently work with or like approximately?\n[Speaker 1001438637037505996]: Yeah.\n[Speaker 3154769298458164648]: ", "contextAfter": ", but then again, that these the early development piece in neuroscience that's probably a couple of hundreds?\n[Speaker 1001438637037505996]: Right.\n[Speaker 1001438637037505996]: Okay.\n[Speaker 1001438637037505996]: Yeah.\n[Speaker 1001438637037505996]: So do you find it's like those 40 folks that you're constantly trying to make sure that you're still like you're communicating with regularly or is it, you know, with the department as well or no?\n[Speaker 3154769298458164648]: No, we mostly work in the project teams for the different molecules.\n[Speaker 3154769298458164648]: So it's the communication happens more in those teams where we have people from clinical operations, MDS, from early development, clinical, pharmacologists, so people from various backgrounds who may again, not have the biology background, of course, they have a basic understanding of science, but where we really deep dive on the molecules and their respective biology behind them.\n[Speaker 1001438637037505996]: Rig...", "callTitle": "Roche & BioRender Basel Onsite - Bastian Zinnhardt"}]}, {"id": "roche_product_organization_d0374e4e", "company": "roche", "gong_entity": "Product Organization", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I run our product organization here.", "snippet_date": "2025-05-07", "person_name": "Christoph Duerr", "person_email": "christoph.duerr@roche.com", "internal_name": "Jon Fan; Matt De Melo; Samara Ona", "internal_email": "jon.fan@biorender.com; matt@biorender.com; samara@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=a3a36320744086761b7d31f25fd3737c7d22449e22e6d1ef4e3a5484c5fb4553", "call_id": "2025-05-07_a3a363207440", "call_count": 1, "all_snippets": [{"quote": "I run our product organization here.", "date": "2025-05-07", "callId": "2025-05-07_a3a363207440", "gongUrl": "https://app.gong.io/call?id=a3a36320744086761b7d31f25fd3737c7d22449e22e6d1ef4e3a5484c5fb4553", "speakerId": "9117926219614591971", "customerName": "Christoph Duerr", "internalName": "Jon Fan; Matt De Melo; Samara Ona", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jon.fan@biorender.com; matt@biorender.com; samara@biorender.com", "sizeMentions": [], "contextBefore": "...e record this?\n[Speaker 8162283192639519739]: Okay, perfect.\n[Speaker 8162283192639519739]: Let's see.\n[Speaker 8162283192639519739]: Okay\u2026 you.\n[Speaker 8162283192639519739]: Awesome.\n[Speaker 8162283192639519739]: So, yeah, maybe we can get started with a short round of introductions.\n[Speaker 8162283192639519739]: My name is Samara.\n[Speaker 8162283192639519739]: I am part of the science designers at biorender, and I work in the team that creates the figures that you can see in the library.\n[Speaker 8162283192639519739]: I also have a background in science.\n[Speaker 8162283192639519739]: I did a bachelor's in biotechnology, and I also did my PHD in structural biology and drug discovery.\n[Speaker 8162283192639519739]: So, yeah, that's pretty much for me.\n[Speaker 8162283192639519739]: Maybe John, you can go.\n[Speaker 9117926219614591971]: Yeah.\n[Speaker 9117926219614591971]: Hey, good to meet you as well.\n[Speaker 9117926219614591971]: My name is John.\n[Speaker 9117926219614591971]: ", "contextAfter": "\n[Speaker 9117926219614591971]: So the product management and product design team is responsible for building the product and the application you see and work pretty closely with Samara and the team to make sure it all fits together with the content and figures they put together.\n[Speaker 9117926219614591971]: I've been at biorender a little over a year and I'm actually based in the San Francisco bay area.\n[Speaker 9117926219614591971]: So, this is my first meeting of the day, just getting started here as well, but great to meet you.\n[Speaker 465134244396160022]: Thank you.\n[Speaker 465134244396160022]: Great to meet you too.\n[Speaker 465134244396160022]: So I don't know if you need my background.\n[Speaker 465134244396160022]: So, I'm obviously with Roche now for 12 to 13 years in different roles.\n[Speaker 465134244396160022]: And currently, I'm mainly doing pharmaceutical development for gene therapies.\n[Speaker 465134244396160022]: This is the main part.\n[Speaker 465134244396160022]:...", "callTitle": "Intro to Roche\u2019s Custom BioRender Library"}]}, {"id": "roche_product_management_and_product_design_team_a38f5120", "company": "roche", "gong_entity": "Product Management and Product Design Team", "gong_parent": "Product Organization", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So the product management and product design team is responsible for building the product and the application", "snippet_date": "2025-05-07", "person_name": "Christoph Duerr", "person_email": "christoph.duerr@roche.com", "internal_name": "Jon Fan; Matt De Melo; Samara Ona", "internal_email": "jon.fan@biorender.com; matt@biorender.com; samara@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=a3a36320744086761b7d31f25fd3737c7d22449e22e6d1ef4e3a5484c5fb4553", "call_id": "2025-05-07_a3a363207440", "call_count": 1, "all_snippets": [{"quote": "So the product management and product design team is responsible for building the product and the application", "date": "2025-05-07", "callId": "2025-05-07_a3a363207440", "gongUrl": "https://app.gong.io/call?id=a3a36320744086761b7d31f25fd3737c7d22449e22e6d1ef4e3a5484c5fb4553", "speakerId": "9117926219614591971", "customerName": "Christoph Duerr", "internalName": "Jon Fan; Matt De Melo; Samara Ona", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jon.fan@biorender.com; matt@biorender.com; samara@biorender.com", "sizeMentions": [], "contextBefore": "...r 8162283192639519739]: Let's see.\n[Speaker 8162283192639519739]: Okay\u2026 you.\n[Speaker 8162283192639519739]: Awesome.\n[Speaker 8162283192639519739]: So, yeah, maybe we can get started with a short round of introductions.\n[Speaker 8162283192639519739]: My name is Samara.\n[Speaker 8162283192639519739]: I am part of the science designers at biorender, and I work in the team that creates the figures that you can see in the library.\n[Speaker 8162283192639519739]: I also have a background in science.\n[Speaker 8162283192639519739]: I did a bachelor's in biotechnology, and I also did my PHD in structural biology and drug discovery.\n[Speaker 8162283192639519739]: So, yeah, that's pretty much for me.\n[Speaker 8162283192639519739]: Maybe John, you can go.\n[Speaker 9117926219614591971]: Yeah.\n[Speaker 9117926219614591971]: Hey, good to meet you as well.\n[Speaker 9117926219614591971]: My name is John.\n[Speaker 9117926219614591971]: I run our product organization here.\n[Speaker 9117926219614591971]: ", "contextAfter": " you see and work pretty closely with Samara and the team to make sure it all fits together with the content and figures they put together.\n[Speaker 9117926219614591971]: I've been at biorender a little over a year and I'm actually based in the San Francisco bay area.\n[Speaker 9117926219614591971]: So, this is my first meeting of the day, just getting started here as well, but great to meet you.\n[Speaker 465134244396160022]: Thank you.\n[Speaker 465134244396160022]: Great to meet you too.\n[Speaker 465134244396160022]: So I don't know if you need my background.\n[Speaker 465134244396160022]: So, I'm obviously with Roche now for 12 to 13 years in different roles.\n[Speaker 465134244396160022]: And currently, I'm mainly doing pharmaceutical development for gene therapies.\n[Speaker 465134244396160022]: This is the main part.\n[Speaker 465134244396160022]: I'm curious to hear what you need from our end to tailor the libraries.\n[Speaker 8162283192639519739]: Awesome.\n[Speaker 8162283192639519739...", "callTitle": "Intro to Roche\u2019s Custom BioRender Library"}]}, {"id": "roche_corporate_donations_and_philanthropy_group_f061b2bf", "company": "roche", "gong_entity": "Corporate Donations and Philanthropy Group", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "in January of this year, I transitioned out of comms to our corporate donations and philanthropy group", "snippet_date": "2025-05-07", "person_name": "Jeffrey Matthews", "person_email": "jeffrey.matthews.jm1@roche.com", "internal_name": "Jacqueline McCoskey; Shiz Aoki; Vijay Shahani", "internal_email": "jacqueline@biorender.com; shiz@biorender.com; vijay.shahani@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=0ff68150eb6981fea7991b3e7eb653bba89d1ece8b6272dcbc2831801db10158", "call_id": "2025-05-07_0ff68150eb69", "call_count": 1, "all_snippets": [{"quote": "in January of this year, I transitioned out of comms to our corporate donations and philanthropy group", "date": "2025-05-07", "callId": "2025-05-07_0ff68150eb69", "gongUrl": "https://app.gong.io/call?id=0ff68150eb6981fea7991b3e7eb653bba89d1ece8b6272dcbc2831801db10158", "speakerId": "8694921314646196652", "customerName": "Jeffrey Matthews", "internalName": "Jacqueline McCoskey; Shiz Aoki; Vijay Shahani", "customerEmail": "jeffrey.matthews.jm1@roche.com", "internalEmail": "jacqueline@biorender.com; shiz@biorender.com; vijay.shahani@biorender.com", "sizeMentions": [], "contextBefore": "...seemed like a great opportunity to put those two worlds together, and help with some of these special initiatives that we're working on.\n[Speaker 7592388193914656289]: So yeah, we'd love to hear your ideas about pathways, and how you're thinking about the world and maybe we could share a little bit of what we're thinking about as well.\n[Speaker 8694921314646196652]: Now, if you're happy, to have all of you on the call and I really appreciate it.\n[Speaker 8694921314646196652]: So maybe just for my side, I, I've been with the company now for six and a half years.\n[Speaker 8694921314646196652]: My background is actually originally in public health, but I joined Roche in 2018 as a communications business partner to P red, you know, initially working with the immunology, infectious diseases, and ophthalmology, therapeutic areas.\n[Speaker 8694921314646196652]: And in the past three years, I was on the diagnostic side in our point of care diagnostics group.\n[Speaker 8694921314646196652]: But ", "contextAfter": ".\n[Speaker 8694921314646196652]: And this biochemical pathways poster.\n[Speaker 8694921314646196652]: The reason it's sitting in CDP as it's called is because this is a, this is a scientific resource that we have provided free of charge to scientists around the globe, you know, students, you know, different individuals who want to have this in their lab and it's kind of changed hands around Roche over the years.\n[Speaker 8694921314646196652]: But given the fact that we kind of held the budget line for the production of the physical posters and then the shipping costs, it was kind of deemed a philanthropic initiative.\n[Speaker 8694921314646196652]: We're in a situation now where\u2026 the digital version of the poster has not been updated in several years.\n[Speaker 8694921314646196652]: And we noted that there was some online conversation among scientists noting some scientific inaccuracies.\n[Speaker 8694921314646196652]: And given the fact that the digital platform where this poster lived w...", "callTitle": "BioRender | Roche - Pathways discussion"}]}, {"id": "roche_ptcg_9b2d7d3a", "company": "roche", "gong_entity": "PTCG", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "That is only for the, for ptcg", "snippet_date": "2025-05-05", "person_name": "Amelie Bauer", "person_email": "amelie.bauer.ab1@roche.com", "internal_name": "Jacqueline McCoskey; Livia Guo; Tim Fung", "internal_email": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=2ed1375d19d8a27a712c2c3f0f82054ebe4e731d0e8647a299703532508aff39", "call_id": "2025-05-05_2ed1375d19d8", "call_count": 1, "all_snippets": [{"quote": "That is only for the, for ptcg", "date": "2025-05-05", "callId": "2025-05-05_2ed1375d19d8", "gongUrl": "https://app.gong.io/call?id=2ed1375d19d8a27a712c2c3f0f82054ebe4e731d0e8647a299703532508aff39", "speakerId": "2886391078890217663", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...t up properly, from the sounds of it.\n[Speaker 6848680811226263463]: We're gonna be there in the morning, another group.\n[Speaker 6848680811226263463]: Perfect.\n[Speaker 6848680811226263463]: Thank you.\n[Speaker 6848680811226263463]: Yeah, we're gonna.\n[Speaker 2886391078890217663]: Be there.\n[Speaker 2886391078890217663]: Yeah, that's great.\n[Speaker 2886391078890217663]: Do you, is, does it show anything about capacity or hard to say it might?\n[Speaker 2886391078890217663]: So I think that you're gonna book quite a large room for us, but I will see if I can find the capacity and share it with you.\n[Speaker 6848680811226263463]: Okay, perfect.\n[Speaker 6848680811226263463]: How large is the, and just to confirm it's with for the ptd cell therapy or cell and gene therapy group that we're hosting this for?\n[Speaker 6848680811226263463]: Is there anyone else that you were looking to include or is that the primary group?\n[Speaker 2886391078890217663]: Nope.\n[Speaker 2886391078890217663]: ", "contextAfter": " and I think I also got contacted by some colleagues from ptd and P red that I think you, you're doing the other session.\n[Speaker 2886391078890217663]: Yeah.\n[Speaker 2886391078890217663]: And we try to make sure that there is no overlap so that there are no double invities.\n[Speaker 2886391078890217663]: So everyone who is invited to our session should not be invited to your session.\n[Speaker 2886391078890217663]: So perfect.\n[Speaker 2886391078890217663]: It's not the case that all of a sudden, no one shows up to our session.\n[Speaker 2886391078890217663]: Okay?\n[Speaker 2886391078890217663]: That's great.\n[Speaker 2886391078890217663]: Yeah, we're hosting.\n[Speaker 6848680811226263463]: A larger like a P red session later in the week.\n[Speaker 6848680811226263463]: So, yeah, that's perfect.\n[Speaker 6848680811226263463]: Ptd.\n[Speaker 6848680811226263463]: I think you folks are a little, we'll get into the content actually later, but yeah, if you want to keep us posted on the amoun...", "callTitle": "BioRender | Roche PTD Onsite Planning"}]}, {"id": "roche_tucson_238ce7a3", "company": "roche", "gong_entity": "Tucson", "gong_parent": "Roche R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I know, in Tucson, if people are shipping stuff in or things, it's all, kind of goes to, the reception desk and they hold on to things", "snippet_date": "2025-06-20", "person_name": "Gaius Augustus", "person_email": "gaius.augustus@roche.com", "internal_name": "Jacqueline McCoskey; Livia Guo; Tim Fung", "internal_email": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "tucson-az-ventana", "manual_node_name": "Tucson, AZ (Ventana Medical Systems)", "manual_node_path": "Roche Research & Development > Global R&D Sites > Tucson, AZ (Ventana Medical Systems)", "confidence": "high", "reasoning": "Clear geographic match - Tucson corresponds to the Ventana Medical Systems site"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=7f2ea71ba04e78b9703b50feef8d94efbdd7302f0066b1cb6d637232001d3256", "call_id": "2025-06-20_7f2ea71ba04e", "call_count": 1, "all_snippets": [{"quote": "I know, in Tucson, if people are shipping stuff in or things, it's all, kind of goes to, the reception desk and they hold on to things", "date": "2025-06-20", "callId": "2025-06-20_7f2ea71ba04e", "gongUrl": "https://app.gong.io/call?id=7f2ea71ba04e78b9703b50feef8d94efbdd7302f0066b1cb6d637232001d3256", "speakerId": "5407184206049929683", "customerName": "Gaius Augustus", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "gaius.augustus@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "....\n[Speaker 1702020487969860766]: And then like a main point of contact that we can turn to if there's any questions, cause I think, and guys, you saw that as well that there was, a little bit of confusion with like the chaperone, coordination and handoffs, like one central person, I think that could potentially make it smoother.\n[Speaker 1702020487969860766]: Yeah, but, we ended up making work, making it all work, which I think was, like the most important part, but to make it more smoother like smoother, in the future, that probably would be something, that could be helpful.\n[Speaker 5407184206049929683]: Yeah, that makes a lot of sense to me.\n[Speaker 5407184206049929683]: And, I definitely think we can, you know, if we do future onsites, we can, we can bring in, perhaps, for example, like a product manager who, is based in that location, and then they can help us coordinate everything and keep everything in one location as far as like, the planning information, you know, typically, ", "contextAfter": ".\n[Speaker 5407184206049929683]: And so that person would know for that particular site, what could be what the location for that would be, that would make the most sense as well?\n[Speaker 1702020487969860766]: Yeah, I agree.\n[Speaker 1702020487969860766]: I think like, the campuses were so vastly different between Basel and pennsburg.\n[Speaker 1702020487969860766]: And I imagine for all of like the other Roche sites as well, is that having someone that's familiar with just like the physical, geography of everything, would make a big difference?\n[Speaker 1702020487969860766]: Cause I think even for us coming in, we weren't sure like where the packages were going to, how we can actually bring things from one spot to another.\n[Speaker 1702020487969860766]: So having someone to just understand the layout would be super helpful.\n[Speaker 5407184206049929683]: Absolutely.\n[Speaker 5407184206049929683]: How did, organizing the like, the food, and that kind of thing go for you all?\n[Speaker 1...", "callTitle": "BioRender |  Roche - on-site debrief"}]}, {"id": "roche_roche_oncology_3b9c57a4", "company": "roche", "gong_entity": "Roche Oncology", "gong_parent": "Roche R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So Roche, I'm in Roche period oncology", "snippet_date": "2025-05-01", "person_name": "Yali Fu", "person_email": "yali.fu@roche.com", "internal_name": "Mackay O'Connor", "internal_email": "mackay.oconnor@biorender.com", "llm_suggested_match": {"manual_node_id": "oncology-hematology-research", "manual_node_name": "Oncology & Hematology Research", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Oncology & Hematology Research", "confidence": "medium", "reasoning": "Fuzzy match - 'Roche Oncology' likely refers to oncology research area, though exact name differs slightly"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=30d962f815d4f266da1af2c8acfb7f51c212e0fd06e87cb810bec1b1a8e5cdd3", "call_id": "2025-05-01_30d962f815d4", "call_count": 1, "all_snippets": [{"quote": "So Roche, I'm in Roche period oncology", "date": "2025-05-01", "callId": "2025-05-01_30d962f815d4", "gongUrl": "https://app.gong.io/call?id=30d962f815d4f266da1af2c8acfb7f51c212e0fd06e87cb810bec1b1a8e5cdd3", "speakerId": "666424980798760135", "customerName": "Yali Fu", "internalName": "Mackay O'Connor", "customerEmail": "yali.fu@roche.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": [], "contextBefore": "...elp us a lot, but it's not our core function.\n[Speaker 666424980798760135]: I would say it's something will help us make our slides look better, but that's not our core competency.\n[Speaker 6739018369184323842]: MM.\n[Speaker 6739018369184323842]: HMM.\n[Speaker 6739018369184323842]: Absolutely.\n[Speaker 6739018369184323842]: And biorender, like they have a presentation focus too, like it has a presentation builder.\n[Speaker 6739018369184323842]: So it'll generate slide decks for specific meetings for you automatically.\n[Speaker 6739018369184323842]: So for lab meetings or conferences or whatnot, it has like automated slide decks, do you think that would be helpful?\n[Speaker 666424980798760135]: MM.\n[Speaker 666424980798760135]: HMM.\n[Speaker 666424980798760135]: MM.\n[Speaker 666424980798760135]: HMM.\n[Speaker 666424980798760135]: MM.\n[Speaker 666424980798760135]: HMM.\n[Speaker 666424980798760135]: So, for us, me and my team were early clinical development.\n[Speaker 666424980798760135]: ", "contextAfter": ", we have two separate parts.\n[Speaker 666424980798760135]: One is in early clinical development, which is my department.\n[Speaker 666424980798760135]: And then we have drug discovery which is separate, you know, those people they make drugs.\n[Speaker 666424980798760135]: So they do bench work, lab stuff that probably your team may be more oriented with, you know, if you want to do the lab presentation for us, it's probably what you mentioned how your graphs will help us in our daily business presentation.\n[Speaker 666424980798760135]: So, if like we want to see what's the future of adcs then you could help us make like, you know, dual payload, the glue.\n[Speaker 6739018369184323842]: Yeah.\n[Speaker 666424980798760135]: The degraders, those things that may help us, but most of our thing is like, it's mainly, you know, the scientific pathways, biological pathways that we got from literature and data we summarize from the, whatever the trials or the literature.\n[Speaker 67390183691843238...", "callTitle": "Call with Roche Ltd. - Yali Fu"}]}, {"id": "roche_drug_discovery_ccc7c369", "company": "roche", "gong_entity": "Drug Discovery", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then we have drug discovery which is separate", "snippet_date": "2025-05-01", "person_name": "Yali Fu", "person_email": "yali.fu@roche.com", "internal_name": "Mackay O'Connor", "internal_email": "mackay.oconnor@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=30d962f815d4f266da1af2c8acfb7f51c212e0fd06e87cb810bec1b1a8e5cdd3", "call_id": "2025-05-01_30d962f815d4", "call_count": 1, "all_snippets": [{"quote": "And then we have drug discovery which is separate", "date": "2025-05-01", "callId": "2025-05-01_30d962f815d4", "gongUrl": "https://app.gong.io/call?id=30d962f815d4f266da1af2c8acfb7f51c212e0fd06e87cb810bec1b1a8e5cdd3", "speakerId": "666424980798760135", "customerName": "Yali Fu", "internalName": "Mackay O'Connor", "customerEmail": "yali.fu@roche.com", "internalEmail": "mackay.oconnor@biorender.com", "sizeMentions": [], "contextBefore": "...6739018369184323842]: MM.\n[Speaker 6739018369184323842]: HMM.\n[Speaker 6739018369184323842]: Absolutely.\n[Speaker 6739018369184323842]: And biorender, like they have a presentation focus too, like it has a presentation builder.\n[Speaker 6739018369184323842]: So it'll generate slide decks for specific meetings for you automatically.\n[Speaker 6739018369184323842]: So for lab meetings or conferences or whatnot, it has like automated slide decks, do you think that would be helpful?\n[Speaker 666424980798760135]: MM.\n[Speaker 666424980798760135]: HMM.\n[Speaker 666424980798760135]: MM.\n[Speaker 666424980798760135]: HMM.\n[Speaker 666424980798760135]: MM.\n[Speaker 666424980798760135]: HMM.\n[Speaker 666424980798760135]: So, for us, me and my team were early clinical development.\n[Speaker 666424980798760135]: So Roche, I'm in Roche period oncology, we have two separate parts.\n[Speaker 666424980798760135]: One is in early clinical development, which is my department.\n[Speaker 666424980798760135]: ", "contextAfter": ", you know, those people they make drugs.\n[Speaker 666424980798760135]: So they do bench work, lab stuff that probably your team may be more oriented with, you know, if you want to do the lab presentation for us, it's probably what you mentioned how your graphs will help us in our daily business presentation.\n[Speaker 666424980798760135]: So, if like we want to see what's the future of adcs then you could help us make like, you know, dual payload, the glue.\n[Speaker 6739018369184323842]: Yeah.\n[Speaker 666424980798760135]: The degraders, those things that may help us, but most of our thing is like, it's mainly, you know, the scientific pathways, biological pathways that we got from literature and data we summarize from the, whatever the trials or the literature.\n[Speaker 6739018369184323842]: Oh, yeah.\n[Speaker 6739018369184323842]: No, I definitely think that would be helpful for our head of product to know.\n[Speaker 6739018369184323842]: I guess, are you going to be in Basel that wee...", "callTitle": "Call with Roche Ltd. - Yali Fu"}]}, {"id": "roche_pharma_department_4fc59086", "company": "roche", "gong_entity": "Pharma Department", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": "30", "confidence": "high", "mention_count": 1, "snippet": "This is for the bioanalytical part of the pharma department of Roche. So we are approximately, well, 30 people, something like that.", "snippet_date": "2025-04-30", "person_name": "Uwe Wessels", "person_email": "uwe.wessels@roche.com", "internal_name": "Jacqueline McCoskey; Livia Guo; Tim Fung", "internal_email": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "global-product-development", "manual_node_name": "Global Product Development (Pharma)", "manual_node_path": "Roche Research & Development > Global Product Development (Pharma)", "confidence": "medium", "reasoning": "Likely refers to pharma division - Global Product Development is the main pharma division in org chart"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=424dead7eb63de1e9b1a208d51f62772143e0e527a90b117eea86da2e95d4de1", "call_id": "2025-04-30_424dead7eb63", "call_count": 1, "all_snippets": [{"quote": "This is for the bioanalytical part of the pharma department of Roche. So we are approximately, well, 30 people, something like that.", "date": "2025-04-30", "callId": "2025-04-30_424dead7eb63", "gongUrl": "https://app.gong.io/call?id=424dead7eb63de1e9b1a208d51f62772143e0e527a90b117eea86da2e95d4de1", "speakerId": "4199465303155978425", "customerName": "Uwe Wessels", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "uwe.wessels@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [{"value": "30", "snippetIndex": 0, "source": {"callDate": "2025-04-30", "customerName": "Uwe Wessels"}}], "contextBefore": "...ah.\nOkay.\nFrom 11 to 12?\nOkay.\nYeah, yeah, I can make it, yeah, organize the meeting here internally and in our department, but you will be on site here.\nYou got it.\nOkay?\nYep.\nSo, yeah, we're for today.\nWe were just kind of looking to walk through some of these logistics, making sure that we're all set and on the same page.\nAnd then I'll pass it over to Tim to kind of walk through like the content that you think would be relevant to go through.\nAnd then, yeah, we can go from there.\nI know I had reached out to you initially because it looks like you're a pretty big user of biorender.\nSo that's awesome.\nWe're excited to hear how you've been using it and different use cases you think your team could benefit from?\nYeah, just to start.\nSo\u2026 I know that you have because you mentioned you have your department meetings on Mondays.\nIs that that's correct?\nYes, we have a regular department meeting on Mondays.\nOkay.\nPerfect.\nWe can use that.\nAwesome.\nOkay.\nAnd that's for the pnrd group, correct?\n", "contextAfter": "\nPerfect.\nOkay.\nSo it's the bioanalytical group of, yes.\nOkay.\nAnd you're within diagnostics.\nIs that or is that, are you?\nNo?\nWe're part of, pharma, PS.\nSo at Roche, in general Roche, pennsburg, we are in pennsburg.\nGenerally, it's mostly diagnostic.\nSo about 90 percent is diagnostic, but we are a small part like a pharma part like five to 600 people working for pharma and we are part of that.\nOh, okay.\nIs it the ptd group or are you a different part of that?\nOr is it outside of?\nPtd?\nNo, it's not ptd.\nNo.\nInteresting.\nOkay.\nWe are in PS.\nSo it's like it's called PS.\nCool.\nWe are mostly based in Basel.\nOkay.\nJust some of just the bioanalytical part is here in pennsburg.\nCool.\nOkay.\nThat's awesome.\nWe're always hearing about new people.\nSo, it's.\ncomplicated.\nIt's changing a lot.\nSo.\nJust as soon as you think you got it figured out, there's, always things that are changing.\nSo that's helpful.\nThank you.\nAppreciate that.\nSo, and then, do you know what actually like what the room would b...", "callTitle": "BioRender | Roche Diagnostics Onsite Planning"}]}, {"id": "roche_bioanalytical_department_1a8361f2", "company": "roche", "gong_entity": "Bioanalytical Department", "gong_parent": "Pharma Department", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "This is for the bioanalytical part of the pharma department of Roche", "snippet_date": "2025-04-30", "person_name": "Uwe Wessels", "person_email": "uwe.wessels@roche.com", "internal_name": "Jacqueline McCoskey; Livia Guo; Tim Fung", "internal_email": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=424dead7eb63de1e9b1a208d51f62772143e0e527a90b117eea86da2e95d4de1", "call_id": "2025-04-30_424dead7eb63", "call_count": 1, "all_snippets": [{"quote": "This is for the bioanalytical part of the pharma department of Roche", "date": "2025-04-30", "callId": "2025-04-30_424dead7eb63", "gongUrl": "https://app.gong.io/call?id=424dead7eb63de1e9b1a208d51f62772143e0e527a90b117eea86da2e95d4de1", "speakerId": "4199465303155978425", "customerName": "Uwe Wessels", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "uwe.wessels@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...9641233592172]: And then, yeah, we can go from there.\n[Speaker 8088499641233592172]: I know I had reached out to you initially because it looks like you're a pretty big user of biorender.\n[Speaker 8088499641233592172]: So that's awesome.\n[Speaker 8088499641233592172]: We're excited to hear how you've been using it and different use cases you think your team could benefit from?\n[Speaker 8088499641233592172]: Yeah, just to start.\n[Speaker 8088499641233592172]: So\u2026 I know that you have because you mentioned you have your department meetings on Mondays.\n[Speaker 8088499641233592172]: Is that that's correct?\n[Speaker 4199465303155978425]: Yes, we have a regular department meeting on Mondays.\n[Speaker 4199465303155978425]: Okay.\n[Speaker 4199465303155978425]: Perfect.\n[Speaker 4199465303155978425]: We can use that.\n[Speaker 8088499641233592172]: Awesome.\n[Speaker 8088499641233592172]: Okay.\n[Speaker 8088499641233592172]: And that's for the pnrd group, correct?\n[Speaker 4199465303155978425]: ", "contextAfter": ".\n[Speaker 4199465303155978425]: So we are approximately, well, 30 people, something like that.\n[Speaker 8088499641233592172]: Perfect.\n[Speaker 8088499641233592172]: Okay.\n[Speaker 8088499641233592172]: So it's the bioanalytical group of, yes.\n[Speaker 8088499641233592172]: Okay.\n[Speaker 8088499641233592172]: And you're within diagnostics.\n[Speaker 8088499641233592172]: Is that or is that, are you?\n[Speaker 8088499641233592172]: No?\n[Speaker 4199465303155978425]: We're part of, pharma, PS.\n[Speaker 4199465303155978425]: So at Roche, in general Roche, pennsburg, we are in pennsburg.\n[Speaker 4199465303155978425]: Generally, it's mostly diagnostic.\n[Speaker 4199465303155978425]: So about 90 percent is diagnostic, but we are a small part like a pharma part like five to 600 people working for pharma and we are part of that.\n[Speaker 8088499641233592172]: Oh, okay.\n[Speaker 8088499641233592172]: Is it the ptd group or are you a different part of that?\n[Speaker 8088499641233592172]: Or is ...", "callTitle": "BioRender | Roche Diagnostics Onsite Planning"}]}, {"id": "roche_cmi_e73271a0", "company": "roche", "gong_entity": "CMI", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": "120", "confidence": "high", "mention_count": 1, "snippet": "I think the whole group is about like 100 and 120 people", "snippet_date": "2025-04-28", "person_name": "Rahel Zulliger", "person_email": "rahel.zulliger@roche.com", "internal_name": "Jacqueline McCoskey; Livia Guo; Tim Fung", "internal_email": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=1f298a5105ee395b50525bc0e26a3712390b0300725e11f54e86e616a4649f75", "call_id": "2025-04-28_1f298a5105ee", "call_count": 1, "all_snippets": [{"quote": "I think the whole group is about like 100 and 120 people", "date": "2025-04-28", "callId": "2025-04-28_1f298a5105ee", "gongUrl": "https://app.gong.io/call?id=1f298a5105ee395b50525bc0e26a3712390b0300725e11f54e86e616a4649f75", "speakerId": "8340904953902482649", "customerName": "Rahel Zulliger", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "rahel.zulliger@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [{"value": "120", "snippetIndex": 0, "source": {"callDate": "2025-04-28", "customerName": "Rahel Zulliger"}}], "contextBefore": "... what they typically use in that room in terms of tech?\n[Speaker 6171268625578966568]: Like for projecting onto the screen?\n[Speaker 6171268625578966568]: Is it like a Google meets link or, okay.\n[Speaker 8340904953902482649]: Okay.\n[Speaker 8340904953902482649]: Yes.\n[Speaker 8340904953902482649]: We do have some other option where you can plug in some kind of, like a dongle.\n[Speaker 8340904953902482649]: Yeah, they don't work that well.\n[Speaker 8340904953902482649]: The easiest thing is literally if you just like log into Google, and join the meeting.\n[Speaker 6171268625578966568]: Perfect.\n[Speaker 6171268625578966568]: Okay.\n[Speaker 6171268625578966568]: That's great.\n[Speaker 6171268625578966568]: And okay, so, I know that the room is booked for 22 people.\n[Speaker 6171268625578966568]: How many folks are there in cmi at the Basel location?\n[Speaker 6171268625578966568]: Like, how many, I guess, what's the population size we're working with here?\n[Speaker 8340904953902482649]: ", "contextAfter": ".\n[Speaker 8340904953902482649]: But, you know, that also includes like clinical scientists that includes associates, that includes admins, that includes everybody.\n[Speaker 8340904953902482649]: So, you know, if you talk about the people who actually use biorender, that's probably like maybe closer to like 50.\n[Speaker 6171268625578966568]: Okay.\n[Speaker 6171268625578966568]: Perfect.\n[Speaker 6171268625578966568]: Awesome.\n[Speaker 6171268625578966568]: And are they close to this room in terms of like getting the people there in person?\n[Speaker 6171268625578966568]: Like, do you see any challenges with that?\n[Speaker 6171268625578966568]: You know, what?\n[Speaker 6171268625578966568]: What we've heard is just like, it seems like Roche is pretty remote or sorry, hybrid working.\n[Speaker 6171268625578966568]: So, it's like making sure that we can get people actually in person.\n[Speaker 6171268625578966568]: So, we want to make sure like we're just trying to understand if like the dis...", "callTitle": "BioRender | Roche - CMI - onsite logistics"}]}, {"id": "roche_tmo_d8373fa1", "company": "roche", "gong_entity": "TMO", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I think we have for tmo, we've reserved from 10 to one actually.", "snippet_date": "2025-04-25", "person_name": "Jochen Schrade; Liza Malong", "person_email": "jochen.schrade@roche.com; liza.malong@roche.com", "internal_name": "Jacqueline McCoskey; Livia Guo; Tim Fung", "internal_email": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=d6a2bc8b84da3c056cb5ba6a1688b252247306b5f731c9e150634cf012e9ad9b", "call_id": "2025-04-25_d6a2bc8b84da", "call_count": 1, "all_snippets": [{"quote": "?\nThe actual session itself?\nI?\nThink we have for tmo, we've reserved from 10 to one actually.\nOkay.\nYeah.\nSo from nine to one, I think.\nAnd then, but,\nwe can put like wherever we want the session in that basically we've booked the room.\nWe haven't adve", "date": "2025-04-25", "callId": "2025-04-25_d6a2bc8b84da", "gongUrl": "https://app.gong.io/call?id=d6a2bc8b84da3c056cb5ba6a1688b252247306b5f731c9e150634cf012e9ad9b", "speakerId": "9072855926826469679", "customerName": "Jochen Schrade; Liza Malong", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "jochen.schrade@roche.com; liza.malong@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...xible spaces, quite perfect.\nThat's.\nawesome.\nYeah.\nLove that.\nOkay.\nDo you know what room like the room number is?\nOr is that something that Andrea will have and can send over to us once she's back, I?\nShould have to, because I, again, I, so.\nShe's she said she will, she, I know she doesn't say on this one, which room number it is.\nShe says it's the one in being linked to, but there's a few.\nYeah.\nI'll look it up and I can send it to you.\nOkay?\nPerfect.\nThat would be helpful.\nAnd I know.\nSo we, it sounds like we get the room for nine that's actually, this is going to be our, we have a ton of sessions throughout the course of the we're in Basel this week and then Pittsburgh the following week.\nSo we have like a ton of sessions running, but this is actually the first one.\nSo we're excited.\nAnd so we would love to maybe get there closer to nine just to work through some of the technical things that could possibly arise.\nDo we, I think we have the session book from 10 to 11?\nIs that right", "contextAfter": "rtised it yet to the.\nPeople, yeah.\nSo.\nYeah.\nSo we can do, and if you want to arrive earlier, I can welcome you on site earlier.\nThat's not a problem.\nIf that was the, your request.\nYeah.\nBecause typically the session is about an hour like the actual session itself.\nWe'd like to get there a little bit ahead of time to obviously set up and then have some time after to stick around and answer questions.\nPeople people have time.\nSo, do you have like a preference in terms of the actual time slot that the session is hosted from?\nWell?\nIf we have the room nine to 12, and we probably can also arrange, I mean this, we will need to check if we can get like some catering or whatever for after.\nI'm not sure, but we could say, okay, so we could say, maybe would it be an option to run actually the same session twice to offer two time slots with you or not so much?\nThat's a good question.\nTim.\nWhat are your thoughts on that?\nYeah.\nI think that definitely could work.\nI mean, the window that we have ...", "callTitle": "BioRender | Roche TMO onsite planning"}]}, {"id": "roche_pharmaceutical_development_group_423fa4b8", "company": "roche", "gong_entity": "Pharmaceutical Development Group", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So, there, there is, the pharmaceutical development group. This is, this is in our department", "snippet_date": "2025-04-23", "person_name": "Christoph Duerr", "person_email": "christoph.duerr@roche.com", "internal_name": "Jacqueline McCoskey; Livia Guo; Tim Fung", "internal_email": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-sciences-technical", "manual_node_name": "Pharmaceutical Sciences (Pharma Technical)", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical)", "confidence": "medium", "reasoning": "Strong semantic match - pharmaceutical development aligns with Pharmaceutical Sciences division which handles drug development activities."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=7ae27cb21ae825fb1bbf1191193fec0a9564775730a971a17496c2e5716a4f96", "call_id": "2025-04-23_7ae27cb21ae8", "call_count": 1, "all_snippets": [{"quote": "So, there, there is, the pharmaceutical development group. This is, this is in our department", "date": "2025-04-23", "callId": "2025-04-23_7ae27cb21ae8", "gongUrl": "https://app.gong.io/call?id=7ae27cb21ae825fb1bbf1191193fec0a9564775730a971a17496c2e5716a4f96", "speakerId": "5741703818535642290", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey; Livia Guo; Tim Fung", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com; livia.guo@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...kay, perfect.\nWe'll do the actual session from 11 to 12, and then we'll do setup from 10 30 to 11, just to make sure we, I went through a hour long setup last week trying to make sure everything was set up properly.\nSo yeah, we just need a little bit of offer time there, but we should be good because we're gonna have sessions the day before.\nSo should, we should probably work through some of the kinks on, the Wednesday.\nSo, we'll be professionals by the time we reach your group, how large is the actual room itself?\nLike how many people does it seat?\n20 22?\n22.\nOkay.\nYeah.\nPerfect.\nAnd how many people are, and just to confirm it's before, let me, it's for the cell and gene therapy group within ptd?\nHow many folks do you have in that group at the Basel location?\nSo.\nWe, so, I would increase the group a little bit.\nSo, there is a, there is the, yeah, I don't want to bore you, with different, departments.\nWe love to hear it.\nActually, it helps us grasp where things are at.\nSo, no worries.\n", "contextAfter": ", and then there will be, the cell and gene therapy.\nThere's a separate department also focusing on cell and gene therapy.\nI would also invite them and I would, to be very honest, I would, invite all interested people from pharmaceutical development in total.\nSo, not only cell and gene therapy because, yeah, it's it, the biorender is new to the whole department.\nYeah.\nSo there might be the one or, the other person interested.\nAnd, yeah, I think that the topics will not be solely, on cell and gene therapy.\nIt, would, will be more.\nOkay.\nSo, can we say that the session will be mainly for like ptd?\nPtd?\nRight.\nBasel ptd?\nFolks.\nOkay.\nYeah, perfect.\nHow many, do you know, how big that group is at Basel or is it hard to say, hey, Livia?\nIn, in total, it would be 80, but I don't expect 80 to be interested.\nSo, of course, I think that a quarter would be.\nSo, I guess that's my guess, I, we did not send out it yet, the invite yet?\nYeah.\nThat is what we planned for.\nSo.\nAnd we'll help with the i...", "callTitle": "BioRender | Roche PTD onsite planning"}]}, {"id": "roche_large_molecules_antibody_research_and_development_cab7ae1a", "company": "roche", "gong_entity": "Large Molecules Antibody Research and Development", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "We're we're working in the large molecules antibody research and development.", "snippet_date": "2025-03-25", "person_name": "Johannes Then", "person_email": "johannes.then@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-development-tech", "manual_node_name": "Biologics Development", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical) > Biologics Development", "confidence": "high", "reasoning": "Excellent semantic match - large molecules and antibodies are biologics, and this department handles biologics development including antibodies."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=04a35beb559c549d9b90f7d75fe4e5f7df9d30e58a07ffc09e6a10c73e7c4b33", "call_id": "2025-03-25_04a35beb559c", "call_count": 1, "all_snippets": [{"quote": "We're we're working in the large molecules antibody research and development.", "date": "2025-03-25", "callId": "2025-03-25_04a35beb559c", "gongUrl": "https://app.gong.io/call?id=04a35beb559c549d9b90f7d75fe4e5f7df9d30e58a07ffc09e6a10c73e7c4b33", "speakerId": "2537645070975902845", "customerName": "Johannes Then", "internalName": "Jacqueline McCoskey", "customerEmail": "johannes.then@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...e.\n[Speaker 2537645070975902845]: Should be fine.\n[Speaker 2537645070975902845]: OK?\n[Speaker 5313404589143487983]: That's that's what we were thinking.\n[Speaker 5313404589143487983]: Some of the folks we were talking to were like sometimes people will take the full week off, but.\n[Speaker 2537645070975902845]: That's OK, there's a lot of people like, I know it's like you?\n[Speaker 5313404589143487983]: Know, we're approaching that time and then it's summertime so we wanted to get this out as, because with this, these new features are launching in a couple of weeks.\n[Speaker 5313404589143487983]: So, but yeah, I have a couple of questions that I can kind of give you an overview of like what the plan is and figure out what we want to do.\n[Speaker 5313404589143487983]: So, do you mind giving me an overview of like the kind of the group that you're a part of and sort of like the side I guess of the business that you're on.\n[Speaker 5313404589143487983]: So.\n[Speaker 2537645070975902845]: ", "contextAfter": "\n[Speaker 2537645070975902845]: So pretty early in the chain and discovery.\n[Speaker 2537645070975902845]: So really the, yeah, first, the first row, you can say, yeah, yeah, my department in particular is producing antibodies.\n[Speaker 2537645070975902845]: Okay?\n[Speaker 2537645070975902845]: For all projects.\n[Speaker 2537645070975902845]: We're the only antibody producing unit left.\n[Speaker 2537645070975902845]: Cool discovery.\n[Speaker 2537645070975902845]: I mean, the G rats in the us.\n[Speaker 2537645070975902845]: But yeah, yeah.\n[Speaker 5313404589143487983]: Yeah, so.\n[Speaker 2537645070975902845]: Yeah.\n[Speaker 2537645070975902845]: Well, that's what we do and we have a lot of project leads in our department.\n[Speaker 2537645070975902845]: I'm one of them neuroscience project, and that is where this bio and the thing comes into play.\n[Speaker 2537645070975902845]: So I often have to create some slides, experience, stuff, storytelling and all.\n[Speaker 2537645070975902845]:...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_ptd_europe_d3774111", "company": "roche", "gong_entity": "PTD Europe", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And currently, it or it will be ptd Europe. So, so there will be a us group and a european group and, it is the european and it's pharmaceutical development.", "snippet_date": "2025-03-19", "person_name": "Christoph Duerr", "person_email": "christoph.duerr@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-sciences-technical", "manual_node_name": "Pharmaceutical Sciences (Pharma Technical)", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical)", "confidence": "medium", "reasoning": "PTD likely stands for Pharmaceutical Technical Development, which aligns with Pharmaceutical Sciences division. The Europe designation suggests regional organization within this division."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b429b7e52b42b59042c3e7c3a8603aef7dd65db4c536dc921f90301f8a4bf025", "call_id": "2025-03-19_b429b7e52b42", "call_count": 1, "all_snippets": [{"quote": "And currently, it or it will be ptd Europe. So, so there will be a us group and a european group and, it is the european and it's pharmaceutical development.", "date": "2025-03-19", "callId": "2025-03-19_b429b7e52b42", "gongUrl": "https://app.gong.io/call?id=b429b7e52b42b59042c3e7c3a8603aef7dd65db4c536dc921f90301f8a4bf025", "speakerId": "87219535446509535", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...e important.\nYeah.\nEven, if I like, so I like bio render but you like holidays better?\nI'm.\nwith you, I'm so with you.\nOkay?\nSo, yeah, let's yeah, keep week of my team.\nSo that's and if it will be September that's fine too.\nOkay.\nSo, we can schedule that as soon as we know more.\nYeah.\nBut then, I will reach out to get it.\nLet's let's say more on a department level or even bring together analytics and development.\nSo that the group, is yeah, big enough, to have questions and the real QA if that makes sense?\nYeah, totally.\nDo you, might, can you remind me which group you're in?\nAre you in cell and gene therapy?\nYes, but yeah.\nSo this, but, this is not a, an official group.\nSo we are more matrix team working on that topic and we are within PD.\nSo I don't know, how good you are already?\nI've gotten pretty.\nGood at it surprisingly over the years.\nSo you're within ptd, right?\nDo I have that, right?\nYes.\nSo at the moment, still, so, and, we are currently reorganizing, so we are in ptd.\nOkay.\n", "contextAfter": "\nBut there is also another analytical group, yes, analytical team Europe.\nOkay.\nThat, okay?\nAnd we could combine that.\nI don't know if you have other contacts, in.\nOkay.\nSo the,\nthe, I was actually speaking with someone in ptd in the cell and gene therapy from Munich yesterday.\nI don't.\nknow Marco Marcus, maybe also it was.\nAmelie Bauer, I'm not sure.\nOkay.\nAmelie, I know her.\nYeah, yes.\nAre you guys in the same group?\nJust different sites?\nLet's let's call it a matrix.\nYeah.\nYeah.\nOkay.\nThat makes sense.\nYeah.\nOkay.\nYeah.\nSo we have a number of just because the, you know, the license has been active for the P red folks for a few years now.\nSo we have a number of people, in those like, I guess groups who have been using it for quite some time and we're going to try to work with them.\nBut I think if there's anyone that, you know, work with or if there's anyone that you could think of that might find value from this too, that we can also like, I can connect with them too and try to set s...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}]}, {"id": "roche_analytical_team_europe_be38db79", "company": "roche", "gong_entity": "Analytical Team Europe", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "But there is also another analytical group, yes, analytical team Europe.", "snippet_date": "2025-03-19", "person_name": "Christoph Duerr", "person_email": "christoph.duerr@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "analytical-development-bio", "manual_node_name": "Analytical Development - Biologics", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical) > Biologics Development > Analytical Development - Biologics", "confidence": "medium", "reasoning": "Good match for analytical team working on biologics. Given context of large molecules discussion, biologics analytical development is most appropriate match."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b429b7e52b42b59042c3e7c3a8603aef7dd65db4c536dc921f90301f8a4bf025", "call_id": "2025-03-19_b429b7e52b42", "call_count": 1, "all_snippets": [{"quote": "But there is also another analytical group, yes, analytical team Europe.", "date": "2025-03-19", "callId": "2025-03-19_b429b7e52b42", "gongUrl": "https://app.gong.io/call?id=b429b7e52b42b59042c3e7c3a8603aef7dd65db4c536dc921f90301f8a4bf025", "speakerId": "87219535446509535", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...91191012]: Are you in cell and gene therapy?\n[Speaker 87219535446509535]: Yes, but yeah.\n[Speaker 87219535446509535]: So this, but, this is not a, an official group.\n[Speaker 87219535446509535]: So we are more matrix team working on that topic and we are within PD.\n[Speaker 87219535446509535]: So I don't know, how good you are already?\n[Speaker 87219535446509535]: I've gotten pretty.\n[Speaker 2893660636991191012]: Good at it surprisingly over the years.\n[Speaker 2893660636991191012]: So you're within ptd, right?\n[Speaker 2893660636991191012]: Do I have that, right?\n[Speaker 2893660636991191012]: Yes.\n[Speaker 87219535446509535]: So at the moment, still, so, and, we are currently reorganizing, so we are in ptd.\n[Speaker 87219535446509535]: Okay.\n[Speaker 87219535446509535]: And currently, it or it will be ptd Europe.\n[Speaker 87219535446509535]: So, so there will be a us group and a european group and, it is the european and it's pharmaceutical development.\n[Speaker 87219535446509535]: ", "contextAfter": "\n[Speaker 87219535446509535]: Okay.\n[Speaker 87219535446509535]: That, okay?\n[Speaker 87219535446509535]: And we could combine that.\n[Speaker 87219535446509535]: I don't know if you have other contacts, in.\n[Speaker 87219535446509535]: Okay.\n[Speaker 87219535446509535]: So the,\n[Speaker 2893660636991191012]: the, I was actually speaking with someone in ptd in the cell and gene therapy from Munich yesterday.\n[Speaker 2893660636991191012]: I don't.\n[Speaker 87219535446509535]: know Marco Marcus, maybe also it was.\n[Speaker 2893660636991191012]: Amelie Bauer, I'm not sure.\n[Speaker 2893660636991191012]: Okay.\n[Speaker 87219535446509535]: Amelie, I know her.\n[Speaker 87219535446509535]: Yeah, yes.\n[Speaker 2893660636991191012]: Are you guys in the same group?\n[Speaker 2893660636991191012]: Just different sites?\n[Speaker 87219535446509535]: Let's let's call it a matrix.\n[Speaker 87219535446509535]: Yeah.\n[Speaker 2893660636991191012]: Yeah.\n[Speaker 2893660636991191012]: Okay.\n[Speaker 2893...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}]}, {"id": "roche_munich_c6b7d51e", "company": "roche", "gong_entity": "Munich", "gong_parent": "Roche R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "What we were looking and just to confirm, are you in Munich or Basel?", "snippet_date": "2025-03-19", "person_name": "Christoph Duerr", "person_email": "christoph.duerr@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "munich-penzberg-germany", "manual_node_name": "Munich/Penzberg, Germany (Innovation Center Munich)", "manual_node_path": "Roche Research & Development > Global R&D Sites > Munich/Penzberg, Germany (Innovation Center Munich)", "confidence": "high", "reasoning": "Exact geographic match - Munich is explicitly listed as a Roche R&D site in the manual org chart."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b429b7e52b42b59042c3e7c3a8603aef7dd65db4c536dc921f90301f8a4bf025", "call_id": "2025-03-19_b429b7e52b42", "call_count": 1, "all_snippets": [{"quote": "What we were looking and just to confirm, are you in Munich or Basel?", "date": "2025-03-19", "callId": "2025-03-19_b429b7e52b42", "gongUrl": "https://app.gong.io/call?id=b429b7e52b42b59042c3e7c3a8603aef7dd65db4c536dc921f90301f8a4bf025", "speakerId": "2893660636991191012", "customerName": "Christoph Duerr", "internalName": "Jacqueline McCoskey", "customerEmail": "christoph.duerr@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...g or like a breakfast or whatever makes the most sense for you guys?\n[Speaker 87219535446509535]: Okay.\n[Speaker 87219535446509535]: Then maybe I will, give me a second.\n[Speaker 2893660636991191012]: Yeah, take your time.\n[Speaker 87219535446509535]: I have to make some notes and these I have to make on paper because if I type it down, I will forget it.\n[Speaker 87219535446509535]: I know I'm so with you.\n[Speaker 2893660636991191012]: I have a notepad with me all the time because I, I'm yeah, something doesn't it's not the same when I type it, no.\n[Speaker 87219535446509535]: And, it stays on my table exactly.\n[Speaker 87219535446509535]: So, so that would mean the lunch and learn would be, I think that would be, nice opportunity because then I could check in with our admins, to organize then lunch yep, and we can do that in parallel.\n[Speaker 87219535446509535]: That would be great way.\n[Speaker 87219535446509535]: And then you said may something, so.\n[Speaker 2893660636991191012]: ", "contextAfter": "\n[Speaker 2893660636991191012]: You're in Basel?\n[Speaker 2893660636991191012]: Okay.\n[Speaker 2893660636991191012]: Yeah, cause we were looking to do both sites and trying to like kind of one week in one spot, one week in the next.\n[Speaker 2893660636991191012]: So we were looking either the week of may nineteenth or the 20 sixth.\n[Speaker 2893660636991191012]: It's kind of looking like the Basel location on the nineteenth, the week sometime in that week.\n[Speaker 2893660636991191012]: So I'm not sure if that's something that you're able to like check in terms of, timing and stuff, but, that's tentatively what we were thinking.\n[Speaker 87219535446509535]: I'm just checking general.\n[Speaker 87219535446509535]: So no, no general holidays that's so, that is one thing.\n[Speaker 2893660636991191012]: That was what we were, I was chatting with someone else and we had to, there was like, you know, we're approaching that season, there's Easter and I know that you guys have may first and sec...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}]}, {"id": "roche_pharmatex_cell_gene_therapies_379b0671", "company": "roche", "gong_entity": "Pharmatex Cell Gene Therapies", "gong_parent": "Roche R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Pharmatex cell gene therapies, okay", "snippet_date": "2025-03-18", "person_name": "Amelie Bauer", "person_email": "amelie.bauer.ab1@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "gene-therapy-manufacturing", "manual_node_name": "Gene Therapy Manufacturing Sciences", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical) > Gene Therapy Manufacturing Sciences", "confidence": "medium", "reasoning": "Strong semantic match for cell and gene therapy activities. Pharmatex likely refers to pharmaceutical technical operations for gene therapies."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "call_id": "2025-03-18_b967005befa5", "call_count": 1, "all_snippets": [{"quote": "Pharmatex cell gene therapies, okay", "date": "2025-03-18", "callId": "2025-03-18_b967005befa5", "gongUrl": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "speakerId": "289705782262410669", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...ng or like what, the scope of the training session will look like.\n[Speaker 289705782262410669]: But, there's a couple of ways that we can do it.\n[Speaker 289705782262410669]: I think a lot of it honestly depends on like room availability and what is available in terms of that side of things, we will.\n[Speaker 6724612687015910624]: bring.\n[Speaker 289705782262410669]: in like lunch, and, or breakfast or whatever time of the day it makes sense just, to make sure that people are fed in that sense.\n[Speaker 289705782262410669]: But what we, I can, I'm just looking at my notes from when we chatted before.\n[Speaker 289705782262410669]: So, you're in gene, are you still in the gene therapy department?\n[Speaker 6724612687015910624]: Yeah.\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: And that's a part of ptd, right?\n[Speaker 6724612687015910624]: So, it is part of PTC,\n[Speaker 289705782262410669]: PTC?\n[Speaker 289705782262410669]: Oh, yeah.\n[Speaker 289705782262410669]: ", "contextAfter": ".\n[Speaker 289705782262410669]: Yep.\n[Speaker 289705782262410669]: And gene therapy has about 140 people.\n[Speaker 289705782262410669]: Is that right?\n[Speaker 289705782262410669]: Yeah.\n[Speaker 6724612687015910624]: Something around that?\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: And do you have smaller teams within gene therapy or is that kind of the like you guys all kind of work together within that group?\n[Speaker 6724612687015910624]: I know.\n[Speaker 6724612687015910624]: So we do have smaller teams.\n[Speaker 6724612687015910624]: So we are based, so basically separated based on area of expertise.\n[Speaker 6724612687015910624]: So, where we are in the process.\n[Speaker 6724612687015910624]: So since we are in the process development, we do have the cell culture process.\n[Speaker 6724612687015910624]: We do have purification process, and then we have the analytical team.\n[Speaker 6724612687015910624]: So, I would say, in general, we do have three large te...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}]}, {"id": "roche_cell_culture_process_e3319899", "company": "roche", "gong_entity": "Cell Culture Process", "gong_parent": "Pharmatex Cell Gene Therapies", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we do have the cell culture process", "snippet_date": "2025-03-18", "person_name": "Amelie Bauer", "person_email": "amelie.bauer.ab1@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "upstream-processing", "manual_node_name": "Upstream Processing", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical) > Biologics Development > Upstream Processing", "confidence": "high", "reasoning": "Excellent match - cell culture is a core component of upstream processing in biologics manufacturing."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "call_id": "2025-03-18_b967005befa5", "call_count": 1, "all_snippets": [{"quote": "we do have the cell culture process", "date": "2025-03-18", "callId": "2025-03-18_b967005befa5", "gongUrl": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "speakerId": "6724612687015910624", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "... that's a part of ptd, right?\n[Speaker 6724612687015910624]: So, it is part of PTC,\n[Speaker 289705782262410669]: PTC?\n[Speaker 289705782262410669]: Oh, yeah.\n[Speaker 289705782262410669]: Pharmatex cell gene therapies, okay.\n[Speaker 289705782262410669]: Yep.\n[Speaker 289705782262410669]: And gene therapy has about 140 people.\n[Speaker 289705782262410669]: Is that right?\n[Speaker 289705782262410669]: Yeah.\n[Speaker 6724612687015910624]: Something around that?\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: And do you have smaller teams within gene therapy or is that kind of the like you guys all kind of work together within that group?\n[Speaker 6724612687015910624]: I know.\n[Speaker 6724612687015910624]: So we do have smaller teams.\n[Speaker 6724612687015910624]: So we are based, so basically separated based on area of expertise.\n[Speaker 6724612687015910624]: So, where we are in the process.\n[Speaker 6724612687015910624]: So since we are in the process development, ", "contextAfter": ".\n[Speaker 6724612687015910624]: We do have purification process, and then we have the analytical team.\n[Speaker 6724612687015910624]: So, I would say, in general, we do have three large teams, that are more or less separated from each other.\n[Speaker 289705782262410669]: I gotcha.\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: Cause what we would typically do are you all based in the pensberg location?\n[Speaker 289705782262410669]: Yes?\n[Speaker 6724612687015910624]: We are.\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: Cause, with a group of around 150 people, typically, I would say we see kind of like 25 to 30 percent of people actually show up to these.\n[Speaker 289705782262410669]: So if we were to keep it for the gene therapy department, I wouldn't obviously, not all 140 people would come.\n[Speaker 289705782262410669]: We probably, it would probably be closer to like 30 to 50 maybe.\n[Speaker 289705782262410669]: And again, it would kind of d...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}]}, {"id": "roche_purification_process_d08dfd44", "company": "roche", "gong_entity": "Purification Process", "gong_parent": "Pharmatex Cell Gene Therapies", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "We do have purification process", "snippet_date": "2025-03-18", "person_name": "Amelie Bauer", "person_email": "amelie.bauer.ab1@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "downstream-processing", "manual_node_name": "Downstream Processing & Purification", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical) > Biologics Development > Downstream Processing & Purification", "confidence": "high", "reasoning": "Exact match - purification process is explicitly mentioned in the downstream processing team name."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "call_id": "2025-03-18_b967005befa5", "call_count": 1, "all_snippets": [{"quote": "We do have purification process", "date": "2025-03-18", "callId": "2025-03-18_b967005befa5", "gongUrl": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "speakerId": "6724612687015910624", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...is part of PTC,\n[Speaker 289705782262410669]: PTC?\n[Speaker 289705782262410669]: Oh, yeah.\n[Speaker 289705782262410669]: Pharmatex cell gene therapies, okay.\n[Speaker 289705782262410669]: Yep.\n[Speaker 289705782262410669]: And gene therapy has about 140 people.\n[Speaker 289705782262410669]: Is that right?\n[Speaker 289705782262410669]: Yeah.\n[Speaker 6724612687015910624]: Something around that?\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: And do you have smaller teams within gene therapy or is that kind of the like you guys all kind of work together within that group?\n[Speaker 6724612687015910624]: I know.\n[Speaker 6724612687015910624]: So we do have smaller teams.\n[Speaker 6724612687015910624]: So we are based, so basically separated based on area of expertise.\n[Speaker 6724612687015910624]: So, where we are in the process.\n[Speaker 6724612687015910624]: So since we are in the process development, we do have the cell culture process.\n[Speaker 6724612687015910624]: ", "contextAfter": ", and then we have the analytical team.\n[Speaker 6724612687015910624]: So, I would say, in general, we do have three large teams, that are more or less separated from each other.\n[Speaker 289705782262410669]: I gotcha.\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: Cause what we would typically do are you all based in the pensberg location?\n[Speaker 289705782262410669]: Yes?\n[Speaker 6724612687015910624]: We are.\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: Cause, with a group of around 150 people, typically, I would say we see kind of like 25 to 30 percent of people actually show up to these.\n[Speaker 289705782262410669]: So if we were to keep it for the gene therapy department, I wouldn't obviously, not all 140 people would come.\n[Speaker 289705782262410669]: We probably, it would probably be closer to like 30 to 50 maybe.\n[Speaker 289705782262410669]: And again, it would kind of depend on the room size.\n[Speaker 289705782262410669]: So, like, ...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}]}, {"id": "roche_analytical_team_dbab89c3", "company": "roche", "gong_entity": "Analytical Team", "gong_parent": "Pharmatex Cell Gene Therapies", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "then we have the analytical team", "snippet_date": "2025-03-18", "person_name": "Amelie Bauer", "person_email": "amelie.bauer.ab1@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "analytical-development-bio", "manual_node_name": "Analytical Development - Biologics", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical) > Biologics Development > Analytical Development - Biologics", "confidence": "medium", "reasoning": "Good match given the context of biologics development discussion. This analytical team appears to be working within the biologics development area."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "call_id": "2025-03-18_b967005befa5", "call_count": 1, "all_snippets": [{"quote": "then we have the analytical team", "date": "2025-03-18", "callId": "2025-03-18_b967005befa5", "gongUrl": "https://app.gong.io/call?id=b967005befa5e04587bdae0f7a7d21ffca47c33af95d31d19d6739b538311f59", "speakerId": "6724612687015910624", "customerName": "Amelie Bauer", "internalName": "Jacqueline McCoskey", "customerEmail": "amelie.bauer.ab1@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...410669]: PTC?\n[Speaker 289705782262410669]: Oh, yeah.\n[Speaker 289705782262410669]: Pharmatex cell gene therapies, okay.\n[Speaker 289705782262410669]: Yep.\n[Speaker 289705782262410669]: And gene therapy has about 140 people.\n[Speaker 289705782262410669]: Is that right?\n[Speaker 289705782262410669]: Yeah.\n[Speaker 6724612687015910624]: Something around that?\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: And do you have smaller teams within gene therapy or is that kind of the like you guys all kind of work together within that group?\n[Speaker 6724612687015910624]: I know.\n[Speaker 6724612687015910624]: So we do have smaller teams.\n[Speaker 6724612687015910624]: So we are based, so basically separated based on area of expertise.\n[Speaker 6724612687015910624]: So, where we are in the process.\n[Speaker 6724612687015910624]: So since we are in the process development, we do have the cell culture process.\n[Speaker 6724612687015910624]: We do have purification process, and ", "contextAfter": ".\n[Speaker 6724612687015910624]: So, I would say, in general, we do have three large teams, that are more or less separated from each other.\n[Speaker 289705782262410669]: I gotcha.\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: Cause what we would typically do are you all based in the pensberg location?\n[Speaker 289705782262410669]: Yes?\n[Speaker 6724612687015910624]: We are.\n[Speaker 289705782262410669]: Okay.\n[Speaker 289705782262410669]: Cause, with a group of around 150 people, typically, I would say we see kind of like 25 to 30 percent of people actually show up to these.\n[Speaker 289705782262410669]: So if we were to keep it for the gene therapy department, I wouldn't obviously, not all 140 people would come.\n[Speaker 289705782262410669]: We probably, it would probably be closer to like 30 to 50 maybe.\n[Speaker 289705782262410669]: And again, it would kind of depend on the room size.\n[Speaker 289705782262410669]: So, like, who we can invite, and what we would t...", "callTitle": "BioRender & Roche Ltd. - Intro Call"}]}, {"id": "roche_it_team_954e5234", "company": "roche", "gong_entity": "IT Team", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "did you speak with Gaius in the it team?", "snippet_date": "2025-03-17", "person_name": "Juliane Benz", "person_email": "juliane.benz@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=6daee1c345113c319399d36ffb645a6de510bea40db36c8608c1f9e2da5e7dc3", "call_id": "2025-03-17_6daee1c34511", "call_count": 1, "all_snippets": [{"quote": "did you speak with Gaius in the it team?", "date": "2025-03-17", "callId": "2025-03-17_6daee1c34511", "gongUrl": "https://app.gong.io/call?id=6daee1c345113c319399d36ffb645a6de510bea40db36c8608c1f9e2da5e7dc3", "speakerId": "1891399847486698875", "customerName": "Juliane Benz", "internalName": "Jacqueline McCoskey", "customerEmail": "juliane.benz@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...lked, I wasn't expecting that it will be that fast.\n[Speaker 8572123162027050155]: I was expecting that it would take some time.\n[Speaker 8572123162027050155]: Yeah.\n[Speaker 8572123162027050155]: No, it definitely.\n[Speaker 1891399847486698875]: Yeah, because I think we spoke probably in September Ish, around there.\n[Speaker 1891399847486698875]: It was in the works but we weren't totally sure what was actually going to end up happening.\n[Speaker 1891399847486698875]: And yeah, all that Christmas time, it kind of was like, yep, we're doing this.\n[Speaker 1891399847486698875]: So it's been exciting.\n[Speaker 1891399847486698875]: We've got a lot of positive feedback so far.\n[Speaker 1891399847486698875]: So, thanks for helping push that internally.\n[Speaker 1891399847486698875]: I think hearing it from you and your team and other folks kind of similar to you has really helped.\n[Speaker 1891399847486698875]: So, yeah, that's I think that might be why.\n[Speaker 1891399847486698875]: So, ", "contextAfter": "\n[Speaker 8572123162027050155]: No, I haven't talked to him yet.\n[Speaker 8572123162027050155]: I just have received his emails, yes.\n[Speaker 8572123162027050155]: Yeah.\n[Speaker 1891399847486698875]: Okay.\n[Speaker 1891399847486698875]: Because he had, when we were like having all this stuff finalized.\n[Speaker 1891399847486698875]: And one of the things that we were talking about with the enterprise licensing is doing some onsite sort of trainings as part of the package and making sure people are like really up to speed and I'm not sure if you guys had spoke before what it was, but he had sent over your name.\n[Speaker 1891399847486698875]: I was like, oh, I spoke with her before, so, yeah, that's great to try to plan something, but.\n[Speaker 8572123162027050155]: Yeah, I think there were some trainings.\n[Speaker 1891399847486698875]: Yeah, there are some virtual trainings upcoming in the next week, I believe.\n[Speaker 8572123162027050155]: Ah, okay.\n[Speaker 8572123162027050155]: Th...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_corelab_462f9c82", "company": "roche", "gong_entity": "CoreLab", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then within diagnostics, we have like huge departments that are called, like corelab that work on like devices and the tests that go on the devices", "snippet_date": "2025-03-14", "person_name": "Jo Stevens", "person_email": "jo.stevens@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "core-lab-solutions", "manual_node_name": "Core Lab Solutions", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Professional Diagnostics R&D > Core Lab Solutions", "confidence": "high", "reasoning": "Exact match - CoreLab maps to Core Lab Solutions, both referring to lab devices and testing within diagnostics"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "call_id": "2025-03-14_d067238de6be", "call_count": 1, "all_snippets": [{"quote": "And then within diagnostics, we have like huge departments that are called, like corelab that work on like devices and the tests that go on the devices", "date": "2025-03-14", "callId": "2025-03-14_d067238de6be", "gongUrl": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "speakerId": "5895796664693401761", "customerName": "Jo Stevens", "internalName": "Jacqueline McCoskey", "customerEmail": "jo.stevens@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...er 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: And I know that's on the diagnostic side, how does that sort of like fit organizationally like in the actual, like what group are you under?\n[Speaker 6782829348298472977]: I guess within like the antibody development, is there a group that you kind of report to or like you're.\n[Speaker 5895796664693401761]: situated under?\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: So you have, Roche diagnostics and Roche pharma, yeah, those are like almost two separate companies.\n[Speaker 5895796664693401761]: Yeah, but in helzberg, we have both on site.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: We're.\n[Speaker 5895796664693401761]: a bit weird in that sense.\n[Speaker 5895796664693401761]: Normally, the sites of Roche are like exclusively Daya, yeah.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 5895796664693401761]: ", "contextAfter": ", okay?\n[Speaker 5895796664693401761]: And then we have, a group of which I belong to that is called, Roche diagnostics solutions that, we do the research.\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: And within that, on penzberg, we have, biological reagent development, and chemistry, chemical reagent, development.\n[Speaker 5895796664693401761]: Okay?\n[Speaker 5895796664693401761]: And we do like research like, you would know it from university.\n[Speaker 5895796664693401761]: So, I think we are the two units that would have the most interest in benchlink.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: Awesome.\n[Speaker 6782829348298472977]: And do, okay.\n[Speaker 6782829348298472977]: So, is the, sorry, I'm just looking at my other computer here, does the, is the antibody development?\n[Speaker 6782829348298472977]: Is that within the biological reagent side of things?\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Oka...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_roche_diagnostics_solutions_35fa47db", "company": "roche", "gong_entity": "Roche Diagnostics Solutions", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then we have, a group of which I belong to that is called, Roche diagnostics solutions that, we do the research.", "snippet_date": "2025-03-14", "person_name": "Jo Stevens", "person_email": "jo.stevens@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "roche-diagnostics-solutions", "manual_node_name": "Roche Diagnostics Solutions (RDS)", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS)", "confidence": "high", "reasoning": "Exact match - entity name matches manual node name exactly, confirmed by context about diagnostics research"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "call_id": "2025-03-14_d067238de6be", "call_count": 1, "all_snippets": [{"quote": "And then we have, a group of which I belong to that is called, Roche diagnostics solutions that, we do the research.", "date": "2025-03-14", "callId": "2025-03-14_d067238de6be", "gongUrl": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "speakerId": "5895796664693401761", "customerName": "Jo Stevens", "internalName": "Jacqueline McCoskey", "customerEmail": "jo.stevens@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...e you under?\n[Speaker 6782829348298472977]: I guess within like the antibody development, is there a group that you kind of report to or like you're.\n[Speaker 5895796664693401761]: situated under?\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: So you have, Roche diagnostics and Roche pharma, yeah, those are like almost two separate companies.\n[Speaker 5895796664693401761]: Yeah, but in helzberg, we have both on site.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: We're.\n[Speaker 5895796664693401761]: a bit weird in that sense.\n[Speaker 5895796664693401761]: Normally, the sites of Roche are like exclusively Daya, yeah.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 5895796664693401761]: And then within diagnostics, we have like huge departments that are called, like corelab that work on like devices and the tests that go on the devices, okay?\n[Speaker 5895796664693401761]: ", "contextAfter": "\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: And within that, on penzberg, we have, biological reagent development, and chemistry, chemical reagent, development.\n[Speaker 5895796664693401761]: Okay?\n[Speaker 5895796664693401761]: And we do like research like, you would know it from university.\n[Speaker 5895796664693401761]: So, I think we are the two units that would have the most interest in benchlink.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: Awesome.\n[Speaker 6782829348298472977]: And do, okay.\n[Speaker 6782829348298472977]: So, is the, sorry, I'm just looking at my other computer here, does the, is the antibody development?\n[Speaker 6782829348298472977]: Is that within the biological reagent side of things?\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: Exactly.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 5895796664693401761]: And ...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_biological_reagent_development_adfe01d9", "company": "roche", "gong_entity": "Biological Reagent Development", "gong_parent": "Roche Diagnostics Solutions", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And within that, on penzberg, we have, biological reagent development, and chemistry, chemical reagent, development.", "snippet_date": "2025-03-14", "person_name": "Jo Stevens", "person_email": "jo.stevens@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "pathology-reagents", "manual_node_name": "Pathology Reagents", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Tissue Diagnostics R&D (Ventana) > Pathology Reagents", "confidence": "medium", "reasoning": "Partial match - biological reagent development could align with pathology reagents team, though not exact match"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "call_id": "2025-03-14_d067238de6be", "call_count": 1, "all_snippets": [{"quote": "And within that, on penzberg, we have, biological reagent development, and chemistry, chemical reagent, development.", "date": "2025-03-14", "callId": "2025-03-14_d067238de6be", "gongUrl": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "speakerId": "5895796664693401761", "customerName": "Jo Stevens", "internalName": "Jacqueline McCoskey", "customerEmail": "jo.stevens@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...ated under?\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: So you have, Roche diagnostics and Roche pharma, yeah, those are like almost two separate companies.\n[Speaker 5895796664693401761]: Yeah, but in helzberg, we have both on site.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: We're.\n[Speaker 5895796664693401761]: a bit weird in that sense.\n[Speaker 5895796664693401761]: Normally, the sites of Roche are like exclusively Daya, yeah.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 5895796664693401761]: And then within diagnostics, we have like huge departments that are called, like corelab that work on like devices and the tests that go on the devices, okay?\n[Speaker 5895796664693401761]: And then we have, a group of which I belong to that is called, Roche diagnostics solutions that, we do the research.\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: ", "contextAfter": "\n[Speaker 5895796664693401761]: Okay?\n[Speaker 5895796664693401761]: And we do like research like, you would know it from university.\n[Speaker 5895796664693401761]: So, I think we are the two units that would have the most interest in benchlink.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: Awesome.\n[Speaker 6782829348298472977]: And do, okay.\n[Speaker 6782829348298472977]: So, is the, sorry, I'm just looking at my other computer here, does the, is the antibody development?\n[Speaker 6782829348298472977]: Is that within the biological reagent side of things?\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: Exactly.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 5895796664693401761]: And I don't know if, you know, Simon leubold,\n[Speaker 6782829348298472977]: I might, there's a number of people that we've been chatting with.\n[Speaker 6782829348298472977]: So,\n[Speaker 5...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_chemistry_975e06fb", "company": "roche", "gong_entity": "Chemistry", "gong_parent": "Roche Diagnostics Solutions", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And within that, on penzberg, we have, biological reagent development, and chemistry, chemical reagent, development.", "snippet_date": "2025-03-14", "person_name": "Jo Stevens", "person_email": "jo.stevens@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "clinical-chemistry-rd", "manual_node_name": "Clinical Chemistry", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Professional Diagnostics R&D > Clinical Chemistry", "confidence": "medium", "reasoning": "Fuzzy match - Chemistry team likely refers to Clinical Chemistry within diagnostics context mentioned in snippet"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "call_id": "2025-03-14_d067238de6be", "call_count": 1, "all_snippets": [{"quote": "And within that, on penzberg, we have, biological reagent development, and chemistry, chemical reagent, development.", "date": "2025-03-14", "callId": "2025-03-14_d067238de6be", "gongUrl": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "speakerId": "5895796664693401761", "customerName": "Jo Stevens", "internalName": "Jacqueline McCoskey", "customerEmail": "jo.stevens@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...ated under?\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: So you have, Roche diagnostics and Roche pharma, yeah, those are like almost two separate companies.\n[Speaker 5895796664693401761]: Yeah, but in helzberg, we have both on site.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: We're.\n[Speaker 5895796664693401761]: a bit weird in that sense.\n[Speaker 5895796664693401761]: Normally, the sites of Roche are like exclusively Daya, yeah.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 5895796664693401761]: And then within diagnostics, we have like huge departments that are called, like corelab that work on like devices and the tests that go on the devices, okay?\n[Speaker 5895796664693401761]: And then we have, a group of which I belong to that is called, Roche diagnostics solutions that, we do the research.\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: ", "contextAfter": "\n[Speaker 5895796664693401761]: Okay?\n[Speaker 5895796664693401761]: And we do like research like, you would know it from university.\n[Speaker 5895796664693401761]: So, I think we are the two units that would have the most interest in benchlink.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: Awesome.\n[Speaker 6782829348298472977]: And do, okay.\n[Speaker 6782829348298472977]: So, is the, sorry, I'm just looking at my other computer here, does the, is the antibody development?\n[Speaker 6782829348298472977]: Is that within the biological reagent side of things?\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: Exactly.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 5895796664693401761]: And I don't know if, you know, Simon leubold,\n[Speaker 6782829348298472977]: I might, there's a number of people that we've been chatting with.\n[Speaker 6782829348298472977]: So,\n[Speaker 5...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_antibody_development_team_3fbe2480", "company": "roche", "gong_entity": "Antibody Development Team", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "You're in the antibody development team.", "snippet_date": "2025-03-14", "person_name": "Jo Stevens", "person_email": "jo.stevens@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "antibody-engineering-pred", "manual_node_name": "Antibody Engineering", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Therapeutic Modalities > Antibody Engineering", "confidence": "high", "reasoning": "Strong semantic match - antibody development aligns with antibody engineering function"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "call_id": "2025-03-14_d067238de6be", "call_count": 1, "all_snippets": [{"quote": "You're in the antibody development team.", "date": "2025-03-14", "callId": "2025-03-14_d067238de6be", "gongUrl": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "speakerId": "6782829348298472977", "customerName": "Jo Stevens", "internalName": "Jacqueline McCoskey", "customerEmail": "jo.stevens@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...rteenth or the week of the fifth of may.\n[Speaker 5895796664693401761]: Perfect.\n[Speaker 5895796664693401761]: I would avoid those two weeks.\n[Speaker 5895796664693401761]: Okay?\n[Speaker 5895796664693401761]: And the week of the fourteenth of may, the eighteenth of April is also a public bank holiday.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: That's that's great.\n[Speaker 6782829348298472977]: That's I'm you guys get such nice holidays.\n[Speaker 6782829348298472977]: I'm jealous but very.\n[Speaker 5895796664693401761]: Well, deserved, just wait until we get to may then.\n[Speaker 6782829348298472977]: I know.\n[Speaker 6782829348298472977]: And then the summer, I know things get crazy.\n[Speaker 6782829348298472977]: So, okay, perfect.\n[Speaker 6782829348298472977]: That's really good to know.\n[Speaker 6782829348298472977]: In terms of your actual group here, I am just looking at my old notes.\n[Speaker 6782829348298472977]: ", "contextAfter": "\n[Speaker 6782829348298472977]: Is that correct?\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: And I know that's on the diagnostic side, how does that sort of like fit organizationally like in the actual, like what group are you under?\n[Speaker 6782829348298472977]: I guess within like the antibody development, is there a group that you kind of report to or like you're.\n[Speaker 5895796664693401761]: situated under?\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 5895796664693401761]: So you have, Roche diagnostics and Roche pharma, yeah, those are like almost two separate companies.\n[Speaker 5895796664693401761]: Yeah, but in helzberg, we have both on site.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: We're.\n[Speaker 5895796664693401761]: a bit weird in that sense.\n[Speaker 5895796664693401761]: Normally, the sites of Roche are like exclusively Daya, yeah.\n[Speaker 6782829348298472977]: Yeah.\n[Speaker 6782...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_pleasanton_41ba483e", "company": "roche", "gong_entity": "Pleasanton", "gong_parent": "Roche R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "We also have some sites, in pleasanton, in California.", "snippet_date": "2025-03-14", "person_name": "Jo Stevens", "person_email": "jo.stevens@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "pleasanton-ca", "manual_node_name": "Pleasanton, CA", "manual_node_path": "Roche Research & Development > Global R&D Sites > Pleasanton, CA", "confidence": "high", "reasoning": "Exact match - Pleasanton site mentioned in snippet matches manual org chart site"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "call_id": "2025-03-14_d067238de6be", "call_count": 1, "all_snippets": [{"quote": "We also have some sites, in pleasanton, in California.", "date": "2025-03-14", "callId": "2025-03-14_d067238de6be", "gongUrl": "https://app.gong.io/call?id=d067238de6be99fbbac2f6a56e95ac80cb5d589b876dddc7a13d341b74303534", "speakerId": "5895796664693401761", "customerName": "Jo Stevens", "internalName": "Jacqueline McCoskey", "customerEmail": "jo.stevens@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...any names, benchlink, benchsci, biorender, they all.\n[Speaker 5895796664693401761]: Have the same names?\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: Would he still also be interested, in biorender too?\n[Speaker 5895796664693401761]: Yeah, exactly.\n[Speaker 5895796664693401761]: So, if we do an online training, I will also include his department.\n[Speaker 6782829348298472977]: Okay, perfect.\n[Speaker 6782829348298472977]: Within how many people are there within the biological reagent development group around?\n[Speaker 5895796664693401761]: Like around 150?\n[Speaker 5895796664693401761]: Okay.\n[Speaker 6782829348298472977]: Perfect.\n[Speaker 6782829348298472977]: And are you all at the penzberg site?\n[Speaker 5895796664693401761]: No, no.\n[Speaker 5895796664693401761]: Okay.\n[Speaker 5895796664693401761]: So we are all in penzberg.\n[Speaker 5895796664693401761]: Okay.\n[Speaker 5895796664693401761]: So the whole department is bigger.\n[Speaker 5895796664693401761]: ", "contextAfter": "\n[Speaker 6782829348298472977]: Okay.\n[Speaker 5895796664693401761]: But in penzberg, we are all there.\n[Speaker 5895796664693401761]: Yeah.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 6782829348298472977]: And there's approximately 150 people there is.\n[Speaker 5895796664693401761]: That, yeah, but not all those people, will be interested in using like, it will be mostly scientists who use.\n[Speaker 6782829348298472977]: Biorender, right?\n[Speaker 6782829348298472977]: Right.\n[Speaker 6782829348298472977]: Okay.\n[Speaker 5895796664693401761]: Oh,\n[Speaker 6782829348298472977]: 150 includes like everyone within that sort of like sector?\n[Speaker 5895796664693401761]: Exactly.\n[Speaker 5895796664693401761]: Okay.\n[Speaker 5895796664693401761]: I think you're talking about like 20 to 30 people?\n[Speaker 6782829348298472977]: Okay, perfect.\n[Speaker 6782829348298472977]: We actually find those are the, almost the perfect size for these types of like lunch and learn, you know, 30 to 40 w...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_cancer_monotherapy_group_799a2d95", "company": "roche", "gong_entity": "Cancer Monotherapy Group", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Yes, I am in the Cancer Monotherapy Group.", "snippet_date": "2025-01-13", "person_name": "Luciana Molinero", "person_email": "molinero.luciana@gene.com", "internal_name": "Matthew Gralewski", "internal_email": "matt.gralewski@biorender.com", "llm_suggested_match": {"manual_node_id": "molecular-oncology-gred", "manual_node_name": "Molecular Oncology", "manual_node_path": "Roche Research & Development > Genentech Research & Early Development (gRED) > Oncology Research (gRED) > Molecular Oncology", "confidence": "medium", "reasoning": "Semantic match - cancer monotherapy group likely aligns with molecular oncology research team"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d64a84d3c9e350d7926b8dc94e4c202b6667e989fed3e297a31beac98086f8f4", "call_id": "2025-01-13_d64a84d3c9e3", "call_count": 1, "all_snippets": [{"quote": "Yes, I am in the Cancer Monotherapy Group.", "date": "2025-01-13", "callId": "2025-01-13_d64a84d3c9e3", "gongUrl": "https://app.gong.io/call?id=d64a84d3c9e350d7926b8dc94e4c202b6667e989fed3e297a31beac98086f8f4", "speakerId": "7933062693024874212", "customerName": "Luciana Molinero", "internalName": "Matthew Gralewski", "customerEmail": "molinero.luciana@gene.com", "internalEmail": "matt.gralewski@biorender.com", "sizeMentions": [], "contextBefore": "... you had?\n[Speaker 7933062693024874212]: Okay.\n[Speaker 7933062693024874212]: You found me just in a moment that I don't have a meeting.\n[Speaker 5325078289340232165]: I'm sorry?\n[Speaker 7933062693024874212]: Yeah.\n[Speaker 7933062693024874212]: Tell me.\n[Speaker 5325078289340232165]: Yeah.\n[Speaker 5325078289340232165]: So, I know I reached out to you trying to set up a one on one with our exec team on some of those topics and you mentioned you were curious how you envisioned BioRender being applied and you were looking for some more detail.\n[Speaker 5325078289340232165]: So, yeah, I mean, one of the things I, we can definitely provide some more detail.\n[Speaker 5325078289340232165]: I guess one of the things I would like to ask is, were there specific, were any of those topics like more important to you within the work you're doing within your group, the cancer immunotherapy group?\n[Speaker 7933062693024874212]: Mm.\n[Speaker 7933062693024874212]: Hmm.\n[Speaker 7933062693024874212]: ", "contextAfter": "\n[Speaker 5325078289340232165]: Yeah.\n[Speaker 5325078289340232165]: So within that group, you, know I mentioned a few topics, right?\n[Speaker 5325078289340232165]: So like the development of AI, the innovation we're doing within BioRender, that kind of stuff.\n[Speaker 5325078289340232165]: I was curious.\n[Speaker 5325078289340232165]: Were there specific topics that were of more interest to you?\n[Speaker 7933062693024874212]: Well, I would love to, I haven't used that much BioRender, I use it, but not so much, But I would love to have something that I say, I give a prompt.\n[Speaker 7933062693024874212]: I say, okay, I would love to see or I want to see a sketch of two cells interacting, blah, blah, blah, and with cell to face receptors, and so on Something that I give a prompt.\n[Speaker 7933062693024874212]: And then the AI provides me with The first attempt on a sketch That would be fantastic because that would solve a lot of time prior to generating myself the design, the sketch.\n[S...", "callTitle": "Call with Genentech - Luciana Molinero"}]}, {"id": "roche_synthetic_molecule_pharmaceutical_science_department_fc720b86", "company": "roche", "gong_entity": "Synthetic Molecule Pharmaceutical Science Department", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Im, coming from the Synthetic Molecule, Pharmaceutical Science Department of Genentech", "snippet_date": "2024-11-01", "person_name": "Nguyek49", "person_email": "nguyek49@gene.com; chen.tao@gene.com; barlowa1@gene.com", "internal_name": "Katy Brenneman; Michael Stanfel; Samara Ona", "internal_email": "katy@biorender.com; michael.stanfel@biorender.com; samara@biorender.com", "llm_suggested_match": {"manual_node_id": "small-molecule-development-tech", "manual_node_name": "Small Molecule Development", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical) > Small Molecule Development", "confidence": "high", "reasoning": "Strong semantic match - synthetic molecules align with small molecule development in pharmaceutical sciences"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ba20bde4107a5b58a4dcb356d322864c5db105efcffe3298c2885be8117b2275", "call_id": "2024-11-01_ba20bde4107a", "call_count": 1, "all_snippets": [{"quote": "Im, coming from the Synthetic Molecule, Pharmaceutical Science Department of Genentech", "date": "2024-11-01", "callId": "2024-11-01_ba20bde4107a", "gongUrl": "https://app.gong.io/call?id=ba20bde4107a5b58a4dcb356d322864c5db105efcffe3298c2885be8117b2275", "speakerId": "2771584499278183870", "customerName": "Nguyek49", "internalName": "Katy Brenneman; Michael Stanfel; Samara Ona", "customerEmail": "nguyek49@gene.com; chen.tao@gene.com; barlowa1@gene.com", "internalEmail": "katy@biorender.com; michael.stanfel@biorender.com; samara@biorender.com", "sizeMentions": [], "contextBefore": "...267056460796717647]: Im, Michael, Im, an illustrator on the creative team here at BioRender.\n[Speaker 267056460796717647]: So I deal mostly in the production of the icons that youll find in the icon library.\n[Speaker 267056460796717647]: And my background is in technical illustration.\n[Speaker 267056460796717647]: So my specialty is actually all those like machinery and equipment type icons, similar to the stuff that you were requesting in that slide deck that you sent over.\n[Speaker 267056460796717647]: So Im, particularly interested in any insights you have into that end of BioRender in terms of the scientific equipment content and how its used and how it could be more useful.\n[Speaker 2771584499278183870]: Cool.\n[Speaker 2771584499278183870]: Nice to meet you, Michael.\n[Speaker 5612551954010750878]: Carol, did you want to introduce yourself next?\n[Speaker 2771584499278183870]: Yeah, sure.\n[Speaker 2771584499278183870]: I can get started.\n[Speaker 2771584499278183870]: So, Im, Chao, ", "contextAfter": " Ive, been in Genentech a little bit over 10 years at this point right now by training analytical chemists.\n[Speaker 2771584499278183870]: So for the first six years here in Genentech Ive, been leading analytical project development from preclinical to phase two.\n[Speaker 2771584499278183870]: Now, Im, currently meeting a high throughput automation group within the same department.\n[Speaker 2771584499278183870]: So, Im, definitely a big fan of a scientific illustration.\n[Speaker 2771584499278183870]: And then I still recall the old days when I was back in my PhD and then we got to write papers and then for those graphs, you can have a lot of software to generate the graphs, right?\n[Speaker 2771584499278183870]: And then like origin and all those.\n[Speaker 2771584499278183870]: So, but when you come to do like illustration, like for your next game or something, and then back then I was doing the hard way, I was just using PowerPoint to draw it out.\n[Speaker 2771584499278183870]: And the...", "callTitle": "User Interview with BioRender (Genentech)"}]}, {"id": "roche_high_throughput_automation_group_882ad174", "company": "roche", "gong_entity": "High Throughput Automation Group", "gong_parent": "Synthetic Molecule Pharmaceutical Science Department", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Im, currently meeting a high throughput automation group within the same department", "snippet_date": "2024-11-01", "person_name": "Nguyek49", "person_email": "nguyek49@gene.com; chen.tao@gene.com; barlowa1@gene.com", "internal_name": "Katy Brenneman; Michael Stanfel; Samara Ona", "internal_email": "katy@biorender.com; michael.stanfel@biorender.com; samara@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=ba20bde4107a5b58a4dcb356d322864c5db105efcffe3298c2885be8117b2275", "call_id": "2024-11-01_ba20bde4107a", "call_count": 1, "all_snippets": [{"quote": "Im, currently meeting a high throughput automation group within the same department", "date": "2024-11-01", "callId": "2024-11-01_ba20bde4107a", "gongUrl": "https://app.gong.io/call?id=ba20bde4107a5b58a4dcb356d322864c5db105efcffe3298c2885be8117b2275", "speakerId": "2771584499278183870", "customerName": "Nguyek49", "internalName": "Katy Brenneman; Michael Stanfel; Samara Ona", "customerEmail": "nguyek49@gene.com; chen.tao@gene.com; barlowa1@gene.com", "internalEmail": "katy@biorender.com; michael.stanfel@biorender.com; samara@biorender.com", "sizeMentions": [], "contextBefore": "...e icons, similar to the stuff that you were requesting in that slide deck that you sent over.\n[Speaker 267056460796717647]: So Im, particularly interested in any insights you have into that end of BioRender in terms of the scientific equipment content and how its used and how it could be more useful.\n[Speaker 2771584499278183870]: Cool.\n[Speaker 2771584499278183870]: Nice to meet you, Michael.\n[Speaker 5612551954010750878]: Carol, did you want to introduce yourself next?\n[Speaker 2771584499278183870]: Yeah, sure.\n[Speaker 2771584499278183870]: I can get started.\n[Speaker 2771584499278183870]: So, Im, Chao, Im, coming from the Synthetic Molecule, Pharmaceutical Science Department of Genentech Ive, been in Genentech a little bit over 10 years at this point right now by training analytical chemists.\n[Speaker 2771584499278183870]: So for the first six years here in Genentech Ive, been leading analytical project development from preclinical to phase two.\n[Speaker 2771584499278183870]: Now, ", "contextAfter": ".\n[Speaker 2771584499278183870]: So, Im, definitely a big fan of a scientific illustration.\n[Speaker 2771584499278183870]: And then I still recall the old days when I was back in my PhD and then we got to write papers and then for those graphs, you can have a lot of software to generate the graphs, right?\n[Speaker 2771584499278183870]: And then like origin and all those.\n[Speaker 2771584499278183870]: So, but when you come to do like illustration, like for your next game or something, and then back then I was doing the hard way, I was just using PowerPoint to draw it out.\n[Speaker 2771584499278183870]: And then I enjoyed it, but it sometimes can be becoming very tedious and very time consuming over there, right?\n[Speaker 2771584499278183870]: So I encouraged my group to, I got to know about BioRender.\n[Speaker 2771584499278183870]: I guess maybe one year ago, I think its getting more and more popular.\n[Speaker 2771584499278183870]: And then, so thats why I also encourage my group membe...", "callTitle": "User Interview with BioRender (Genentech)"}]}, {"id": "roche_department_of_biochemical_and_cellular_pharmacology_ba8c74aa", "company": "roche", "gong_entity": "Department of Biochemical and Cellular Pharmacology", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So, Im, in the Department of Biochemical and Cellular Pharmacology, which is Mainly in vitro assays across a variety of things.", "snippet_date": "2024-11-01", "person_name": "Ryan Cook", "person_email": "cook.ryan@gene.com", "internal_name": "Katy Brenneman; Michael Stanfel; Samara Ona", "internal_email": "katy@biorender.com; michael.stanfel@biorender.com; samara@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=16eec8471b339e14de32dbf4ab3a0ceccf8b98bdbb1cbaa20eeb3fb1e18b7c83", "call_id": "2024-11-01_16eec8471b33", "call_count": 1, "all_snippets": [{"quote": "So, Im, in the Department of Biochemical and Cellular Pharmacology, which is Mainly in vitro assays across a variety of things.", "date": "2024-11-01", "callId": "2024-11-01_16eec8471b33", "gongUrl": "https://app.gong.io/call?id=16eec8471b339e14de32dbf4ab3a0ceccf8b98bdbb1cbaa20eeb3fb1e18b7c83", "speakerId": "7653985815089673450", "customerName": "Ryan Cook", "internalName": "Katy Brenneman; Michael Stanfel; Samara Ona", "customerEmail": "cook.ryan@gene.com", "internalEmail": "katy@biorender.com; michael.stanfel@biorender.com; samara@biorender.com", "sizeMentions": [], "contextBefore": "...73450]: My name is Samara.\n[Speaker 7653985815089673450]: I am part of the creative team as well.\n[Speaker 7653985815089673450]: Im, a science designer And I work in the team that creates the templates that you can see in BioRender.\n[Speaker 7653985815089673450]: And I have an academic background.\n[Speaker 7653985815089673450]: I got a PhD in molecular genetics, And my research field was mainly in structural biology.\n[Speaker 7653985815089673450]: And happy to be here and hear some of your thoughts regarding these icon and template library that you have put together.\n[Speaker 7653985815089673450]: Excellent.\n[Speaker 7653985815089673450]: Well, Im, Ryan, I have been at Genentech, basically my entire career.\n[Speaker 7653985815089673450]: Im, the subject matter expert here at Genentech on this one, the point of contact for anyone who has any issues or wants to know, I dont know any of the licensing, but I am primarily in the lab, Im, in assay development.\n[Speaker 7653985815089673450]: ", "contextAfter": "\n[Speaker 7653985815089673450]: But my background education is in genetics, but most of the work I do is immunology.\n[Speaker 822964053994105406]: Thanks.\n[Speaker 822964053994105406]: We can jump right into it then, Ryan, And yeah, maybe we can get through it quickly and we can give you some time back.\n[Speaker 822964053994105406]: But is there a chance youd be able to pull up BioRender and share your screen?\n[Speaker 822964053994105406]: Is that possible?\n[Speaker 7653985815089673450]: You want me to pull up mine?\n[Speaker 7653985815089673450]: Okay, sure.\n[Speaker 822964053994105406]: Weve enabled it for you in the app.\n[Speaker 822964053994105406]: So were curious if you could wed, love to see if you can discover it and see if we put it in the right places to make sure that its easy to find.\n[Speaker 7653985815089673450]: Absolutely.\n[Speaker 7653985815089673450]: So let me log in and then Ill, share my screen.\n[Speaker 822964053994105406]: All right.\n[Speaker 822964053994105406]: ...", "callTitle": "Genentech <> BioRender (Library Review)"}]}, {"id": "roche_research_review_committee_10d2914c", "company": "roche", "gong_entity": "Research Review Committee", "gong_parent": "Roche R&D", "entity_type": "committee", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "Those are what are called RRCs for the research review committee", "snippet_date": "2024-10-24", "person_name": "Ryan Cook", "person_email": "cook.ryan@gene.com", "internal_name": "Jacqueline McCoskey; Katy Brenneman; Tim Fung", "internal_email": "jacqueline@biorender.com; katy@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=e75ac3a8fc9da69f8be1494fabec1ca8c3302a288afcd61b68a43f6354da3bfc", "call_id": "2024-10-24_e75ac3a8fc9d", "call_count": 1, "all_snippets": [{"quote": "Those are what are called RRCs for the research review committee", "date": "2024-10-24", "callId": "2024-10-24_e75ac3a8fc9d", "gongUrl": "https://app.gong.io/call?id=e75ac3a8fc9da69f8be1494fabec1ca8c3302a288afcd61b68a43f6354da3bfc", "speakerId": "3000548241294178576", "customerName": "Ryan Cook", "internalName": "Jacqueline McCoskey; Katy Brenneman; Tim Fung", "customerEmail": "cook.ryan@gene.com", "internalEmail": "jacqueline@biorender.com; katy@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...quite that advanced yet, but hopefully we get there.\n[Speaker 7952069281422711793]: Weve definitely heard that a couple times from folks and were kind of just like dipping into AI and how we can like auto generate images based off needs.\n[Speaker 7952069281422711793]: So definitely something, on our radar before I share what our thoughts are in terms of the solution and get your thoughts on it.\n[Speaker 7952069281422711793]: Id, love to know where you find the figures today from folks that youre reusing?\n[Speaker 7952069281422711793]: Is it in some sort of like sharepoint, google drive?\n[Speaker 7952069281422711793]: Like how do you, how do you even find these images that you want to reuse?\n[Speaker 3000548241294178576]: I would say either a colleagues presentation, we, there are an ungodly amount of presentations that happen here.\n[Speaker 3000548241294178576]: And, and so some presentations, the big presentations that are supposed to be, very polished.\n[Speaker 3000548241294178576]: ", "contextAfter": ".\n[Speaker 3000548241294178576]: Thats where a project lead is basically justifying to the company why we should continue funding or justify why we should not continue funding a project.\n[Speaker 3000548241294178576]: And so that is where sometimes that, where the presenter will reach out and gather images, graphics, whatever from team members.\n[Speaker 3000548241294178576]: Also, we have regular project team meetings and those are a little bit more rough, but those get uploaded.\n[Speaker 3000548241294178576]: I think most teams are now using as a g drive so you can go back and find a presentation.\n[Speaker 3000548241294178576]: The problem is just this actually just happened where someone reached out to me and they said, you know, I remember you presenting this data but I cant find it because, you know, the g drive is not organized at all.\n[Speaker 3000548241294178576]: It goes by date.\n[Speaker 3000548241294178576]: And if you just know it was sometime in the year or something, you w...", "callTitle": "Genentech-specific content library"}]}, {"id": "roche_infectious_disease_department_7543b36c", "company": "roche", "gong_entity": "Infectious Disease Department", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm in the infectious disease department", "snippet_date": "2024-09-19", "person_name": "Markus Eckl", "person_email": "markus.eckl@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "infectious-diseases-research", "manual_node_name": "Infectious Diseases Research", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Infectious Diseases Research", "confidence": "high", "reasoning": "Clear semantic match - 'Infectious Disease Department' aligns with 'Infectious Diseases Research' therapeutic area in pRED."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "call_id": "2024-09-19_d132aba88672", "call_count": 1, "all_snippets": [{"quote": "I'm in the infectious disease department", "date": "2024-09-19", "callId": "2024-09-19_d132aba88672", "gongUrl": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "speakerId": "1493537282318889744", "customerName": "Markus Eckl", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "markus.eckl@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...cess will be made Roche wide versus just P RED and G RED.\n[Speaker 3068414967322493854]: These are things that we're like just working through the final licensing logistics of it.\n[Speaker 3068414967322493854]: But yeah, that's kind of where we're at right now.\n[Speaker 1493537282318889744]: Yeah, that's really good news.\n[Speaker 1493537282318889744]: We have a distribution list, so around my peer levels or team leads and development leads.\n[Speaker 1493537282318889744]: Yeah.\n[Speaker 1493537282318889744]: So I would be happy to share the info.\n[Speaker 3068414967322493854]: Perfect.\n[Speaker 3068414967322493854]: That would be because I just if I'm clear, you're in the development and infectious disease.\n[Speaker 3068414967322493854]: Is that right?\n[Speaker 3068414967322493854]: Okay.\n[Speaker 1493537282318889744]: Yeah, so it's core lab development.\n[Speaker 1493537282318889744]: So everything that's in the central lab, this is my peer group, right?\n[Speaker 1493537282318889744]: ", "contextAfter": ", but there are others, cardiac oncology, I don't know.\n[Speaker 1493537282318889744]: Yeah, okay.\n[Speaker 3068414967322493854]: And yeah, so if you want to, is there, Sierra made a note that there's about 150 people in your group.\n[Speaker 3068414967322493854]: Is that within infectious disease or is that within like all the other groups.\n[Speaker 1493537282318889744]: So that's all of the color people there.\n[Speaker 3068414967322493854]: Okay, perfect.\n[Speaker 3068414967322493854]: Yeah, because if you want to send, like once we get the information, I can send it to you as well as a way to get access on the back end.\n[Speaker 3068414967322493854]: It's just like a link and it'll be able to redirect them.\n[Speaker 3068414967322493854]: And then if you want to pass that around to those other 150 people as well as training options.\n[Speaker 3068414967322493854]: Yeah, the more the merrier that we definitely want to use this as an opportunity for people to test it out and figure out w...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_core_lab_development_1ff30b75", "company": "roche", "gong_entity": "Core Lab Development", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "it's core lab development", "snippet_date": "2024-09-19", "person_name": "Markus Eckl", "person_email": "markus.eckl@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "core-lab-solutions", "manual_node_name": "Core Lab Solutions", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Professional Diagnostics R&D > Core Lab Solutions", "confidence": "medium", "reasoning": "Fuzzy match - 'Core Lab Development' is similar to 'Core Lab Solutions' in diagnostics R&D, though 'Development' vs 'Solutions' suggests slightly different focus."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "call_id": "2024-09-19_d132aba88672", "call_count": 1, "all_snippets": [{"quote": "it's core lab development", "date": "2024-09-19", "callId": "2024-09-19_d132aba88672", "gongUrl": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "speakerId": "1493537282318889744", "customerName": "Markus Eckl", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "markus.eckl@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...n so that when they do join, they'll know what they're doing.\n[Speaker 3068414967322493854]: And then hopefully what will happen at the end of it is that the access will be made Roche wide versus just P RED and G RED.\n[Speaker 3068414967322493854]: These are things that we're like just working through the final licensing logistics of it.\n[Speaker 3068414967322493854]: But yeah, that's kind of where we're at right now.\n[Speaker 1493537282318889744]: Yeah, that's really good news.\n[Speaker 1493537282318889744]: We have a distribution list, so around my peer levels or team leads and development leads.\n[Speaker 1493537282318889744]: Yeah.\n[Speaker 1493537282318889744]: So I would be happy to share the info.\n[Speaker 3068414967322493854]: Perfect.\n[Speaker 3068414967322493854]: That would be because I just if I'm clear, you're in the development and infectious disease.\n[Speaker 3068414967322493854]: Is that right?\n[Speaker 3068414967322493854]: Okay.\n[Speaker 1493537282318889744]: Yeah, so ", "contextAfter": ".\n[Speaker 1493537282318889744]: So everything that's in the central lab, this is my peer group, right?\n[Speaker 1493537282318889744]: I'm in the infectious disease department, but there are others, cardiac oncology, I don't know.\n[Speaker 1493537282318889744]: Yeah, okay.\n[Speaker 3068414967322493854]: And yeah, so if you want to, is there, Sierra made a note that there's about 150 people in your group.\n[Speaker 3068414967322493854]: Is that within infectious disease or is that within like all the other groups.\n[Speaker 1493537282318889744]: So that's all of the color people there.\n[Speaker 3068414967322493854]: Okay, perfect.\n[Speaker 3068414967322493854]: Yeah, because if you want to send, like once we get the information, I can send it to you as well as a way to get access on the back end.\n[Speaker 3068414967322493854]: It's just like a link and it'll be able to redirect them.\n[Speaker 3068414967322493854]: And then if you want to pass that around to those other 150 people as well ...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_cardiac_c37757dd", "company": "roche", "gong_entity": "Cardiac", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "there are others, cardiac oncology", "snippet_date": "2024-09-19", "person_name": "Markus Eckl", "person_email": "markus.eckl@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "cardiovascular-metabolic-research", "manual_node_name": "Cardiovascular & Metabolic Diseases Research", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Cardiovascular & Metabolic Diseases Research", "confidence": "medium", "reasoning": "Semantic match - 'Cardiac' relates to cardiovascular research. The entity appears to be shorthand for the cardiovascular therapeutic area."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "call_id": "2024-09-19_d132aba88672", "call_count": 1, "all_snippets": [{"quote": "there are others, cardiac oncology", "date": "2024-09-19", "callId": "2024-09-19_d132aba88672", "gongUrl": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "speakerId": "1493537282318889744", "customerName": "Markus Eckl", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "markus.eckl@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... and G RED.\n[Speaker 3068414967322493854]: These are things that we're like just working through the final licensing logistics of it.\n[Speaker 3068414967322493854]: But yeah, that's kind of where we're at right now.\n[Speaker 1493537282318889744]: Yeah, that's really good news.\n[Speaker 1493537282318889744]: We have a distribution list, so around my peer levels or team leads and development leads.\n[Speaker 1493537282318889744]: Yeah.\n[Speaker 1493537282318889744]: So I would be happy to share the info.\n[Speaker 3068414967322493854]: Perfect.\n[Speaker 3068414967322493854]: That would be because I just if I'm clear, you're in the development and infectious disease.\n[Speaker 3068414967322493854]: Is that right?\n[Speaker 3068414967322493854]: Okay.\n[Speaker 1493537282318889744]: Yeah, so it's core lab development.\n[Speaker 1493537282318889744]: So everything that's in the central lab, this is my peer group, right?\n[Speaker 1493537282318889744]: I'm in the infectious disease department, but ", "contextAfter": ", I don't know.\n[Speaker 1493537282318889744]: Yeah, okay.\n[Speaker 3068414967322493854]: And yeah, so if you want to, is there, Sierra made a note that there's about 150 people in your group.\n[Speaker 3068414967322493854]: Is that within infectious disease or is that within like all the other groups.\n[Speaker 1493537282318889744]: So that's all of the color people there.\n[Speaker 3068414967322493854]: Okay, perfect.\n[Speaker 3068414967322493854]: Yeah, because if you want to send, like once we get the information, I can send it to you as well as a way to get access on the back end.\n[Speaker 3068414967322493854]: It's just like a link and it'll be able to redirect them.\n[Speaker 3068414967322493854]: And then if you want to pass that around to those other 150 people as well as training options.\n[Speaker 3068414967322493854]: Yeah, the more the merrier that we definitely want to use this as an opportunity for people to test it out and figure out when they would use it.\n[Speaker 30684149...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_early_development_f11ecc9d", "company": "roche", "gong_entity": "Early Development", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we have the colleagues of early development right in the building next to us", "snippet_date": "2024-09-19", "person_name": "Markus Eckl", "person_email": "markus.eckl@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "early-clinical-development", "manual_node_name": "Early Clinical Development", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Clinical Operations (pRED) > Early Clinical Development", "confidence": "medium", "reasoning": "Good semantic match - 'Early Development' aligns with 'Early Clinical Development' team, though could also refer to broader early development activities."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "call_id": "2024-09-19_d132aba88672", "call_count": 1, "all_snippets": [{"quote": "we have the colleagues of early development right in the building next to us", "date": "2024-09-19", "callId": "2024-09-19_d132aba88672", "gongUrl": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "speakerId": "1493537282318889744", "customerName": "Markus Eckl", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "markus.eckl@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...ed to do that, whatever is easiest.\n[Speaker 3068414967322493854]: But yeah, typically people will Try to join that one and then if there is like some conflicts and stuff we can set up something for you guys.\n[Speaker 1493537282318889744]: Sounds good.\n[Speaker 1493537282318889744]: Yeah.\n[Speaker 3068414967322493854]: I actually do have one quick question for you.\n[Speaker 3068414967322493854]: Do you know, like I know that you're in.\n[Speaker 3068414967322493854]: Diagnostics, like the research, it's quite large, right?\n[Speaker 3068414967322493854]: It's like a.\n[Speaker 1493537282318889744]: large group of people?\n[Speaker 1493537282318889744]: From the outside it looks quite large and from the inside it's...\n[Speaker 1493537282318889744]: I can't oversee everything.\n[Speaker 1493537282318889744]: You know, we have...\n[Speaker 1493537282318889744]: So I'm based in Penzbeck, south of Munich.\n[Speaker 1493537282318889744]: We do Z Core Lab development.\n[Speaker 1493537282318889744]: ", "contextAfter": " okay we have the pathology guys in tucson yeah so we have some guys in basel we have you're all over not connected to them so okay.\n[Speaker 3068414967322493854]: okay so but as a function though it is like you have like thousands of people in diagnostics and.\n[Speaker 1493537282318889744]: Yeah, it's quite large.\n[Speaker 1493537282318889744]: Yeah.\n[Speaker 3068414967322493854]: yeah yeah no that's kind of what we've been hearing too so hopefully this will make this will make access like a lot more widespread beyond those groups that everyone can access it so and i will say i think once we actually get this up and running we are looking to do some like in person sort of training sessions as well so we'll be kind of on site and if that's ever the case i'll let you know and then we could do something for your group while we're in the area awesome well thanks marcus i appreciate your time and i will be in touch shortly.\n[Speaker 1493537282318889744]: Thanks a lot.\n[Speaker 149353728231...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_pathology_84c94adc", "company": "roche", "gong_entity": "Pathology", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we have the pathology guys in tucson", "snippet_date": "2024-09-19", "person_name": "Markus Eckl", "person_email": "markus.eckl@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "tissue-diagnostics-rd", "manual_node_name": "Tissue Diagnostics R&D (Ventana)", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Tissue Diagnostics R&D (Ventana)", "confidence": "medium", "reasoning": "Semantic match - 'Pathology' relates to tissue diagnostics. The mention of 'Tucson' in snippet aligns with Ventana's location."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "call_id": "2024-09-19_d132aba88672", "call_count": 1, "all_snippets": [{"quote": "we have the pathology guys in tucson", "date": "2024-09-19", "callId": "2024-09-19_d132aba88672", "gongUrl": "https://app.gong.io/call?id=d132aba8867288a30cd7516e24c6115b77c3085fc096826147847f17de6d4215", "speakerId": "1493537282318889744", "customerName": "Markus Eckl", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "markus.eckl@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...ally people will Try to join that one and then if there is like some conflicts and stuff we can set up something for you guys.\n[Speaker 1493537282318889744]: Sounds good.\n[Speaker 1493537282318889744]: Yeah.\n[Speaker 3068414967322493854]: I actually do have one quick question for you.\n[Speaker 3068414967322493854]: Do you know, like I know that you're in.\n[Speaker 3068414967322493854]: Diagnostics, like the research, it's quite large, right?\n[Speaker 3068414967322493854]: It's like a.\n[Speaker 1493537282318889744]: large group of people?\n[Speaker 1493537282318889744]: From the outside it looks quite large and from the inside it's...\n[Speaker 1493537282318889744]: I can't oversee everything.\n[Speaker 1493537282318889744]: You know, we have...\n[Speaker 1493537282318889744]: So I'm based in Penzbeck, south of Munich.\n[Speaker 1493537282318889744]: We do Z Core Lab development.\n[Speaker 1493537282318889744]: we have the colleagues of early development right in the building next to us okay ", "contextAfter": " yeah so we have some guys in basel we have you're all over not connected to them so okay.\n[Speaker 3068414967322493854]: okay so but as a function though it is like you have like thousands of people in diagnostics and.\n[Speaker 1493537282318889744]: Yeah, it's quite large.\n[Speaker 1493537282318889744]: Yeah.\n[Speaker 3068414967322493854]: yeah yeah no that's kind of what we've been hearing too so hopefully this will make this will make access like a lot more widespread beyond those groups that everyone can access it so and i will say i think once we actually get this up and running we are looking to do some like in person sort of training sessions as well so we'll be kind of on site and if that's ever the case i'll let you know and then we could do something for your group while we're in the area awesome well thanks marcus i appreciate your time and i will be in touch shortly.\n[Speaker 1493537282318889744]: Thanks a lot.\n[Speaker 1493537282318889744]: Take care.\n[Speaker 149353728231...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_roche_it_c77ebb26", "company": "roche", "gong_entity": "Roche IT", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "It'll be Roche IT paying BioRender for this contract", "snippet_date": "2024-08-07", "person_name": "Gaius Augustus; George Abousleiman; Kawal Kaur", "person_email": "gaius.augustus@roche.com; abousleg@gene.com; kaurk5@gene.com", "internal_name": "Jacqueline McCoskey; Tim Fung; Walid Habboub", "internal_email": "jacqueline@biorender.com; tim@biorender.com; walid@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=b4817c5133e0026dfd55555f6136da51bdd5a5e57445f48aafd7d3c34fd5b214", "call_id": "2024-08-07_b4817c5133e0", "call_count": 1, "all_snippets": [{"quote": "It'll be Roche IT paying BioRender for this contract", "date": "2024-08-07", "callId": "2024-08-07_b4817c5133e0", "gongUrl": "https://app.gong.io/call?id=b4817c5133e0026dfd55555f6136da51bdd5a5e57445f48aafd7d3c34fd5b214", "speakerId": "6241790713165453869", "customerName": "Gaius Augustus; George Abousleiman; Kawal Kaur", "internalName": "Jacqueline McCoskey; Tim Fung; Walid Habboub", "customerEmail": "gaius.augustus@roche.com; abousleg@gene.com; kaurk5@gene.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com; walid@biorender.com", "sizeMentions": [], "contextBefore": "...0578885818385]: So they have a...\n[Speaker 3938310578885818385]: The P RED budget is paying for that group.\n[Speaker 3938310578885818385]: The G RED budget is paying for that group.\n[Speaker 3938310578885818385]: it doesn't really work as well if you are charging it back to each team.\n[Speaker 3938310578885818385]: And I think from what I remember in diagnostics, is that the way that you're still planning to sort of like budget this is each team would be paying for the seat that they want to purchase or does diagnostics have like some sort of a research budget?\n[Speaker 6241790713165453869]: Yeah, so going forward, we're moving whatever period and GRED budget was for this platform, we're moving that under my portfolio.\n[Speaker 6241790713165453869]: So that's what I was trying to explain you that the budget will sit under one centralized place.\n[Speaker 6241790713165453869]: So you don't have to worry about it's coming for you from either period or GRED.\n[Speaker 6241790713165453869]: ", "contextAfter": ".\n[Speaker 6241790713165453869]: And then same thing will happen.\n[Speaker 6241790713165453869]: That's why I want to learn how what that number would look like for a future contract.\n[Speaker 6241790713165453869]: So I am ready to pay for Daya as well.\n[Speaker 6241790713165453869]: So I'm going to request additional budget to support Daya users.\n[Speaker 6241790713165453869]: Right now the budget transfer that's internally happening is just for P RED and G VID and we already took care of it.\n[Speaker 6241790713165453869]: Now for future users who want to adopt the platform, I need to understand from BioRender how this future contract would look like so I can secure more funding.\n[Speaker 3938310578885818385]: Perfect, okay, yeah, but I think we're in the exact same sort of like situation here where on our side too we don't exactly know what that number looks like in terms of who would be interested.\n[Speaker 3938310578885818385]: We know that there's demand, we get requests all the t...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_corporate_brand_team_d05a24e3", "company": "roche", "gong_entity": "Corporate Brand Team", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And I'm in the corporate brand team.", "snippet_date": "2024-08-07", "person_name": "Tiina S.", "person_email": "tiina.sipilae@roche.com; damian.amherd@roche.com", "internal_name": "Katy Brenneman; Tim Fung", "internal_email": "katy@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=ff65bd3113c2712b8cd1c8f2a2cfb5290f59b23d8519910b7848b5bad4f88ca7", "call_id": "2024-08-07_ff65bd3113c2", "call_count": 1, "all_snippets": [{"quote": "And I'm in the corporate brand team.", "date": "2024-08-07", "callId": "2024-08-07_ff65bd3113c2", "gongUrl": "https://app.gong.io/call?id=ff65bd3113c2712b8cd1c8f2a2cfb5290f59b23d8519910b7848b5bad4f88ca7", "speakerId": "7851041043447193261", "customerName": "Tiina S.", "internalName": "Katy Brenneman; Tim Fung", "customerEmail": "tiina.sipilae@roche.com; damian.amherd@roche.com", "internalEmail": "katy@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...oduce herself.\n[Speaker 8654778793493917332]: Yeah.\n[Speaker 8654778793493917332]: Hi, nice to meet you.\n[Speaker 8654778793493917332]: Like Tim said, I'm Katie.\n[Speaker 8654778793493917332]: I work on the product team at BioRender.\n[Speaker 8654778793493917332]: So what that means is that I look at the BioRender app to see how it should evolve over time and how we should improve it in an effort to do that.\n[Speaker 8654778793493917332]: I don't have a science background actually.\n[Speaker 8654778793493917332]: So I interview a lot of scientists and companies that we work with to figure out what the best direction is for the product.\n[Speaker 8654778793493917332]: So yeah, I'm excited to see where this conversation goes today.\n[Speaker 7851041043447193261]: All right.\n[Speaker 7851041043447193261]: Nice to meet you.\n[Speaker 7851041043447193261]: My name is Dina.\n[Speaker 7851041043447193261]: Yes, we're logged on in my computer so you can see it there.\n[Speaker 7851041043447193261]: ", "contextAfter": "\n[Speaker 7851041043447193261]: We are the ones who set the visual expression for the corporate brand and try to help define how to express it in multitude of touch points.\n[Speaker 7851041043447193261]: And as such, really great to be discussing with you because I think you hold a You know, big piece of this in your heads.\n[Speaker 7851041043447193261]: And very briefly, my name is Damian.\n[Speaker 7851041043447193261]: I'm part of the same team as Tina, more or less with the same remit.\n[Speaker 7851041043447193261]: We both are a bit more on the conceptual strategic side.\n[Speaker 7851041043447193261]: And then in our team, we also have four creatives, be it visual designers, photographers, videographers that cover the more creative side of branding.\n[Speaker 7851041043447193261]: Awesome.\n[Speaker 7851041043447193261]: But they're on vacation, so it's just the two of us.\n[Speaker 7851041043447193261]: You have to deal with this.\n[Speaker 2268703346183064753]: Yeah, I was actually s...", "callTitle": "BioRender | Roche - branding connect"}]}, {"id": "roche_sequencing_network_99229474", "company": "roche", "gong_entity": "Sequencing Network", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm part of, the sequencing network.", "snippet_date": "2024-07-18", "person_name": "Jo-Anne Penkler", "person_email": "jo-anne.penkler@roche.com", "internal_name": "Sierra Barnes", "internal_email": "sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "sequencing-technologies", "manual_node_name": "Sequencing Technologies", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Molecular Diagnostics R&D > Sequencing Technologies", "confidence": "medium", "reasoning": "Good semantic match - 'Sequencing Network' relates to 'Sequencing Technologies' in molecular diagnostics, though 'Network' suggests broader cross-functional collaboration."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d91b4936a0d77c5f1d383923a9481df758b9180e7385130e46b77c9a17e39f43", "call_id": "2024-07-18_d91b4936a0d7", "call_count": 1, "all_snippets": [{"quote": "I'm part of, the sequencing network.", "date": "2024-07-18", "callId": "2024-07-18_d91b4936a0d7", "gongUrl": "https://app.gong.io/call?id=d91b4936a0d77c5f1d383923a9481df758b9180e7385130e46b77c9a17e39f43", "speakerId": "1524884107094530045", "customerName": "Jo-Anne Penkler", "internalName": "Sierra Barnes", "customerEmail": "jo-anne.penkler@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...urious if you've heard of it or had an opportunity to play around with it.\n[Speaker 426745186800795378]: No, so.\n[Speaker 1524884107094530045]: We haven't but we also at, are kind of tied into using google slides.\n[Speaker 426745186800795378]: Okay.\n[Speaker 1524884107094530045]: Makes it a little more challenging.\n[Speaker 426745186800795378]: Are you making all of your slides, in google slides now then?\n[Speaker 426745186800795378]: Okay, then it probably wouldn't be too much benefit to you.\n[Speaker 426745186800795378]: I assume it might be on a road map to maybe integrate with google slides as well, but it's just an integration to help kind of make presentations a little bit quicker.\n[Speaker 426745186800795378]: But currently, right now, it's only with Microsoft Powerpoint.\n[Speaker 426745186800795378]: So I wouldn't be of too much value to you guys as well.\n[Speaker 426745186800795378]: And just so I can confirm which team are you a part of at roc?\n[Speaker 1524884107094530045]: ", "contextAfter": "\n[Speaker 1524884107094530045]: And so, it's a sequencing workflows and applications, research and development team.\n[Speaker 426745186800795378]: And what are others on your team currently using to create their visuals for their presentations?\n[Speaker 1524884107094530045]: They are typically not using anything?\n[Speaker 426745186800795378]: Not not including visuals in their presentations.\n[Speaker 1524884107094530045]: Well, not visual stepped.\n[Speaker 1524884107094530045]: They need by window full.\n[Speaker 426745186800795378]: Okay.\n[Speaker 426745186800795378]: And do you think, is there a awareness of BioRender across the team or is it is hard to say I?\n[Speaker 1524884107094530045]: In my team, that definitely is because I use it.\n[Speaker 1524884107094530045]: I just think that for the most part the presentations that they're giving their lab scientists mostly who are presenting to people who are fairly familiar with the workflow.\n[Speaker 1524884107094530045]: So having a si...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_sequencing_workflows_and_applications_f0c1c0a8", "company": "roche", "gong_entity": "Sequencing Workflows and Applications", "gong_parent": "Sequencing Network", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "it's a sequencing workflows and applications, research and development team.", "snippet_date": "2024-07-18", "person_name": "Jo-Anne Penkler", "person_email": "jo-anne.penkler@roche.com", "internal_name": "Sierra Barnes", "internal_email": "sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "sequencing-technologies", "manual_node_name": "Sequencing Technologies", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Molecular Diagnostics R&D > Sequencing Technologies", "confidence": "medium", "reasoning": "Strong semantic match - sequencing workflows and applications would logically fall under sequencing technologies team in molecular diagnostics"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d91b4936a0d77c5f1d383923a9481df758b9180e7385130e46b77c9a17e39f43", "call_id": "2024-07-18_d91b4936a0d7", "call_count": 1, "all_snippets": [{"quote": "it's a sequencing workflows and applications, research and development team.", "date": "2024-07-18", "callId": "2024-07-18_d91b4936a0d7", "gongUrl": "https://app.gong.io/call?id=d91b4936a0d77c5f1d383923a9481df758b9180e7385130e46b77c9a17e39f43", "speakerId": "1524884107094530045", "customerName": "Jo-Anne Penkler", "internalName": "Sierra Barnes", "customerEmail": "jo-anne.penkler@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...Speaker 426745186800795378]: No, so.\n[Speaker 1524884107094530045]: We haven't but we also at, are kind of tied into using google slides.\n[Speaker 426745186800795378]: Okay.\n[Speaker 1524884107094530045]: Makes it a little more challenging.\n[Speaker 426745186800795378]: Are you making all of your slides, in google slides now then?\n[Speaker 426745186800795378]: Okay, then it probably wouldn't be too much benefit to you.\n[Speaker 426745186800795378]: I assume it might be on a road map to maybe integrate with google slides as well, but it's just an integration to help kind of make presentations a little bit quicker.\n[Speaker 426745186800795378]: But currently, right now, it's only with Microsoft Powerpoint.\n[Speaker 426745186800795378]: So I wouldn't be of too much value to you guys as well.\n[Speaker 426745186800795378]: And just so I can confirm which team are you a part of at roc?\n[Speaker 1524884107094530045]: I'm part of, the sequencing network.\n[Speaker 1524884107094530045]: And so, ", "contextAfter": "\n[Speaker 426745186800795378]: And what are others on your team currently using to create their visuals for their presentations?\n[Speaker 1524884107094530045]: They are typically not using anything?\n[Speaker 426745186800795378]: Not not including visuals in their presentations.\n[Speaker 1524884107094530045]: Well, not visual stepped.\n[Speaker 1524884107094530045]: They need by window full.\n[Speaker 426745186800795378]: Okay.\n[Speaker 426745186800795378]: And do you think, is there a awareness of BioRender across the team or is it is hard to say I?\n[Speaker 1524884107094530045]: In my team, that definitely is because I use it.\n[Speaker 1524884107094530045]: I just think that for the most part the presentations that they're giving their lab scientists mostly who are presenting to people who are fairly familiar with the workflow.\n[Speaker 1524884107094530045]: So having a simple table of conditions suffices, like they don't need to have\u2026 you know, pretty pictures of tubes to show how a se...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_analytical_department_86fb7c0b", "company": "roche", "gong_entity": "Analytical Department", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm in the analytical department.", "snippet_date": "2024-07-15", "person_name": "Katrin Heinrich", "person_email": "katrin.heinrich@roche.com", "internal_name": "Sierra Barnes", "internal_email": "sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "analytical-development-sm", "manual_node_name": "Analytical Development", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical) > Small Molecule Development > Analytical Development", "confidence": "medium", "reasoning": "Generic analytical department could match either small molecule or biologics analytical development teams; choosing small molecule as more common reference"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=2d305aa082f505a7ea08ecfc91c8df4bcb7c11b0bba713bcabb107df0cebc7f8", "call_id": "2024-07-15_2d305aa082f5", "call_count": 1, "all_snippets": [{"quote": "I'm in the analytical department.", "date": "2024-07-15", "callId": "2024-07-15_2d305aa082f5", "gongUrl": "https://app.gong.io/call?id=2d305aa082f505a7ea08ecfc91c8df4bcb7c11b0bba713bcabb107df0cebc7f8", "speakerId": "8823219584383707337", "customerName": "Katrin Heinrich", "internalName": "Sierra Barnes", "customerEmail": "katrin.heinrich@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...337]: I do not know if you have any information about this.\n[Speaker 62159824319951106]: It's kind of the inspiration, for the phone call.\n[Speaker 62159824319951106]: We've like in the past few years work to set up, the red researchers with access.\n[Speaker 62159824319951106]: And now we want to make sure that it's more equitable across the ocean that other teams that could benefit from having access to by render also have access.\n[Speaker 62159824319951106]: So, yeah, making these phone calls to see where it's been a value, to different teams.\n[Speaker 62159824319951106]: So, I'm happy we're connected.\n[Speaker 62159824319951106]: How large is the development department?\n[Speaker 8823219584383707337]: Sure.\n[Speaker 8823219584383707337]: No.\n[Speaker 8823219584383707337]: We're about 300\u2026 people in the, yeah, 300 people.\n[Speaker 8823219584383707337]: I the.\n[Speaker 62159824319951106]: are you part of a specific team within the development department?\n[Speaker 8823219584383707337]: ", "contextAfter": "\n[Speaker 8823219584383707337]: Yeah.\n[Speaker 8823219584383707337]: And there is, yeah, it's not hard, to tell people what's going on in our essays and so on.\n[Speaker 8823219584383707337]: And it's really cool to have\u2026 the visualization very easy and simple.\n[Speaker 62159824319951106]: And how large is the analytical department?\n[Speaker 8823219584383707337]: We're about 100, I think.\n[Speaker 62159824319951106]: Okay.\n[Speaker 62159824319951106]: And are all those people based, in germany or?\n[Speaker 8823219584383707337]: In germany and in switzerland?\n[Speaker 62159824319951106]: Okay.\n[Speaker 62159824319951106]: Very cool.\n[Speaker 62159824319951106]: And so, it sounds like, you know, there's at least a few people across the department that are still using older tools like Powerpoint and paint.\n[Speaker 62159824319951106]: How are you guys collaborating on figures currently?\n[Speaker 8823219584383707337]: Yeah.\n[Speaker 8823219584383707337]: Sometimes, I do the figures for my c...", "callTitle": "Call with Roche Ltd. - Katrin Heinrich"}]}, {"id": "roche_reagent_research_and_design_0667cf12", "company": "roche", "gong_entity": "Reagent Research and Design", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I'm in reagent research and design. We specialise in providing services to a lot of the other teams within\u2026 the organization.", "snippet_date": "2024-07-04", "person_name": "Taariq Firfirey", "person_email": "taariq.firfirey@roche.com", "internal_name": "Sierra Barnes", "internal_email": "sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "pathology-reagents", "manual_node_name": "Pathology Reagents", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Tissue Diagnostics R&D (Ventana) > Pathology Reagents", "confidence": "medium", "reasoning": "Reagent research and design providing services to other teams aligns with pathology reagents team supporting tissue diagnostics"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=703d92988c66f21913d2f471e7a3d922e5b76a5822cd28020514066d1685f0c1", "call_id": "2024-07-04_703d92988c66", "call_count": 1, "all_snippets": [{"quote": "So I'm in reagent research and design. We specialise in providing services to a lot of the other teams within\u2026 the organization.", "date": "2024-07-04", "callId": "2024-07-04_703d92988c66", "gongUrl": "https://app.gong.io/call?id=703d92988c66f21913d2f471e7a3d922e5b76a5822cd28020514066d1685f0c1", "speakerId": "2900785077647915400", "customerName": "Taariq Firfirey", "internalName": "Sierra Barnes", "customerEmail": "taariq.firfirey@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...ng to audience that they may have a scientific background but not really in the area that we specialise in.\nAnd just outside communication as well.\nWe cannot always take them into the laboratory to see the things.\nJust having something that looks very similar but also\u2026 looks like very good quality is not like a pillar image or something like that.\nThat also helps just convey and engages with them to think.\nSo.\nI think it has a lot of value like, I suppose also the professionalism having very good quality images also out.\nMm, HMM.\nYeah, that's kind of in alignment with what we're hearing from other groups at rosh, especially when the science gets a bit more nuanced, and you're talking to people that might not be specialists or experts, in the area that you are.\nAnd it just kind of helps get everybody on the same page that's definitely kind of what we're hearing across different teams but which you mentioned you're in rosh, diagnostics, are you part of a specific team within that?\nYeah.\n", "contextAfter": "\nYeah, in cape town, we specialise in\u2026 our group is in technologies for\u2026 NGS.\nSo next generation sequencing, we develop NGS library, pre kits, R and a library, pre kits\u2026 of library quantification, PCR agents\u2026 et cetera.\nI don't know if it would help.\nI don't know if you ever heard of a company called Cap buyer systems.\nI actually, I used to work for alumina, so it's kind of my wheelhouse all the NGS library prep stuff.\nSo that's a funny coincidence.\nBut, how large is the reagent research and design team?\nIt's not actually very big.\nCurrently.\nI think we, there is a few hirings taking place.\nI think we have now maybe two more later this year joining.\nSo it's fairly small group.\nSo that department split into two sections, enzyme evolution.\nIt works on.\nIf you're familiar with Cap, they used to do the compartmentalized of replication in bubbles so that team is still existing.\nAnd then there is my team that does the project station purification work.\nAnd then the, so that's just what we ca...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_enzyme_evolution_944b7223", "company": "roche", "gong_entity": "Enzyme Evolution", "gong_parent": "Reagent Research and Design", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So that department split into two sections, enzyme evolution.", "snippet_date": "2024-07-04", "person_name": "Taariq Firfirey", "person_email": "taariq.firfirey@roche.com", "internal_name": "Sierra Barnes", "internal_email": "sierra.barnes@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=703d92988c66f21913d2f471e7a3d922e5b76a5822cd28020514066d1685f0c1", "call_id": "2024-07-04_703d92988c66", "call_count": 1, "all_snippets": [{"quote": "So that department split into two sections, enzyme evolution.", "date": "2024-07-04", "callId": "2024-07-04_703d92988c66", "gongUrl": "https://app.gong.io/call?id=703d92988c66f21913d2f471e7a3d922e5b76a5822cd28020514066d1685f0c1", "speakerId": "2900785077647915400", "customerName": "Taariq Firfirey", "internalName": "Sierra Barnes", "customerEmail": "taariq.firfirey@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...hnologies for\u2026 NGS.\n[Speaker 2900785077647915400]: So next generation sequencing, we develop NGS library, pre kits, R and a library, pre kits\u2026 of library quantification, PCR agents\u2026 et cetera.\n[Speaker 2900785077647915400]: I don't know if it would help.\n[Speaker 2900785077647915400]: I don't know if you ever heard of a company called Cap buyer systems.\n[Speaker 6159906293072374701]: I actually, I used to work for alumina, so it's kind of my wheelhouse all the NGS library prep stuff.\n[Speaker 6159906293072374701]: So that's a funny coincidence.\n[Speaker 6159906293072374701]: But, how large is the reagent research and design team?\n[Speaker 2900785077647915400]: It's not actually very big.\n[Speaker 2900785077647915400]: Currently.\n[Speaker 2900785077647915400]: I think we, there is a few hirings taking place.\n[Speaker 2900785077647915400]: I think we have now maybe two more later this year joining.\n[Speaker 2900785077647915400]: So it's fairly small group.\n[Speaker 2900785077647915400]: ", "contextAfter": "\n[Speaker 2900785077647915400]: It works on.\n[Speaker 2900785077647915400]: If you're familiar with Cap, they used to do the compartmentalized of replication in bubbles so that team is still existing.\n[Speaker 2900785077647915400]: And then there is my team that does the project station purification work.\n[Speaker 2900785077647915400]: And then the, so that's just what we call our, the reign research and design.\n[Speaker 2900785077647915400]: And then there's a research and early development team as well.\n[Speaker 2900785077647915400]: That is a more focus on the workflows of Ng.\n[Speaker 2900785077647915400]: So they will put together the kids.\n[Speaker 2900785077647915400]: I, we will provide a buffer and, or enzyme solutions that they can re, formulate into kits.\n[Speaker 2900785077647915400]: So, there is a library prep kit that consists probably of six or seven people and ordinary library pre kit that consists about the same amount of people.\n[Speaker 2900785077647915400]: So that...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_pdd_group_84b9e4c1", "company": "roche", "gong_entity": "PDD Group", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I know that last time Felix and I spoke, we're kind of chatting about a way to get access for the PDD group", "snippet_date": "2024-07-02", "person_name": "Felix Kuhne; Thomas Jungwirth", "person_email": "felix.kuhne@roche.com; thomas.jungwirth@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "global-product-development", "manual_node_name": "Global Product Development (Pharma)", "manual_node_path": "Roche Research & Development > Global Product Development (Pharma)", "confidence": "medium", "reasoning": "PDD likely stands for Product Development Division, which would align with Global Product Development (Pharma)"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ea1569b496c097a817ab0a742955cb5cf1bf7e4d7024f169c1fe5d7ea3210f86", "call_id": "2024-07-02_ea1569b496c0", "call_count": 1, "all_snippets": [{"quote": "I know that last time Felix and I spoke, we're kind of chatting about a way to get access for the PDD group", "date": "2024-07-02", "callId": "2024-07-02_ea1569b496c0", "gongUrl": "https://app.gong.io/call?id=ea1569b496c097a817ab0a742955cb5cf1bf7e4d7024f169c1fe5d7ea3210f86", "speakerId": "1103093793434741809", "customerName": "Felix Kuhne; Thomas Jungwirth", "internalName": "Jacqueline McCoskey", "customerEmail": "felix.kuhne@roche.com; thomas.jungwirth@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...omas, I'm sure that Felix, I'm not sure if you got you up to speed with kind of our conversation that we had before.\n[Speaker 6810304842830039606]: Got a introduction is, yes.\n[Speaker 6810304842830039606]: Okay.\n[Speaker 6810304842830039606]: Yeah, perfect.\n[Speaker 1103093793434741809]: Perfect.\n[Speaker 1027589886936369011]: I guess.\n[Speaker 1103093793434741809]: To intro myself, I'm kind of the primary point of contact between binder and I've been working with you guys for a few years now.\n[Speaker 1103093793434741809]: So I have all the like the history if you need a, if you have any questions there.\n[Speaker 1103093793434741809]: But yeah, anything that you know, you need, I'll be able the person to help your group get access depending on, you know, what group you're part of.\n[Speaker 1103093793434741809]: We have different plans, different options.\n[Speaker 1103093793434741809]: So, but yeah, I guess to start as I just rambled there for a second.\n[Speaker 1103093793434741809]: ", "contextAfter": ".\n[Speaker 1103093793434741809]: Is that still the case right now Felix?\n[Speaker 1027589886936369011]: Right?\n[Speaker 1027589886936369011]: So I can give you an update, correct?\n[Speaker 1027589886936369011]: So first of all, so Thomas is responsible for software.\n[Speaker 1027589886936369011]: Okay?\n[Speaker 1027589886936369011]: So this is why he's also attending the call and I've been\u2026 so I did\u2026 I've been talking to\u2026 my colleagues us and the whole department.\n[Speaker 1027589886936369011]: Actually.\n[Speaker 1027589886936369011]: Okay.\n[Speaker 1027589886936369011]: The status right now is that approximately, I don't know three people would need access all right right now.\n[Speaker 1027589886936369011]: So not only access but they would need a licensed version for publication.\n[Speaker 1027589886936369011]: Okay?\n[Speaker 1027589886936369011]: But they also had the idea if it is or if it would be an option to have something like a pooled\u2026 license for the whole department, so that ...", "callTitle": "BioRender | Roche follow up"}]}, {"id": "roche_pharmacology_group_ed3e8e67", "company": "roche", "gong_entity": "Pharmacology Group", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "which is part of the pharmacology group, which is part of the oncology group", "snippet_date": "2024-06-25", "person_name": "Sasha Simons", "person_email": "sasha.simons@roche.com", "internal_name": "Sierra Barnes", "internal_email": "sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "clinical-pharmacology-pred", "manual_node_name": "Clinical Pharmacology", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Clinical Operations (pRED) > Clinical Pharmacology", "confidence": "medium", "reasoning": "Pharmacology group in oncology context would align with clinical pharmacology team within pRED"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=092be935c476f6e4d47e1a60ad7e697924362c5879017ea479770aee247157b5", "call_id": "2024-06-25_092be935c476", "call_count": 1, "all_snippets": [{"quote": "which is part of the pharmacology group, which is part of the oncology group", "date": "2024-06-25", "callId": "2024-06-25_092be935c476", "gongUrl": "https://app.gong.io/call?id=092be935c476f6e4d47e1a60ad7e697924362c5879017ea479770aee247157b5", "speakerId": "7039201041252679901", "customerName": "Sasha Simons", "internalName": "Sierra Barnes", "customerEmail": "sasha.simons@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...int, I did use and before, but yeah, yeah, whatever was available either by downloading images from the internet and super posing them and cutting them and shaping them.\n[Speaker 7039201041252679901]: Yeah, stuff like that.\n[Speaker 3220874620643073974]: And how did you find that transition going from using Powerpoint in google images to not having access to BioRender.\n[Speaker 7039201041252679901]: Yeah, much easier.\n[Speaker 7039201041252679901]: Much faster.\n[Speaker 7039201041252679901]: And there's also a lot more functionality is.\n[Speaker 3220874620643073974]: And have you used the poster builder within BioRender?\n[Speaker 7039201041252679901]: Not yet?\n[Speaker 7039201041252679901]: No, but it is soon, to be used.\n[Speaker 3220874620643073974]: Okay.\n[Speaker 3220874620643073974]: Very cool.\n[Speaker 3220874620643073974]: And which group are you a part of in, at Roche?\n[Speaker 7039201041252679901]: So, I'm part of the precision cancer modeling and in legal pharmacology group, ", "contextAfter": ".\n[Speaker 7039201041252679901]: So, yeah.\n[Speaker 3220874620643073974]: And is that part of P red at Roche?\n[Speaker 7039201041252679901]: Exactly.\n[Speaker 7039201041252679901]: Yeah.\n[Speaker 3220874620643073974]: Okay.\n[Speaker 3220874620643073974]: So we can probably keep this pretty short and sweet.\n[Speaker 3220874620643073974]: We actually do have something set up centrally for pre at Roche.\n[Speaker 3220874620643073974]: So it gives all pre researchers at Roche access to BioRender premium, which will unlock a lot of different functionality within your account.\n[Speaker 3220874620643073974]: So, it's something that we're working on with other branches of Roche like the diagnostic side and the pharma technical group.\n[Speaker 3220874620643073974]: They're they're kind of separate entities, right?\n[Speaker 3220874620643073974]: From P, read, they don't yes.\n[Speaker 3220874620643073974]: Yeah.\n[Speaker 3220874620643073974]: So that's something that we're working on, but I can se...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_precision_cancer_modeling_and_in_legal_pharmacology_group_d786d9e6", "company": "roche", "gong_entity": "Precision Cancer Modeling and In Legal Pharmacology Group", "gong_parent": "Pharmacology Group", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm part of the precision cancer modeling and in legal pharmacology group, which is part of the pharmacology group", "snippet_date": "2024-06-25", "person_name": "Sasha Simons", "person_email": "sasha.simons@roche.com", "internal_name": "Sierra Barnes", "internal_email": "sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "cancer-biology-mechanisms", "manual_node_name": "Cancer Biology & Mechanisms", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Oncology & Hematology Research > Cancer Biology & Mechanisms", "confidence": "medium", "reasoning": "Precision cancer modeling would logically fit within cancer biology and mechanisms research team in oncology"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=092be935c476f6e4d47e1a60ad7e697924362c5879017ea479770aee247157b5", "call_id": "2024-06-25_092be935c476", "call_count": 1, "all_snippets": [{"quote": "I'm part of the precision cancer modeling and in legal pharmacology group, which is part of the pharmacology group", "date": "2024-06-25", "callId": "2024-06-25_092be935c476", "gongUrl": "https://app.gong.io/call?id=092be935c476f6e4d47e1a60ad7e697924362c5879017ea479770aee247157b5", "speakerId": "7039201041252679901", "customerName": "Sasha Simons", "internalName": "Sierra Barnes", "customerEmail": "sasha.simons@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...sentations?\n[Speaker 7039201041252679901]: Whatever was attached to Powerpoint, I did use and before, but yeah, yeah, whatever was available either by downloading images from the internet and super posing them and cutting them and shaping them.\n[Speaker 7039201041252679901]: Yeah, stuff like that.\n[Speaker 3220874620643073974]: And how did you find that transition going from using Powerpoint in google images to not having access to BioRender.\n[Speaker 7039201041252679901]: Yeah, much easier.\n[Speaker 7039201041252679901]: Much faster.\n[Speaker 7039201041252679901]: And there's also a lot more functionality is.\n[Speaker 3220874620643073974]: And have you used the poster builder within BioRender?\n[Speaker 7039201041252679901]: Not yet?\n[Speaker 7039201041252679901]: No, but it is soon, to be used.\n[Speaker 3220874620643073974]: Okay.\n[Speaker 3220874620643073974]: Very cool.\n[Speaker 3220874620643073974]: And which group are you a part of in, at Roche?\n[Speaker 7039201041252679901]: So, ", "contextAfter": ", which is part of the oncology group.\n[Speaker 7039201041252679901]: So, yeah.\n[Speaker 3220874620643073974]: And is that part of P red at Roche?\n[Speaker 7039201041252679901]: Exactly.\n[Speaker 7039201041252679901]: Yeah.\n[Speaker 3220874620643073974]: Okay.\n[Speaker 3220874620643073974]: So we can probably keep this pretty short and sweet.\n[Speaker 3220874620643073974]: We actually do have something set up centrally for pre at Roche.\n[Speaker 3220874620643073974]: So it gives all pre researchers at Roche access to BioRender premium, which will unlock a lot of different functionality within your account.\n[Speaker 3220874620643073974]: So, it's something that we're working on with other branches of Roche like the diagnostic side and the pharma technical group.\n[Speaker 3220874620643073974]: They're they're kind of separate entities, right?\n[Speaker 3220874620643073974]: From P, read, they don't yes.\n[Speaker 3220874620643073974]: Yeah.\n[Speaker 3220874620643073974]: So that's somethin...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_oncology_group_1e25570d", "company": "roche", "gong_entity": "Oncology Group", "gong_parent": "Roche R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "which is part of the oncology group", "snippet_date": "2024-06-25", "person_name": "Sasha Simons", "person_email": "sasha.simons@roche.com", "internal_name": "Sierra Barnes", "internal_email": "sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "oncology-hematology-research", "manual_node_name": "Oncology & Hematology Research", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Oncology & Hematology Research", "confidence": "high", "reasoning": "Direct match - oncology group clearly aligns with the Oncology & Hematology Research therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=092be935c476f6e4d47e1a60ad7e697924362c5879017ea479770aee247157b5", "call_id": "2024-06-25_092be935c476", "call_count": 1, "all_snippets": [{"quote": "which is part of the oncology group", "date": "2024-06-25", "callId": "2024-06-25_092be935c476", "gongUrl": "https://app.gong.io/call?id=092be935c476f6e4d47e1a60ad7e697924362c5879017ea479770aee247157b5", "speakerId": "7039201041252679901", "customerName": "Sasha Simons", "internalName": "Sierra Barnes", "customerEmail": "sasha.simons@roche.com", "internalEmail": "sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "..., whatever was available either by downloading images from the internet and super posing them and cutting them and shaping them.\n[Speaker 7039201041252679901]: Yeah, stuff like that.\n[Speaker 3220874620643073974]: And how did you find that transition going from using Powerpoint in google images to not having access to BioRender.\n[Speaker 7039201041252679901]: Yeah, much easier.\n[Speaker 7039201041252679901]: Much faster.\n[Speaker 7039201041252679901]: And there's also a lot more functionality is.\n[Speaker 3220874620643073974]: And have you used the poster builder within BioRender?\n[Speaker 7039201041252679901]: Not yet?\n[Speaker 7039201041252679901]: No, but it is soon, to be used.\n[Speaker 3220874620643073974]: Okay.\n[Speaker 3220874620643073974]: Very cool.\n[Speaker 3220874620643073974]: And which group are you a part of in, at Roche?\n[Speaker 7039201041252679901]: So, I'm part of the precision cancer modeling and in legal pharmacology group, which is part of the pharmacology group, ", "contextAfter": ".\n[Speaker 7039201041252679901]: So, yeah.\n[Speaker 3220874620643073974]: And is that part of P red at Roche?\n[Speaker 7039201041252679901]: Exactly.\n[Speaker 7039201041252679901]: Yeah.\n[Speaker 3220874620643073974]: Okay.\n[Speaker 3220874620643073974]: So we can probably keep this pretty short and sweet.\n[Speaker 3220874620643073974]: We actually do have something set up centrally for pre at Roche.\n[Speaker 3220874620643073974]: So it gives all pre researchers at Roche access to BioRender premium, which will unlock a lot of different functionality within your account.\n[Speaker 3220874620643073974]: So, it's something that we're working on with other branches of Roche like the diagnostic side and the pharma technical group.\n[Speaker 3220874620643073974]: They're they're kind of separate entities, right?\n[Speaker 3220874620643073974]: From P, read, they don't yes.\n[Speaker 3220874620643073974]: Yeah.\n[Speaker 3220874620643073974]: So that's something that we're working on, but I can se...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_maynooth_32474b2d", "company": "roche", "gong_entity": "Maynooth", "gong_parent": "Roche R&D", "entity_type": "site", "team_size": "70", "confidence": "high", "mention_count": 1, "snippet": "I'm just looking at Maynooth, and I see that there's quite a few users. I see over like 70 users. Within Maynooth", "snippet_date": "2024-06-19", "person_name": "Richard Roche", "person_email": "richard.roche@mu.ie", "internal_name": "Julianna Cheung", "internal_email": "julianna.cheung@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=0c8b75ee7c43f3c5d11c42c456292f6c3daa8a6e5cc7899e791bd42320a8305e", "call_id": "2024-06-19_0c8b75ee7c43", "call_count": 1, "all_snippets": [{"quote": "I'm just looking at Maynooth, and I see that there's quite a few users.\nI see over like 70 users.\nYeah.\nWithin Maynooth, and I see that there's like a, quite a few that are on the individual license f", "date": "2024-06-19", "callId": "2024-06-19_0c8b75ee7c43", "gongUrl": "https://app.gong.io/call?id=0c8b75ee7c43f3c5d11c42c456292f6c3daa8a6e5cc7899e791bd42320a8305e", "speakerId": "4772598804483647010", "customerName": "Richard Roche", "internalName": "Julianna Cheung", "customerEmail": "richard.roche@mu.ie", "internalEmail": "julianna.cheung@biorender.com", "sizeMentions": [], "contextBefore": "...ence level.\nOkay.\nOkay.\nBecause I do know like within our library that we do have like we have institutes like from psychology or psychiatry or neuroscience that use like some of the icons and templates within BioRender because it's not just icons.\nWe also have like poster templates as well.\nSo, I know that when some folks or researchers are building posters or, you know, they need a template for grants that's also something that they use as well, not just limited to the icons.\nYeah.\nSo I guess like, I know you mentioned that you kind of have seen BioRender maybe through emails, but have you like just curious to hear if any of your researchers have mentioned BioRender?\nYeah.\nCool.\nYeah.\nOkay.\nNot that I know of, but they may have, and I've just kind of forgotten specifically who, but possibly it's definitely, it's a name I've heard but I can't exactly remember where.\nYeah, because I'm just looking here and like my data might be skewed.\nSo don't like take this with a grain of salt, but ", "contextAfter": "or like one of our paid licenses and that just allows them to, you know, own their figures and publish their figures.\nAnd yeah, so, I, you know, I really appreciate you taking the time to talk with you.\nHello?\nOkay.\nMmhmm.\nOkay.\nI know that you mentioned that it might not be something that you might like use within your department and it might be other departments that might use it more.\nBut, what would it mean or what would I, what impact would it have if your figures could be better?\nAnd let's say it's not limited to just like the cellular level?\nLike let's say you have access to figures for specifically psychology?\nLike what would it mean if all your figures look more professional and standardized across the department?\nYeah.\nI think it probably could really help with grants as you mentioned earlier, applying for grants.\nSo they often look for like, you know, schemaics of projects, and the outline of, you know, workflows and things like that.\nSo I think that potentially would be som...", "callTitle": "Call with Richard Roche"}]}, {"id": "roche_analytics_department_b78a2b76", "company": "roche", "gong_entity": "Analytics Department", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I work for the pharma, technical development in the analytics department.", "snippet_date": "2024-06-14", "person_name": "Felix Kuhne", "person_email": "felix.kuhne@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "analytical-development-sm", "manual_node_name": "Analytical Development", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical) > Small Molecule Development > Analytical Development", "confidence": "medium", "reasoning": "Analytics department in pharma technical development context aligns with analytical development for small molecules"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "call_id": "2024-06-14_5820c7bc82da", "call_count": 1, "all_snippets": [{"quote": "So I work for the pharma, technical development in the analytics department.", "date": "2024-06-14", "callId": "2024-06-14_5820c7bc82da", "gongUrl": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "speakerId": "1372854872117518306", "customerName": "Felix Kuhne", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "felix.kuhne@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...3714562823197]: Will.\n[Speaker 1372854872117518306]: So\u2026 no, nothing particular, actually.\n[Speaker 1372854872117518306]: So.\n[Speaker 1372854872117518306]: Well, maybe if there is a workaround as long as we don't have a team license, is there may be a workaround for us to use BioRender.\n[Speaker 1372854872117518306]: Also, I mean at least for internal presentations, that will be one question, maybe, yeah.\n[Speaker 8593743714562823197]: Yeah, totally.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: So I can kind of give you an overview of how the setup could work.\n[Speaker 8593743714562823197]: Just a couple of questions for you before, to figure out what sort of option would work best.\n[Speaker 8593743714562823197]: So, you had made a note that you are part of ptd.\n[Speaker 8593743714562823197]: Do you mind giving an overview of kind of like your role and organizationally where that fits in to re.\n[Speaker 1372854872117518306]: Sure.\n[Speaker 1372854872117518306]: ", "contextAfter": "\n[Speaker 1372854872117518306]: There, we have a department for the characterization of our molecules.\n[Speaker 1372854872117518306]: So, and there I work\u2026 in the position of one of our innovation leads, innovation lead.\n[Speaker 1372854872117518306]: They are for technology questions and for improving our technology, for the characterization of our molecules\u2026 my role.\n[Speaker 8593743714562823197]: Perfect.\n[Speaker 8593743714562823197]: That's super helpful.\n[Speaker 8593743714562823197]: So just to clarify you're within so that we have just looking at my other screen so we have PD and then there's an analytics group.\n[Speaker 8593743714562823197]: And then there's a characterization of molecules, smaller group.\n[Speaker 8593743714562823197]: And that's the part that you're the group that you're part of, right?\n[Speaker 8593743714562823197]: Yeah.\n[Speaker 8593743714562823197]: Got you.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: How many people are within tha...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_characterization_of_molecules_e623453d", "company": "roche", "gong_entity": "Characterization of Molecules", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "There, we have a department for the characterization of our molecules.", "snippet_date": "2024-06-14", "person_name": "Felix Kuhne", "person_email": "felix.kuhne@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "call_id": "2024-06-14_5820c7bc82da", "call_count": 1, "all_snippets": [{"quote": "There, we have a department for the characterization of our molecules.", "date": "2024-06-14", "callId": "2024-06-14_5820c7bc82da", "gongUrl": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "speakerId": "1372854872117518306", "customerName": "Felix Kuhne", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "felix.kuhne@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...72117518306]: So.\n[Speaker 1372854872117518306]: Well, maybe if there is a workaround as long as we don't have a team license, is there may be a workaround for us to use BioRender.\n[Speaker 1372854872117518306]: Also, I mean at least for internal presentations, that will be one question, maybe, yeah.\n[Speaker 8593743714562823197]: Yeah, totally.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: So I can kind of give you an overview of how the setup could work.\n[Speaker 8593743714562823197]: Just a couple of questions for you before, to figure out what sort of option would work best.\n[Speaker 8593743714562823197]: So, you had made a note that you are part of ptd.\n[Speaker 8593743714562823197]: Do you mind giving an overview of kind of like your role and organizationally where that fits in to re.\n[Speaker 1372854872117518306]: Sure.\n[Speaker 1372854872117518306]: So I work for the pharma, technical development in the analytics department.\n[Speaker 1372854872117518306]: ", "contextAfter": "\n[Speaker 1372854872117518306]: So, and there I work\u2026 in the position of one of our innovation leads, innovation lead.\n[Speaker 1372854872117518306]: They are for technology questions and for improving our technology, for the characterization of our molecules\u2026 my role.\n[Speaker 8593743714562823197]: Perfect.\n[Speaker 8593743714562823197]: That's super helpful.\n[Speaker 8593743714562823197]: So just to clarify you're within so that we have just looking at my other screen so we have PD and then there's an analytics group.\n[Speaker 8593743714562823197]: And then there's a characterization of molecules, smaller group.\n[Speaker 8593743714562823197]: And that's the part that you're the group that you're part of, right?\n[Speaker 8593743714562823197]: Yeah.\n[Speaker 8593743714562823197]: Got you.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: How many people are within that characterization of molecules group?\n[Speaker 1372854872117518306]: 40 roughly.\n[Speaker 85937437145...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_pharma_division_79d0ae17", "company": "roche", "gong_entity": "Pharma Division", "gong_parent": "Roche R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So we have the diagnostics, and then we have the pharma, yeah, separate divisions.", "snippet_date": "2024-06-14", "person_name": "Felix Kuhne", "person_email": "felix.kuhne@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "global-product-development", "manual_node_name": "Global Product Development (Pharma)", "manual_node_path": "Roche Research & Development > Global Product Development (Pharma)", "confidence": "high", "reasoning": "Clear reference to pharma division as separate from diagnostics, matches Global Product Development (Pharma) division"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "call_id": "2024-06-14_5820c7bc82da", "call_count": 1, "all_snippets": [{"quote": "So we have the diagnostics, and then we have the pharma, yeah, separate divisions.", "date": "2024-06-14", "callId": "2024-06-14_5820c7bc82da", "gongUrl": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "speakerId": "1372854872117518306", "customerName": "Felix Kuhne", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "felix.kuhne@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... helpful.\n[Speaker 8593743714562823197]: So just to clarify you're within so that we have just looking at my other screen so we have PD and then there's an analytics group.\n[Speaker 8593743714562823197]: And then there's a characterization of molecules, smaller group.\n[Speaker 8593743714562823197]: And that's the part that you're the group that you're part of, right?\n[Speaker 8593743714562823197]: Yeah.\n[Speaker 8593743714562823197]: Got you.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: How many people are within that characterization of molecules group?\n[Speaker 1372854872117518306]: 40 roughly.\n[Speaker 8593743714562823197]: 40?\n[Speaker 8593743714562823197]: Okay, perfect.\n[Speaker 8593743714562823197]: I have a question for you.\n[Speaker 8593743714562823197]: How do I?\n[Speaker 8593743714562823197]: Pt, isn't a part of like diagnostics or\u2026 like it's completely separate from those two groups.\n[Speaker 1372854872117518306]: Yeah.\n[Speaker 1372854872117518306]: ", "contextAfter": "\n[Speaker 1372854872117518306]: And within the pharma division, the research and development is separate organization if you want.\n[Speaker 1372854872117518306]: So, and then we have, the technical development.\n[Speaker 1372854872117518306]: So the process development unit, and then we have the commercial unit which is today basically produce the product in the end.\n[Speaker 1372854872117518306]: And those are the three big organizations and the research so pre and in the us is great.\n[Speaker 1372854872117518306]: The research units are larger than the technical development unit.\n[Speaker 1372854872117518306]: And also the commercial units are larger technical development.\n[Speaker 1372854872117518306]: Is, I mean, we have technical development activities in basel in pennsburg, and in san Francisco.\n[Speaker 1372854872117518306]: Mainly, I would say probably there are some other\u2026 sites where they also have technical development activities.\n[Speaker 1372854872117518306]: But those are ...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_commercial_unit_8e790857", "company": "roche", "gong_entity": "Commercial Unit", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "and then we have the commercial unit which is today basically produce the product in the end.", "snippet_date": "2024-06-14", "person_name": "Felix Kuhne", "person_email": "felix.kuhne@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "call_id": "2024-06-14_5820c7bc82da", "call_count": 1, "all_snippets": [{"quote": "and then we have the commercial unit which is today basically produce the product in the end.", "date": "2024-06-14", "callId": "2024-06-14_5820c7bc82da", "gongUrl": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "speakerId": "1372854872117518306", "customerName": "Felix Kuhne", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "felix.kuhne@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "...t of, right?\n[Speaker 8593743714562823197]: Yeah.\n[Speaker 8593743714562823197]: Got you.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: How many people are within that characterization of molecules group?\n[Speaker 1372854872117518306]: 40 roughly.\n[Speaker 8593743714562823197]: 40?\n[Speaker 8593743714562823197]: Okay, perfect.\n[Speaker 8593743714562823197]: I have a question for you.\n[Speaker 8593743714562823197]: How do I?\n[Speaker 8593743714562823197]: Pt, isn't a part of like diagnostics or\u2026 like it's completely separate from those two groups.\n[Speaker 1372854872117518306]: Yeah.\n[Speaker 1372854872117518306]: So we have the diagnostics, and then we have the pharma, yeah, separate divisions.\n[Speaker 1372854872117518306]: And within the pharma division, the research and development is separate organization if you want.\n[Speaker 1372854872117518306]: So, and then we have, the technical development.\n[Speaker 1372854872117518306]: So the process development unit, ", "contextAfter": "\n[Speaker 1372854872117518306]: And those are the three big organizations and the research so pre and in the us is great.\n[Speaker 1372854872117518306]: The research units are larger than the technical development unit.\n[Speaker 1372854872117518306]: And also the commercial units are larger technical development.\n[Speaker 1372854872117518306]: Is, I mean, we have technical development activities in basel in pennsburg, and in san Francisco.\n[Speaker 1372854872117518306]: Mainly, I would say probably there are some other\u2026 sites where they also have technical development activities.\n[Speaker 1372854872117518306]: But those are the main sites, I would say.\n[Speaker 8593743714562823197]: I understand.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: So pharma has like three, three main groups there's, the P red.\n[Speaker 8593743714562823197]: So like, the research side, and then there's the technical development.\n[Speaker 8593743714562823197]: And then commercial that, do...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_san_francisco_7a83a74a", "company": "roche", "gong_entity": "San Francisco", "gong_parent": "Roche R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Is, I mean, we have technical development activities in basel in pennsburg, and in san Francisco.", "snippet_date": "2024-06-14", "person_name": "Felix Kuhne", "person_email": "felix.kuhne@roche.com", "internal_name": "Jacqueline McCoskey; Sierra Barnes", "internal_email": "jacqueline@biorender.com; sierra.barnes@biorender.com", "llm_suggested_match": {"manual_node_id": "south-san-francisco-gred", "manual_node_name": "South San Francisco, CA (Genentech/gRED)", "manual_node_path": "Roche Research & Development > Global R&D Sites > South San Francisco, CA (Genentech/gRED)", "confidence": "high", "reasoning": "San Francisco reference clearly matches South San Francisco Genentech site, which is the main Roche R&D location in the SF Bay Area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "call_id": "2024-06-14_5820c7bc82da", "call_count": 1, "all_snippets": [{"quote": "Is, I mean, we have technical development activities in basel in pennsburg, and in san Francisco.", "date": "2024-06-14", "callId": "2024-06-14_5820c7bc82da", "gongUrl": "https://app.gong.io/call?id=5820c7bc82da1ab7b5ba65082d0aa97e43866d0e1683b8c8dd242cd3156c72ac", "speakerId": "1372854872117518306", "customerName": "Felix Kuhne", "internalName": "Jacqueline McCoskey; Sierra Barnes", "customerEmail": "felix.kuhne@roche.com", "internalEmail": "jacqueline@biorender.com; sierra.barnes@biorender.com", "sizeMentions": [], "contextBefore": "... How do I?\n[Speaker 8593743714562823197]: Pt, isn't a part of like diagnostics or\u2026 like it's completely separate from those two groups.\n[Speaker 1372854872117518306]: Yeah.\n[Speaker 1372854872117518306]: So we have the diagnostics, and then we have the pharma, yeah, separate divisions.\n[Speaker 1372854872117518306]: And within the pharma division, the research and development is separate organization if you want.\n[Speaker 1372854872117518306]: So, and then we have, the technical development.\n[Speaker 1372854872117518306]: So the process development unit, and then we have the commercial unit which is today basically produce the product in the end.\n[Speaker 1372854872117518306]: And those are the three big organizations and the research so pre and in the us is great.\n[Speaker 1372854872117518306]: The research units are larger than the technical development unit.\n[Speaker 1372854872117518306]: And also the commercial units are larger technical development.\n[Speaker 1372854872117518306]: ", "contextAfter": "\n[Speaker 1372854872117518306]: Mainly, I would say probably there are some other\u2026 sites where they also have technical development activities.\n[Speaker 1372854872117518306]: But those are the main sites, I would say.\n[Speaker 8593743714562823197]: I understand.\n[Speaker 8593743714562823197]: Okay.\n[Speaker 8593743714562823197]: So pharma has like three, three main groups there's, the P red.\n[Speaker 8593743714562823197]: So like, the research side, and then there's the technical development.\n[Speaker 8593743714562823197]: And then commercial that, do I have that correct?\n[Speaker 8593743714562823197]: Okay?\n[Speaker 1372854872117518306]: We trying to sugar?\n[Speaker 8593743714562823197]: This out for a while.\n[Speaker 8593743714562823197]: So this makes sense.\n[Speaker 1372854872117518306]: Commercial is the manufacturing.\n[Speaker 8593743714562823197]: And within like ptd, how large is that as like a, as a function?\n[Speaker 8593743714562823197]: I guess?\n[Speaker 1372854872117518306...", "callTitle": "BioRender & Roche - Follow Up Call"}]}, {"id": "roche_lysosome_lab_40320024", "company": "roche", "gong_entity": "Lysosome Lab", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I think the lab is like specifically called Lisa, some lab.", "snippet_date": "2024-04-23", "person_name": "Alexandra Gehrlein; Ravi Jagasia", "person_email": "alexandra.gehrlein@roche.com; ravi.jagasia@roche.com", "internal_name": "Jacqueline McCoskey; Tim Fung", "internal_email": "jacqueline@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=df2063e526abb86115551541ecff5d7c19c63dfd98f4edc20ebeed3d64f7b8fa", "call_id": "2024-04-23_df2063e526ab", "call_count": 1, "all_snippets": [{"quote": "I think the lab is like specifically called Lisa, some lab.", "date": "2024-04-23", "callId": "2024-04-23_df2063e526ab", "gongUrl": "https://app.gong.io/call?id=df2063e526abb86115551541ecff5d7c19c63dfd98f4edc20ebeed3d64f7b8fa", "speakerId": "1871910431500025892", "customerName": "Alexandra Gehrlein; Ravi Jagasia", "internalName": "Jacqueline McCoskey; Tim Fung", "customerEmail": "alexandra.gehrlein@roche.com; ravi.jagasia@roche.com", "internalEmail": "jacqueline@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...66583445532]: And yeah, still loving research in neuroscience.\n[Speaker 8885855354632213505]: Yeah.\n[Speaker 3339752518064847600]: Okay.\n[Speaker 3339752518064847600]: Is it neurons in rare disease or is that, yeah, are?\n[Speaker 1814248266583445532]: Exactly.\n[Speaker 1814248266583445532]: Yeah.\n[Speaker 1814248266583445532]: Okay.\n[Speaker 1814248266583445532]: That's how.\n[Speaker 1814248266583445532]: Okay.\n[Speaker 1814248266583445532]: All.\n[Speaker 3339752518064847600]: Yeah.\n[Speaker 3339752518064847600]: And are you within like a smaller group within that as well?\n[Speaker 3339752518064847600]: I guess like or is like a smaller group that you specialize in something?\n[Speaker 3339752518064847600]: Or is it just neuro side?\n[Speaker 3339752518064847600]: Yeah, yeah.\n[Speaker 1814248266583445532]: Yes.\n[Speaker 1814248266583445532]: Yeah, I mean, we do.\n[Speaker 1871910431500025892]: Is lysosoms\u2026 yeah.\n[Speaker 1871910431500025892]: Yeah, exactly.\n[Speaker 1871910431500025892]: ", "contextAfter": "\n[Speaker 3339752518064847600]: Cool.\n[Speaker 3339752518064847600]: Okay.\n[Speaker 3339752518064847600]: How many people are in the lab?\n[Speaker 3339752518064847600]: Curious?\n[Speaker 1871910431500025892]: Not many.\n[Speaker 1871910431500025892]: Okay?\n[Speaker 3339752518064847600]: Okay.\n[Speaker 1871910431500025892]: How many people are in the lab, Alex?\n[Speaker 1814248266583445532]: Well, with you, it's five people.\n[Speaker 3339752518064847600]: Okay, perfect.\n[Speaker 3339752518064847600]: So.\n[Speaker 1871910431500025892]: Yeah, exactly.\n[Speaker 1871910431500025892]: So right now, it's three associates and one scientist.\n[Speaker 1871910431500025892]: Okay?\n[Speaker 1871910431500025892]: And so it used to be a lot larger but I, I'm kind of a micro manager.\n[Speaker 1871910431500025892]: Well, I like to think I'm a micro manager and the science was getting a little bit.\n[Speaker 1871910431500025892]: The quality of the science was getting a bit bad.\n[Speaker 18719104315000258...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_r&d_7cf7cb4e", "company": "roche", "gong_entity": "R&D", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I'm in R and D.", "snippet_date": "2024-04-16", "person_name": "", "person_email": "juliane.benz@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "roche-rd", "manual_node_name": "Roche Research & Development", "manual_node_path": "Roche Research & Development", "confidence": "high", "reasoning": "Direct acronym match for Roche Research & Development, the top-level R&D organization"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=709ead3935e2ad83e19cc626e637fd33611c45540648fe5156b451c9bb0a58e3", "call_id": "2024-04-16_709ead3935e2", "call_count": 1, "all_snippets": [{"quote": "So I'm in R and D.", "date": "2024-04-16", "callId": "2024-04-16_709ead3935e2", "gongUrl": "https://app.gong.io/call?id=709ead3935e2ad83e19cc626e637fd33611c45540648fe5156b451c9bb0a58e3", "speakerId": "2852946406941478705", "customerName": "", "internalName": "Jacqueline McCoskey", "customerEmail": "juliane.benz@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "... you're hoping to gather today besides like pricing for your depart for your group?\n[Speaker 2207004362524546456]: Or was that kind of the primary thing you?\n[Speaker 2852946406941478705]: Yeah.\n[Speaker 2852946406941478705]: I think the primary thing is, to get to know which options would be there, to get a license for our team department.\n[Speaker 2852946406941478705]: Yeah.\n[Speaker 2207004362524546456]: Okay, perfect.\n[Speaker 2207004362524546456]: And so I have a couple of questions just to kind of understand, you know, the team and the setup.\n[Speaker 2207004362524546456]: And then we can figure out like what would be the best option\u2026 to start.\n[Speaker 2207004362524546456]: Do you mind giving me?\n[Speaker 2207004362524546456]: Like, I know you're in diagnostics, but do you mind giving me a sort of overview in terms of like the team and department that you sit within in here?\n[Speaker 2207004362524546456]: Yeah.\n[Speaker 2852946406941478705]: Yeah.\n[Speaker 2852946406941478705]: ", "contextAfter": "\n[Speaker 2852946406941478705]: Yeah, in the department of protein chemistry.\n[Speaker 2852946406941478705]: Okay?\n[Speaker 2852946406941478705]: And so our whole department is around 150 members.\n[Speaker 2852946406941478705]: And I think for example, frank cone, he's one of my colleagues.\n[Speaker 2852946406941478705]: He's also in the protein chemistry department.\n[Speaker 2852946406941478705]: I think he approached you almost a year ago because he had the same question.\n[Speaker 2207004362524546456]: Yeah.\n[Speaker 2852946406941478705]: And I think he now has some individual licenses.\n[Speaker 2207004362524546456]: Yep.\n[Speaker 2852946406941478705]: But yeah, it pops up in our department from time to time, we were thinking if there would be an option just with, I don't know 10 or dependent on how you offer it floating licences, for our whole department.\n[Speaker 2852946406941478705]: Yeah.\n[Speaker 2207004362524546456]: Yeah.\n[Speaker 2207004362524546456]: Okay.\n[Speaker 220700436...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_diabetes_care_a4ca8ae2", "company": "roche", "gong_entity": "Diabetes Care", "gong_parent": "Roche R&D", "entity_type": "business_unit", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "And then within dy that also kinda includes\u2026 diabetes care, and some other kind of subsidiary businesses like sequencing solutions, things like that.", "snippet_date": "2024-03-19", "person_name": "", "person_email": "alexander.brown@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "diabetes-care-rd", "manual_node_name": "Diabetes Care R&D", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Diabetes Care R&D", "confidence": "high", "reasoning": "Exact match with Diabetes Care R&D team under Roche Diagnostics, mentioned as subsidiary business which aligns with diagnostics division"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=9e91cefedfc0ec5b5b59b080184b441a077782ac8879391f8ae96ded7ab9bd9a", "call_id": "2024-03-19_9e91cefedfc0", "call_count": 1, "all_snippets": [{"quote": "And then within dy that also kinda includes\u2026 diabetes care, and some other kind of subsidiary businesses like sequencing solutions, things like that.", "date": "2024-03-19", "callId": "2024-03-19_9e91cefedfc0", "gongUrl": "https://app.gong.io/call?id=9e91cefedfc0ec5b5b59b080184b441a077782ac8879391f8ae96ded7ab9bd9a", "speakerId": "1570913027692445240", "customerName": "", "internalName": "Jacqueline McCoskey", "customerEmail": "alexander.brown@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...t of like how like where you're located and that kind of like organizationally where you fit in there?\n[Speaker 1570913027692445240]: Yeah.\n[Speaker 1570913027692445240]: I think I'll just have to give you like a verbal, we have all these kind of it's over 100,000 people in the company.\n[Speaker 1570913027692445240]: So there's like hierarchy org, charts and stuff, which is a useful reference point.\n[Speaker 1570913027692445240]: But I don't know if I can actually share my screen for showing you that.\n[Speaker 1570913027692445240]: But yeah, yeah.\n[Speaker 1570913027692445240]: So\u2026 we're I, I'm in diagnostics part of the greater Roche business.\n[Speaker 1570913027692445240]: I don't know the headcount of people india, but maybe it is\u2026 a quarter of the company because it makes up about a quarter of the revenue, something like that.\n[Speaker 1570913027692445240]: Okay?\n[Speaker 1570913027692445240]: But still 25,000 people, something like that.\n[Speaker 1570913027692445240]: And then I, ", "contextAfter": "\n[Speaker 1570913027692445240]: But I'm in R and D.\n[Speaker 1570913027692445240]: So we call this research and early development.\n[Speaker 1570913027692445240]: And then I'm also working a team in anti body development.\n[Speaker 1570913027692445240]: So for my purposes, I would want it for the greater R and D aspects of the diagnostics business.\n[Speaker 1570913027692445240]: And then I'm at the very earliest stages of this R and D pipeline in discovery.\n[Speaker 1570913027692445240]: So we come up with, very much like the academic side of things where you're kind of figuring out what is an interesting idea.\n[Speaker 1570913027692445240]: How do we test like the minimum viable way of testing that and then pass it off to somebody in more downstream development if it has like, yeah, yeah.\n[Speaker 7332779724309139706]: Hey, I appreciate that overview.\n[Speaker 7332779724309139706]: I am curious because it sounds like you have some good context here.\n[Speaker 7332779724309139706]: What i...", "callTitle": "BioRender | Roche Diagnostics"}]}, {"id": "roche_sequencing_solutions_030e69ea", "company": "roche", "gong_entity": "Sequencing Solutions", "gong_parent": "Roche R&D", "entity_type": "business_unit", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "And then within dy that also kinda includes\u2026 diabetes care, and some other kind of subsidiary businesses like sequencing solutions, things like that.", "snippet_date": "2024-03-19", "person_name": "", "person_email": "alexander.brown@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "sequencing-technologies", "manual_node_name": "Sequencing Technologies", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Molecular Diagnostics R&D > Sequencing Technologies", "confidence": "medium", "reasoning": "Close match between Sequencing Solutions and Sequencing Technologies team. Context suggests subsidiary business which fits under diagnostics"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=9e91cefedfc0ec5b5b59b080184b441a077782ac8879391f8ae96ded7ab9bd9a", "call_id": "2024-03-19_9e91cefedfc0", "call_count": 1, "all_snippets": [{"quote": "And then within dy that also kinda includes\u2026 diabetes care, and some other kind of subsidiary businesses like sequencing solutions, things like that.", "date": "2024-03-19", "callId": "2024-03-19_9e91cefedfc0", "gongUrl": "https://app.gong.io/call?id=9e91cefedfc0ec5b5b59b080184b441a077782ac8879391f8ae96ded7ab9bd9a", "speakerId": "1570913027692445240", "customerName": "", "internalName": "Jacqueline McCoskey", "customerEmail": "alexander.brown@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...t of like how like where you're located and that kind of like organizationally where you fit in there?\n[Speaker 1570913027692445240]: Yeah.\n[Speaker 1570913027692445240]: I think I'll just have to give you like a verbal, we have all these kind of it's over 100,000 people in the company.\n[Speaker 1570913027692445240]: So there's like hierarchy org, charts and stuff, which is a useful reference point.\n[Speaker 1570913027692445240]: But I don't know if I can actually share my screen for showing you that.\n[Speaker 1570913027692445240]: But yeah, yeah.\n[Speaker 1570913027692445240]: So\u2026 we're I, I'm in diagnostics part of the greater Roche business.\n[Speaker 1570913027692445240]: I don't know the headcount of people india, but maybe it is\u2026 a quarter of the company because it makes up about a quarter of the revenue, something like that.\n[Speaker 1570913027692445240]: Okay?\n[Speaker 1570913027692445240]: But still 25,000 people, something like that.\n[Speaker 1570913027692445240]: And then I, ", "contextAfter": "\n[Speaker 1570913027692445240]: But I'm in R and D.\n[Speaker 1570913027692445240]: So we call this research and early development.\n[Speaker 1570913027692445240]: And then I'm also working a team in anti body development.\n[Speaker 1570913027692445240]: So for my purposes, I would want it for the greater R and D aspects of the diagnostics business.\n[Speaker 1570913027692445240]: And then I'm at the very earliest stages of this R and D pipeline in discovery.\n[Speaker 1570913027692445240]: So we come up with, very much like the academic side of things where you're kind of figuring out what is an interesting idea.\n[Speaker 1570913027692445240]: How do we test like the minimum viable way of testing that and then pass it off to somebody in more downstream development if it has like, yeah, yeah.\n[Speaker 7332779724309139706]: Hey, I appreciate that overview.\n[Speaker 7332779724309139706]: I am curious because it sounds like you have some good context here.\n[Speaker 7332779724309139706]: What i...", "callTitle": "BioRender | Roche Diagnostics"}]}, {"id": "roche_antibody_development_07e1667e", "company": "roche", "gong_entity": "Antibody Development", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then I'm also working a team in anti body development.", "snippet_date": "2024-03-19", "person_name": "", "person_email": "alexander.brown@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "antibody-engineering-pred", "manual_node_name": "Antibody Engineering", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Therapeutic Modalities > Antibody Engineering", "confidence": "medium", "reasoning": "Antibody Development closely matches Antibody Engineering team. Both involve antibody-related work, though development vs engineering have slightly different focus"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=9e91cefedfc0ec5b5b59b080184b441a077782ac8879391f8ae96ded7ab9bd9a", "call_id": "2024-03-19_9e91cefedfc0", "call_count": 1, "all_snippets": [{"quote": "And then I'm also working a team in anti body development.", "date": "2024-03-19", "callId": "2024-03-19_9e91cefedfc0", "gongUrl": "https://app.gong.io/call?id=9e91cefedfc0ec5b5b59b080184b441a077782ac8879391f8ae96ded7ab9bd9a", "speakerId": "1570913027692445240", "customerName": "", "internalName": "Jacqueline McCoskey", "customerEmail": "alexander.brown@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...45240]: So there's like hierarchy org, charts and stuff, which is a useful reference point.\n[Speaker 1570913027692445240]: But I don't know if I can actually share my screen for showing you that.\n[Speaker 1570913027692445240]: But yeah, yeah.\n[Speaker 1570913027692445240]: So\u2026 we're I, I'm in diagnostics part of the greater Roche business.\n[Speaker 1570913027692445240]: I don't know the headcount of people india, but maybe it is\u2026 a quarter of the company because it makes up about a quarter of the revenue, something like that.\n[Speaker 1570913027692445240]: Okay?\n[Speaker 1570913027692445240]: But still 25,000 people, something like that.\n[Speaker 1570913027692445240]: And then I, and then within dy that also kinda includes\u2026 diabetes care, and some other kind of subsidiary businesses like sequencing solutions, things like that.\n[Speaker 1570913027692445240]: But I'm in R and D.\n[Speaker 1570913027692445240]: So we call this research and early development.\n[Speaker 1570913027692445240]: ", "contextAfter": "\n[Speaker 1570913027692445240]: So for my purposes, I would want it for the greater R and D aspects of the diagnostics business.\n[Speaker 1570913027692445240]: And then I'm at the very earliest stages of this R and D pipeline in discovery.\n[Speaker 1570913027692445240]: So we come up with, very much like the academic side of things where you're kind of figuring out what is an interesting idea.\n[Speaker 1570913027692445240]: How do we test like the minimum viable way of testing that and then pass it off to somebody in more downstream development if it has like, yeah, yeah.\n[Speaker 7332779724309139706]: Hey, I appreciate that overview.\n[Speaker 7332779724309139706]: I am curious because it sounds like you have some good context here.\n[Speaker 7332779724309139706]: What is like the primary difference between the diagnostic side of the business versus like red and like the pharma side?\n[Speaker 1570913027692445240]: Yeah.\n[Speaker 1570913027692445240]: The diagnose is in part plays a supp...", "callTitle": "BioRender | Roche Diagnostics"}]}, {"id": "roche_global_procurement_team_c87ace65", "company": "roche", "gong_entity": "Global Procurement Team", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So, yeah, a quick one for me, a global procurement team here at rush.", "snippet_date": "2024-03-18", "person_name": "Bernardo Antunes", "person_email": "bernardo.antunes@roche.com", "internal_name": "Jacqueline McCoskey; Jeff Roy; Tim Fung", "internal_email": "jacqueline@biorender.com; jeff@biorender.com; tim@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=71c284a8112f250251fc1967da72ae3509b4268e0c901b6f35d058d223161d61", "call_id": "2024-03-18_71c284a8112f", "call_count": 1, "all_snippets": [{"quote": "So, yeah, a quick one for me, a global procurement team here at rush.", "date": "2024-03-18", "callId": "2024-03-18_71c284a8112f", "gongUrl": "https://app.gong.io/call?id=71c284a8112f250251fc1967da72ae3509b4268e0c901b6f35d058d223161d61", "speakerId": "7561597607623908374", "customerName": "Bernardo Antunes", "internalName": "Jacqueline McCoskey; Jeff Roy; Tim Fung", "customerEmail": "bernardo.antunes@roche.com", "internalEmail": "jacqueline@biorender.com; jeff@biorender.com; tim@biorender.com", "sizeMentions": [], "contextBefore": "...aving some issues with his Okta, being overseas so, but I wanted to introduce you to Tim anyways.\n[Speaker 486063500795366637]: Tim.\n[Speaker 486063500795366637]: Do you wanna kind of introduce himself?\n[Speaker 486063500795366637]: I'm not sure if you guys have been on e-mail threads together or not.\n[Speaker 486063500795366637]: But, yeah.\n[Speaker 8002851032859057093]: Maybe, but yeah, no, Bernardo.\n[Speaker 8002851032859057093]: It's good to meet you.\n[Speaker 8002851032859057093]: I work closely with Jacqueline to support the scientists at both Roche and genentech\u2026 to make sure they're getting the most value from the platform.\n[Speaker 8002851032859057093]: So, you know, joining this call to just learn more about, you know, the future plans for the buyer under license and just really excited to get to work with you to continue making BioRender success?\n[Speaker 7561597607623908374]: Yeah, thanks, Sam.\n[Speaker 7561597607623908374]: Nice to meet you.\n[Speaker 7561597607623908374]: ", "contextAfter": "\n[Speaker 7561597607623908374]: So I've been working with this by render Renewal and master contract as well that we're trying to get over the line.\n[Speaker 7561597607623908374]: This proving to be a little bit more tricky than we expected at first.\n[Speaker 7561597607623908374]: I think\u2026 thanks Jacqueline again.\n[Speaker 7561597607623908374]: Yeah, no problem.\n[Speaker 7561597607623908374]: Nice to see you too.\n[Speaker 486063500795366637]: Okay.\n[Speaker 486063500795366637]: I was hoping, I know that we had our daylight savings like two weeks ago, and I don't think you guys have had it yet.\n[Speaker 486063500795366637]: So, I was hoping that the timing wasn't wrong in your calendar because I just moved it out a couple of weeks.\n[Speaker 486063500795366637]: So I'm happy you're able to make it today.\n[Speaker 7561597607623908374]: It's fine.\n[Speaker 7561597607623908374]: And I'm happy, to keep this going.\n[Speaker 7561597607623908374]: I think we might want to start just to put an a...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_lab_science_research_diagnostic_group_725c1fc0", "company": "roche", "gong_entity": "Lab Science Research Diagnostic Group", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So people are in the lab science research diagnostic group.", "snippet_date": "2024-03-08", "person_name": "Ruichen Zheng", "person_email": "ren.zheng.rz1@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "roche-diagnostics-rd", "manual_node_name": "Roche Diagnostics R&D", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D", "confidence": "medium", "reasoning": "The entity mentions 'lab science research diagnostic' which aligns with Roche Diagnostics R&D division that encompasses laboratory-based diagnostic research activities"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ea7c76d3d479bbd5090a53006dba841aa0be1364416d73a124d9cb8809d692d8", "call_id": "2024-03-08_ea7c76d3d479", "call_count": 1, "all_snippets": [{"quote": "So people are in the lab science research diagnostic group.", "date": "2024-03-08", "callId": "2024-03-08_ea7c76d3d479", "gongUrl": "https://app.gong.io/call?id=ea7c76d3d479bbd5090a53006dba841aa0be1364416d73a124d9cb8809d692d8", "speakerId": "5412767455533012515", "customerName": "Ruichen Zheng", "internalName": "Jacqueline McCoskey", "customerEmail": "ren.zheng.rz1@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...100221]: I'm the dedicated account up here at brand for Roche, so I can provide you all sort of the context\u2026 in terms of like what's going on right now before doing that.\n[Speaker 6692052275950100221]: Do you mind providing me a little bit of an overview of what you're hoping to gather today just to make sure I can answer your questions properly.\n[Speaker 6692052275950100221]: Okay?\n[Speaker 5412767455533012515]: Okay.\n[Speaker 5412767455533012515]: So, can you repeat that?\n[Speaker 5412767455533012515]: I, someone I had to answer someone's questions?\n[Speaker 6692052275950100221]: No worries.\n[Speaker 6692052275950100221]: Yeah, I was just gonna say, I know that you have reached out, but I was hoping to get a better sense of like exactly what you're looking for, just to make sure I answer all your questions properly.\n[Speaker 5412767455533012515]: Yes.\n[Speaker 5412767455533012515]: So here in the Seattle team, we have a little bit less than 100 people.\n[Speaker 5412767455533012515]: ", "contextAfter": "\n[Speaker 5412767455533012515]: So within Rose, there's all these offices across United States, you know, Europe and everything we primarily work with people in the United States and Europe.\n[Speaker 5412767455533012515]: Okay.\n[Speaker 5412767455533012515]: And, I reached out to product managers within Rose and no one really knows who has additional information for is not related to, you know, the product manager.\n[Speaker 5412767455533012515]: They don't know anything of that or maybe I'm just not reaching the correct product manager.\n[Speaker 5412767455533012515]: Yes, there are many within.\n[Speaker 5412767455533012515]: Yeah, and not all the information is transparent.\n[Speaker 5412767455533012515]: So we have a couple teams that want to use the BioRender web product.\n[Speaker 5412767455533012515]: I don't know what they call it specifically because I don't use that product, but I'm on their behalf, I'm trying to get more information because it seems like Roche agent is on the fro...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_ptd_group_6bd78a19", "company": "roche", "gong_entity": "PTD Group", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "we have been getting numerous requests from diagnostics as well as from the ptd sort of group", "snippet_date": "2024-03-08", "person_name": "Ruichen Zheng", "person_email": "ren.zheng.rz1@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=ea7c76d3d479bbd5090a53006dba841aa0be1364416d73a124d9cb8809d692d8", "call_id": "2024-03-08_ea7c76d3d479", "call_count": 1, "all_snippets": [{"quote": "we have been getting numerous requests from diagnostics as well as from the ptd sort of group", "date": "2024-03-08", "callId": "2024-03-08_ea7c76d3d479", "gongUrl": "https://app.gong.io/call?id=ea7c76d3d479bbd5090a53006dba841aa0be1364416d73a124d9cb8809d692d8", "speakerId": "6692052275950100221", "customerName": "Ruichen Zheng", "internalName": "Jacqueline McCoskey", "customerEmail": "ren.zheng.rz1@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "... diagnostics group, is that right?\n[Speaker 5412767455533012515]: Yes.\n[Speaker 5412767455533012515]: Okay.\n[Speaker 5412767455533012515]: Not the, and it's on the side, not a side, yes.\n[Speaker 6692052275950100221]: Okay.\n[Speaker 6692052275950100221]: So you're on the Roach diagnostics?\n[Speaker 6692052275950100221]: So let me give you a little bit of context right now.\n[Speaker 6692052275950100221]: So currently, we have basically by under access for every single person in genentech\u2026 primarily the it's funded by the G red folks.\n[Speaker 6692052275950100221]: And then at Roche, the P red folks have full sort of like access for every single person in pre.\n[Speaker 6692052275950100221]: Amazing.\n[Speaker 6692052275950100221]: So.\n[Speaker 5412767455533012515]: Yeah, the Utica side for now, I\u2026\n[Speaker 6692052275950100221]: They, are like one of our largest customers actually.\n[Speaker 6692052275950100221]: So, they, you know, we're really widespread in that side of the business, but ", "contextAfter": ".\n[Speaker 6692052275950100221]: And, it's funny you reached out now because we're in talks right now to try to figure out a way to make it available on a larger scale.\n[Speaker 6692052275950100221]: Like for everyone at Roche\u2026 I actually spoke with someone earlier this week and we're trying to figure out a way to sort of incorporate your group within there.\n[Speaker 6692052275950100221]: If you wanted.\n[Speaker 6692052275950100221]: Let me give you the name of the person that I've been working with.\n[Speaker 6692052275950100221]: His name is Bernardo and he is the person who's sort of working through the contracting.\n[Speaker 6692052275950100221]: So if you're able to reach out to him and let him know that your group is interested, I'll pass that information along as well.\n[Speaker 6692052275950100221]: I have like biweekly meetings with him but it'll at least allow him to understand sort of where these requests are coming from.\n[Speaker 6692052275950100221]: His name is Bernardo and ...", "callTitle": "BioRender | Roche"}]}, {"id": "roche_information_management_unit_f419ca45", "company": "roche", "gong_entity": "Information Management Unit", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "but I'm looking now to get a temporary job information management unit with which I'm working since", "snippet_date": "2023-12-21", "person_name": "Steffen Sachse", "person_email": "steffen.sachse@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "roche-information-solutions", "manual_node_name": "Roche Information Solutions (RIS)", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Information Solutions (RIS)", "confidence": "medium", "reasoning": "Information Management Unit aligns semantically with Roche Information Solutions which handles laboratory informatics and data management systems"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=09122fbe3555fd95d085e795f3188361f3a762e8739488a2f956628ee75b7f3c", "call_id": "2023-12-21_09122fbe3555", "call_count": 1, "all_snippets": [{"quote": "but I'm looking now to get a temporary job information management unit with which I'm working since", "date": "2023-12-21", "callId": "2023-12-21_09122fbe3555", "gongUrl": "https://app.gong.io/call?id=09122fbe3555fd95d085e795f3188361f3a762e8739488a2f956628ee75b7f3c", "speakerId": "405267528710156760", "customerName": "Steffen Sachse", "internalName": "Jacqueline McCoskey", "customerEmail": "steffen.sachse@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...e the look at the pieces like it's a product.\n[Speaker 641129010400056043]: Yes.\n[Speaker 405267528710156760]: Yeah.\n[Speaker 405267528710156760]: I am a product owner.\n[Speaker 405267528710156760]: Yeah.\n[Speaker 641129010400056043]: Yeah.\n[Speaker 641129010400056043]: Okay.\n[Speaker 405267528710156760]: So, it, yeah, it, is a\u2026\n[Speaker 641129010400056043]: Well, that's such terrible days before the holiday.\n[Speaker 641129010400056043]: And so, are you gonna just like, are you gonna retire earlier?\n[Speaker 641129010400056043]: What are you, what are you thinking?\n[Speaker 641129010400056043]: Are you gonna try to find something part time or?\n[Speaker 405267528710156760]: No, I, so I'm going to stop working end of June next year.\n[Speaker 405267528710156760]: Okay?\n[Speaker 405267528710156760]: So normally, my, I would set free for six months.\n[Speaker 641129010400056043]: Okay.\n[Speaker 405267528710156760]: Page\u2026\n[Speaker 641129010400056043]: Yep.\n[Speaker 405267528710156760]: And, ", "contextAfter": ".\n[Speaker 641129010400056043]: Yeah.\n[Speaker 641129010400056043]: Okay.\n[Speaker 405267528710156760]: This is an option to extend it a bit.\n[Speaker 405267528710156760]: And then I have two other years I'm paid that sitting at home and watching the stars?\n[Speaker 641129010400056043]: You deserve it.\n[Speaker 641129010400056043]: You should go on another nice road trip.\n[Speaker 405267528710156760]: I question.\n[Speaker 641129010400056043]: Take some time to go skiing and, you know, you've worked so hard for so long, so.\n[Speaker 405267528710156760]: So that's what I said.\n[Speaker 405267528710156760]: We have very good social plans.\n[Speaker 641129010400056043]: That's good if\u2026\n[Speaker 405267528710156760]: You long enough as a companies and.\n[Speaker 641129010400056043]: How long have you been at row for?\n[Speaker 405267528710156760]: Since 1997.\n[Speaker 405267528710156760]: So, 27 years?\n[Speaker 641129010400056043]: Wow.\n[Speaker 641129010400056043]: My goodness.\n[Speaker 405267...", "callTitle": "BioRender/Roche"}]}, {"id": "roche_protein_science_79cff514", "company": "roche", "gong_entity": "Protein Science", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "No, I'm yeah, just a research associate in protein science.", "snippet_date": "2023-11-28", "person_name": "Deborah Barbiera", "person_email": "deborah.khalfa@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "protein-therapeutics-gred", "manual_node_name": "Protein Therapeutics", "manual_node_path": "Roche Research & Development > Genentech Research & Early Development (gRED) > Therapeutic Discovery (gRED) > Protein Therapeutics", "confidence": "medium", "reasoning": "Protein Science as a research area closely aligns with the Protein Therapeutics team under gRED's Therapeutic Discovery department"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=5e9c217f6a5658fddd3225b2f321d69bbe52d1a894d088c201a57cd79c07921c", "call_id": "2023-11-28_5e9c217f6a56", "call_count": 1, "all_snippets": [{"quote": "No, I'm yeah, just a research associate in protein science.", "date": "2023-11-28", "callId": "2023-11-28_5e9c217f6a56", "gongUrl": "https://app.gong.io/call?id=5e9c217f6a5658fddd3225b2f321d69bbe52d1a894d088c201a57cd79c07921c", "speakerId": "5767840400232346805", "customerName": "Deborah Barbiera", "internalName": "Jacqueline McCoskey", "customerEmail": "deborah.khalfa@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...because it's only access for P red right now.\n[Speaker 864296496783148867]: But yeah, if that, if you were able to get access and use it for your presentation, then we.\n[Speaker 5767840400232346805]: Yeah.\n[Speaker 5767840400232346805]: Actually, I tried a few years a few months ago and it didn't work.\n[Speaker 5767840400232346805]: And now, because I need it, I really needed it in the last few days, I tried again and they gave me the access.\n[Speaker 5767840400232346805]: They get me, the license.\n[Speaker 5767840400232346805]: I don't know why it changed but yeah, I\u2026\n[Speaker 864296496783148867]: Have you always been a part of red or?\n[Speaker 864296496783148867]: Okay.\n[Speaker 864296496783148867]: That's weird that you weren't able to get access the first time then.\n[Speaker 864296496783148867]: So are you just a couple of questions?\n[Speaker 864296496783148867]: Like are you part of, the post of association or are you like within a specific section?\n[Speaker 5767840400232346805]: ", "contextAfter": "\n[Speaker 864296496783148867]: Sciences.\n[Speaker 864296496783148867]: Okay, perfect.\n[Speaker 864296496783148867]: That makes sense.\n[Speaker 864296496783148867]: Okay.\n[Speaker 864296496783148867]: Well, that's great.\n[Speaker 864296496783148867]: I am happy were able to get access, then we probably, if you need anything, feel free to send me an e-mail but if not, we can probably cut the short.\n[Speaker 864296496783148867]: Okay?\n[Speaker 5767840400232346805]: I\u2026\n[Speaker 864296496783148867]: Asked to start just one other question.\n[Speaker 864296496783148867]: Did you use it or do you use the poster builder or did you use\u2026 a like to create the images for the poster?\n[Speaker 5767840400232346805]: To create the images?\n[Speaker 5767840400232346805]: Like you can just print it like Charlie.\n[Speaker 5767840400232346805]: Awesome.\n[Speaker 5767840400232346805]: That's so good.\n[Speaker 5767840400232346805]: I just printed here now.\n[Speaker 5767840400232346805]: So like it's not, the b...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_recombinant_proteins_and_display_technologies_b4766f45", "company": "roche", "gong_entity": "Recombinant Proteins and Display Technologies", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Group group is, we have basically six scientists and myself as a group lead.", "snippet_date": "2023-02-28", "person_name": "Frank Kroner; Simone T\u00e4uber", "person_email": "frank.kroner@roche.com; simone.taeuber@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "protein-therapeutics-gred", "manual_node_name": "Protein Therapeutics", "manual_node_path": "Roche Research & Development > Genentech Research & Early Development (gRED) > Therapeutic Discovery (gRED) > Protein Therapeutics", "confidence": "medium", "reasoning": "Recombinant proteins and display technologies are core protein engineering activities that would fall under the Protein Therapeutics team's scope"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d6408c63cdc0bd4e889d57f8300d940678f3b584120ea4b701dbfc3b6bc48d54", "call_id": "2023-02-28_d6408c63cdc0", "call_count": 1, "all_snippets": [{"quote": "Group group is, we have basically six scientists and myself as a group lead.", "date": "2023-02-28", "callId": "2023-02-28_d6408c63cdc0", "gongUrl": "https://app.gong.io/call?id=d6408c63cdc0bd4e889d57f8300d940678f3b584120ea4b701dbfc3b6bc48d54", "speakerId": "312119473358144432", "customerName": "Frank Kroner; Simone T\u00e4uber", "internalName": "Jacqueline McCoskey", "customerEmail": "frank.kroner@roche.com; simone.taeuber@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "... know, groups continue to show that it's something that they find value from.\n[Speaker 6996033806919020033]: But yeah, like he had mentioned right now, it makes most sense to do groups here and there.\n[Speaker 6996033806919020033]: When did you speak with Stephen last?\n[Speaker 6996033806919020033]: Was it recently or?\n[Speaker 312119473358144432]: Last week?\n[Speaker 6996033806919020033]: Last week.\n[Speaker 6996033806919020033]: Okay.\n[Speaker 6996033806919020033]: Sounds good.\n[Speaker 6996033806919020033]: So within your group, is it, it's re, competent protines in display technologies?\n[Speaker 6996033806919020033]: Is that the group that you're looking to get access for?\n[Speaker 312119473358144432]: Yeah.\n[Speaker 6996033806919020033]: Okay, perfect.\n[Speaker 6996033806919020033]: And how many people are, do you mind giving me a little bit of a overview of like the organizational structure within that group?\n[Speaker 6996033806919020033]: Like how?\n[Speaker 312119473358144432]: ", "contextAfter": "\n[Speaker 312119473358144432]: Yeah.\n[Speaker 312119473358144432]: Yeah, I don't we don't need all of us.\n[Speaker 312119473358144432]: We will definitely not work.\n[Speaker 312119473358144432]: I don't know if the license model is for each person or if it's a kind of floating thing that we have access for three four fee because we will not work all the time, everyone at the same time.\n[Speaker 6996033806919020033]: Yeah.\n[Speaker 6996033806919020033]: So it is, it's not a floating license just because of the nature of the product.\n[Speaker 6996033806919020033]: It has to, we have to be able to tie the IP to an individual person.\n[Speaker 6996033806919020033]: So basically the premium license gives you the commercial rights to use it, you know, in your presentations, any publication, and yeah, it has to be tied to an individual person.\n[Speaker 6996033806919020033]: So within like your team is re competent proteins and display technologies.\n[Speaker 6996033806919020033]: Is that like i...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_design_and_analytics_department_0495def8", "company": "roche", "gong_entity": "Design and Analytics Department", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "No, we are part of the design and analytics department and then it goes up to the normal an.", "snippet_date": "2023-02-28", "person_name": "Frank Kroner; Simone T\u00e4uber", "person_email": "frank.kroner@roche.com; simone.taeuber@roche.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "data-analytics-pred", "manual_node_name": "Data & Analytics", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > Data & Analytics", "confidence": "medium", "reasoning": "Design and Analytics Department aligns with the Data & Analytics department under pRED, which handles analytical and computational work"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d6408c63cdc0bd4e889d57f8300d940678f3b584120ea4b701dbfc3b6bc48d54", "call_id": "2023-02-28_d6408c63cdc0", "call_count": 1, "all_snippets": [{"quote": "No, we are part of the design and analytics department and then it goes up to the normal an.", "date": "2023-02-28", "callId": "2023-02-28_d6408c63cdc0", "gongUrl": "https://app.gong.io/call?id=d6408c63cdc0bd4e889d57f8300d940678f3b584120ea4b701dbfc3b6bc48d54", "speakerId": "312119473358144432", "customerName": "Frank Kroner; Simone T\u00e4uber", "internalName": "Jacqueline McCoskey", "customerEmail": "frank.kroner@roche.com; simone.taeuber@roche.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": [], "contextBefore": "...ill definitely not work.\n[Speaker 312119473358144432]: I don't know if the license model is for each person or if it's a kind of floating thing that we have access for three four fee because we will not work all the time, everyone at the same time.\n[Speaker 6996033806919020033]: Yeah.\n[Speaker 6996033806919020033]: So it is, it's not a floating license just because of the nature of the product.\n[Speaker 6996033806919020033]: It has to, we have to be able to tie the IP to an individual person.\n[Speaker 6996033806919020033]: So basically the premium license gives you the commercial rights to use it, you know, in your presentations, any publication, and yeah, it has to be tied to an individual person.\n[Speaker 6996033806919020033]: So within like your team is re competent proteins and display technologies.\n[Speaker 6996033806919020033]: Is that like is there a department that it's a part of or is it like a standalone team or how does it sort of like lead up?\n[Speaker 312119473358144432]: ", "contextAfter": "\n[Speaker 6996033806919020033]: Yeah.\n[Speaker 6996033806919020033]: Okay, perfect.\n[Speaker 6996033806919020033]: But you're sort of your smaller group and Frank, you're the.\n[Speaker 312119473358144432]: Yeah, we're clear at the bottom.\n[Speaker 6996033806919020033]: Kind of, I understand.\n[Speaker 6996033806919020033]: Yep.\n[Speaker 6996033806919020033]: Okay.\n[Speaker 6996033806919020033]: Perfect.\n[Speaker 312119473358144432]: Once you have to do the work, you know, that.\n[Speaker 6996033806919020033]: Well, it's the most important thing to be able to move everything along.\n[Speaker 6996033806919020033]: So hopefully we can kind of help you with the solution.\n[Speaker 6996033806919020033]: And so there's six of you within your group specifically.\n[Speaker 6996033806919020033]: Okay, perfect.\n[Speaker 6996033806919020033]: And is it, are you Frank sort of the person that like decides on the budget if it's something you want to move forward with or is there other people that have to...", "callTitle": "BioRender & Roche - Intro Call"}]}, {"id": "roche_procurement_delivery_450bfe70", "company": "roche", "gong_entity": "Procurement Delivery", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Like I'm from procurement delivery.", "snippet_date": "2023-02-01", "person_name": "Piotr Motyka", "person_email": "piotr.motyka@roche.com", "internal_name": "Jacqueline McCoskey; Ryan Marien", "internal_email": "jacqueline@biorender.com; ryan@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=31630f3d5e317270a08cb661c9d40088999865a0a7d151f1379e2d7d530885d8", "call_id": "2023-02-01_31630f3d5e31", "call_count": 1, "all_snippets": [{"quote": "Like I'm from procurement delivery.", "date": "2023-02-01", "callId": "2023-02-01_31630f3d5e31", "gongUrl": "https://app.gong.io/call?id=31630f3d5e317270a08cb661c9d40088999865a0a7d151f1379e2d7d530885d8", "speakerId": "4266845445202854424", "customerName": "Piotr Motyka", "internalName": "Jacqueline McCoskey; Ryan Marien", "customerEmail": "piotr.motyka@roche.com", "internalEmail": "jacqueline@biorender.com; ryan@biorender.com", "sizeMentions": [], "contextBefore": "...266845445202854424]: She's more twice and Polish to be our.\n[Speaker 366761600293525338]: Bit above totally.\n[Speaker 366761600293525338]: Well, thanks so much for joining.\n[Speaker 366761600293525338]: I know it's probably later in your day, I guess at three 30 at this point, but that's\u2026\n[Speaker 4266845445202854424]: You have a few, no worries.\n[Speaker 366761600293525338]: Yep.\n[Speaker 366761600293525338]: Yep.\n[Speaker 366761600293525338]: Okay.\n[Speaker 366761600293525338]: Perfect.\n[Speaker 366761600293525338]: I know we, so we had a brief conversation yesterday and we just wanted to make sure we can clarify all the numbers for you.\n[Speaker 366761600293525338]: So everything looks good on your end.\n[Speaker 366761600293525338]: Is there anything off the bat that we can like answer before getting into that side of things Peter?\n[Speaker 4266845445202854424]: So I wanted maybe better to introduce myself and maybe speak a little bit on my role here.\n[Speaker 4266845445202854424]: ", "contextAfter": "\n[Speaker 4266845445202854424]: So I'm responsible for the contract.\n[Speaker 4266845445202854424]: We can say commercial conditions like conditions, this more operational part here.\n[Speaker 4266845445202854424]: Maria from my side is more working with the client being sort of business partner, adjusting or adapting to any strategies we may have in place et cetera.\n[Speaker 4266845445202854424]: I believe you experience certain chaos or a little bit and clarities around on our side and I can only say I'm sorry for that.\n[Speaker 4266845445202854424]: Let me put a little bit of background here, right?\n[Speaker 4266845445202854424]: So Rosh went through a pretty significant transformation on the way.\n[Speaker 4266845445202854424]: So working you probably heard it, but it has also some sort of price we're still handling with full adapting fully adapting to these new ways of working and some decision points or decision power was simply moved through that process.\n[Speaker 4266845445202854...", "callTitle": "BioRender/Roche"}]}, {"id": "roche_genentech_drug_delivery_team_b6f77000", "company": "roche", "gong_entity": "Genentech Drug Delivery Team", "gong_parent": "Roche R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "for example, if there's someone was inquiring on behalf of just their small team like the gen tech drug delivery team", "snippet_date": "2023-01-30", "person_name": "Maria Benitez Mendo; Piotr Motyka; Sandra Krause; Steffen Sachse", "person_email": "maria.benitez_mendo@roche.com; piotr.motyka@roche.com; sandra.krause@roche.com; steffen.sachse@roche.com", "internal_name": "Jacqueline McCoskey; Jeff Roy; Ryan Marien", "internal_email": "jacqueline@biorender.com; jeff@biorender.com; ryan@biorender.com", "llm_suggested_match": {"manual_node_id": "delivery-technologies", "manual_node_name": "Delivery Technologies", "manual_node_path": "Roche Research & Development > Pharma Research & Early Development (pRED) > RNAHub > Delivery Technologies", "confidence": "medium", "reasoning": "Drug delivery team from Genentech aligns with the Delivery Technologies team, though the parent organization differs (pRED vs gRED)"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=455e0f1c2599fe6545d8c161a06b8faa8ef1dc4b03fc11d0b2c9af0a2218ea06", "call_id": "2023-01-30_455e0f1c2599", "call_count": 1, "all_snippets": [{"quote": "for example, if there's someone was inquiring on behalf of just their small team like the gen tech drug delivery team", "date": "2023-01-30", "callId": "2023-01-30_455e0f1c2599", "gongUrl": "https://app.gong.io/call?id=455e0f1c2599fe6545d8c161a06b8faa8ef1dc4b03fc11d0b2c9af0a2218ea06", "speakerId": "6003822387281640535", "customerName": "Maria Benitez Mendo; Piotr Motyka; Sandra Krause; Steffen Sachse", "internalName": "Jacqueline McCoskey; Jeff Roy; Ryan Marien", "customerEmail": "maria.benitez_mendo@roche.com; piotr.motyka@roche.com; sandra.krause@roche.com; steffen.sachse@roche.com", "internalEmail": "jacqueline@biorender.com; jeff@biorender.com; ryan@biorender.com", "sizeMentions": [], "contextBefore": "...de of it.\n[Speaker 3180164249110616240]: And yeah, the column is the confirmed.\n[Speaker 4016691281058175566]: So just.\n[Speaker 6003822387281640535]: Just just so when we have been speaking to these groups, they, they've either inquired with Biorender at some point throughout the year.\n[Speaker 6003822387281640535]: And then we'd like to join a license or get a license.\n[Speaker 6003822387281640535]: And when we asked them how many people were in their group that they were inquiring on behalf, they gave us a number and that's the number and call.\n[Speaker 6003822387281640535]: So, for example, like tissue diagnostics, when they had required, they said there's up to a 1,000 people here who could use a license in our, on our teams.\n[Speaker 6003822387281640535]: They didn't commit to that at that point in time.\n[Speaker 6003822387281640535]: But that's what they were interested in potentially giving access to and so that's where the numbers come from.\n[Speaker 6003822387281640535]: So, ", "contextAfter": ", they were a small team.\n[Speaker 6003822387281640535]: And so they're just saying, well, we don't know, but anybody else, but we know we're looking for it.\n[Speaker 6003822387281640535]: Whereas larger teams like molecular labs, for example, they were inquiring, you know, for a larger group of individuals.\n[Speaker 8273574062362549103]: Thank you very much for the qualification.\n[Speaker 8273574062362549103]: So, this about the, or the people that, who call you?\n[Speaker 6003822387281640535]: That's right?\n[Speaker 8273574062362549103]: Was I missing, maybe just to understand the better today?\n[Speaker 8273574062362549103]: How many of those are you using today?\n[Speaker 8273574062362549103]: The licensing?\n[Speaker 6003822387281640535]: That's the part that we don't know exactly Stephen, you might have some better?\n[Speaker 4016691281058175566]: Information because we shared.\n[Speaker 6003822387281640535]: The, we have a list of free users, but on our side, we don't have visibility ...", "callTitle": "BioRender/Roche"}]}, {"id": "roche_tissue_diagnostics_7aa339b7", "company": "roche", "gong_entity": "Tissue Diagnostics", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": "1,000", "confidence": "high", "mention_count": 1, "snippet": "for example, like tissue diagnostics, when they had required, they said there's up to a 1,000 people here who could use a license in our, on our teams", "snippet_date": "2023-01-30", "person_name": "Maria Benitez Mendo; Piotr Motyka; Sandra Krause; Steffen Sachse", "person_email": "maria.benitez_mendo@roche.com; piotr.motyka@roche.com; sandra.krause@roche.com; steffen.sachse@roche.com", "internal_name": "Jacqueline McCoskey; Jeff Roy; Ryan Marien", "internal_email": "jacqueline@biorender.com; jeff@biorender.com; ryan@biorender.com", "llm_suggested_match": {"manual_node_id": "tissue-diagnostics-rd", "manual_node_name": "Tissue Diagnostics R&D (Ventana)", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Tissue Diagnostics R&D (Ventana)", "confidence": "high", "reasoning": "Exact match - Tissue Diagnostics directly corresponds to the Tissue Diagnostics R&D (Ventana) team in the manual org chart"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=455e0f1c2599fe6545d8c161a06b8faa8ef1dc4b03fc11d0b2c9af0a2218ea06", "call_id": "2023-01-30_455e0f1c2599", "call_count": 1, "all_snippets": [{"quote": "for example, like tissue diagnostics, when they had required, they said there's up to a 1,000 people here who could use a license in our, on our teams", "date": "2023-01-30", "callId": "2023-01-30_455e0f1c2599", "gongUrl": "https://app.gong.io/call?id=455e0f1c2599fe6545d8c161a06b8faa8ef1dc4b03fc11d0b2c9af0a2218ea06", "speakerId": "6003822387281640535", "customerName": "Maria Benitez Mendo; Piotr Motyka; Sandra Krause; Steffen Sachse", "internalName": "Jacqueline McCoskey; Jeff Roy; Ryan Marien", "customerEmail": "maria.benitez_mendo@roche.com; piotr.motyka@roche.com; sandra.krause@roche.com; steffen.sachse@roche.com", "internalEmail": "jacqueline@biorender.com; jeff@biorender.com; ryan@biorender.com", "sizeMentions": [{"value": "1,000", "snippetIndex": 0, "source": {"callDate": "2023-01-30", "customerName": "Maria Benitez Mendo; Piotr Motyka; Sandra Krause; Steffen Sachse"}}], "contextBefore": "...64249110616240]: We can.\n[Speaker 8273574062362549103]: Double check.\n[Speaker 8273574062362549103]: Sorry, just to understand the column B means what the number of the current license users?\n[Speaker 8273574062362549103]: What is it?\n[Speaker 3180164249110616240]: This was the original group size that they had inquired about, just their entire, sorry, their entire group that was more so like the internal side of it.\n[Speaker 3180164249110616240]: And yeah, the column is the confirmed.\n[Speaker 4016691281058175566]: So just.\n[Speaker 6003822387281640535]: Just just so when we have been speaking to these groups, they, they've either inquired with Biorender at some point throughout the year.\n[Speaker 6003822387281640535]: And then we'd like to join a license or get a license.\n[Speaker 6003822387281640535]: And when we asked them how many people were in their group that they were inquiring on behalf, they gave us a number and that's the number and call.\n[Speaker 6003822387281640535]: So, ", "contextAfter": ".\n[Speaker 6003822387281640535]: They didn't commit to that at that point in time.\n[Speaker 6003822387281640535]: But that's what they were interested in potentially giving access to and so that's where the numbers come from.\n[Speaker 6003822387281640535]: So, for example, if there's someone was inquiring on behalf of just their small team like the gen tech drug delivery team, they were a small team.\n[Speaker 6003822387281640535]: And so they're just saying, well, we don't know, but anybody else, but we know we're looking for it.\n[Speaker 6003822387281640535]: Whereas larger teams like molecular labs, for example, they were inquiring, you know, for a larger group of individuals.\n[Speaker 8273574062362549103]: Thank you very much for the qualification.\n[Speaker 8273574062362549103]: So, this about the, or the people that, who call you?\n[Speaker 6003822387281640535]: That's right?\n[Speaker 8273574062362549103]: Was I missing, maybe just to understand the better today?\n[Speaker 8273574062...", "callTitle": "BioRender/Roche"}]}, {"id": "roche_molecular_labs_cdff3a8c", "company": "roche", "gong_entity": "Molecular Labs", "gong_parent": "Roche R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Whereas larger teams like molecular labs, for example, they were inquiring, you know, for a larger group of individuals", "snippet_date": "2023-01-30", "person_name": "Maria Benitez Mendo; Piotr Motyka; Sandra Krause; Steffen Sachse", "person_email": "maria.benitez_mendo@roche.com; piotr.motyka@roche.com; sandra.krause@roche.com; steffen.sachse@roche.com", "internal_name": "Jacqueline McCoskey; Jeff Roy; Ryan Marien", "internal_email": "jacqueline@biorender.com; jeff@biorender.com; ryan@biorender.com", "llm_suggested_match": {"manual_node_id": "molecular-diagnostics-rd", "manual_node_name": "Molecular Diagnostics R&D", "manual_node_path": "Roche Research & Development > Roche Diagnostics R&D > Roche Diagnostics Solutions (RDS) > Molecular Diagnostics R&D", "confidence": "medium", "reasoning": "Molecular Labs aligns with Molecular Diagnostics R&D team which handles molecular-based diagnostic technologies and laboratory work"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=455e0f1c2599fe6545d8c161a06b8faa8ef1dc4b03fc11d0b2c9af0a2218ea06", "call_id": "2023-01-30_455e0f1c2599", "call_count": 1, "all_snippets": [{"quote": "Whereas larger teams like molecular labs, for example, they were inquiring, you know, for a larger group of individuals", "date": "2023-01-30", "callId": "2023-01-30_455e0f1c2599", "gongUrl": "https://app.gong.io/call?id=455e0f1c2599fe6545d8c161a06b8faa8ef1dc4b03fc11d0b2c9af0a2218ea06", "speakerId": "6003822387281640535", "customerName": "Maria Benitez Mendo; Piotr Motyka; Sandra Krause; Steffen Sachse", "internalName": "Jacqueline McCoskey; Jeff Roy; Ryan Marien", "customerEmail": "maria.benitez_mendo@roche.com; piotr.motyka@roche.com; sandra.krause@roche.com; steffen.sachse@roche.com", "internalEmail": "jacqueline@biorender.com; jeff@biorender.com; ryan@biorender.com", "sizeMentions": [], "contextBefore": "...7281640535]: And then we'd like to join a license or get a license.\n[Speaker 6003822387281640535]: And when we asked them how many people were in their group that they were inquiring on behalf, they gave us a number and that's the number and call.\n[Speaker 6003822387281640535]: So, for example, like tissue diagnostics, when they had required, they said there's up to a 1,000 people here who could use a license in our, on our teams.\n[Speaker 6003822387281640535]: They didn't commit to that at that point in time.\n[Speaker 6003822387281640535]: But that's what they were interested in potentially giving access to and so that's where the numbers come from.\n[Speaker 6003822387281640535]: So, for example, if there's someone was inquiring on behalf of just their small team like the gen tech drug delivery team, they were a small team.\n[Speaker 6003822387281640535]: And so they're just saying, well, we don't know, but anybody else, but we know we're looking for it.\n[Speaker 6003822387281640535]: ", "contextAfter": ".\n[Speaker 8273574062362549103]: Thank you very much for the qualification.\n[Speaker 8273574062362549103]: So, this about the, or the people that, who call you?\n[Speaker 6003822387281640535]: That's right?\n[Speaker 8273574062362549103]: Was I missing, maybe just to understand the better today?\n[Speaker 8273574062362549103]: How many of those are you using today?\n[Speaker 8273574062362549103]: The licensing?\n[Speaker 6003822387281640535]: That's the part that we don't know exactly Stephen, you might have some better?\n[Speaker 4016691281058175566]: Information because we shared.\n[Speaker 6003822387281640535]: The, we have a list of free users, but on our side, we don't have visibility into which of these teams they're on.\n[Speaker 6003822387281640535]: So we know that there's we know people have individually reached out to our sales team or our customer success team and re.\n[Speaker 831907104687983056]: It\u2026\n[Speaker 6003822387281640535]: Saying we want to join a license here's.\n[Speaker ...", "callTitle": "BioRender/Roche"}]}, {"id": "roche_pharmatech_da2ca410", "company": "roche", "gong_entity": "Pharmatech", "gong_parent": "Roche R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "usage within parmatech and diagnostics in particular won't justify the level of investment", "snippet_date": "2023-01-24", "person_name": "Steffen Sachse", "person_email": "steffen.sachse@roche.com", "internal_name": "Jacqueline McCoskey; Jeff Roy", "internal_email": "jacqueline@biorender.com; jeff@biorender.com", "llm_suggested_match": {"manual_node_id": "pharmaceutical-sciences-technical", "manual_node_name": "Pharmaceutical Sciences (Pharma Technical)", "manual_node_path": "Roche Research & Development > Pharmaceutical Sciences (Pharma Technical)", "confidence": "medium", "reasoning": "Entity 'Pharmatech' appears to be a shortened/informal reference to 'Pharmaceutical Sciences (Pharma Technical)' division. The context mentions 'parmatech and diagnostics' which aligns with the organizational structure where Pharma Technical and Diagnostics are separate major divisions under Roche R&D."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=db92f28c1736dea8839f8464787124151a954fd1dffe21be503f8acc506ccbea", "call_id": "2023-01-24_db92f28c1736", "call_count": 1, "all_snippets": [{"quote": "usage within parmatech and diagnostics in particular won't justify the level of investment", "date": "2023-01-24", "callId": "2023-01-24_db92f28c1736", "gongUrl": "https://app.gong.io/call?id=db92f28c1736dea8839f8464787124151a954fd1dffe21be503f8acc506ccbea", "speakerId": "6018236838595504557", "customerName": "Steffen Sachse", "internalName": "Jacqueline McCoskey; Jeff Roy", "customerEmail": "steffen.sachse@roche.com", "internalEmail": "jacqueline@biorender.com; jeff@biorender.com", "sizeMentions": [], "contextBefore": "...]: So, thanks for jumping on.\n[Speaker 353870122837205951]: I really appreciate it.\n[Speaker 353870122837205951]: So, yeah, Jeff had, sorry, Ryan had a chance to speak with Sandra yesterday, so we kinda wanted to just like fill you in on what our side of where it sounds like we're standing right now, but I guess before we do that, like is there anything from your side that you know, you feel is outstanding at this point or like any sort of like updates from what your team has at this point, right?\n[Speaker 3926970623126115238]: No, no.\n[Speaker 3926970623126115238]: Let's start with your update?\n[Speaker 3926970623126115238]: Yeah.\n[Speaker 353870122837205951]: Great.\n[Speaker 353870122837205951]: Yeah, perfect.\n[Speaker 6018236838595504557]: I'll maybe kick us out cause I had a couple of conversations with Ryan yesterday about it like it sounds like overall relatively productive conversation although I think Sanders concern lies with as you well know, the fact that she's worried that ", "contextAfter": " that we're proposing.\n[Speaker 6018236838595504557]: And essentially, she gets left carrying the bag on the entire contract because they're willing ing, to commit dollars to fund their portion of the agreement because usage hasn't justified it.\n[Speaker 6018236838595504557]: And so, I think like some of that probably comes from the fact that like she's a little newer to working with fire render and so she hasn't lived through this sort of the history that you have.\n[Speaker 6018236838595504557]: But I'm curious from your perspective, did I, before we propose to share a bunch of information that might help alleviate that concern?\n[Speaker 6018236838595504557]: I wanna make sure that like you agree that that's probably where the concern lies at this point?\n[Speaker 3926970623126115238]: To be honest and I would like to ask you not to share it.\n[Speaker 3926970623126115238]: I'm a bit frustrated about our internal setup.\n[Speaker 3926970623126115238]: So we are since 18 months or so in a...", "callTitle": "BioRender/Roche"}]}]}